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Abstract 
Pseudomonas aureofaciens P A 147 -2 can inhibit the in vitro growth of phytopathogenic 
fungi, and suppress Phytophthora rot of asparagus in the glasshouse and in the field. 
Three antifungal defective mutants ofPA147-2 were examined in detail. Two mutants, 
P Al 09 and PA138, were shown to have mutations in global regulator genes. The mutated 
gene in P Al 09 (designated fin 1) has similarity to members of the two-component regulator 
family, while PA138 has an insertion in a gene encoding a putative LysR-type 
transcriptional regulator (designated finR). FinR was found to be required in cis for the 
regulation of an adjacent gene (tinA), and a mutation infinA resulted in a reduction of 
antifungal activity. Protein analysis indicated that FinR and FinT have both positive and 
negative regulatory effects, and the two regulators have common targets for regulation. 
The N-terminal sequence of a protein that is not expressed by finR and finT mutants was not 
similar to any known protein. 
P. aureofaciens mutant P AH26 was shown to have an insertion in pstA. Consistent with 
findings in other organisms, the insertion in pstA conferred defects in high affinity 
phosphate uptake and interfered with regulation of the phosphate regulon. Results suggest 
that the inability ofP AH26 to inhibit fungal growth is not directly related to known 
functions of Pst A. Both P AH26 and PAl 09 are capable of fungal inhibition in phosphate 
excess conditions, implicating FinT in the phosphate-mediated regulation of antifungal 
activity. 
The recA gene ofPAl47-2 was cloned, and a simple system to construct recA deletions was 
developed. Creation of recA mutants using this system will facilitate trans 
complementation experiments. 
A preliminary field trial demonstrated that P. aureofaciens was able to protect asparagus 
from Phytophthora rot, and revealed that a high population ofPAl47-2 was not maintained 
in the field. In vitro experiments indicated that some antifungal-defective mutants have 
increased fitness relative to P Al4 7 -2, and such mutants in laboratory culture conditions can 
outcompete the parental strain. 
Chapter 1 Biological control: Nature versus nature 1 
Chapter 1 
Biological control: Nature versus nature 
1.1 Introduction. 
Biology is about balances. With few conceivable exceptions, organisms evolve alongside 
those with whom they share an environment. Ecosystems are dynamic. The numerous 
species present may interact in a variety of fashions, from parasitism, antagonism, 
symbiosis to apparent altruism. The balance that is struck by these interactions contributes 
to the overall stability of the system, and the underlying state of flux. Disruption to 
ecosystems would be predicted to have serious consequences; one example of this is the 
removal of plant and animal species to make way for agriculture. Alteration of the natural 
equilibrium has left agricultural plants susceptible to a variety of maladies, which require 
control by further human intervention. 
Biocontrol has been defined as the reduction of disease through the agency of one or more 
living organisms other than the host or man (Baker, 1968). In a manner of speaking, 
biological control is an attempt to alter the balance in an artificially created ecosystem 
(agriculture). Because agricultural practices tend to involve mono-culture of crop plants, 
the multiplication of a single pathogen could have dire consequences on the productivity of 
the plants. In a worst case scenario, a single pathogen could reduce an entire crop to 
nothing. The goal ofbiocontrol is to introduce a natural enemy of the pathogen in order to 
reduce its population, thus creating a system with desirable traits. In essence, biocontrol is 
the application of an organism to a system in an attempt to reduce the popUlation of an 
undesirable organism, and ultimately favour the growth of a desirable organism (usually a 
crop plant). Thus, the phrase "nature versus nature" is an apt summation of the concept of 
biological control. 
In this opening chapter it is my intention to review relevant literature pertaining to the role 
of bacteria in biological control, and to examine some examples of successful application. 
Clearly this is a large and active field of research, so an exhaustive review is not 
undertaken. Rather, examples are provided to highlight the progress made in biocontrol 
research in recent years. Given the subject ofthis thesis, the use of a bacterium to control 
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fungal disease, it seems reasonable to limit consideration to the control of soil-borne fungal 
pathogens. Since much current research is devoted to the mechanism of antibiotic 
production by biocontrol organisms, a major feature ofthis review will be the examination 
ofthe genetic basis for antibiotic production and regulation, focusing on five well-known 
examples. Environmental factors influencing biocontrol will be discussed. The 
introduction to the current study will survey the existing knowledge on Pseudomonas 
aureofaciens PA147-2, and outline the objectives of this work. 
1.2 Why biological control? 
Biological control is not a new concept. Successful experiments on the use ofbiocontrol to 
reduce crop diseases have been carried out since the early part of last century (cited in 
Baker, 1987), but its acceptance in agriculture has been slow. This may be due in part to 
the development of disease-resistant crops, but is probably largely the result of the 
tremendous success of chemical control strategies. However, more recent biocontrol 
research has utilised an integrative approach combining the power of molecular biology 
with biochemistry and plant pathology. This has coincided with an increasing realisation of 
the hazards associated with chemical pesticides, and a growing repugnance toward their 
use. Thus, the pursuit ofbiocontrol has been reinvigorated as people have come to 
recognise the potential benefits. 
1.3 Disease suppressive soils. 
Certain soils have a natural ability to prevent the development of disease. These soils are 
considered to be "suppressive", as opposed to "conducive" soils that do not prevent disease. 
While some soils are naturally suppressive, others can develop suppressive characteristics 
over time, particularly when they are consistently used in mono culture (Schroth & 
Hancock, 1982). There are biological and physical factors involved with disease 
suppression by soil, and these are considered below. 
1.3.1 Soil composition and characteristics. 
Numerous properties contribute to the description of a "soil", making soils difficult to 
characterise. They are produced by the weathering of rocks and minerals, and the nature of 
Chapter 1 Biological control: Nature versus nature 3 
these rocks and minerals contributes greatly to soil structure and composition. The 
formation of new minerals (clays) also has an influence on the structure of soil, and this in 
turn influences the composition of the biota in the soil. Biological activities of microbes 
and plants give soil further characteristic properties, and influence the organic content of 
soil. So, in addition to the minerals that originally contributed to the formation of soil, the 
interaction of physical and biological processes has a major impact on the nature of any 
given soil (Berger, 1965; Buckman & Brady, 1969). The complexity and range of soils 
make a proper treatment of the subject impractical here, so structural and physical aspects 
of soil as they relate to biocontrol will receive minor attention. 
An example of the influence of soil structure. 
Stutz et al (1989) investigated the composition of suppressive (MS 1) and conducive (MCI) 
soils from the Morens region in Switzerland. As discussed below, disease suppression can 
sometimes be transferred from a suppressive to a conducive soil, by mixing of the 
suppressive and conducive soils. However, this was not observed with the conducive 
Morens soils. In their examination of this phenomenon, Stutz et al (1989) found that MS1 
was composed mainly ofvermiculitic clay, while MCI was mainly illitic and smectitic. By 
making artificial soils from vermiculite and illite, it was shown that P. jluorescens CHAO 
could contribute to suppression of black root rot oftobacco in the vermiculite but not illite 
clays. Furthermore, the vermiculite clay allowed the bacterium to colonise the tobacco 
roots while colonisation in illite was poor. Thus, the suppressivity of soil could be altered 
by changing minerals, demonstrating that the mineral composition of soils is an important 
consideration in biocontrol (Stutz et aI., 1989). 
Chemical nature of soil. 
The pH of soil has been associated with its ability to suppress disease. However, there is 
no pH optimum at which all diseases are suppressed. Rather, the suppressive pH is likely 
to be related to other factors such as the growth parameters of the pathogen. For example, 
acidifying soil that normally suppressed carnation wilting caused by Fusarium correlated 
with increased carnation wilting, while in another experiment, increasing the pH led to 
increased radish infection in a Rhizoctonia suppressive soil (Liu & Baker, 1980; Scher & 
Baker, 1980). It is difficult to know whether pH is important because of a direct 
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relationship with the pathogen, or whether pH changes alter other soil factors such as the 
range of indigenous organisms, which might outcompete and suppress the pathogen. 
Regardless, pH is clearly important in disease suppression. Another chemical factor that 
may be of importance is salinity (Schroth & Hancock, 1982), but as with pH, the exact 
nature of its influence is difficult to discern. 
1.3.2 Biological factors. 
A number of observations regarding the characteristics of suppressive soils suggested that 
biological factors such as indigenous microbes are at least partly responsible for disease-
controlling ability. For example, a conducive soil can be made suppressive by mixing in a 
small amount of suppressive soil, an observation that seems incompatible with a purely 
physical phenomenon. In addition, suppressive characteristics can be inactivated by heat 
treatment and fumigation, which suggests microbes could be involved in suppression, but 
are killed by the treatments. However, while compelling, the circumstantial nature of these 
observations is insufficient to draw strong conclusions. For this reason, the nature of 
suppression was investigated in a number of soil types. In a study on suppression of 
Gaeumannomyces graminis, eight fluorescent pseudomonads were isolated from 
suppressive soils that, when added to conducive soils, could suppress G. graminis on wheat 
as well as the original suppressive soil (Cook & Rovira, 1976). Two further illustrative 
examples are the studies on Fusarium and Rhizoctonia suppressive soils (Liu & Baker, 
1980; Scher & Baker, 1980). In both of these studies, suppressive soils were shown to have 
populations of organisms that, when transferred to conducive soil, were able to induce 
disease suppression. In the case of Fusarium suppression the organisms in question were 
Pseudomonas spp. When these bacteria were introduced in sterile conducive soil (Fort 
Collins clay loam) and subjected to heat treatment, the population was shown to decline in 
a way that correlated with reduced ability of the original soil to suppress disease (Scher & 
Balcer, 1980). The Rhizoctonia suppressive soil was found to contain the fungus 
Trichoderma, which alone was shown to be capable of transferring suppressiveness to 
conducive soil (Liu & Balcer, 1980). 
Studies such as those described above indicate the importance of bacteria in suppression of 
diseases, but offer no realistic approach to the application of the findings. Furthermore, 
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only a limited understanding of mechanism has been gained from such investigations. 
Given that bacteria are associated with suppression in the aforementioned experiments, 
considerable effort has been made to isolate and characterise specific antagonists with 
respect to their potential for biocontroL These efforts allowed experiments in biocontrol to 
be conducted, revealing a number of important traits that contribute to effective biocontroL 
1.4 Bacteria in biocontrol. 
As an initial screen for biocontrol candidates, large numbers of soil microbes have been 
isolated and screened for in vitro inhibition of pathogens. There has been considerable 
debate regarding the value of such screening given that a number of studies failed to find a 
correlation between in vitro inhibition and in situ disease suppression. However, some 
studies have successfully used in vitro screening to identify strains that show activity in 
vitro and in vivo (reviewed in Fravel, 1988). A number of strains have been isolated and 
characterised that show strong activity in vitro and in situ. 
Bacteria representing several genera have been demonstrated to have the potential to 
control fungal or bacterial diseases. Among these are Agrobacterium, Bacillus, 
Enterobacter, Erwinia, and Streptomyces (Hadar et aI., 1983; Keams & Mahanty, 1998; 
Rothrock & Gottlieb, 1984; Ryder et aI., 1999; Weller, 1988). Of increasing importance 
for biocontrol of soilborne pathogenic fungi are the fluorescent pseudomonads, which have 
shown great promise (Weller, 1988). A number have been isolated and examined in detail, 
in terms of their ability to control disease, and the mechanisms by which they act. 
1.4.1 Experiments in biocontrol. 
Given the lack of correlation between in vitro assays and disease suppression, it is 
important to demonstrate that the organisms in question have potential for use beyond 
laboratory-based studies. This is initially achieved using glasshouse and field trials. Such 
investigations have been carried out as a means to assess the potential of bacterial isolates 
for control, and also to establish whether host plants of differing disease susceptibility 
contribute to variability in biocontrol (King & Parke, 1993; Rankin & Paulitz, 1994; Ryder 
& Rovira, 1993). 
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1.4.2 Pseudomonas spp. as biocontrol agents. 
Fluorescent Pseudomonas spp. are abundant in nature. Perhaps this is why they are so 
often isolated in the search for biocontrol agents. Many fluorescent pseudomonads have 
proved their worth in biocontrol by suppressing disease symptoms and enhancing crop 
productivity, and useful candidates are still being found (Ross et aI., 2000). Coupled with 
the appeal of the variety of secondary metabolites they produce, many are vigourous 
colonisers of the rhizosphere, which is a desirable trait in the suppression of root disease. 
The observations of plant growth stimulation and root colonisation have led to a number of 
Pseudomonas spp. being grouped among the so-called "plant growth promoting 
rhizobacteria" (PGPR) (Weller, 1988). Experiments demonstrating the in situ efficacy of 
Pseudomonas spp. isolates in biocontrol are numerous. Examples of their successful 
application include the suppression of Pythium ultimum and Rhizoctonia on cotton 
seedlings, suppression of Fusarium wilt on radish by seed treatment, suppression of 
tobacco root rot, and enhanced yields of sugar beet (Howell & Stipanovic, 1979; Howell & 
Stipanovic, 1980; Keel et aI., 1989; Leeman et aI., 1995b; Suslow & Schroth, 1982). While 
these studies provide clear evidence for the potential application ofbiocontrol, they do not 
adequately examine the mechanism of control. The long-standing question of whether 
biocontrol efficacy can be explained by nutrient competition, antibiosis, induction of 
systemic resistance in the plant, or a combination of effects remains unanswered. 
1.5 Mechanisms involved in biocontrol. 
The ability of certain strains to act as biocontrol agents is probably a consequence of 
evolutionary adaptations that allow the organism to maintain its existence in complex and 
difficult environments. For this reason, it seems likely that the organisms that provide the 
best biocontrol would use a number of strategies to maximise their survival in competitive 
environments. Among these strategies are traits that have come to be viewed as important 
for the successful utilisation of organisms for biocontrol. 
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1.5.1 Competition for nutrients. 
Fungal pathogens need nutrients for gennination of spores and subsequent invasion of the 
host. Clearly, one mechanism that could contribute to biocontrol would be to limit the 
availability of such nutrients (Baker, 1968). Establishing large populations of bacteria on 
roots (before planting or from seed coating) would effectively reduce the nutrients available 
to other organisms such as pathogens. Pathogens might also be excluded from preferred 
sites of attack, which are present where root exudates are abundant, by a pre-existing 
bacterial population (Weller, 1988). It is believed that the versatility of pseudo monads 
make them ideal for competitive exclusion (Weller, 1988). Baker (1968) reviewed 
literature that suggests competition for carbon, nitrogen, and vitamins all have a role in 
pathogen suppression. One further example that has been thoroughly investigated is 
competition for iron, mediated by siderophore compounds. 
Siderophore production. 
Siderophores are microbial iron(III)-transport agents (Leong, 1986), and have been defined 
as "a low-molecular-weight (500-1000 daltons) virtually ferric-specific legand (sic), the 
biosynthesis of which is carefully regulated by iron and the function of which is to supply 
iron to the cell" (Neilands, 1981). This definition is sufficiently broad to accommodate a 
range of structures, while being specific in its functional requirements. A large number of 
microbes produce siderophores of some kind in response to low levels of extracellular iron. 
This is because although iron is an abundant element, it is generally found in the Fe3+ 
(ferric) state, which is largely insoluble in water, and thus inaccessible as a nutrient. At 
pH7, ferric iron is soluble in water at about 1 0-17M, however microbes require 
concentrations around 1O-6M for growth (Leong, 1986; O'Sullivan & O'Gara, 1992). To 
circumvent the problem of iron availability, microbes manufacture and secrete siderophores 
to mediate high affinity iron transport. Uptake of the ferric-siderophore complex is via a 
siderophore-specific receptor, and the iron is likely to be released from the complex by 
reduction, since siderophores have a low affinity for Fe2+ (Leong, 1986). Soil 
pseudomonads often produce fluorescent siderophore compounds, which are classified as 
either pyoverdins or pseudobactins (O'Sullivan & O'Gara, 1992). 
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What role do siderophores play in biocontrol? The most obvious suggestion would be that 
by sequestering available ferric iron, siderophores make the ferric iron unavailable to all but 
the siderophore producer. Because of the specific nature of siderophore uptake, it is 
generally the case that only the producing organism can benefit. Experimental evidence 
comes from the isolation of the siderophore pseudobactin from Pseudomonas sp. BlO. It 
was demonstrated that the pseudobactin from B 1 0 was able to reduce fungal populations on 
the rhizoplane of potato much like the producing organism did, and enhance plant growth. 
This growth enhancement was not apparent when ferric-siderophore was applied, indicating 
the iron sequestering ability ofthe pseudobactin as the mechanism (Kloepper et aI., 1980a). 
In disease control trials, addition of the pseudobactin to conducive soils was correlated with 
induced suppression of take-all of wheat and Fusarium wilt of flax (Kloepper et aI., 1980b). 
Although some siderophores are potent antibiotics (Neilands, 1981), evidence of this nature 
would appear to eliminate an antibiotic effect since the only variable was the iron 
concentration. As long as completely_pure siderophore is used, this kind of experiment has 
the potential to go beyond simply implicating siderophores in biocontrol, and generate data 
that could reveal a mechanism for the contribution siderophores make to biocontrol. 
An alternative experimental approach, the use of siderophore-defective mutants, has 
yielded varied results. Although such experiments cannot specify a role for the 
siderophore, experiments with mutants are a powerful tool for testing the involvement of 
siderophores in biocontro1. For example, Paulitz and Loper (1991) generated pyoverdine 
(Pvd) mutants of P. putida, and demonstrated that these strains could suppress Pythium 
damping-off of cucumber as well as the wildtype, indicating no role for Pvd. The fact that 
the mutants were non-fluorescent suggested that the strain of P. putida did not produce 
additional fluorescent siderophore compounds (paulitz & Loper, 1991). In contrast, 
fluorescent siderophores were shown to be important in the control of Pythium ultimum by 
a P. fluorescens strain. Mutants that no longer produced siderophore were less able to 
protect cotton from pre-emergence damping-off than the wildtype, although it is interesting 
to note that the mutants were more protective than untreated controls (Loper, 1988). This 
result suggests a significant contribution by a siderophore, and some additional control 
from an unidentified factor. Further experiments that utilise antibiotic defective, 
siderophore-producing strains derived from disease suppressing wildtypes, have also been 
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conducted. An example of this approach is the analysis of the role siderophores play in 
disease suppression by P. jluorescens 2-79, which is known to produce the antibiotic 
phenazine-l-carboxylic acid (PCA). PCA has previously been implicated in biocontrol 
processes using strain 2-79 (Thomashow & Weller, 1988), so the role of siderophores was 
assessed by comparing the ability of siderophore mutants, PCA mutants, and 
siderophore/PCA double mutants to suppress G. graminis var. tritid (Hamdan et aI., 1991). 
In both PCA plus and minus backgrounds, the ability of2-79 to produce fluorescent 
siderophores had little influence on disease suppression. The work outlined above, 
although not exhaustive, suggests the conclusion that siderophores can be, but are not 
always, important in biocontroI. One problem with assessing the role of siderophore-
mediated iron binding mechanisms is that other mechanisms for iron binding are not 
excluded. Given the inhibitory nature of some siderophores, it is possible that their 
contribution is varied, depending on the specific compound involved. In mechanistic 
telms, the contribution of siderophores to biocontrol probably falls into place somewhere 
between rhizosphere competence and antibiosis. 
1.5.2 Induced systemic resistance. 
In addition to direct interactions with pathogens, some evidence exists suggesting that 
PGPR can indirectly cause suppression of fungal pathogens by inducing resistance in the 
host plant. Two examples ofthis have demonstrated suppression of foliar pathogens by 
PGPR (van Peer et aI., 1991; Wei et aI., 1991). In both examples, the use of foliar 
pathogens enabled an assessment of induced resistance without the complicating factor of 
direct interaction between pathogen and control agent. The PGPR could not be isolated at 
the sites of pathogen infection, suggesting that suppression was mediated by host plant 
resistance. Since resistance was increased when plant roots were already populated by 
PGPRs, the observed resistance was concluded to result from PGPR-induced resistance. It 
is important to note that not all disease suppressing PGPR can induce systemic resistance. 
Of94 strains tested by Wei et al (1991), only six appeared to induce resistance, although all 
94 were thought to be capable of suppressing P. ultimum or R. solani, or promoting 
seedling emergence (Wei et aI., 1991). The situation with respect to root pathogens is 
somewhat more complex. Since it is difficult to physically separate pathogen and 
biocontrol agent, interactions and other suppression mechanisms may interfere with 
assessment of induced resistance. Nonetheless, induced resistance to black root rot of 
tobacco has been suggested to be a contributing factor in the ability of P. fluorescens CHAO 
to control the disease. In his review on biocontrol, Weller (1988) suggests that HCN can 
induce resistance to black root rot caused by Thielaviopsis basi cola. HCN production has 
been shown to contribute to suppression of black root rot by P. fluorescens CHAO by 
experiments in which a HCN mutant was less suppressive than the wildtype, and transfer of 
HCN production genes to a nonnally non-suppressing strain conferred the ability to control 
the disease (Voisard et al, 1989). In another set of experiments, the induction of systemic 
resistance to Fusarium wilt was found to be promoted by the 0 antigen side chain of P. 
fluorescens LPS (Leeman et al, 1995a). Using bioassays in rockwool growth cubes, 
Leeman et al (1995) were able to physically separate root pathogen and biocontrol agent. 
By using 0 antigen mutants and cell wall extracts from those mutants and the wildtype, the 
contribution of 0 antigen to Fusarium wilt resistance was examined. The wildtype strain 
and its purified LPS were able to suppress Fusarium wilt whereas the 0 antigen mutants 
and purified LPS from those mutants could not suppress the disease (Leeman et al, 1995a). 
Although these experiments cannot definitively eliminate other mechanisms, they provide 
compelling evidence to suggest that induced resistance can contribute to biocontrol in some 
cases. 
1.5.3 Rhizosphere colonisation. 
Successful colonisation of the root environment is critical to the biocontrol of root 
pathogens, since it is in the vicinity of the root that the pathogens operate (O'Sullivan & 
O'Gara, 1992). There are a number of factors that influence the ability of bacteria to 
successfully colonise the rhizosphere. These include features of the soil as well as 
important bacterial traits. As outlined previously, soil properties include pH, structural 
features (e.g. clay versus sandy), temperature, and mineral content, but experimentation to 
distinguish between these has been difficult (O'Sullivan & O'Gara, 1992). The presence of 
biological entities such as bacteriophage and protozoa can also influence colonisation, by 
killing the biocontrol organism, although at least one study suggests predation by protozoa 
is not a factor in rhizosphere competence (Jjemba & Alexander, 1999; Stephens et aI., 
1987). The colonisation strategies that bacteria have evolved are somewhat simpler to 
study, although an in vivo assay system is still required. 
Cell surface polysaccharides, osmotolerance, pili, and flagella have all been implicated as 
important for successful root colonisation (Weller, 1988). Exopolysaccharide (EPS) could 
aid in bacterial adherence, since it binds cells together and may help reduce the likelihood 
of being displaced by indigenous microbes. Pili are thought to allow attachment, while 
flagella allow bacteria to actively move to desirable locations. This mechanism may work 
along with chemotaxis. If there is sufficient soil moisture, chemotaxis and motility would 
allow bacteria to move toward root exudates (Weller, 1988), while the contribution flagella 
could make in low moisture environments would be minimal. Although flagella-mediated 
motility has been implicated as important in some studies (de Weger et a1., 1987; Schippers 
et al., 1987), other studies are contradictory (Bowers & Parke, 1993; Howie et al., 1987; 
Scher et al., 1988). Recently, molecular studies on in vitro biofilm formation by 
Pseudomonas spp. have implicated pili and flagella in this process (OlToole & Kolter, 
1998a; Q1Toole & Kolter, 1998b). In a recent review, it is suggested that rhizosphere 
colonisation might be an example ofbiofilm fOlIDation (Davey & UToole, 2000). If 
indeed this proves to be the case, the use of in vitro biofilm mutants may give further 
insight into the role of flagella, pili and chemotaxis. 
A P. putida isolate that has plant growth-promoting properties and disease suppression 
capabilities (Fusarium wilt of cucumber) was shown to interact with agglutinin, a plant 
protein that causes agglutination ofthe bacterium (Anderson, 1983). Agglutination 
appeared to playa role in colonisation, and mutants that could not be agglutinated were less 
able to colonise (Anderson et al., 1988). Interestingly, those mutants were also reduced in 
their ability to suppress disease and enhance plant growth (Tari & Anderson, 1988). These 
results show that agglutination can be an important factor in colonisation, and also correlate 
colonisation with biocontrol. However, the role agglutination plays in long term 
colonisation is less certain, and Glandorf et al (1994) concluded that agglutination may be 
important in short telID colonisation, but their evidence did not support a decisive role in 
root colonisation for all Pseudomonas spp. (Glandorf et al., 1994). 
In a recent study, the role of superoxide dismutase activity has been assessed in relation to 
rhizosphere colonisation (Kim et a1., 2000). In that study, P. putida mutants were made 
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with mutations in either sodA (encodes manganese-superoxide dismutase), sodB (encodes 
iron-superoxide dismutase), or both sodA and sodB. These mutants were assessed for their 
ability to colonise the rhizosphere of bean plants, alone and in competition with the parental 
strain. Both the sodA and the so dB mutants were able to colonise as well as the wildtype, 
while the sodAlsodB mutant was impaired. In competition, the sodA mutant was 
sufficiently competitive to remain at a similar population to the wildtype, while the sodB 
mutant and the double mutant were out-competed by the wildtype. Two possibilities were 
offered as explanations. Firstly, the active metabolism at growing root tips could lead to 
high levels of reactive oxygen species to which sod mutants are sensitive. The alternative 
explanation was that increased O2- generation in the mutants could inhibit metabolic 
pathways, reducing the ability of the sod strains to metabolise available nutrients (Kim et 
aI., 2(00). Clearly this study is intriguing, but the significance in broad terms will be 
established when comparative studies with other PGPR are carried out. 
In an innovative study ofrhizosphere colonisation by P. fluorescens SBW25, Rainey 
(1999) used in vivo expression technology to trap promoters that were specifically induced 
in the rhizosphere environment. Rainey demonstrated that at least 20 genes were 
specifically induced in the rhizosphere, and suggested that these genes were important for 
successful colonisation (Rainey, 1999). Clearly, rhizosphere colonisation is a multifactorial 
process, and the current understanding of the process is incomplete. 
1.5.4. Antibiotics involved in biocontrol. 
Despite the numerous different bacterial strains that have been shown to have biocontrol 
potential, it seems there may be comparatively few antibiotics that are of importance in the 
suppression of fungal diseases. Among the well studied Pseudomonas spp., there is a 
recurring theme of disease control by the same small group of compounds. In addition to 
the contribution to disease control, these compounds have been studied for their role in 
ecological fitness, and molecular studies have uncovered the genes required for production 
and regulation of these compounds. The current understanding of the most well-
characterised of these antimicrobial metabolites, phenazines, 2, 4-diacetylphloroglucinol, 
pyoluteorin, pyrrolnitrin and HCN is outlined below. 
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PHENAZINES. 
Phenazine (Phz) antibiotics are produced by a number of fluorescent pseudomonads, and 
are derived from chorismate. There are over 50 different phenazine compounds known to 
occur in nature, and some organisms simultaneously produce multiple phenazines (Turner 
& Messenger, 1986). These molecules have broad activity against bacteria and fungi, and 
it is possible that DNA intercalating activity and/or oxidative activity ofphenazines 
contribute to the broad spectrum of activity (Turner & Messenger, 1986). 
Role in disease suppression. 
The contribution of phenazine antibiotics to biocontrol of root diseases is well established. 
In experiments with P. jluorescens 2-79, comparisons of disease control provided by the 
wildtype and Phz mutants revealed that Phz mutants were deficient in suppression of take-
all of wheat. The control could be restored by complementation of the mutation, supporting 
the importance ofPhz biosynthesis in biocontrol (Thomashow & Weller, 1988). Further 
investigations with strain 2-79 showed that the presence of this strain resulted in few G. 
graminis var. tritid lesions on wheat roots, while Phz mutants could not prevent lesion 
formation (Bull et aI., 1991). To more directly address the issue ofPhz production and its 
correlation with disease control, Thomashow et al (1990) recovered the antibiotic from the 
roots of plants that grew from seeds treated with the Phz producers P. jluorescens 2-79 or 
P. aureofadens 30-84. No antibiotic could be recovered from plants that were grown from 
seeds treated with Phz mutants, and the recovery of antibiotic correlated with lower levels 
oftake-all (Thomashow et aI., 1990). In an inventive approach to address the role ofPhz in 
disease suppression, Mazzola et al (1995) examined the Phz sensitivity of various G. 
graminis strains and found Phz resistant varieties of G. graminis. Interestingly, Phz-
producing strains were able to suppress disease caused by G. graminis strains that were 
sensitive to Phz in vitro, but these strains could not control disease caused by Phz-resistant 
G. graminis (Mazzola et aI., 1995). This study revealed a useful correlation between Phz 
sensitivity in vitro and the control by Phz producing pseudomonads in situ. 
Ecological role. 
In addition to its usefulness in combating fungal diseases, examination ofPhz production 
by the strains 2-79 and 30-84 has demonstrated a more fundamental role for the antibiotic. 
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It seems that the ability to produce Phz improves the rhizosphere competence of these 
bacteria. ill long term studies, Phz-producing 2-79 and 30-84 survived better than Phz 
mutants in both bulk soil and rhizosphere environments. When tested in pasteurised soil, 
the antibiotic mutants were better able to maintain their population size. These results 
suggested that Phz production was important for survival in the presence of indigenous 
micro flora, probably because the antimicrobial properties ofPhz allow producing 
organisms to kill their competitors. Additionally, Phz seemed to be more important for 
survival on healthy roots than diseased, possibly due to the fact that take-all lesions lead to 
nutrient leakage from the plants, which allows the rhizosphere to sustain higher populations 
(Mazzola et aI., 1992). Since biocontrol strains such as P. aureofaciens 30-84 interact with 
the target fungus on the rhizoplane (Pierson & Pierson, 1996), it is probably not surprising 
that the relative nutrient levels on the root surface are important factors for microbial 
competition in the rhizosphere. The experiments above indicate that the ability to produce 
Phz gives producing strains an advantage in a highly competitive environment. 
Molecular biology of phenazine production. 
Recently, the genes required for Phz production in 2-79 have been described (Mavrodi et 
aI., 1998). Using transposon mutagenesis, the region of DNA required for Phz production 
was found to span approximately 6kb, and transcription in this region was shown to 
proceed in a single direction. Analysis of DNA sequence revealed the presence of seven 
open reading frames, phzABCDEFG. The construction of chromosomal mutants of phzC, 
D, E, and G demonstrated that these genes were essential for Phz production. Expression 
of the entire gene cluster in coli resulted in peA (Phenazine-l-carboxylic acid) 
production, whereas expression of phzCD EFG led to low levels of peA plus a mixture of 
heterocyclic, nitrogen containing compounds. On the basis of DNA sequence similarity, 
functions for some gene products were predicted. The products of genes phzCDEFG are 
involved in the synthesis of phenazine-l ,6-dicarboxylic acid (the precursor to peA) from 
chorismate (Figure 1.1). While no DNA sequences submitted to various nucleotide 
databases yet match phzA or phzB, the observations made regarding peA production in E. 
coli led to the tentative suggestion that the respective products might stabilise a 
multi enzyme complex for peA production, increasing efficiency and specificity. Finally, 
the high degree of similarity between the gene cluster in 2-79 and 
that of 30-84 suggested that the seven gene cluster is required for PCA production, and 
other genes encoded proteins that are involved with modifying PCA to produce the variety 
ofPhz derivatives seen in some organisms (Mavrodi et aI., 1998). This suggestion was 
supported in a subsequent report. Delaneyet al (2001) identified a gene called phzO 
downstream of the phz cluster in 30-84, and demonstrated that its product was required for 
the conversion of PCA to 2-hydroxyphenazine-1-carboxylic acid. In the same report, it is 
also suggested that the product of a gene called phzH in P. chloraphis converted PCA to 
phenazine-1-carboxamide (Delaney et aI., 2001). 
f)lnirlQ(jfJOxyis()~ 
c/loris/tlic acid ("DIG) 
3·\1ydroxy· 
onthronilii; acid 
Figure 1.1. Proposed biosynthetic pathway fQY phenazine-l-carboxylic acid. Possible roles for PhzD, PhzE, 
PbzF, and PbzG are indicated. This figure was reproduced from Mavrodi et al (1998). 
Regulation of phenazine biosynthesis. 
In addition to biosynthetic genes, the phz locus also encodes the genes phzR and phzI, 
which are required for cell density-dependent regulation of PC A synthesis inP. 
aureofaciens 30-84 (Pierson et aI., 1994; Wood & Pierson, 1996). The phzR gene was 
identified by screening cosmids for the ability to enhance expression of a phzB: :lacZ fusion 
(Pierson et aI., 1994), while phzlwas found by DNA sequencing adjacent to phzR (Wood & 
Pierson, 1996). The phzRlI system positively regulates PCA expression, due to 
accumulation of a diffusible N-acyl-homoserine lactone molecule synthesised by PhzI, and 
subsequent activation ofPhzR, which in turn leads to increased expression of phz genes 
(Pierson & Pierson, 1996). 
2, 4-DIACETYLPHLOROGLUCINOL. 
The antibiotic 2, 4-diacetylphloroglucinol (PhI) is produced via polyketide biosynthesis by 
a number of plant-associated Pseudomonas spp. (Bender et aI., 1999). Strains that produce 
Phi have been shown to occur in a number of soils that suppress take-all of wheat 
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(Raaijmakers et aI., 1997), and the biosynthetic locus for PhI production appears to be 
conserved among diverse Phi-producing pseudomonads (Keel et al., 1996). 
Role in biocontrol. 
The importance of PhI production for biocontrol of black root rot of tobacco has been 
established (Keel et al., 1990). A PhI-defective mutant of P.jluorescens CHAO was shown 
to be significantly less able to suppress black root rot of tobacco than either the wildtype 
strain or an in trans-complemented PhI mutant. Additional indirect evidence for the role of 
Phi in biocontrol comes from a study by Raaijmakers et al (1997), in which a correlation 
emerged between soils suppressive to talce-all of wheat, and PhI-producing bacteria. Of 
seven soils examined, the three suppressive soils harboured Phi-producing populations of 
between 5.1x105 and 1.6x106 cfufg of root, while PhI-producers in the conducive soils were 
either undetectable or present at 40-fold lower numbers (Raaijmakers et al., 1997). While 
not formally showing the importance 6fPhl production in the suppressive soils, this 
correlation certainly adds support to the suggestion that PhI is important for biocontrol. 
The argument is further strengthened by the use of HPLC to demonstrate that PhI was 
produced on the roots of wheat grown in the suppressive soils, but could not be detected on 
wheat roots from conducive soils (Raaijmakers et aI., 1999). It is important to note that 
although the presence of PhI-producing bacteria and PhI on roots correlates with 
suppression of disease, differences in soil composition could also have an influence on 
disease suppression. 
Molecular biology of PhI production. 
Two recent reports describe the molecular characterisation of the biosynthetic region for 
PhI. The initial work demonstrated that a 6.5kb region from P. jluorescens Q2-87 could 
confer PhI production upon normally non-producing Pseudomonas species, and 
mutagenesis ofthe region defined a 5kb sequence with two divergent transcriptional units 
(Bangera & Thomashow, 1996). Subsequently, a cluster of six genes for PhI biosynthesis 
was identified within the 6.5kb clone from Q2-87. These genes were designated 
phlACBDEF (Bangera & Thomashow, 1999). The DNA sequence analysis shows that 
phlACBDE are oriented in the opposite direction to phlF, as predicted in the earlier study 
by Bangera and Thomashow (1996). Bangera and Thomashow (1999) carried out 
functional studies that suggested that PhlD was essential for the production ofMAPG 
(monoacetylphloroglucinol, the precursor to 2,4-diacetylphloroglucinol), possibly by 
condensation of two acetoacetyl-CoA molecules, producing an eight-carbon polyketide, 
followed by a cyclisation reaction, yielding MAPG. These putative functions are supported 
by the sequence similarity ofPhlD to CHS/STS genes from plants, which are homodimeric 
proteins capable of catalysis of condensation reactions and subsequent cyclisation in 
polyketide synthesis. The gene products PhlA, PhlB, and PhlC were suggested to function 
together, since mutations in any have the same phenotypic consequences. They are 
necessary for conversion ofMAPG to 2, 4-DAPG, but also seem to be required for MAPG 
synthesis (Figure 1.2). In addition to the biosynthetic genes, a putative transport protein 
(PhlE) was identified, its gene located upstream of phlACBD, and a regulator gene (phlF) 
was found upstream of the other genes, encoded in a divergent direction. 
$·CoA HlC 
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Figure 1.2. Biosynthetic scheme for 2,4-diacetylphloroglucinot Possible roles for PhlA, PhlB, PhlC, and 
PhlD are shown. This figure was taken from Bangera and Thornashow (1999). 
Regulation of PhI synthesis. 
When the genes for PhI were identified, it was suggested that the gene phlF encoded a 
repressor protein, based upon a number of observations. Firstly, a clone ofthe PhI gene 
cluster lacking an intact phlF can confer PhI production upon normally non-producing 
Pseudomonas strains, but a larger clone which included phlF was unable to confer the 
ability to synthesise PhI (Bangera & Thomashow, 1996). In addition, PhI production is 
enhanced in P. jluorescens strains harbouring a chromosomal copy of phlACBDE, with a 
truncated phlF (Bangera & Thomashow, 1999). Thirdly, sequence similarity with other 
repressors, and the presence of a helix-turn-helix motif in the predicted translation product, 
is consistent with the identification ofPhlF as a DNA-binding regulator protein (Bangera & 
Thomashow, 1999). The ph IF gene has also been found in P. jluorescens F113 by Delany 
et al (2000), and its role as a repressor has been further substantiated by three observations 
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from that study. Firstly, purified PhlF was shown to bind specifically to the inter genic 
region between ph IF and phlA (these genes are divergently transcribed). Secondly, over-
expression of PhlF in FIB resulted in a greater than 90% reduction in PhI production. 
Finally, a phlF mutation in F113 led to significant increases in PhI synthesis. In contrast to 
the impact of phlF mutation and PhlF over-expression on PhI production, production of 
other secondary metabolites by FIB was unaffected, strongly supporting PhlF as a specific 
regulator of PhI (Delany et aI., 2000). In P. fluorescens CHAO, phlA was shown to be 
autoinduced by PhI, and repressed by other secondary metabolites including pyoluteorin, 
and PhlF was concluded to mediate both processes (Schnider-Keel et aI., 2000) 
PYOLUTEORIN. 
Pyoluteorin is a polyketide antibiotic composed of a resorcinol ring linked to a 
bichlorinated pyrrole, and is inhibitory toward bacteria and fungi (Bender et aI., 1999). 
Role in biocontrol. 
P. fluorescens Pf-5 was analysed during an investigation into the biocontrol of P. ultimum 
damping-off disease on cotton seedlings. It was known that Pf-5 produced pyrrolnitrin, but 
this antibiotic was not inhibitory to P. ultimum. However, Pf-5 could still inhibit P. 
ultimum growth in vitro, suggesting production of a second antibiotic. This was 
subsequently shown to be pyoluteorin. In the course of their study, Howell and Stipanovic 
(1980) showed that treating cotton seeds with Pf-5 or purified pyoluteorin led to improved 
survival in P. ultimum-infested soil, indicating a role for pyoluteorin in disease suppression 
(Howell & Stipanovic, 1980). Contrary to this observation, Kraus and Loper (1992) 
showed little correlation between the ability ofPf-5 to produce pyoluteorin and the 
suppression of pre-emergence damping off in cucumber (caused by P. ultimum). Mutants 
defective in pyoluteorin biosynthesis were not significantly worse than the wildtype strain 
at protecting the cucumbers (Kraus & Loper, 1992). Thus, the role ofpyoluteorin in 
biocontrol has not been unequivocally demonstrated, and the possibility that different host 
and pathogen systems might respond to pyoluteorin production must be considered. 
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Molecular biology of pyoluteorin synthesis. 
A number of studies have led to a working model for pyoluteorin biosynthesis. The 
genomic region ofPf-5 that encodes pyoluteorin was first identified by mutagenesis, and 
subsequently isolated by Kraus and Loper (Kraus & Loper, 1992; Kraus & Loper, 1995). 
In their 1995 study, Kraus and Loper demonstrated that mutations causing a pyoluteorin-
defective phenotype spanned nearly 21kb. Using fusions to the promoterless ice nucleation 
gene (inaZ) it was shown that the genes within the pyoluteorin region were likely to be 
transcribed in a single direction from at least two promoters (Kraus & Loper, 1995). 
Further investigations revealed that there were ten open reading frames within the 
pyoluteorin biosynthetic region (Nowak-Thompson et a1., 1999), and that the largest two of 
these (PltB and plte) appear to encode proteins with sequence and organisational similarity 
to type I polyketide synthases (PKSs) (Nowak-Thompson et aI., 1997). Nowak-Thompson 
et al (1997) proposed that the putative PKSs could synthesise the resorcinol moiety that 
constitutes part ofpyoluteorin. A pathway based upon the ten ORFs that make up the 
pyoluteorin cluster has been proposed (Bender et a1., 1999), and is outlined briefly here (see 
Figure 1.3). The polyketide synthases PltB and PltC use an activated precursor in the 
synthesis of the resorcinol ring. Such a precursor is likely to be proline, which could be 
activated by PItF (a putative acyl-CoA-synthetase), since starter units are often activated as 
acyl-CoA derivatives. PItG is proposed to be responsible for terminating the assembly of 
the polyketide because it has similarity to thioesterases. Synthesis ofthe pyrrole ring is 
thought to be carried out by PltE, a putative acyl-CoA dehydrogenase. The proteins PItA, 
PltD, and PltM all have similarity to halogenases, so are proposed to be involved in the 
chlorination of the pyrrole ring (Bender et a1., 1999). PltL has no lmown function, and PltR 
is a LysR-type transcriptional regulator (Nowak-Thompson et al., 1999). 
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Figure 1.3. Model for biosynthesis ofpyoluteorin. Two alternative variations are shown, and the possible 
roles for the proteins PIt, PItA, PltB, PltC, PltE, PltF, PItG, and PltM are suggested. This scheme was taken 
from Nowak-Thompson et al (1999). 
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Regulation of pyoluteorin biosynthesis. 
In the study ofthe pyoluteorin biosynthetic cluster, the gene pltR was sequenced and found 
to encode a LysR-type transcriptional regulator. Mutational studies demonstrated that PltR 
was necessary for pyoluteorin production. Transcriptional fusion studies showed that PltR 
was required for the expression of pyoluteorin biosynthetic genes pltB, pltE, and pltF, 
suggesting a specific role for PltR in the regulation ofpyoluteorin biosynthesis (Nowak-
Thompson et aL, 1999). 
PYRROLNITRlN . 
Pyrrolnitrin is an antifungal metabolite produced by a number of Pseudomonas spp, and 
tryptophan is the precursor for its synthesis (Kirner et al., 1998). In addition to 
Pseudomonas spp, an Enterobacter agglomerans strain has also been shown to produce 
pyrrolnitrin, and purified pyrrolnitrin from this strain exhibited broad spectrum antifungal 
and antibacterial activity (Chernin et al., 1996). 
Role in biocontrol. 
As with the other antibiotics detailed above, experiments have revealed that pyrrolnitrin is 
important in the biocontrol activity of producing strains. In a study analogous to early 
investigations into pyoluteorin, it was shown that treatment of cotton seeds with a P. 
fluorescens isolate, or the pyrrolnitrin it produced, resulted in increased protection of cotton 
seedlings from R. solani (Howell & Stipanovic, 1979). An investigation into suppression 
of Fusarium sambucinum dry rot suggested a correlation between suppression by P. 
cepacia B37w and pyrrolnitrin production (Burkhead et al., 1994). The strength of this 
study was that pyrrolnitrin could be isolated from the site of fungal infection, indicating the 
biocontrol agent produced the compound in situ. However, although not detected, 
production of other antifungal compounds was not ruled out. A more conclusive 
investigation was carried out by Hill et al (1994). Mutants of P. fluorescens BL915 unable 
to produce pyrrolnitrin had a concomitant loss ofbiocontrol efficacy. Furthermore, a 
genetic locus isolated from wildtype BL915 was able to confer pyrrolnitrin production and 
disease suppression upon normally non-producing P. fluorescens strains (Hill et a1., 1994). 
In contrast, a study using pyrrolnitrin mutants of P. cepacia J82 failed to find a correlation 
between antibiotic production and disease suppression (McLoughlin et al., 1992). In their 
experiments on sunflower wilt fungus (Sclerotinia sclerotiorum), McLoughlin et al showed 
that pyrrolnitrin-defective mutants suppressed disease as effectively as the wildtype. Thus, 
it may be that disease suppression by pyrrolnitrin production is system- or environment-
specific, and therefore not effective in every situation. 
Molecular biology of pyrrolnitrin biosynthesis. 
Using mutants of P. fluorescens BL915, Hill et al (1994) was able to isolate a genomic 
region that could not only restore pyrrolnitrin production to the mutants, but was capable of 
confening pynolnitrin production upon other P. fluorescens strains (BL914 and BL922). 
These results indicated that the genomic clone was genetically sufficient for pyrrolnitrin 
production, and subcloning suggested that the required genes were found within a 4.5kb 
region (Hill et aI., 1994). However, subsequent analysis revealed that the BL915 fragment 
encoded the global regulator GacA, and the heterologous hosts were genetically capable of 
pyrrolnitrin biosynthesis, but lacked the required positive regulator. 1n order to isolate 
biosynthetic genes, Hammer et al (1997) took advantage ofBL914. Genes in BL914 that 
required GacA for expression were identified by using a transposon with a promoterless 
lacZYas a promoter-probe. Fusions to lacZY that were activated upon introduction of 
gacAIS were studied further, since these represented mutants with insertions in GacA-
dependent genes. One such mutant could not produce pyrrolnitrin, but did produce other 
GacA regulated products. The genomic region flanking the transposon insertion was used 
as a probe to isolate a cosmid with the wildtype sequence from BL915. Mutagenesis was 
used to show that the genes for pyrrolnitrin were located within a 6.2kb region, and DNA 
sequencing identified four open reading frames (prnABCD), probably transcribed as one 
unit. A clone ofthese four genes under control ofthe tac promoter could confer 
pyrrolnitrin production upon E. coli, supporting the suggestion that the four genes encode 
the requirements for pyrrolnitrin biosynthesis (Hammer et aI., 1997). The functions ofthe 
products of each gene were elucidated using deletion mutants of each, and examination of 
the intermediate products that accumulated (Kirner et aI., 1998) (see Figure 1.4). PmA 
converts tryptophan to 7-chlorotryptophan, which is then used by PmB to synthesise 
monodechloroaminopyrrolnitrin (MDA). MDA is converted to aminopyrrolnitrin (APRN) 
by PmC, and finally PrnD oxidises the amino group of APRN to a nitro group, thus 
completing the production ofpyrrolnitrin (Kirner et aI., 1998). Comparison with other 
pyrrolnitrin-producing strains indicated that there is a high degree of conservation among 
pyrrolnitrin biosynthetic loci (Hammer et aI., 1999). 
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Figure 1.4. Biosynthetic pathway for PYlTolnitrin biosynthesis. The steps catalysed by PrnA, PrnB, PmC, 
and PmD are indicated. This was reproduced from Kimel' et al (1998). The lower pathway is the 
previously accepted model for pyrrolnitrin biosynthesis. 
HYDROGEN CYANIDE. 
Although HCN has been implicated in the induction of systemic resistance, its role in 
biocontrol could be more complex given the toxic nature ofthe compound. The fact that 
HCN can inhibit the in vitro growth of phytopathogenic fungi is worth considering in the 
context of an antimicrobial compound, although inhibition of fungi in the rhizosphere has 
not been shown (Blumer & Haas, 2000a). 
Biosynthesis of HeN. 
A genetic locus encoding HCN biosynthesis in P. fiuorescens CHAO was first isolated by 
Voisard et al (1989). They found that an 8.4leb region of CHAO genome was capable of 
conferring HCN production upon another P. fiuorescens strain. Disruption of a 5kb 
subclone with an antibiotic resistance cassette, and subsequent introduction of this mutation 
into the CHAO genome resulted in loss ofHCN synthesis (Voisard et aI., 1989). In a 
subsequent study, the genes involved in HCN synthesis were located by mutagenesis, and 
found to occupy a 3.8kb region ofthe CHAO genome. Nucleotide sequence data indicated 
the presence of three open reading frames, labelled hcnABC (Laville et aI., 1998). 
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Expression ofthese genes, under control of the T7 promoter in E. coli, led to HCN 
production. This confirmed their role in HCN synthesis. The products HcnA, HcnB, and 
HcnC are probably subunits of the HCN synthase. The predicted amino acid sequence of 
each subunit shows similarity with lmown dehydrogenases, supporting the dehydrogenase 
model for HCN synthesis. This model suggests that glycine is oxidised to iminoacetic acid, 
and the C-C bond is split in a second dehydrogenase reaction, releasing HCN and CO2 
(Laville et aI., 1998). This reaction is shown in Figure 1.5. 
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Figure 1.5. Production ofHCN by HCN synthase (comprised ofHcnABC). This reaction scheme was taken 
from Blumer and Haas (2000). 
Regulation of HeN biosynthesis. 
Production ofHCN in P. fluorescens CHAO is stimulated by glycine, the biosynthetic 
precursor, probably via a post-translational mechanism (Blumer & Haas, 2000a). In 
addition, HCN production in P. fluorescens CHAO is regulated by ANR (anaerobic 
regulator of arginine deaminase and nitrate reductase) (Laville et aI., 1998). The role for 
ANR was deduced from the observation that the -40 region of the promoter for hcnA had a 
consensus FNRlANR binding sequence, and the fact that HCN is produced under oxygen-
limited conditions. Subsequent mutagenesis of anr yielded a strain that produced very little 
HeN, and could not express an hcnA::lacZ fusion, but could still produce PHL and 
pyoluteorin (Laville et aI., 1998). 
METABOLITE SPECIFIC AND GLOBAL REGULATION. 
Of the antifungal metabolites discussed above, aU but pyrrolnitrin have been associated 
with specific mechanisms for their regulation. Due to the fact that the regulator genes are 
often found in close proximity to the target genes, the genes responsible for the regulation 
can often be identified during DNA sequencing of the biosynthetic region encoding a 
particular antibiotic. This appears to have been the case for PhI and pyoluteorin regulation, 
but not for the identification of regulators for HCN production by P. fluorescens CHAO, or 
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phenazine production by P. aureofaciens 30-84. In addition to the specific regulation of 
these metabolites, each is also under the influence of at least one global regulatory 
mechanism. Indeed, in P. fluorescens CHAO, the two-component system GacA/GacS 
controls HCN, PhI, and pyoluteorin (Laville et al., 1992). The global regulation of 
antifungal metabolites is discussed in chapter 5. 
1.5.5 Nutritional influences on antibiotic production. 
Since antibiotic production appears to be one of the most important traits for biocontrol, an 
assessment of environmental factors influencing antibiotic production is essential. One 
variable feature that could impact upon biocontrol performance is the type and availability 
of elemental nutrients, such as minerals and carbon source. A number of studies have 
approached this topic, mostly using liquid culture conditions to examine the impact of 
various nutrients on antibiotic production. Production of three antibiotics by P. fluorescens 
HV37a was shown to vary depending upon glucose concentration in solid media. One 
antibiotic required a minimum glucose concentration (0.2%), whereas expression ofthe 
other two antibiotics was optimal with no added glucose (James & Gutterson, 1986). In a 
study of PC A production by P. fluorescens 2-79, adenine reduced production while 
cytosine increased PCA accumulation. The minerals FeS04, H3B03, MgS04, and ZnS04 
all appeared to enhance PCA production when added to cultures with low inoculum 
density, but the increase in PCA correlated with increased growth, indicating that the effect 
of these minerals on PCA production probably related to improved growth. However, 
when added to a culture with a high inoculum density, FeS04, ZnS04, and (NH4)6M07024 
led to increased PCA accumulation in a manner that was not growth dependent, and adding 
both zinc and iron led to a further increase of PC A (Slininger & Jackson, 1992). In a more 
comprehensive study, Duffy and Defago (1999) examined the effect of minerals and carbon 
source on PhI, pyoluteorin, and pyrrolnitrin biosynthesis by P. fluorescens CHAO. Eleven 
different minerals were added to NBY medium (nutrient broth and yeast extract), either 
alone or with glucose or glycerol supplementation. ZnS04, (NH4)6M07024, glycerol and 
glucose all increased PhI production. In addition, a synergistic effect was observed with 
glycerol plus each of ZnS04, (NH4)6M07024, and CUS04' No significant interactions 
between mineral treatment and glucose were reported. Pyoluteorin production was 
enhanced by ZnS04, CoCh, and glycerol. Glycerol plus CoCh or ZnS04 increased 
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pyoluteorin compared to the control with no minerals, but these combinations produced less 
antibiotic than the mineral-alone cultures. Fructose, mannitol and glycerol significantly 
increased both PhI and pyoluteorin production in the presence of ZnS04 and 
(NH4)6M07024. Pyrrolnitrin production was increased by fructose, mannitol, glycerol and 
glucose. The effect of zinc, inorganic phosphate, and glucose was then assessed on a range 
of biocontrol strains that had been grouped into three groups based upon amplified 
ribosomal DNA restriction analysis (ARDRA). The effect of ZnS04 on PhI production was 
significant in ARDRA group 1, which comprised 11 ofthe 42 strains, but only influenced 
two other strains. PhI production was stimulated by glucose in all but six strains. 
Pyoluteorin was only made by ARDRA group 1, and while its production by most strains· 
was stimulated by ZnS04, it was reduced below the detection limit in glucose enriched 
media. Inorganic phosphate at greater than 10mM reduced PhI and pyoluteorin synthesis 
by all strains tested, but did not affect pyrrolnitrin by CHAO (Duffy & Defago, 1999). In a 
glasshouse trial using gnotobiotic systems, Fe3+ was shown to be important in disease 
suppression, and this ability correlated with the stimulation ofHCN production by Fe3+ in 
the test strains (Keel et aI., 1989). 
It is evident from the research outlined above that biocontrol of fungal root pathogens using 
fluorescent Pseudomonads is influenced by a myriad of factors. Not only must the 
organism be capable of establishing itself in the rhizosphere, it must have a means by which 
to suppress the pathogen. In the majority of cases it seems as though producing one or 
more antifungal metabolite enables pathogen suppression, but other possibilities such as 
siderophore production and induction of systemic resistance may also be important, either 
alone or in combination with antibiosis. However, even if the organism in question 
possesses the desirable traits, efforts in biocontrol can be thwarted by environmental factors 
such as nutrient availability, predation, and soil structure. Biocontrol has unquestionable 
promise, either as a replacement for chemical pesticides or as part of an integrated 
management system, but there is clearly considerable research still to be done. 
1.6 P. aureofaciens PA147-2. 
P. aureofaciens PA147 was isolated from soil at Lincoln, near Christchurch, New Zealand 
during a search for soil organisms with biocontrol potential, and was identified on the basis 
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of API 20 NE strip analysis. Subsequently, a spontaneous rifampicin resistant mutant was 
isolated and designated PA147-2 (Carruthers, 1994). PA147-2 is a Gram-negative rod with 
a single polar nagellum (Figure 1.6), and recent analysis of the 16s rDNA sequence showed 
it is most closely related to a P. aureo[(lciens type strain (S. Godfrey, Pers. Comm.). 
PA147-2 was chosen for study as a potential biocontrol agent because of its broad spectrum 
in vitro antifungal activity (Carruthers, 1994). 
Figure 1.6. Transmission electron micrograph or P ([lIreo/elciells P A 147-2. The single polar t1agellun1 is 
dearl y visible. 
1.6.1 Previous research on fungal inhibition by PA147-2. 
Molecular biology. 
In an effort to understand the molecular basis of antifungal activity from PA147-2, 
Carruthers (1994) used 1'n5 to generate a collection o f mutants that were deficient in their 
il1 vitro antifungal activity (Ar). The DNA nanking the transposon insertion points of three 
mutants was sequenced. Two of these mutants were auxotrophs - PAF30 required 
phenylalanine, tyrosine and tryptophan for growth, while PAF35 needed to be supplied 
with arginine and uraci 1. The DNA sequence from PAF30 indicated a mutation ill aroH, 
the gene encoding 3-dchydroquinatc synthase, which is required early in the shikimic acid 
pathway. The insertion in PAF35 was round to be in c{[rA, the gene for the small subunit 
of carbamoylphosphate synthetase, which is an intermediate in the biosynthesis of both 
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arginine and uracil. Thus, the nucleotide sequence was in agreement with the auxotrophic 
requirements of these two mutants (Carruthers, 1994). The third mutant to be analysed was 
PAI09. The transposon was found to be in a 16kb EcoRl fragment from PA147-2, and 
preliminary sequence data indicated it interrupted the gene for a two-component regulator. 
However, the sequence was not completed by Carruthers. Analysis ofthe 16kb region 
using saturation mutagenesis indicated the presence of other genes that were required for 
antifungal activity, and these were presumed to be regulated by the two-component 
regulator (Carruthers, 1994). Allele replacement of the mutation in PA109 by a cosmid 
from the P A14 7 -2 genomic library ( creating PAl 09R -186) was shown to restore antifungal 
activity (Carruthers et aI., 1994). 
Disease suppression. 
Although PA147-2 is a strong inhibitor offungal growth in vitro, it was important to 
establish its abilityto suppress disease in planta. A glasshouse trial was conducted in 
whichPA147-2, PA109 and the allele replacement strainPA109R-186 were assessed for 
their ability to suppress Phytophthora rot of asparagus (Carruthers, 1994; Carruthers et aI., 
1995). The results indicated that PA147-2 and the PAI09R-186 were able to suppress 
disease, which correlated with in vitro antibiosis. PAl 09 was unable to suppress 
Phytophthora rot. Interestingly, although PA109 did not significantly reduce root rot, it did 
reduce the incidence of diseased shoots, and all strains tested appeared able to enhance the 
growth of asparagus seedlings (root length and plant weight) independent of the presence of 
the fungal pathogen. These data supported the suggestion that PA147-2 was a good 
biocontrol candidate, and indicated it could provide additional benefits to plants 
(CalTUthers, 1994; Carruthers et aI., 1995). 
Biochemical analysis. 
Two researchers have carried out experiments aimed at identifying the chemical nature of 
the antifungal compound(s) produced by P A14 7 -2. Initially, crude antifungal extracts were 
prepared from PA147-2 grown on solid media. A bacteria/agar slurry was extracted with 
80% acetone, and after acetone removal the aqueous fraction was applied to a C8 column. 
An active fraction was eluted with methanol and subjected to HPLC analysis using a 0.1 % 
trifluoroacetic acid-acetonitrile gradient (30-60%) over 20 minutes. Comparison ofHPLC 
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traces for PAl 47-2 and three mutants (PAI09, PAl, and PAl38) showed that all three 
mutants were missing a peak, and antifungal assays demonstrated that the peale correlated 
with antifungal activity. Unfortunately insufficient sample was prepared for further 
purification (Carruthers, 1994). In a more recent study, Godfrey (1997) attempted the 
further eharacterisation of antifungal compounds from PAI47-2. Initially it was 
demonstrated that PA147-2 does not produce HCN or PCA. Further analysis consisted of 
preparing a crude extract from plate cultures, and separating compounds by polarity using 
dry flash chromatography. Two fractions, one polar and the other non-polar, showed 
activity, and were further investigated. Circular chromatography was used to separate the 
non-polar extract into three fractions, one of which showed activity. However, mass 
spectrometry analysis suggested that the active fraction actually contained three compounds 
that were thought to be decomposition products from the active compound. The active 
polar fraction from dry flash was examined using CI8 reverse-phase HPLC. While 
separation was achieved, yields were either too low or not stable enough for a positive 
antifungal assay result. The conclusion was that at least one compound in the extracts from 
PA147-2 was relatively unstable, and hence difficult to chemically characterise, and 
obtaining sufficient compound for detailed analysis was extremely difficult (Godfrey, 
1997). 
1. 7 Objectives of the present study. 
The present study was undertaken with two broad objectives. Firstly, to increase the 
understanding of the molecular basis of antifungal activity by P A14 7-2, using a previously 
created collection of mutants. A second objective was to complement the molecular studies 
with biological experiments that relate to the biocontrol potential ofPAI47-2. To address 
the broad objectives, several aims were defined at the beginning and during the research. 
These are outlined below. 
1. Create a system that would allow trans complementation experiments to be carried out. 
2. Broadly characterise all mutants in the collection on a molecular level. The outcome of 
this aim was intended to determine subsequent goals. 
3. Characterise mutants PAl 09, PA138, and P AH26 with respect to the impact the Tn5 
insertion has on antifungal activity. 
4. Conduct a field trial to further establish the potential ofPA147-2 as a biocontrol agent. 
5. Based upon observations of bacterial survival in the field, carry out preliminary 
experiments to examine the fitness ofPA147-2, and the possibility that producing 
antifungal compounds has a negative impact on fitness. 
Biochemical characterisation of the antifungal compound(s) produced by PA147-2 was not 
a direct objective of this research for two reasons. Firstly, work by Godfrey (1997) 
indicated that the compound lacked stability in extracts, making analysis extremely 
difficult. Secondly, the mutants that were analysed by DNA sequencing in the preliminary 
study did not have disruptions in any gene known to encode a protein with a direct role in 
antibiotic synthesis. An investigation into the identity of the antifungal compound(s) is 
ongoing in collaboration with the department of chemistry, University of Canterbury. 
Chapter 2 
Experimental Procedures 
2.1 Bacterial strains, plasmids and phage. 
All bacterial strains and phage used in this study are listed in Table 2.1. Plasmids not 
created in this study are also listed in Table 2.1. Plasmids constructed during this 
investigation are described in detail in section 2.7. 
Table 2.1. Bacterial strains, plasmids and bacteriopbage 
Strain, plasmid or Genotype/Description Reference or source 
phage 
E. coli 
PB2480 thr1leu6lacYl supE44 tonAZl P. Berquist 
CSR603 phrl recAl uvrA6 thrlleuB6 argE3 thi! (Sancar et aI., 1979) 
ara14lacYl galK2 xyl5 mtll supE44 tsx33 
gyrA96 rpsL31 
DE880 fl(lac-argF)U169 relAl thi-l cps-3 (Ennis et aI., 1989) 
suIA::Mu d (lac Ap)XCam (Mu+) 
sri C3 00: : Tnl 0 
DE1491 fl(lac-argF)U169 relAl thi-l cps-3 (Ennis et aI., 1989) 
maIF55::Tn5 suIA::Mu d (lac Ap)XCam 
(Mu+) fl(recA -srlR)30 1: :Tnl 0 
DH5a supE44 fllacU169( $lacZb.M15) hsdR17 thi- (Hanahan, 1983) 
1 relAl recAl endAl gyr A96 
ZK4 araD139 fl(lacIPOZYA-grgF)U169 rpsL thi (Gilson et aI., 1987) 
recA56 supO 
MT2 ilv his rpsL recAl (N7N53cl+) (Toman et aI., 1985) 
S17-1 thi pro hsdR- hsd¥ flrecA RP4-2-Tc::Mu- (Simon et aI., 1983) 
Km::Tn7 
W3110 Wild-type K12 (Kohara et aI., 1987) 
Strain, plasmid or GenotypelDescription Reference or source 
phage 
P. aureofaciens 
PA147-2 Rf- wildtype; antifungal (At) positive (Carruthers et a1., 
1994) 
PA109 Tn5 mutant ofPA147-2; Rf-, KmR; Af /I 
PAH26 Tn5 mutant ofPA147-2; Rf-, KmR; Af, (Carruthers, 1994) 
biofilm defective 
PAl38 Tn5 mutant ofPA147-2; Rf-, KmR; Af 1/ 
PAl Tn5 mutant ofPA147-2; Rf-, Knl; Af II 
PAB108 miniTn5 mutant ofPA147-2; Rf-, KmR; Af, (Monds, 2000) 
Biofilm defective 
PAE21 Tn5 mutant ofPA147-2; Rf-, KmR; Af (Carruthers, 1994) 
PA168 Tn5 mutant ofPA147-2; Rf-, KmR; Af /I 
PAF30 Tn5 mutant ofPA147-2; Rf-, KmR; Af II 
PAF35 Tn5 mutant ofPA147-2; Rf-, KmR; Af /I 
PAIl 7 Tn5 mutant ofPA147-2; Rf-, I{nl; Af /I 
PAI75 Tn5 mutant ofPA147-2; Rf-, KmR; Af II 
PAI95 Tn5 mutant ofPA147-2; Rf-, KmR; Af /I 
PA138R9 P Al38 allele replacement strain; At This study 
PA138R16 PA138 allele replacement strain; At II 
PA147-2flnRll PA147-2 withflnR deletion; Rf-, KmR; Af 1/ 
PA147-2flnA606 PA147-2 with GmRinsertion inflnA; Rf-, 1/ 
GmR; Afreduced 
PA147-2recAl PA147-2 with recA::TnlO 1; Rf-, KmR 1/ 
PAl 47-2recA4 PA147-2 with recA::TnlO 4; Rf-, KmR 1/ 
PAl 47-2recll PA147-2 with recA deletion; Rf-, KmR GmR /I 
PA109recll PAI09 with recA deletion; Rf-, KmR GmR II 
PAl 38recll PA138 with recA deletion; Rf-, KmR GmR 1/ 
PAH26recll PAH26 with recA deletion; Rf-, KmR GmR II 
PAI47-9.2 PA147-2 with mutation from pAF9.2 1/ 
introduced into the genome by al1ele 
exchange; Rf-, KmR, At 
PA147-9.38 As for PA147-9.2, except created with /I 
pAF9.38; Rf-, KmR, At 
Strain, plasmid or Genotype/Description Reference or source 
phage 
PAI47-9,45 As for PAI47-9.2, except created with 
pAF9.45; RtR, KmR, At 
This study 
PAI47-9.55 As for PAI47-9.2, except created with 
pAF9.55; RtR, KmR, At 
II 
PAI47-9.6 As for PAI47-9.2, except created with 
pAF9.6; RtR, KmR, At 
II 
PAI47-9.66 As for P A14 7 -9.2, except created with 
pAF9.66; RtR, KmR, At 
II 
PAI47-9.68 As for PAI47-9.2, except created with 
pAF9.68; RtR, KmR, At 
II 
P. aeruginosa 
PAOI Wildtype, clinical origin (Holloway et aI., 
1977) 
NTI PA01I1pstCAB-phoU, KmR (Nikata et aI., 1996) 
Plasmids 
pACYC184 p15a ort; CmR, TcR (Chang & Cohen, 
1978) 
pBLUESCRlPT ColE! ori lacZalKS polylinker (polylinker Stratagene 
(M13-, KS, SK) in opposite direction for SK); ApR 
pBR322 ColEl ori ApR, TcR (Bolivar et aI., 1977) 
pHP45-nCm ApR, carries n CmR cassette (Prentki & Krisch, 
1984) 
pHRP309 GmR, lacZ', IncQ (Parales & Harwood, 
1993) 
pHRP315 ApR, carries n SmR cassette flanked by II 
multicloning sites 
pHRP317 KmR, carries n SmRcassette flanked by /I 
multicloning sites 
pJQ200 GmR, has sacB gene for sucrose sensitivity (Quandt & Hynes, 
1993) 
pLAFR3 pRK290 derivative; IncP-l; ACOS, pUC9 (Staskawicz et aI., 
multicloning site and lacZa; TcR 1987) 
Table 2.1. Continued. 
Strain, plasmid or GenotypelDescription Reference or source 
phage 
pME6000 pBBRIMCS derivative; lacZa/multicloning Stephen Heeb 
site polylinker; mob; rep; TcR 
pME6001 pBBRIMCS derivative; lacZalmulticloning " 
site polylinker; mob; rep; GmR 
pUC18 ColEl ori; lacZa/polylinker; ApR (Yanisch-Perron et 
aI., 1985) 
pNK2859 plasmid containing miniTnlO derivative 103 (Kleckner et aI., 
1991) 
pPS132 pLAFR3 containing PA147-2 genomic DNA Lab Collection 
spanning the insertion point in PA138 
pPSl92 pLAFR3 containing PA147-2 genomic DNA " 
spanning the insertion point in P A 138 
pPS2122 pLAFR3 containing PA147-2 genomic DNA /I 
spanning the insertion point in PA138 
pPS7138 Cosmid complementary to mutated region in (Carruthers et at, 
PAI09 1994) 
pFCI 16kb::Tn5 EcoRI clone from PAl in " 
pBR322; ApR, TcR, KmR 
pFCI09 16kb::Tn5 EcoRI clone from PAI09 in /I 
pBR322; ApR, TcR, KmR 
pWT109 wildtype 16kb EcoRI region complementary /I 
to mutated region in PAI09, cloned from 
pPS7138 in pACYCI84; TcR 
pRECI Cosmid from PA147-2 genomic library. (Silby & Mahanty, 
Confers MMSR and UVR on recA strains of 2000) 
E. coli; TcR, recA+ 
Phage 
ANK1205 Lambda delivery vehicle for miniTnlO (Kleckner et aI., 
derivative 112 (KmR, lacZ~ 1991) 
ANK1316 Lambda delivery vehicle for miniTnlO /I 
derivative 103 (KmR) 
Pl vir (Silhavyet aI., 1984) 
2.2 Fungal strains. 
Fungal strains used in this study are listed in Table 2.2. 
Table 2.2. Fungal strains 
Fungus 
Gaeumannomyces graminis var. tritid 
Phytophthora rnegasperma var. sojae 
Rhizoctonia solani 
Sourcea 
Tony Coleb 
ICl\.t1P 9489 
ICl\.t1P 11620 
International collection of microorganisms from plants (Landcare research, Auckland, New 
Zealand). bTony Cole, Department of Plant and Microbial Sciences, University of Canterbury. 
2.3 Buffers, solutions and media. 
Buffers, solutions and media used in this study were prepared as outlined in Appendix 1. 
2.4 Bacteriological and fungal methods. 
2.4.1 Routine culture conditions for bacteria and fungi. 
All E. coli and P. aureofadens strains were grown aerobically in LB (Sambrook et aI., 
1989), lxA (Miller, 1972) or Pseudomonas minimal medium (PMM) (Kirner et aI., 1996) 
at either 37°C or 30°C respectively unless otherwise specified. When required, media were 
solidified by the addition of 1.5% bactoagar (Gibco). Bacterial cultures were inoculated 
from a single colony from a selective plate or from frozen stocks. When required, 
antibiotics and supplements were added to culture media as outlined in Table 2.3. Fungal 
strains were grown on potato dextrose agar (PDA, Oxoid) at 21°C. Fresh plates were 
inoculated by removing a plug from the periphery of a growing colony (or from storage) 
and placing it at the center of a fresh plate. 
Table 2.3. Antibiotics and supplements used in this study 
Antibiotic or supplement 
Ampicillin (Ap) 
Chloramphenicol (Cm) 
Cycloheximide 
Gentamicin (Gm) 
Kanamycin (Km) 
Nalidixic acid (Nal) 
Rifampicin (Rf) 
Streptomycin (Sm) 
Tetracycline (T c ) 
Methyl methanesulphonate (MMS) 
Mitomycin C (MC) 
5-bromo-4-chloro-3-indolyl-p':'D-galadopyranoside 
(Xgal) 
5-bromo-4-chloro-3-indolyl-phosphate (BCIP) 
2.4.2 Storage of bacteria and fungi. 
Final concentration 
100 )lglmL 
30 )lglmL 
100 )lglml 
15 )lglmL 
50 )lglmL 
30 )lglmL 
50 )lglmL 
50 Ilg/mL 
15 IlglmL 
200 flglmL 
0.5 )lg/mL 
20 )lglmL 
20 flglmL 
For long term storage, bacterial strains were grown for 16 hours in LB, harvested by 
centrifugation, and frozen at -80°C in LB supplemented with 15% glycerol. For day to day 
use, streaks of bacteria were kept on agar plates at 4°C. For long term fungal storage, two 
methods were used: (i) plugs of fresh mycelium were taken from a fungal colony and 
frozen in 10% glycerol at -80°C; (ii) the fungal strains were grown on PDA slopes in 
universal bottles, then overlayed with sterile paraffin oil. 
2.4.3 Collecting bacteria by centrifugation. 
Bacteria were harvested from liquid culture and suspensions by centrifugation at 5000 x g 
unless otherwise specified. Centrifugation of bacteria was generally carried out at ambient 
temperature, except in the case of competent cell preparation, during which all centrifuge 
steps were conducted at 4°C. 
2.4.4 Antifungal bioassay (Modified from Carruthers et aI, 1994). 
The in vitro assay for antifungal activity was carried out on Tris-buffered potato dextrose 
agar plates (TPDA). Tris-HCI (PH 7.6) was used at a final concentration of80mM. TPDA 
plates were inoculated with the desired fungus and incubated for one to two days before 
bacteria for bioassay were streaked 1.5-2cm from the edge ofthe growing fungal colony. 
The bioassays were carried out at 21°C, and typically took between four and eight days 
before a definitive result could be seen. 
2.4.5 Mutant crossfeeding assays. 
Each of the Tn5-generated antifungal mutants ofPA147-2 was grown in LB broth for 18 
hours. As a control, aliquots (5JlL) of each mutant were placed onto bioassay plates 
approximately 2cm from the growing fungal colonies, to confinn the mutant phenotypes. 
For the cross-feeding, aliquots of each mutant were combined with aliquots of each of the 
other mutants and then placed on bioassay plates for the inhibition assay. P Al4 7 -2 was 
included on each plate. Typically, eight combinations could be assessed on each bioassay 
plate. Each experiment was carried out three times to ensure reproducibility. 
2.5 Conjugation, transformation and transduction. 
2.5.1 Conjugation. 
Plasmid DNA was routinely introduced to P. aureofaciens strains by conjugation. For all 
conjugation experiments, E. coli S 17 -1 was transfonned by the appropriate plasmid in order 
to serve as the donor strain. The donor and recipient strains were grown overnight 
(approximately 18 hours) with relevant antibiotic selection and then cells from 500JlL of 
culture were harvested by centrifugation. Cell pellets were washed twice with fresh LB, 
and finally resuspended in 200JlL ofLB. At this point the donor and recipient strains were 
mixed and an 100JlL aliquot was pipetted onto a LB plate and allowed to dry. Plates were 
incubated at 30°C for between eight and 18 hours before scraping the bacteria from the 
surface and suspending them in LB. The suspension was spread plated onto LB agar plus 
antibiotics and returned to the incubator until colonies appeared. 
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2.5.2 Transformation. 
CALCIUM CHLORIDE TRANS FORMA TION OF E. COLI. 
Calcium chloride transformation was carried out as described by Sambrook et a1. (1989), 
with modifications. To prepare competent cells, the desired E. coli strain was grown to 
saturation in LB, subcultured (1 :50) in fresh LB, and grown with vigorous shaking 
(300rpm) to an OD600 of 004-0.5. After cooling the culture on ice, the cells were collected, 
suspended in Yz volume of cold 10mM NaCI, and held on ice for five minutes. The cells 
were collected again and resuspended in V4 volume of 100rnM CaCho After incubating on 
ice for ten minutes the bacteria were harvested, suspended in Ys volume of 100rnM CaCh 
and retumed to ice for a further 30 minutes. In each transformation, 100-50Ong of DNA 
was added to 50!lL of competent cells, and this mixture was incubated on ice for 30 
minutes. After the ice incubation the DNAJbacteria mix was subjected to a heatshock 
(42°C, 90 seconds) and then placed back on ice for two minutes. One mL ofLB was added 
and the transformation mixture was incubated at 37° for one to two hours to allow 
expression of antibiotic resistance genes. Transformants were selected by plating aliquots 
ofthe transformation on LB supplemented with selective antibiotics. In cases where 
transformants were expected to be rare, the bacteria were concentrated by centrifugation, 
the supematant was removed and the bacteria were resuspended in a smaller volume. This 
allowed the entire transformation mix to be plated. 
TRANSFORMATION OF E. COLI BY ELECTROPORATION. 
A 100mL exponential culture was started by diluting (1: 100) a saturated broth culture of the 
desired E. coli strain in fresh LB. The culture was grown with vigorous shaking (300 rpm) 
to an OD600 of 0.6-0.8, after which it was placed on ice to cool. Bacteria were harvested, 
resuspended in 100mL of cold sterile dH20 (sdH20), collected again and resuspended in 
50mL sdH20. The cells were collected, resuspended in 1mL sterile 10% glycerol, 
centrifuged and finally resuspended in 500!lL of 10% glycerol. Aliquots of cells (40!lL 
each) were either used immediately or stored at -80°C until required. Stored competent 
cells were thawed on ice before use. 
Electroporation was carried out with a Biorad Gene Pulser™ and Pulse Controller 
following the manufacturer's recommendations (Gene PulserTM set at a capacitance of 
25J..lFD and Pulse Controller set at 2000). Sterile electroporation cuvettes (O.lcm gap) and 
the chamber slide were cooled on ice prior to use. Approximately 100-200ng of DNA 
(dissolved in sdH20) was added to the competent cells, mixed and incubated on ice for one 
minute. The mixture was transferred to a cuvette, which was placed into the chamber slide 
in the electroporation chamber. The sample was pulsed at 18kV/cm. hnmediately after the 
pulse ImL of SOC (appendix 1) was added to the cuvette, and the entire sample was 
removed and placed into an Eppendorftube and incubated at 37°C for one hour. 
Transformants were selected as described above for CaCh transformation. 
2.5.3 Pl Transduction. 
PREPARATION OF PI STOCK. 
E. coli W311 0 was grown in 3mL ofLB broth for 18 hours before the addition of 25 J..lL of 
1M CaCho The culture was returned to the 3 rc shaking waterbath for ten minutes. A 
1 mL aliquot was transferred to an Eppendorf tube to which 100J..lL of P 1 vir stock was added. 
The phage were allowed to adsorb (without shaking) for ten minutes at 37°C prior to the 
addition of 10J..lL of 1M CaCh and 20J..lL of 20% glucose. This mixture was added to 3mL 
of molten (50°C) H-Top agar (appendix 1) which was then poured onto a pre-warmed LB 
plate. After setting, the plate was incubated for eight hours at 37°C after which 5mL of 
cold LB broth was poured over the surface. The plate was then incubated at 4°C for 15 
hours. The phage lysate was pipetted from the plate into a centrifuge tube. A 50J..lL aliquot 
of chloroform was mixed with the lysate prior to centrifugation (five minutes, 10000 x g, 
ambient temperature). The lysate was transferred to a sterile Universal bottle for use. The 
lysate was stored at 4°C in a Universal bottle with 25 J..lL of chloroform. 
PI TRANSDUCTION. 
PI transduction was carried out essentially as described by Miller (1972). One mL of 
saturated recipient culture was harvested by centrifugation, resuspended in 1 mL of MC 
buffer (appendix 1), and incubated at 37°C for ten minutes. Aliquots of 100J..lL were 
transferred to three Eppendorftubes, to which either 0, 10 or 1 OOIlL ofP1Y ir stock was 
added. The phage were adsorbed at 3JOC for 20 minutes and lOOIlL of 1M sodium citrate 
was added. The volume was increased to 1mL with MC buffer, and an aliquot (WilL) was 
removed for viable cfu/mL determination. The cells from the remaining 990llL were 
collected by centrifugation and plated on the appropriate medium (also containing 10ruM 
sodium citrate) for growth of transduced bacteria. 
2.6 DNA isolation and manipulation. 
2.6.1 Isolation of plasmid DNA. 
SMALL SCALE ALKALINE LYSIS. (MODIFIED FROM SAMBROOK ET AL, 1989) 
A 5001ll-1mL aliquot of a saturated bacterial culture was centrifuged in an Eppendorf tube 
to collect the cells. After removal of the supernatant by aspiration, the pellet was 
suspended in lOOIlL of solution 1. A 200llL aliquot of solution 2 was then added, and 
mixed until viscous and clear. One hundred and fifty microlitres of solution 3 was added 
and mixed well to break up the precipitate. The precipitate was removed from solution by 
centrifugation (ten minutes, 17000 x g, ambient temperature), and the supernatant was 
transferred to a clean tube. DNA was precipitated from the solution by the addition of 1mL 
of 100% ethanol, and the DNA was collected by centrifugation (ten minutes, 17000 x g, 
ambient temperature). The supernatant was removed by aspiration and the DNA pellet 
rinsed with 70% ethanol. The ethanol was removed by aspiration and the DNA was dried 
under vacuum. The pellet was dissolved in 30-1 00 ilL T lOEI (TE, appendix 1) or sdHzO. 
This method generally yielded DNA of sufficient quality and quantity for analysis by 
restriction digestion and agarose gel electrophoresis. For larger yields and higher quality 
DNA the method below was used. 
LARGE SCALE PREPARATION OF HIGH QUALITY DNA. 
This method is a modification of the above alkaline lysis protocol. In this method the same 
first three solutions are used, in the same ratios employed above (for a 1mL bacterial 
sample). After removal ofthe precipitate produced by solution three, steps are taken to 
further purify the DNA by removing RNA and contaminating proteins. Outlined below is 
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the method for a 10mL culture, but this can easily be scaled up for higher yields from larger 
cultures. 
The bacteria from 10mL of culture were collected in a 30mL centrifuge tube, and 
suspended in 1mL of solution 1. This was held on ice for five minutes prior to the addition 
of 2mL of solution 2. After mixing, the preparation was again held on ice for five minutes. 
Solution 3 (l.5mL) was then added and mixed. After five minutes of incubation on ice the 
precipitate was removed by centrifugation (ten minutes, 12000 x g, ambient temperature). 
The supernatant was transferred to a clean tube and the DNA was precipitated by the 
addition of 4.5mL of cold 2-propanol. After mixing well, the precipitate was recovered by 
centrifugation (ten minutes, 12000 x g, ambient temperature). The pellet was dissolved in 
1mL sdH20, and then 1mL of 5M LiCI was added (Sambrook et aI., 1989). The solution 
was thoroughly mixed, and placed on ice for ten minutes. The high molecular weight RNA 
precipitated by the addition ofLiCI was removed from solution by centrifugation (ten 
minutes, 12000 x g, 4°C) and the supernatant was transferred to another clean tube. The 
DNA was precipitated with 2-propanol (2mL) and the resulting pellet dissolved in 200~L 
TE. The DNA solution was transferred to an Eppendorftube and treated with RNase (final 
concentration O.l~g/~L) for 15 minutes at 37°C. Contaminating proteins were removed by 
phenol/chloroform extraction (Section 2.6.3). The DNA was precipitated by adding 1110 
volume 3M sodium acetate and 2 volumes of 100% ethanol. DNA was recovered by 
centrifugation (ten minutes, 17000 x g, 4°C), washed with 70% ethanol, vacuum dried, and 
dissolved in 50-200~L TE or sdH20. 
2.6.2 Preparation of genomic DNA. 
Genomic DNA was prepared from P. aureofaciens strains using a rapid extraction with 
guanidium thiocyanate (Pitcher et aI., 1989). The cells from 1mL of culture (grown for 16-
20 hours) were collected in an Eppendorftube by centrifugation and suspended in 100~L of 
TE prior to the addition of 500~L of GES lysis solution (appendix 1). This was incubated 
at 65°C for 15 minutes, followed by the addition of250~L of cold 7.5M ammonium 
acetate. After ten minutes on ice, 500~L of 24: 1 chloroform:isoamyl alcohol was added 
and mixed thoroughly by vortexing until an emulsion formed. The mixture was centrifuged 
(ten minutes, 17000 x g, ambient temperature) and the top phase transferred to a new tube. 
The chloroform:isoamyl alcohol extraction step was repeated, and the top phase was 
transferred into a clean tube. To precipitate the DNA, 0.54 volumes of cold 2-propanol 
were added, mixed well, and held at ambient temperature for 10-15 minutes. At this stage 
the DNA could easily be seen floating in solution. The DNA was collected by 
centrifugation (two minutes, 17000 x g, ambient temperature), and washed three times with 
70% ethanol as described for precipitation of DNA from solution (section 2.6.4). The DNA 
was dried under vacuum, and dissolved in 751lL 
2.6.3 Phenol/chloroform extraction of contaminants from DNA solutions. 
When required, contaminants were removed from DNA solutions by phenol/chloroform 
extractions according to the method of Sambrook et a1. (1989). Briefly, one volume of 
phenol saturated with Tris-HCI, pH 8 (Gibco BRL) and one volume of chloroform:isoamyl 
alcohol (24:1) were added to the DNA solution. The solutions were mixed until a 
homogenous emulsion formed, and centrifuged (five minutes, 17000 x g, ambient 
temperature). The aqueous (upper) phase was transferred to a new tube, and two volumes 
of 24: 1 chloroform:isoamyl alcohol was added. The solutions were mixed and centrifuged, 
and the aqueous phase recovered. DNA was precipitated from solution using ethanol 
(section 2.6.4) and dissolved in an appropriate volume ofTE or sdH20. 
2.6.4 Precipitation of DNA from solution. 
DNA was precipitated from solution as described by Sambrook et a1. (1989) unless 
otherwise stated. A 0.1 volume aliquot of 3M sodium acetate was added to the DNA 
solution, followed by two volumes of cold (-20°C) 100% ethanol. After mixing, the DNA-
containing tube was placed on ice for ten to 30 minutes, and the DNA was recovered by 
centrifugation (ten minutes, 17000 x g, 4°C). After removal of the supernatant, the DNA 
pellet was washed by the addition of 1mL of 70% ethanol and centrifugation for two 
minutes. The supernatant was again removed by aspiration, the DNA pellet dried under 
vacuum, and finally dissolved in an appropriate volume ofTE or sdH20. DNA solutions 
were stored at 4°C or -20°C. 
PRECIPITATION OF LIGATED DNA FOR ELECTROPORATlON. 
Prior to transformation of E. coli by electroporation, ligated DNA was precipitated. The 
ligation reaction volume was increased to SOIlL by the addition of water. Potassium acetate 
(6.25IlL of 2M, pH 8) was added, followed by 12 0 ilL of 100% ethanol. After mixing and 
incubation on ice (30 minutes), the DNA was recovered by centrifugation and washed with 
70% ethanol as described above. The DNA was dissolved in 1 o ilL of sdH20. 
2.6.5 Restriction digestion of DNA in solution. 
Digestion of DNA by restriction enzymes (Gibco BRL) was carried out according to 
manufacturer's instructions. Generally, digests were set up in 10-20IlL volumes, and 
incubated at the appropriate temperature for one to four hours. If the restricted DNA was to 
be examined by electrophoresis, it was mixed with loading buffer (Section 2.6.7) and used. 
If the DNA was required for other purposes such as ligation, restriction enzymes were 
removed by phenol/chloroform extraction or inactivated by heat treatment (7Soe, ten 
minutes). 
2.6.6 Isolation, digestion and FIGE of total DNA in agarose plugs. 
EMBEDDING BACTERIA IN AGAROSE. 
Appropriate bacterial strains were grown for 16-18 hours in LB plus antibiotics. One mL 
aliquots were centrifuged, and the pellet resuspended in ImL SE (appendix 1) buffer. The 
bacteria were centrifuged again, and resuspended in ImL SE buffer for a second time. The 
bacterial suspension was incubated at 37°e for ten minutes to increase the temperature of 
the suspension, then lOOIlL of bacteria (approximately 1 x 108 cells) was mixed with 
IOOIlL of molten 2% agarose (dissolved in sdH20) which had been equilibrated to 50°C. 
The agarose/bacteria mixture was immediately pipetted into a plug mold (Biorad). 
LYSIS OF CELLS EMBEDDED IN AGAROSE. 
Once set, agarose plugs of bacteria were removed from the mold and incubated for 18 hours 
in ImL lysis buffer (appendix 1). After lysis, plugs were carefully subjected to three, one 
hour washes with TE. Following the washes, plugs were stored at 4°e in TE. 
RESTRICTION DIGESTION OF AGAROSE EMBEDDED DNA 
For each digest, Y4 of a plug was used. The plug was twice equilibrated in 400jlL of Ix 
restriction buffer for 15 minutes each time. The plug was then placed in a clean tube with 
200jlL of Ix restriction buffer plus 10 units of SpeI and incubated at 37°C for 16-20 hours. 
One mL ofTE was added to stop the reaction prior to electrophoresis. 
FIELD INVERSION GEL ELECTROPHORESIS (FIGE). 
Field inversion gel electrophoresis (FIGE) was used to separate and visualise the large 
DNA fragments produced by digesting agarose-embedded DNA with the rare-cutting 
restriction enzyme SpeI. FIGE was carried out by using a Biorad FIGE MapperTM 
Electrophoresis System according to the manufacturer's recommendations. 
A 1 (Yo gel was made by dissolving Ig of agarose in 100mL ofO.5x TBE. This was used to 
cast a 5mm thick, 15 well gel in a 15cm x 15cm casting tray. While the gel was left to cool, 
the digested agarose-embedded DNA samples were equilibrated in TBE by first being 
placed in ImL of 0.5 x TBE, incubated at ambient temperature for 15 minutes, then 
transferred to ImL of fresh 0.5 x TBE and equilibrated a further 15 minutes at ambient 
temperature. The samples were loaded into the wells of the gel with a spatula, pushed to 
the front of the wells, and sealed in with agarose (the same solution used to cast the gel). 
Approximately l.6L of 0.5 x TBE was poured into the FIGE Mapper electrophoresis cell 
and circulated at approximately 0.75L1minute by using the variable speed pump. The 
casting tray and gel were placed into the electrophoresis cell, and a buffer coverage of2mm 
was achieved by adding or removing buffer. Run parameters were determined empirically, 
and are described in appendix 2. Electrophoresis was carried out at ambient temperature 
for the appropriate time. A Biorad pulsed-field standard lambda concatemer was used as a 
molecular weight standard. The gel was stained and processed as described below (section 
2.1l.1) 
2.6.7 Agarose gel electrophoresis of DNA. 
Agarose gel electrophoresis was used to separate and visualise DNA fragments from 
restriction digests and PCRs. Agarose was dissolved in Ix TAE (appendix 1) to give a final 
concentration of 0.6-1.5%, depending on the size of DNA fragments to be visualised. Gels 
were cast with either 8, 12, or 16 wells using casting apparatus supplied with the Hoefer 
HE33 mini horizontal submarine unit. Once the gel was prepared, an appropriate volume 
of 6x loading buffer (appendix 1) was added to the DNA samples, which were then loaded 
into the gel. Electrophoresis was carried out in a Hoefer HE33 mini horizontal submarine 
unit, typically at 7V / cm with 1 x T AE as the running buffer. Gels were stained in a 
0.5~g/mL solution of ethidium bromide. DNA was visualised on an Ultralum UV 
transilluminator (254nm) and an image was produced by using a Kodak Digital Science 
Electrophoresis Documentation and Analysis System (EDAS) 120. Sizes of DNA 
fragments were determined by comparison to known standards. Molecular weight 
standards were the 100bp ladder (Bior~d), the lkb ladder (Biorad) and bacteriophage 
lambda DNA digested with HindlIl (Gibco BRL). 
2.6.8 Dephosphorylation of 5' single stranded DNA. 
When linearised plasmid vectors had compatible ends, 5' phosphate groups were removed 
to prevent vector self-ligation. The dephosphorylation was accomplished using Roche Calf 
Intestinal Alkaline Phosphatase (ClAP). The vector DNA was recovered from the 
restriction digest by ethanol precipitation, and dissolved in sdH20. Typically 
dephosphorylation reactions were carried out in 50~L volumes containing 5J.iL 10 x ClAP 
buffer, ClAP (for each ~g of DNA, one unit of ClAP was used), DNA and sdH20. The 
reaction was incubated at 37°C for one hour and the ClAP was inactivated by heating to 
75°C for ten minutes, or removed by phenol/chloroform extraction. After ethanol 
precipitation the vector was used in ligations. 
2.6.9 DNA ligation. 
COHESIVE END LIGATION. 
Generally, ligation reactions between DNA molecules with compatible cohesive termini 
were carried out in 20J.iL volumes consisting of 4J.iL of 5x DNA ligase buffer, 1 ~L of DNA 
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ligase (Life Teclmologies) and 100-50Ong of DNA. An insert to vector ratio of 
approximately 3:1 was used. The reaction was allowed to proceed at 20°C for one to 16 
hours. The DNA was ethanol precipitated prior to use in electrotransformation of E. coli. 
BLUNT END LIGATION. 
To ligate DNA molecules with blunt ends 20/lL reactions were used. These were as 
described for cohesive-end ligation except that 2.5/lL of DNA ligase was used, and 
approximately l/lg of DNA was included in the reaction. Blunt end ligations were 
incubated at 14-16°C for 20 hours. As for cohesive-end ligations, the DNA was ethanol 
precipitated before further use. 
2.6.10 Filling in 5' overhangs. 
To create blunt ends on restriction fragments that had 5' single stranded DNA overhangs, 
the ends were filled in using the 5'-3' polymerase activity of the Klenow fragment of DNA 
polymerase 1 (Life Teclmologies), as described (Ausubel et aI., 1989). DNA was digested 
as outlined above (section 2.6.5) and either treated with phenol/chloroform (section 2.6.3), 
recovered from an agarose gel (section 2.6.11) or used directly. If the DNA was used 
directly, the reaction volume was increased to 20/lL by the addition of l/lL of appropriate 
restriction buffer, 2.51lL ofO.2mM dNTPs, 2 units ofthe Klenow fragment and sdH20. 
This reaction was incubated at 30°C for 15 minutes before being stopped by the addition of 
l/lL O.5M EDTA and heating to 75°C for ten minutes. The DNA was purified by 
phenol/chloroform extraction. For other DNA samples, a 20llL reaction mixture consisting 
of DNA, 2.5 ilL dNTPs, 2/lL ofKlenow reaction buffer, two units of the Klenow fragment 
and sdH20 was made. This was treated as outlined above. 
2.6.11 Recovery of DNA from agarose gels. 
When required,fragments of DNA were extracted from agarose gels using the Prep-A-
DNA purification kit (Biorad) following the manufacturer's instructions. The 
desired DNA fragment in an ethidium bromide-stained gel was visualised on a Sigma 
T2210 UV transilluminator (302nm), excised using a scalpel, and placed in an Eppendorf 
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tube. The volume of gel slice was estimated by assuming 1 g of gel slice is equivalent to 
ImL. Based on the volume of the gel slice and the desired amount of Prep-A-Gene matrix 
to be added (typically 5-1 O/-LL) , three volumes of Prep-A-Gene binding buffer was added to 
the gel slice. This was incubated at 50°C until the gel slice had dissolved (about ten 
minutes). Prep-A-Gene matrix was added (5/-LL per /-Lg of DNA to be recovered) and 
incubated at ambient temperature for ten minutes with frequent agitation. The matrix (with 
bound DNA) was removed from solution by centrifugation (one minute, 17000 xg, ambient 
temperature) and then resuspended in a volume of DNA binding buffer equivalent to 25 
times the volume of matrix used. The DNA-bound matrix was centrifuged again, and 
resuspended in 25 times the matrix volume of 80% ethanol. After repeat centrifugation, the 
DNA-bound matrix was suspended in the same amount of 80% ethanol and re-centrifuged. 
The pellet was allowed to air-dry before resuspending in two pellet volumes of sdH20 and 
incubating at 37°C for 15 minutes to allow DNA to be eluted from the matrix. The mixture 
of DNA solution and matrix was separated by centrifugation and transfer of the supernatant 
to a clean tube. This step was repeated to ensure no residual matrix inadvertently remained 
in the DNA solution. 
2.7 Plasmid constructs. 
2.7.1 Cloning TnS insertion points. 
A series of clones was made to allow the DNA sequence flanking the Tn5 insertion point in 
mutants to be ascertained. The majority of these clones took advantage of the unique Sal! 
site in Tn5, which is found at base 2684, and the relative frequency of Sal! sites in the P. 
aureofaciens genome. These features allowed the recovery ofKmR clones that had the 5' 
2684bp ofTn5 (encodes KmR) plus adjacent P. aureofaciens DNA. A number of insertion 
points also were cloned with EcoRI which has no recognition site in Tn5, resulting in KmR 
clones that contain an intact Tn5 flanked by P. aureofaciens DNA on both sides (see Figure 
2.1 for illustration). 
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a. Sal! EeoR! Sal! 
I 
EeoR! 
I KmR ....... , .............. 
b. Sal! Sal! 
\ 
I KmR 
c. EeoR! EcoRl 
KmR I 
Figure 2.1. Strategy for cloning Tn5-interrupted sequences. Grey boxes indicate Tn5. a. Diagram ofTn5 
inserted into the genome ofPA147-2. Broken lines indicate continuation of the genome in both directions. b. 
SalT clone derived from the Tn5 mutated region. Note that the clone has Tn5 sequence remaining (~2.7kb), 
which includes the KmR gene. This clone only contains chromosomal DNA on one side of the Tn5. Double 
lines indicate cloning vector DNA. c. EcoR! clone derived from the Tn5 mutated region. This clone contains 
the entire Tn5, and has chromosomal DNA on each side of the transposon. Double lines indicate vector 
DNA. 
pCMl. 
4kb Sal! fragment from PAl cloned in pBLUESCRIPT KS-. Immediately adjacent to the 
transposon are the first 43 bases of jinT. 
pCMI09. 
5kb Sal! fragment from PAI09 cloned in pBLUESCRIPT KS-. The clone contains the 5' 
1371 bases ofjinT. 
pCM138. 
4kb Sal! fragment from P Al3 8 cloned in pBLUESCRIPT KS-. The cloned sequence 
containsjinR interrupted by Tn5. 
pCM168. 
6.4kb Sal! fragment from PAl68 cloned in pBLUESCRIPT KS-. DNA sequence adjacent 
to the transposon has no significant similarity to known genes. 
pCME21. 
6.5kb Sal! fragment from P AE21 cloned in pBLUESCRIPT KS-. The Tn5 is within a 
sequence showing similarity to a galactosyl transferase gene. 
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pCMH26. 
4.2kb Sail fragment from P AH26 cloned in pBLUESCRIPT KS-. pstA is interrupted by the 
transposon in this clone. 
5.8kb Sall fragment from PAI17 cloned in pBLUESCRIPT KS-. DNA sequence adjacent 
to the transposon has no significant similarity to lmown genes. 
pCMI75. 
7kb Sall fragment from PAI75 cloned in pBLUESCRIPT KS-. The transposon interrupts a 
sequence with similarity to the 3' end of an alginate lyase 
6.9kb Sail fragment from P AI95 cloned in pBLUESCRIPT KS-. The predicted translation 
product derived from the sequence adjacent to the transposon has similarity to RagC and 
other multi drug efflux pumps. 
11.5kb EcoRI fragment from PA138 cloned in pBLUESCRIPT KS-. This clone contains 
finR with a Tn5 insertion. 
20kb EcoRI fragment from P AA3 cloned in pBLUESCRIPT KS-. The DNA sequence 
flanking the transposon in this clone has no significant similarity to known genes. 
pCMA3B. 
9kb BamHI-EcoRI fragment from pCMA3E cloned with pME6000. 
pCMH26E. 
9 .5kb EcoRI fragment from P AH26 cloned in pBLUESCRIPT KS-. This clone contains 
pstA with a Tn5 insertion, pstC, and part of pstS. 
2.7.2 recA constructs. 
pPRAM1 AND pPRAM4. 
The plasmids pPRAM1 and pPRAM4 were created by insertional mutagenesis ofpRECl 
with miniTnlO derivative 112 (section 2.15). Both plasmids could confer TcR and KmR 
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upon host bacteria, but were unable to confer UV and MMS resistance. pPRAM1 has a 
miniTnlO insertion approximately 500 bp into recA, while pPRAM4 has an insertion 
approximately 950 bases into the recA gene. 
pPRAM1.1 ANDPPRAM4.1. 
These plasmids were made by digesting pPRAM1 and pPRAM4 with BamHI and ligating 
with BamHI digested pBR322. The desired clones were selected on the basis ofKmR, the 
gene for which is not interrupted by the BamHI site in the miniTnlO. The resulting 
subclones have approximately half ofthe miniTnl 0 (one copy ofIS 10) and P A 147 -2 DNA 
flanking the insertion point in the cosmid. pPRAM1.1 has approximately 200 bases of the 
PA147-2 recA gene, while pPRAM4.1 has approximately 600 bases ofthe recA gene. 
Subcloning of an MMSR region from pREC1 was accomplished by digesting the cosmid 
with EcoRI and HindIII, and ligating to identically digested pME6001. The ligation was 
used to transfonn E. coli DH5a to GmR and MMSR. A 6kb EcoRIlHindIII fragment was 
found to confer MMS (methane methyl sulphonate) resistance, and the clone was 
designated pREC6g. 
pREC6Ml, pREC6M2, AND pREC6M3. 
pREC6g was mutagenised using miniTnlO derivative 103 (KmR). Restriction mapping 
demonstrated that each of these clones has a different insertion, as shown in Figure 2.2. 
Each of these clones is GmR and KmR, and unable to confer MMSR upon recA strains of E. 
coli, indicating insertions in recA. 
Ml M2 M3 VVV lkb 
··· .. ""·""·,,· .. ·"·""·'1 -::L-Y,I,:L------'T'I-------~:::::r:r"::::"":::: .... "= .. ·.. = .... ·=" .. ·~ .... · 
EcoRI BamBI BamBI HindlIl 
Figure 2.2. MiniTnlO insertion points in the 6kb EcoRIIBamHI recA region of pREC6g. The broken line 
indicates the vector pME600 1. 
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pRECEB, pRECB, AND pRECBH. 
In order to sequence the P. aureofaciens recA, three subclones of pREC6g were generated 
by ligation of EcoRIlBamHI, BamHI, or BamHIIHindIII cut DNA with appropriately 
digested pBLUESCRIPT KS- (Stratagene). The subclones were designated pRECEB, 
pRECB, and pRECBH (Figure 2.3). With respect to the multicloning site in 
pBLUESCRIPT KS-, the cloned fragments are oriented as follows. The EcoRIlBamHI 
fragment has the EcoRI site 5' relative to the BamHI site. The BamHI fragment in pRECB 
has the left most BamHI site (as illustrated in Figure 2.3) at the 3' end, close to the T3 
promoter-primer binding site. The BamHIIHindIII fragment is oriented with the HindIII 
site 5' relative to the BamHI site. 
··· .... ··· ...... ···· .... rl ---'Ir--------"-----------rl················· .. ····· pREC6g 
EcoRI Bam HI BamHI Hil1dIII 
i. pRECEB 
.---lk-b--~------------ji~:P-RE-C-B--------------~;PRECBH 
Figure 2.3. Sub cloning ofpREC6g to create the clones pRECEB, pRECB, and pRECBH. The horizontal 
broken line indicates the vector for pREC6g (pME6001). 
pREC6L. 
To construct a plasmid that would facilitate the creation of recA deletions in P. 
aureofaciens, a vector that is unstable in P. aureofaciens is desirable. For this reason, the 
6kb recA-containingEcoRIlHindIII fragment was cloned from pREC6g into pLAFR3, 
creating the clone pREC6L which was used in further recA constructions. 
pREC6L~B. 
This plasmid was constructed by digesting pREC6L at the two BamHI sites, one of which 
is found within the recA coding region and the other is 2.4kb upstream of recA. The 
digested DNA was ligated to itself and used to transform E. coli DH5a. The transformants 
were screened for MMSs, and then for loss of the 2.4kb BamHI fragment. 
Chapter 2 Experimental procedures 51 
pREC6L~BG. 
pREC6L~Bg was constructed by introducing the 2.4kb GmR BamHI fragment from 
Tn5B61 into the unique BamHI site in pREC6L~, thus introducing a selectable marker 
into the construct for use in allele exchange mutagenesis of recA. 
2.7.3 Plasmids used in the study ofjinR (PA138). 
pCM1380S AND PCMSUB. 
pCM1380S is a Sal! subclone from pCM138E. Relative to pCM138, this clone has the 
other side ofthe Tn5 from PA138, plus adjacent DNA (see Figure 2.4). pCMsub is a 
BamHVEcoRI sub clone from pCM138E. It contains the I(mR gene from Tn5, and the 
complete jinR138 allele (see chapter 5). 
Tn5 
V pCM138E I I 
RI H RI pCM138 
50 I I pCM1380S s s 
pCMsub 
I I 
B RI 
Figure 2.4. Construction ofpCM138 subclones. The bold line indicatesfinR, and the triangle indicates the 
relative position of Tn5 in finR. S=SalI; B=BamHI; RI=EcoRI. 
pHRP309CM. 
The CmR 0 cassette from pHP45-0Cm was cloned in the Bam HI site of pME6000, 
resulting in the plasmid pMEO. The CmR cassette was cloned from pMEO into pHRP309 
using Sal! and EcoRI. pHRP309Cm has an omega cassette inserted adjacent to the start of 
the promoterless ZacZ, to reduce read-through from plasmid sequences. 
pFRTR833. 
This plasmid was constructed by a three-step procedure. Firstly, an 833bp SalVCZaI 
fragment from pCM138E was cloned in pBLUESCRIPT KS to create pFIN833. This 
digestion resulted in the sub cloning of jinR, from position 45 in the predictedjinR coding 
sequence (Sal! side), and the CZaI recognition sequence begins at base pair 570 of the 
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predictedfinA coding sequence. Thus, promoters for bothfinR andfinA were likely to be 
within the 833bp. pFIN833 was digested with EcoRI and KpnI, and cloned with identically 
digested pMEO. The resulting clone had the intact 833bp region adjacent to the Oem 
sequence, with the finR promoter oriented such that finR reads away from the Oem 
sequence. The final step in creating pFRTF833 was subcloning the entire 833bp plus Oem 
region into the lacZ fusion vector pHRP309, using KpnI andXbaI. In pFRTF833 thefinR 
promoter reads toward lacZ, resulting in a transcriptional fusion. Read through from the 
vector should be eliminated by the 0 cassette. 
pFATF833. 
pF ATF833 was constructed in a similar way to pFRTF833. The 833bp region from 
pFIN833 was cloned into pHRP315 using EcoRI and KpnI, resulting in plasmid pHRP833. 
The 833-bp insert in pHRP833 is adjacent to a OSm cassette, and thefinA promoter reading 
away from the cassette. The entire 833bp plus the OSm was then cloned in pHRP309 in 
such a way that finA is oriented toward the lacZ gene. This was achieved using EcoRI and 
XbaI. The presence of the 0 cassette on the other side ofthefinA promoter (relative to 
lacZ) should prevent transcriptional or translational read-through from the vector. 
pFATFlOOO. 
pFATFIOOO was constructed in a two-step process. Firstly, a SalIlEcoRI fragment from 
pMSAI03 was cloned into equivalently digested pHRP833. pMSA103 is a Sall subclone 
from cosmid pPS192, and contains all offinR except the initial 39bp, which is contained in 
pHRP833. Thus, ligation ofthe SalIlEcoRI fragment into pHRP833 results in the 
reconstruction offinR, by joining the sequences at the Sall sites. Like pFATF833, thefinA 
promoter reads away from the OSm cassette, which is found downstream offinR. This 
clone was called pHRPIOOO. pHRPIOOO was digested to completion with EcoRI, and then 
partially digested withXbaI prior to ligation with EcoRIlXbaI digested pHRP309. The 
resultingfinA::lacZ fusion construct was called pFATFIOOO. 
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pFATF2000. 
To clone thefinR138 allele adjacent to thefinA promoter in pHRP833, pCM138 was 
digested with SaIl and Sma!. pHRP833 was digested with XhoI, end-filled with Klenow, 
then digested with SaIl. The digests were mixed and ligated. The resulting clone, in which 
afinR138 allele is reconstructed by ligation of the SaIl ends was named pHRP2000. This 
clone has finA promoter reading away from finR13 8, which has the nSm cassette 
downstream of it. pHRP2000 was digested to completion with EcoRI, then partially 
digested withXbaI. These fragments were ligated to EcoRIlXbaI digested pHRP309, 
resulting in the creation ofpFATF2000. pFATF2000 has afinA::lacZ fusion with a 
finR138 allele downstream. The entire EcoRIlXbaI insert DNA is approximately 6kb. 
pDELKL. 
pDELKL was generated in several steps, beginning with PCR amplification of the 
sequences tlankingfinR. As indicated-in the Figure 2.5, one primer in each pair had a 
BamHI recognition sequence included (see appendix 3). 
pDELl and pDEL2 were constructed by PCR and cloning of the amplified DNA. After 
BamHI digestion and ligation, PCR using primers 1 and 4 allowed the amplification of the 
finR deletion. Following construction ofpDEL3, a KmR gene (from pNK2859) was cloned 
into the BamHI site, resulting in pDELKg. Finally, the EcoRI region from pDELKg was 
cloned in pLAFR3, creating pDELKL. The cloned EcoRI region has the complete deletion 
ofjinR, replaced with the KmR gene. 
pDELl 
6 
BamHI 
-ctL 
......, 
Ball/HI 
~ • • 
~ • • • • 
e 
BamHI 
PCR using primer pairs 1+2 and 3+4 
Cloning with pGEMT-Easy 
pDEL2 
BamHLdigests ofpDBLl andpDEL2 
Ligation.of:t;l:rie.B41'nHI ends ... 
peR atnplifiCEltlOlly.ith.prlmersl +4 
Cloning \vithpGEMT-Ea~y 
Figure 2.5. Construction ofpDEL3. The thick line representsfinR, while the thin horizontal lines represent 
flanking DNA. Horizontal arrows represent primers, 1,finRdFwdl; 2,finRdRevla; 3,finRdFwd2; 4, 
finRdRev2 
pRED2L AND pRED2LGM. 
pRED2L was constructed by cloning a 2kb Sall fragment that extends from base 45 infinR 
throughfinA to the next extragenic Sall site. pRED2L contains the entirefinA ORF. 
Initially the SalI fragment was cloned in pUC18 (called pRED2). pRED2L was created by 
cloning the 2kb Sall fragment from pRED2 into pLAFR3, using EcoRl and HindIIl from 
the p UC18 multi-cloning site. pRED2Lgm was constructed by digesting pRED2L with 
Clal, and using the Klenow fragment to fill in the overhanging ends. The GmR gene from 
the plasmid pJQ200 was isolated by Hindill digestion, and following end-filling using 
Klenow, the GmR encoding fragment was ligated with the linear pRED2L. 
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2.7.4 Plasmids constructed for the study of PAl 09 (fi1lT). 
pAFl6M. 
pAFl6M was constructed by cloning the l6kb EcoRI fragment from cosmid pPS7138 in 
the vector pME6000. The l6kb region is that which is interrupted by transposon insertions 
in PAl09 and PAl. 
pAF9. 
9kb BamHIIEcoRI fragment from pAFl6M cloned in pLAFR3. 
p AF9: :MINITN 10. 
Seven miniTnlO insertion mutants of pAF9 were made. These were named pAF9.2, 
pAF9.38, pAF9.45, pAF9.55, pAF9.6, pAF9.66, and pAF9.68. The positions of these 
insertions within the 9kb are shown in. Figure 2.6. 
BamHI 
I 
9.2 
\! 
SstI 
lkb I 
9.38 9.45 
\! \! 
9.6 9.66 9.68 
9~5~ W 
EcoRI 
Figure 2.6. MiniTnlO insertions in pAF9. Triangles represent miniTnlO. Numbers above the triangles 
indicate the name of the particular plasmid with an insertion mutation. The bold line between BamHI and Sst! 
indicates finT. 
p AF9M, pAF8M, P AF7M, P AF6M, AND P AF2M. 
These five plasmids are sub clones from pAFl6M, cloned in the vector pME6000 for 
complementation experiments. Their construction is illustrated in Figure 2.7. 
pAF2BK. 
The clone pAF2BK was constructed by cloning the 2kb BamHIISstI fragment from pAF2M 
with the vector pBLUESCRIPT KS-. 
RI B Ss RI 
pAFl6M 1\------.R!IIIIIIJI!IIIIIII4----------l yQ 
pAF6M ! 
pAF8M ,r--------+--...., 
pAF2M 
pAF9M I 
pAF7M , 
Figure 2.7. Construction ofjinTsubclones. pAF9M, pAF8M, pAF7M, pAF6M, and pAF2M were created 
by subcloning from pAFI6M. The number in each clone's name indicates the size of the cloned region in kb. 
RI=EcoRI; B=BamHI; Ss=SstI. For reference, the sites of transposon insertion in P A 109 and PAl are 
indicated with triangles. The position ofjinT is indicated by the bold horizontal line in pAF16M. 
2.8 Protein labelling eSS-cysteine and 3SS-methionine). 
2.8.1 Maxicells. 
GENERATION OF MAXICELLS. 
In order to generate maxicells, the E. coli strain CSR603 was transfonned by the 
appropriate plasmids. Cultures of CSR603 containing the plasmids were grown for 18 
hours in LB, then subcultured 1:100 into K-medium (appendix 1) supplemented with Tc, 
and allowed to grow until an OD600 of 0.5 was reached. The bacteria were subcultured 1 :50 
in K-medium and allowed to grow to OD600 of 0.4.-0.5. Aliquots (2mL) were placed in 
Petri dish bases and exposed to UV light (250j..tJ/cm2) using an Ultralum UVC515 
ultraviolet multilinker. Immediately after irradiation, the bacteria were placed in foil-
wrapped Universal bottles and incubated for one hour at 37°C. To assess the number of 
survivors, 50j..tL aliquots were spread onto LB plates, which were incubated for 24 hours. 
Generally this procedure yielded less than 20 cfulmL after the UV treatment. Once the 
50j..tL sample had been removed, fresh D-cycloserine solution was added (final 
concentration 100j..tg/mL) and incubation was continued for 16-18 hours. 
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LABELING PROTEINS EXPRESSED IN MAXICELLS. 
Cells were collected by centrifugation and washed twice with sulphate-free Hershey salts 
before resuspending in 1.5mL of Hershey medium. The cultures were incubated for one 
hour (37°C) before the addition of 35S-labelled methionine and cysteine (Promix, 
Amersham Pharmacia Biotech, 14mCi/mL) to a concentration of 2011Ci/mL, and a further 
one hour incubation. Cells were harvested by centrifugation and suspended in 50-100)lL 
dH20. An equal volume of2x treatment buffer (appendix 1) was added, and the samples 
were then boiled for three minutes and used, or stored at -80°C until required. 
2.8.2 Total soluble proteins. 
Total soluble proteins expressed by PA147-2, PAI09, and PA138 were labeled during 
growth under conditions known to support antifungal compound synthesis. The 
appropriate bacteria were grown for two days in 20mL of buffered PDB at 25°C before the 
addition of 35S-1abelled methionine and cysteine (2011Ci/mL). Incubation was continued 
for a further hour before 1.5 mL of the bacteria were harvested by centrifugation, and 
washed in cold minimal salts to remove extraneous labeled amino acids. The bacteria were 
suspended in 10011L dH20 and an equal volume of 2x treatment buffer. Samples were 
boiled for three minutes prior to protein separation by SDS-PAGE. Excess sample was 
held at -80°C for further use. 
2.9 SDS-P AGE of labeled proteins. 
2.9.1 SDS-PAGE. 
Denaturing polyacrylamide gels were made according to recipes outlined in Biorad 
instruction manuals accompanying the protein electrophoresis systems. Recipes for buffers 
and gels are given in appendix 1. 
SDS-PAGE was carried out using either a Biorad mini protean II or a Biorad protean II 
system. Gel casting apparatus was assembled as described by the manufacturer using 
0.75mm spacers. The resolving gel was prepared and poured between the glass plates, then 
overlaid with water or water-saturated butanol to exclude oxygen and thus aid 
polymerisation. Once poiymerisation was complete, the water or butanol was removed and 
the exposed gel surface rinsed with dHzO prior to pouring the stacking gel and inserting the 
appropriate well-fonning comb. After one hour the gel and electrophoresis apparatus were 
assembled and the appropriate volume of Tris-glycine tank buffer was poured into the 
upper and lower reservoirs. The protein samples (with treatment buffer) were boiled for 
three minutes before loading between 10 and SOI-lL onto the gel. Proteins were subjected to 
electrophoresis at lS0V using the Mini protean II system, or at l3mA for the stacking gel 
and 18mA through the resolving gel (per gel) when using the Protean II equipment. A wide 
range protein standard (Sigma) was used as a molecular weight marker. 
After electrophoresis, gels were stained in Coomassie Brilliant Blue (R-2S0) for one hour, 
then destained in destain solution 1 (one to three hours) and destain solution 2 (12-16 
hours) (see appendix 1). 
2.9.2 Autoradiography. 
After destaining, gels were rinsed in dHzO, soaked in AmplifyTM (Amersham) for 30 
minutes, then rinsed in dHzO again. Gels were dried onto Whatman number 1 
chromatography paper for two to five hours using a Biorad model 443 slab dryer. 
Amersham hyperfilm-MP was exposed to the dried gel in an autoradiography cassette at -
80°C for between one and four days. The film was then developed in AGF A G-lS0 
developer for five minutes, followed by a one minute rinse in dHzO. The film was fixed in 
AGF A G-334 fixer for two minutes, and rinsed in tap water. 
2.10 DNA sequencing. 
The nucleotide sequence of dsDNA was determined using an ABI Prism Model 377 
Automated Sequencer utilizing Rhodamine terminator chemistry, or by using aLI-COR 
Model 4000L Automated DNA sequencer with infrared dye (IRD40) teclmology. All DNA 
sequencing utilised chain tenninating dideoxynucleoside triphosphate (Sanger et aI., 1977). 
2.10.1 ABI Prism automated sequencing. 
Automated sequencing using the ABI Prism 377 was carried out at the Waikato DNA 
sequencing facility (Department of Biological Sciences, The University ofWaikato). This 
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system was used when primers other than the T7 and T3 promoter primers were required. 
DNA templates and primers were dissolved in sdH20 and supplied at concentrations of 
200ng/flL (12flL total) and 0.8pmol/flL (5flL total) respectively. 
2.10.2 LI-COR automated sequencing. 
When templates could be sequenced using T7 and/or T3 promoter primers, aLI-COR 
4000L DNA sequencer was used. 
CYCLE SEQUENCING REACTION. 
DNA sequencing reactions were carried out using the Thermosequenase fluorescent primer 
cycle sequencing kit with 7-deaza-dGTP (Amersham Pharmacia biotech). Preparation of 
reaction mixes was carried out on ice, and tubes were covered with foil to minimize 
exposure to light. In 0.5flL microfuge tubes, template DNA (lpmol), IR-labelled primer 
(2pmol) and sdH20 were mixed in a tQtal volume of 17flL. Four 0.5flL tubes were labeled 
with A, T, G, and C, and 2.0flL of the appropriate thermosequenase reagent mix (contains 
dNTPs, the appropriate ddNTP, buffer and thermosequenase DNA polymerase) was added 
to each tube. Four microlitres ofthe template/primer mix were added to each tube and 
mixed, and the tubes were then overlaid with 50flL of PCR mineral oil. Reactions were 
cycled in a Hybaid Omnigene thermocyc1er (Appendix 2). Following the thermocyc1ing 
reactions, 4flL of stop solution (formamide, EDT A, fuschin loading dye) were added. 
Reactions were held on ice or at -20°C until the electrophoresis step. 
SEQUENCING GEL ELECTROPHORESIS. 
The LI-COR gel casting apparatus (using 66cm glass plates) was assembled as described by 
the manufacturer. A 4% Long RangerTM Gel Solution (FMC Bioproducts) was prepared 
and cast, after which a 32-well rectangular comb was added. After allowing two hours for 
polymerisation, the comb was removed and the wells washed with 1 x TBE. The apparatus 
was assembled and the gel was pre-run for one hour in Ix TBE running buffer, using 
version 2.31 Data Collection DEV7 software. Scanner control parameters are listed in 
appendix 2. Samples were denatured for three minutes at 95°C, wells were washed for a 
second time, and samples were loaded. Electrophoresis was carried out for 16 hours, and 
results were obtained using Version 2.30 Image Analysis program. 
DNA SEQ'UENCE SIMILARITY SEARCHES. 
DNA sequence data was compared to sequences in public databases using the Blastn and 
Blastx programs (Altschul et aI., 1990; Altschul et ai., 1997) accessible at the website ofthe 
National Centre for Biotechnology Information (http://www.ncbi.nlm.nih.gov/blast). 
2.11 Southern transfer and hybddisation. 
2.11.1 Transfer of DNA from agarose gels to nylon membranes. 
DNA was transferred from 0.7-1.0% agarose gels and immobilised on Hybond N+ 
membranes using a Pharrnacia Vacugene XL blotting system. The apparatus was 
assembled as described by the manufacturer, with the membrane pre-wetted in dH2o. A 
vacuum pressure of 45mbar was applied and maintained throughout the transfer procedure. 
TRANSFER FROM STANDARD AGAROSE GELS. 
The DNA was partially depurinated by covering the gel with 0.25M HCI for ten minutes. 
The HCI was rinsed from the apparatus with dH20, and then the transfer and fixing was 
achieved in a single step by flooding the apparatus with OAM NaOH (alkaline transfer). 
After one hour the NaOH was removed, and the membrane was rinsed in 2xSSC (appendix 
1). The membrane was either used immediately or wrapped in Glad WrapTM and stored at 
4°C until required. The efficiency of transfer was assessed qualitatively by staining the gel 
in ethidium bromide after the transfer was complete and examining it for remaining DNA. 
As specified by the FIGE unit manufacturer (Biorad), FIGE gels were stained for 30 
minutes in fresh ethidium bromide, irradiated with 60mJouies ofUV (Ultralum UVC515 
ultraviolet multilinker) to cleave large DNA fragments, then destained in 0.5x After 
photographing the gel, it was soaked in OAM NaOH for 15 minutes and then the DNA was 
transferred to Hybond N+ using OAM NaOH as the transfer solution. The transfer was 
carried out for four hours with a vacuum pressure of 45mbar. After transfer the membrane 
was washed in 2 x SSC and used as described below. 
2.11.2 Probe labelling, hybrldisation and signal detection using ECLTM. 
ECLTM was used routinely for all Southern detections except those involving membranes 
prepared from FIGE gels. 
LABELING AND HYBRIDISATION. 
Hybridisations were carried out using hybridisation tubes in a Hybaid mini-hybridisation 
oven. DNA transferred from standard agarose gels was hybridised with probes labeled with 
the non-radioactive ECLTM (enhanced chemiluminescence) kit (Amersham). Membranes 
were pre-hybridised in sufficient (approximately 0.lmLlcm2 of membrane) ECL Gold 
hybridisation buffer for one hour at 42°C, during which time the probe was labelled. DNA 
to be labeled was generally a restriction fragment purified from an agarose gel. 
Approximately 100ng of DNA in IOIlL sdH20 in an Eppendorftube was labeled by firstly 
denaturing by heating for five minutes in a boiling water bath and then cooled on ice for a 
fUliher five minutes. After a brief centrifuge spin, 10llL of ECL labeling reagent was 
added and mixed. Immediateiy after, 10llL of glutaraldehyde was added and mixed. 
Contents of the tube were collected by brief centrifugation, and the mixture was incubated 
at 37°C for 15 minutes. Following this, the probe was added to the hybridisation tube 
containing the membrane and hybridisation buffer. Hybridisation took place for 
approximately 16 hours at 42°C. 
WASHING AND SIGNAL DE1ECTION. 
Following hybridisation, the hybridisation buffer was washed from the tube by replacing 
the buffer with 5xSSC and heating the oven to 55°C. Once the temperature had reached 
55°C, the SSC was replaced by primary wash buffer (0.4% SDS, 0.2xSSC) which had been 
warmed to 55°C. The stringency washing was continued for a total 20 minutes, consisting 
of an initial ten minute wash followed by two five minute washes, using fresh, warmed 
primary wash buffer for each wash. The blot was removed from the tube and washed twice 
with 2xSSC, each wash for five minutes. Excess SSC was drained from the blot. 
Signal was detected by exposing the labeled DNA side of the membrane to a mixture of 
equal volumes of detection reagents' 1 'and '2', as specified by the manufacturer. The 
detection reagents were drained from the membrane after one minute, at which time the 
membrane was wrapped in gladwrap. Amersham Hyperfilm-MP was exposed to the 
membrane in an autoradio graphy cassette for two minutes, after which the film was 
developed. The result obtained allowed additional exposure times to be determined, 
depending on the strength of signal. 
DEVELOPING EXPOSED HYPERFILM-MP. 
In a darkroom, the film was agitated in AGF A G-150 developer for five minutes, and then 
rinsed in running water for one minute. After rinsing, the film was immersed in AGF A G-
334 fixer for two minutes. The film was washed in water and allowed to drip-dry. 
2.11.3 Probing FIGE blots using [a_32p] dCTP-Iabeled probe DNA. 
PREP ARA TION OF LABELLED PROBE. 
Linear DNA extracted from an agarose gel was labeled with [a)ZPJ dCTP using the Ready-
To-GoTM DNA labeling kit (-dCTP) (Amersham Pharmacia biotech). 
The contents of the reaction mix tube were reconstituted by adding 20llL of dHzO, and the 
tube was then incubated on ice for 30 minutes. Linear DNA was denatured by heating for 
five minutes in a boiling water bath followed by immediate cooling on ice for five minutes. 
The denatured DNA was added to the reaction mix, followed by l-31lL [a_3Zp] dCTP (3000 
Ci/mM) and dHzO to make up the final volume to 50ttL. The contents of the tube were 
mixed gently and then incubated at 37°C for 15 minutes. 
HYBRIDISA TlON OF LABELED PROBE AND IMMOBILISED DNA. 
The membrane was pre-wetted in 95% ethanol followed by brief immersion in dHzO. The 
membrane was rolled and placed in a Hybaid tube with 10mL of pre-hybrid is at ion buffer 
(preheated to 68°C) (appendix 1). The tube was incubated for at least one hour at 68°C in a 
Hybaid mini-hybridisation oven, and then the solution was replaced with preheated (68°C) 
hybridisation solution (appendix l)containing labeled probe DNA. Hybridisation was 
carried out for 16 hours at 68°C. 
After hybridisation, unbound probe was removed by three washes, all of which were 
carried out for 15 minutes at 68°C. The first wash solution was 100mL of2 x SSC and 
0.1 % SDS, and the two subsequent washes were 100mL of 0.2 x SSC and 0.1 % SDS. The 
washed membrane was dried and wrapped in Glad WrapTM. A Kodak Storage Phosphor 
screen was exposed to the membrane for four to 24 hours. 
DETECTION OF SIGNAL FROM KODAK STORAGE PHOSPHOR SCREENS. 
Exposed Kodak Storage Phosphor screens were scanned with the Molecular Dynamics 
Storm™ 840 system, (Scanner Control version 4.00, build 54), using the Phosphor screen 
scanner type at 7 40V. Data were viewed and manipulated using the Molecular Dynamics 
ImageQuaNTTM (version 4.2a, build 13) software package. 
2.12 Uptake of inorganic phosphate ([32p]K2HP04). 
Cells grown overnight in LB (18-24 hours) were harvested, washed in phosphate-free salts 
(PGTIPS), and then grown to exponential phase in either KlO with the desired 
concentration of Pi, or the appropriate phosphate defined medium. Exponentially growing 
bacteria were chilled on ice and then washed twice with PGTIPS and suspended in 600~L 
ofPGTIPS supplemented with Tc (a translation inhibitor). Ofthis 600~L, 100~L was used 
to determine the viable cells per mL. eZp]KzP04 was added to 500llL aliquots of cells to a 
final concentration of20~M (200mCi.mMor1), and SO~L samples were taken at one, two, 
and three minute intervals. Each 50~L sample was immediately mixed with 500~L of 
PMM saIts (excess unlabelled Pi) in order to effectively halt uptake oflabeled Pi by 
providing a high concentration of unlabelled Pi to dilute labelled Pi to negligible levels. 
Samples were then applied to Millipore filters (0.22~m pore size) by filtration, and the 
immobilized cells were washed twice by filtering through minimal salts (SmL per wash). 
Filter membranes were removed and placed in scintillation vials containing SmL of 
scintillant fluid (Packard Ultima gold). Pi-uptake was measured using a Wallac 1410 liquid 
scintillation counter (Pharmacia) to determine beta counts per minute. 
By constructing a standard curve using beta counts produced by known amounts of 
eZp]KzP04 it was possible to convert the beta counts per minute from the samples into 
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amount of Pi up taken. Standard curves were constructed at the same time as the assays for 
which they would be used were carried out. Viable, culturable cell counts for each test 
culture were used to calculate the amount of 32Pi uptake per 1 x 108 bacterial cells. 
2.13 Alkaline phosphatase assays. 
2.13.1 Qualitative assay. 
Qualitative assays for alkaline phosphatase were carried out by adding BCIP to the 
appropriate agar plate. BCIP is a chromogenic substrate for alkaline phosphatase, and 
when cleaved by a bacterium producing APase, produces distinctive blue colonies. 
2.13.2 Quantitative assay. 
Quantitative assays were carried out using broth cultures of bacteria grown in the 
appropriate liquid medium. Cultures were grown to either exponential phase or overnight 
(16 hours). After the OD600 was determined, 500~L aliquots of cells were treated with 
20flL of chloroform and lOflL of 0.1 % SDS and incubated at ambient temperature for ten 
minutes to partially disrupt the cell membrane. After disruption of the membrane, the pH 
was adjusted by the addition of200~L of 1M Tris-HCI (PH8). p-Nitrophenol phosphate, a 
chromogenic substrate for alkaline phosphatase, was added at (20~L of a 50~M stock). 
The reaction was allowed to proceed at ambient temperature, and was stopped by adding 
1 OO~L of 2 o Omg/mL glycerol-3-phosphate once sufficient yellow colouration had 
developed. After separation from the cell debris by centrifugation (ten minutes, 17000 x g, 
ambient temperature) the yellow reaction product was measured at OD410. Alkaline 
phosphatase activity is expressed as nM p-nitrophenol produced per minute per OD600. The 
amount ofp-nitrophenol produced was calculated with the relationship that 0.05~M.mL-l 
gives an OD410 reading of 0.89. 
2.14 ~-galactosidase activity assay. 
Assays for ~-galactosidase activity were carried out essentially as described (Miller, 1972). 
Cultures were grown in the appropriate medium for the desired length of time, following 
which 1mL of cells were collected by centrifugation, and washed with cold minimal salts. 
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The cells were resuspended in 1mL of minimal salts. An OD600 reading was taken from 
900f.LL of cell suspension and the remaining lOOf.LL of the suspension was added to 900f.LL 
of Z-buffer. Two drops of chloroform and one drop of 0.1 % SDS were added to disrupt 
cell membranes. Following ten seconds of vortex mixing, the lysed culture was 
equilibrated at 30°C for ten minutes, before the addition of 200f.LL of ONPG (4mg/mL, 
dissolved in Z-buffer). The reaction was left until a yellow colour developed, after which it 
was stopped by adding 500f.LL of 1M Na2C03. The time in minutes was recorded. The 
reaction sample was centrifuged to remove cellular debris (ten minutes, 17000 x g, ambient 
temperature), and the OD420 of the solution was measured. ~-galactosidase activity was 
calculated in Miller units using Equation 2.1. 
Units = 1000 x __ O_D--=42=O,--_ 
tx vx OD600 
Equation 2.1. Formula for calculation of ~-galactosidase activity in Miller units (Miller, 1972). t = time of 
assay (minutes); v = volume of cell suspension used in the assay (mL); OD600 is the cell density before the 
assay; OD420 is the reading of the yellow colour from the assay. 
2.15 Insertional mutagenesis with miniTnlO. 
Insertional mutagenesis using miniTnlO elements was carried out essentially as described 
(Kleckner et aI., 1991). The miniTnlO elements used in this study were carried on phage Iv. 
GROWING PHAGE Iv LYSATES. 
A high titre phage stock (1010 cfu/mL or greater) was prepared as follows. An LB plate 
was overlaid with H -Top agar containing lOOf.LL of a saturated culture of E. coli PB2480 (a 
permissive host) grown in LBMM. Phage stock was 10-fold serially diluted and lOf.LL 
aliquots of the dilutions were applied to the plate. After overnight incubation at 37°C, a 
single well-isolated phage plaque was picked and transferred to 10mL ofLBMM broth 
containing lOOf.LL of a fresh saturated PB2480 culture (grown in LBMM). This culture was 
allowed to grow for five to six hours with vigorous shaking (350rpm) until it had visibly 
cleared. To maximise cell lysis, lOOf.LL of chloroform was added, and the culture was 
shaken before being allowed to settle for ten minutes at ambient temperature. Cellular 
debris was removed by centrifugation, and the supernatant was transferred to a sterile 
Universal bottle for storage at 4°C. 
GENERA TING INSERTIONS INTO PLASMIDS. 
The plasmids to be mutated were used to transform coli MC41 00, a supO strain that is 
not permissive for replication of the phage/.. vehicle. The transformants were grown to 
saturation in LBMM, and concentrated to approximately 1010 cells per mL in fresh LB. 
Phage were added to the bacteria at various multiplicities of infection (range from 0.1 to 1) 
and allowed to adsorb for 15 minutes at ambient temperature followed by 15 minutes at 
37°C, Cells were washed in LB containing sodium citrate (50mM) and grown in LB plus 
citrate for one hour, after which they were plated on LB supplemented with sodium 
pyrophosphate (L25mM) and appropriate selection for the presence of the plasmid and 
transposon. The colonies were washed off the plate and plasmid DNA was prepared from 
them. The plasmid DNA was used to transform MC4100. Transformants were selected on 
LB supplemented with antibiotics to select plasmids bearing a transposon insert 
Transformants were screened for the desired phenotype, or plasmids were extracted and the 
site of insertion was determined by restriction mapping. 
2.16 Field trial methods. 
2.16.1 Treatment of crowns. 
PA147-2 was cultured at 30°C in LB media to a viable count of 1 x 108 CFU mr! (250 
rpm, 24 h). The culture was maintained on ice during transportation to the field. Asparagus 
crowns were inoculated by submergence in a suspension ofPA147-2 for 25 minutes with 
gentle agitation. Untreated controls were dipped in sterile distilled water (dH20), and LB 
treatment was carried out by dipping crowns in the medium. Crowns were planted within 
30 minutes of treatment. 
2.16.2 Bacterial population study. 
Aerobic, Rf bacteria were isolated at two-week intervals from the rhizosphere and soil 
surrounding the rhizosphere (non-rhizosphere) from both P A14 7-2 inoculated and control 
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crowns within guard rows. Random soil samples of Ig each were collected from each 
sample area and placed in 100 mL of sterile dH20 containing 109 of sterile gravel (7mm 
coarse chip). Following agitation (250 rpm for 20 minutes), seriallO-fold dilutions were 
spread-plated on LB agar supplemented with Rf and Cx and incubated (30°C for 24 h). 
Culturable rifampicin resistant (R:f) CFU g-l were determined for rhizosphere and non-
rhizosphere samples and the mean determined for the four samples. 
2.16.3 ruR isolate analysis. 
The following procedures used a -80°C stock of the original PA147-2 inoculation culture as 
a comparative control in all experiments. Colony morphology ofR:f isolates was compared 
using a stereo microscope and cellular morphology was observed by Gram staining. 
Bioassays against P. megasperma var. sojae were carried out as described (Carruthers et 
al., 1994). Fluorescent siderophore production was determined by incubation (30°C for 72 
h) of isolates on Pseudomonas Minimal Media (PMM) followed by viewing under UV 
illumination (260 nm). Antibiotic resistance of isolates was determined by replica-plating 
onto LB agar supplemented with either Rf, Ap, Km, Gm, Nal, 8m or Tc and following 
incubation for 24-72 h at 30°C, bacterial growth was assessed. Analytical profile index 
(API) 20 NE strip analysis was performed according to the manufacturer's protocol (Bio-
merieux). 
2.16.4 Harvest statistical analysis. 
After harvest, individual plants were visually graded on percentage of diseased foliage 
using a scale of 1 - 5 (1 = 0%, 2 = 1-20 %, 3 = 21-40%, 4 = 41-80%,5 8 00%) and 
analysed by fitting an ordinal logistic model. Fern dry weights for each treatment were 
analysed for significant differences using a one-sided t-test. 
2.17 Construction of lacZY marked PA147-2. 
The lacZY genes from E. coli were introduced into PA147-2 as described (Barry, 1988). 
pMON7197 containing a modified Tn7 element bearing lacZYwas mobilised into PA147-2 
by conjugation. P. aureofaciens strains bearing a transposon insertion were selected by the 
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ability to grow on lactose minimal medium (M9 supplemented with 0.4% lactose as the 
sole carbon source). 
2.18 Competition experiments. 
Competition experiments were carried out in 20mL ofPMM at 2SoC. Competition cultures 
were inoculated with 1 :200 dilutions of the appropriate bacteria grown for 20 hours in LB. 
The 20 hour old inoculum was started from stock held at -80°C. The competition cultures 
were sampled every 24 hours, and these samples were 10-fold serially diluted. Plating of 
serial diluted cultures on PMM plus Xgal, PMM plus Km, and M9 lactose medium allowed 
enumeration of Lac + and KmR bacteria in addition to counts of blue and white colonies on 
PMM, supplemented with Xgal. 
2.19 Amplification of DNA by the polymerase chain reaction (PCR). 
Target regions of the P. aureofaciens PA147-2 genome were amplified using AmpliTaq 
Gold (Perkin-Elmer). PCR was carried out in O.SmL, thin-walled tubes, in total reaction 
volumes of2S).tL. The composition of the reaction included l).tL of template (either 
bacterial total DNA, or a suspension of bacterial cells), 2.S).tL lOx PCR buffer, O.S).tL 
dNTPs (from a 10mM stock), 10pmol of each primer, O.S).tL of AmpliTaq gold, and an 
empirically determined concentration ofMgCb. Reactions were made up to the total 
volume with sdH20, and overlaid with mineral oil. Thermal cycling was carried out in a 
Hybaid omnigene, using the programs listed in appendix 2. Following completion of the 
amplification, PCR products were examined using agarose gel electrophoresis, and purified 
as required for further use. 
2.20 Reverse transcription PCR (RT-PCR). 
2.20.1 RNA preparation. 
RNA was prepared from PA147-2 using the SV total RNA isolation system (Promega), 
following manufacturer's recommendations. The RNA extracts were subjected to an 
additional DNase treatment using RNase-free DNase (Life technologies) followed by 
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phenol!chlorofonn and chlorofonn extractions. Finally, RNA was precipitated using three 
volumes of ethanol and 1120 volumes of 5M NaCI, and was washed with 70% ethanol. 
2.20.2 RT-PCR. 
RT-PCR was carried out using Ready-to-go RT-PCR beads (Amersham Phannacia 
biotech). The manufacturer's instructions for one-step RT-PCR were followed. A control 
reaction was carried out in which reverse transcriptase was inactivated by heating at 95°C 
for 10 minutes prior to the reverse-transcription step. No DNase-treatment control was 
used since the RNA had been DNase treated twice, and such a control was not suggested to 
be necessary by the manufacturer. Reactions consisted of 10pmoi of each primer, 500-
1000ng of RNA, and the contents of the Ready-to-go bead (M-MuLV reverse transcriptase, 
Taq polymerase, reaction buffer, dNTPs, RNase inhibitor). Reaction volumes were made 
up to 50~L with diethyl pyrocarbonate (DEPC)-treated sdH20, and cycled in a Hybaid 
omnigene thennal cycler (see appendix 2 for program details). Amplified DNA was 
visualised by agarose gel electrophoresis. 
2.21 N-terminal protein sequencing. 
2.21.1 Transfer of proteins to PVDF membrane. 
SDS-PAGE was carried out as described above. Once complete, the proteins were 
transferred to PVDF membrane (Biorad) using a Biorad mini trans-blot® electrophoretic 
transfer cell, according to the manufacturer's instructions. The gel was allowed to 
equilibrate in the transfer buffer (25mM Tris, 192mM glycine, 20% v/v methanol) for one 
hour. To wet the PVDF membrane, it was submerged in methanol for five seconds, and 
then transferred to a container of transfer buffer. Membrane saturation was apparent when 
the membrane stopped floating on the buffer surface. Two pieces of Whatman number 3 
filter paper cut to the size of the gel were saturated with transfer buffer, as were two fibre 
pads. A "transblot sandwich" was prepared by placing items in the following order into the 
gel holder cassette. First, a fibre pad was laid onto the holder. One piece of filter paper 
was layered onto the pad, and then the gel was carefully layered onto the paper. The pre-
wet PVDF was placed onto the gel, ensuring that there were no air bubbles trapped between 
the gel and membrane. Filter paper and finally the second fibre pad were layered on top of 
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the membrane. The cassette could then be closed, placed in the transfer tame, and covered 
with cold (4°C) buffer. The transfer was carried out at 30V for 16 hours, in a 4°C 
refrigerator. The buffer was continually circulated using a magnetic stirrer. 
After the transfer was complete, the PVDF membrane was removed from the apparatus, 
rinsed in dH20, and saturated in methanol for five seconds, prior to staining. Protein on the 
membrane was detected by staining with Coomassie brilliant blue R250 (see appendix 1 for 
recipe). After saturating the membrane in methanol, it was transferred to the Coomassie 
blue stain, and allowed to stain for one minute with constant orbital shaking. Immediately 
after the staining, the membrane was transferred to 50% methanol to destain. Several 
changes of destain were required to properly visualise the proteins of interest. 
2.21.2 N-terminal sequence determination. 
The protein of interest on the stained membrane was marked on the membrane with pencil. 
The membrane was carefully packaged and sent to The University of Auckland Protein 
Analysis Facility for N-terminal sequence determination using an Applied Biosystems 
Procise sequencer. N-terminal sequence obtained from this procedure was used to search 
the Swissprot database for similar proteins, using the ExP ASy www server 
(http://expasy.proteome.org.auitools/scnpsit2.html). 
2.22 Abiotic biofilm assay. 
Abiotic biofilm assays were carried out essentially as described (O'Toole & Kolter, 1998b). 
Briefly, the wells of PVC microtitre plates were filled with 98f!L of the appropriate 
medium, and then inoculated with 2f!L of bacteria from an overnight culture. The plate 
was covered and incubated at 30°C for 16 hours. Following incubation, 25f!L of 1 % 
crystal violet solution was added to each well and allowed to stain for 20 minutes, after 
which the wells were vigorously rinsed with tap water. Biofilm formation was indicated by 
the presence of a ring of stained bacteria adhered to the well at the oxygen/medium 
interface. 
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Chapter 3 
Construction of recA strains of Pseudomonas aureofaciens 
PA147-2 and its mutants 
3.1 Introduction. 
3.1.1 The utility of complementation. 
Much of the knowledge regarding the molecular basis of phenotypes is derived from the 
study of mutants. When examining such mutants it is useful to confirm that the mutation 
under investigation is indeed the cause of the altered phenotype, and that the phenotype is 
not a consequence of some other unknown mutation. This can be accomplished in a 
number of ways. Reconstruction experiments can be carried out by (i) isolating the 
mutated region of chromosome and using it to recreate the mutation by homologous 
recombination, or (ii) transferring the mutation to the parental strain by generalised 
transduction. If the recreated mutant shows the original mutant phenotype one can proceed 
confidently with analysing the mutant. Another approach is to isolate a complementary 
DNA sequence obtained from a genomic library and use it to replace the mutated region by 
homologous recombination. If the mutation was the genuine cause of the observed 
phenotype, the allele replacement should restore the wildtype properties. As databases of 
DNA sequence become annotated with functional information some mutants may become 
amenable to a purely bioinformatic approach. The DNA sequence surrounding the 
mutation may be similar to known genes, and may allow a correlation with the observed 
phenotype. Examples where this approach might be sufficient include analysis of an 
auxotroph, or investigation of a mutant deficient in a well-studied property such as flagella 
synthesis. The obvious limitation with the bioinformatic approach is the assumption that 
sequence similarity gives functional identity. A fourth method used to confirm the cause of 
a mutant phenotype is trans complementation. This method assesses the ability of a 
wildtype DNA sequence complementary to the mutated region to restore the wildtype 
phenotype without replacing the mutated region. Trans-complementation has some 
advantages over the other approaches outlined here. Because trans complementation does 
not replace the mutated region, it requires the complementing sequence to be genetically 
sufficient to restore the wildtype phenotype to the mutant. Thus, in addition to confirming 
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the nature of the observed phenotype, trans complementation provides additional 
information regarding the presence of intact genes or operons within the complementing 
sequence. This is in contrast to allele exchange in which the mutated sequence is replaced 
by the wildtype allele. While giving the same confIrmation as trans complementation with 
a wildtype sequence, allele exchange can be achieved with a DNA region that is not itself 
suffIcient to complement the mutation. All that is required is that the exchanged sequence 
has DNA from both sides of the mutation, allowing recombination to replace the mutated 
region, whereas an intact gene or operon is necessary for trans complementation to be 
observed. Probably the most powerful use for trans complementation is in combination 
with the other approaches outlined. For example, a comparison between trans 
complementation and allele exchange has the power to give insight into phenomena such as 
cis/trans requirements of the mutated genes, and polar effects arising from the mutation. 
3.1.2 Complementation in Pseudomonas aureofaciens PA147-2. 
In a previous study (Carruthers, 1994), it was reported that trans complementation was not 
possible in PA147-2 mutants due to a high rate of homologous recombination and vector 
instability. This was a particular problem when cosmids were used since they have large 
genomic regions for recombination to occur and the vector pLAFR3 is unstable in PA147-2 
in the absence of antibiotic resistance selection. To circumvent the problem, allele 
exchange was used to replace the mutation with the wildtype sequence (Carruthers et aL, 
1994), a technique which has also been employed in the present study (chapter 5). Given 
the potential benefIts of using trans complementation, the development of a system that 
would permit trans complementation was undertaken. Although some cloning vectors that 
are stable in Pseudomonas spp. are available (Stephen Heeb, Pers Comm; Heeb et aL, 
2000), their use for trans complementation would be limited because vector stability was 
only part of the problem. Additionally, the use of new vectors would not alleviate the 
problem with respect to cosmid complementation since the P A14 7 -2 genomic library is 
constructed in pLAFR3. A new library could be constructed in a stable vector, but since 
this would only partially solve the problem, it was decided that a better approach would be 
to develop a system that would allow complementation in trans. To this end, it was 
decided to create a recA defective strain ofPA147-2. 
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3.1.3 recA. 
The recombination deficient phenotype involving recA in E. coli was first discovered 
during Hfr mating experiments, when it was noted that a recipient strain inherited 
nutritional markers at a lower than expected frequency (Clark & Margulies, 1965). The 
defect was shown to be in homologous recombination between incoming DNA and the 
recipient genome. RecA is now known to be a multifunctional protein in E. coli, with well-
characterised roles in homologous recombination (Kowalczykowski et aI., 1994), 
recombinational DNA repair, and induction of the SOS regulon (Miller & Kokjohn, 1990). 
In the first two of these processes, RecA promotes homologous pairing and strand 
exchange, while in the SOS response RecA acts as a co-protease in the cleavage of the 
LexA repressor ofthe SOS regulon. RecA also appears to function in homologous 
recombination and DNA repair in P. fluorescens (De Mot et aI., 1993) P. putida (Luo et aI., 
1993) and P. aeruginosa (Sano & Kageyama, 1987). In addition to the functions above, 
recA has been shown to be involved in the secretion of an extracellular nuclease by Serratia 
marcescens (Ball et aI., 1990), and in the regulation of colicin E 1 expression in coli 
(Salles et aI., 1987). Construction of recA mutant strains of P. syringae (Willis et aI., 1988) 
and P. putida (Luo et aI., 1993) resulted in strains that were useful in trans 
complementation studies. 
The interest in the recA system of P. aureofaciens PA147-2 was two-fold. Firstly, since the 
loss of cosmids has often been accompanied by allele exchange between the cosmid and the 
genome, it was of interest to examine any possible role ofRecA in this phenotype. 
Secondly, construction ofrecA mutants might facilitate further genetic analysis ofPA147-2 
and its derivatives by stable in trans complementation experiments, since this has been a 
successful approach in related pseudomonads. 
3.1.4 Objectives. 
The main objective of the work reported in this chapter was to create recA-deficient strains 
ofPA147-2 and to assess the usefulness of these strains as a trans complementation system. 
To achieve this, several aims were defined, and are as follows. 
1. Recover a recA+ cosmid from the PAI47-2library. 
Chapter 3 Construction ofP. aureofaciens recA strains 74 
2. Use miniTnlO mutagenesis to disrupt recA in a cosmid and introduce the mutated recA 
into the PA147-2 genome by homologous recombination. 
3. Assess the effect of disrupting recA on cosmid stability and recombination frequency. 
4. Develop a system that would allow recA to be mutated in the Tn5 mutants ofPA147-2. 
3.2 Scope of this chapter. 
This chapter contains the development of a trans complementation system in PA147-2. 
The introduction has outlined the background and rationale for this work, and provides the 
objectives and aims of the work. Following this section, the chapter describes (i) the 
isolation and mutagenesis of arecA cosmid from the genomic library ofPA147-2; (ii) the 
demonstration that the PA147-2 recA can restore recA-dependent functions to recA mutants 
of E. coli; (iii) the construction of two recA mutants ofPA147-2 by miniTnlO mutagenesis 
of the recA cosmid and allele exchange in PA147-2. These strains (PA147-2recAl and 
P A14 7 -2recA 4) were used to test the stability of cosmids in recA mutants. The research up 
to this point was published in the Canadian Journal of Microbiology (Silby & Mahanty, 
2000). Following the published work, the DNA sequence of the PA147-2 recA is shown, 
and the development of a system to create partial recA deletions in the Tn5-generated 
antifungal mutants ofPA147-2 is described. All clones and mutagenised plasmids created 
in this work are described in section 2.7.2. 
3.3 Results and Discussion. 
3.3.1 Isolation, sub cloning and mutagenesis ofPA147-2 recA. 
Isolation of arecA cosmid. 
The ability to provide recA-defective E. coli strains with resistance to the DNA-damaging 
agent MMS has previously been associated with complementation by heterologous recA 
clones (Better & Helinski, 1983). The genomic library ofPA147-2 (stored in E. coli 
DH5a(recA-)) was plated on LB plates supplemented with tetracycline and MMS. Six 
colonies grew after overnight incubation, and these were all shown to contain identical 
cosmids (data not shown). One ofthe cosmids (pRECl) was used to transform arecA 
mutant of E. coli ZK4 to MMS resistance, thus confirming the ability to confer MMS 
resistance and lending support to the possibility that pRECl contained P. aureofaciens 
recA. 
A 6kb EcoRIIHindIII fragment from pRECI was sub cloned into pME6001 to produce 
pREC6g, and both pRECl and pREC6g were mutagenised with miniTnlO (Kleckner et aI., 
1991) resulting in the clones pPRAMI (pLAFR3-based), pPRAM4 (pLAFR3-based), 
pREC6Ml (PME6001-based), pREC6M2 (PME6001-based), and pREC6M3 (PME6001-
based). 
3.3.2 The MMSR clone from PA147-2 complements recA mutations in E. coli. 
Having isolated and sub cloned a DNA region from PA147-2 that can confer MMS 
resistance upon recA strains of E. coli, it was necessary to show that the clone did indeed 
contain recA. In order to confirm this, pREC6g was tested for its ability to complement a 
number ofRecA-dependent functions in E. coli. 
Induction of the SOS response in E. coli. 
RecA plays a critical role in the SOS response in E. coli, acting as a catalyst in cleavage of 
the LexA protein and thus derepresses the SOS regulon. Expression of sulA is induced in E. 
coli by the SOS response and SulA arrests cell division through interaction with FtsZ (8i & 
Lutkenhaus,1993). We tested the ability of the PA147-2 recA to induce an SOS response 
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by measuring expression of the sulA gene in E. coli strains DE1491(recA) and 
DE880(recA+). DE1491 and DE880 have a Mudlac insertion into sulA, creating an in-
frame sulA: :lacZ fusion. The expression of sulA can therefore be inferred by measuring the 
~-galactosidase level according to the method of Miller (1972). When pREC6g(recA+) 
was present in DE1491, an increase in sulA expression was observed, relative to DE1491 
harbouring either pME6001 or pREC6M3(recA). The expression of sulA was further 
increased when the SOS response was induced by exposure to the DNA-damaging agent 
mitomycin C for 60 minutes prior to the ~-galactosidase assay. In contrast to these 
observations, the presence of either pME6001 or pREC6M3 in DE1491 had no impact on 
suI A expression with or without addition of mitomycin C (Figure 3.1). When E. coli 
DE880, an otherwise isogenic recA+ strain ofDE1491, was assayed under the above 
conditions, the level of ~-galactosidase produced after mitomycin C exposure was 
comparable to that from DE1491 (PREC6g) (Figure 3.1). 
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Figure 3.1. Induction of the SOS response in E. coli DE880(recA+) and DEI491(recA) and its derivatives. 
The ~-galactosidase level from DE 1491 harbouring the plasrnids pREC6g(recA+), pME6001, or pREC6M3 
(recA) was measured, with and without rnitomyciu C (MC) exposure. The recA+ straiu DE880 was included 
as a coutrol. Both E. coli DE1491 aud DE880 have a suIA::lacZ fusion, so ~-galactosidase levels reflect the 
level of SulA, which is iuduced iu the SOS response. Data are the average of four experiments. Standard 
error was less than 10%. 
Resistance to DNA damage induced by UV and MMS. 
E. coli strains DH5a and MC4100 are sensitive to exposure to UV and MMS, due to DNA 
damage. Resistance to UV and MMS was assessed qualitatively by the ability of bacterial 
strains to survive treatment with these DNA damaging agents. When pREC6g was present 
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in trans, both strains showed an increased resistance to UV and MMS, as measured by their 
ability to grow after UV exposure or in the presence ofMMS. However, this increase in 
resistance was not detected when pREC6g(recA+) was replaced with either pME600 I or 
pREC6M3(recA). Neither strain could form colonies after UV exposure or on MMS 
supplemented plates, indicating a role for the PA147-2 recA gene in the provision ofUV 
and MMS resistance, presumably by the restoration ofRecA-dependent DNA-damage 
repair systems. P. aureofaciens PA147-2 recA mutants (described below) showed 
increased sensitivity to both UV and MMS, and resistance was restored by 
complementation with pREC6g, but not with pME6001 or pREC6M3 (data not shown). 
Promotion of homologous recombination by pREC6g(recA+). 
The ability of the MMS resistance-encoding clone pREC6g to promote homologous 
recombination was tested by PI transduction of functional amino acid biosynthetic his and 
ilv alleles to a his ilv E. coli mutant (E: coli MT2). Plvir stock was grown on E. coli W311 0, 
and used to transduce the auxotrophic E. coli strains (Miller, 1992). Inheritance of either 
nutritional marker was used to indicate recombination between the transduced DNA and the 
genome of the recipient. Strains (E. coli MT2) containing pREC6g showed inheritance of 
transduced markers whereas transductants of the control strains harbouring either 
pME6001 orpREC6M3 were not detected (Table 3.1). No spontaneous revertants ofMT2 
to either His+ or I1v+ were detected (data not shown). 
The primary motivation for this study was to investigate the possibility that disruption of 
recA inPA147-2 might alleviate the problem of recombination during trans 
complementation experiments. Since genetic systems are not well developed in P. 
aureofaciens, an E. coli system was used to test homologous recombination frequency. The 
data show that the wildtype recA clone ofPA147-2 (PREC6g) can promote homologous 
recombination in E. coli, and an insertional mutant (PREC6M3) was unable to promote this 
RecA-dependent function (Table 3.1). 
Table 3.1. Promotion of homologous recombination. 
Strain Inheritance of hisa 
MT2 (pREC6g) 3.7 x 10-6 
MT2 (pREC6M3) < 2.6 x 10-7 
MT2 (pME600l) < 1.8 x 10-7 
Inheritance of ilva 
9.5 X 10-5 
< 2.6 X 10-7 
< 1.8 X 10-7 
Notes: Homologous recombination is from the frequency ofinberitance. 
a Inheritance is expressed as the number of cells inheriting the particular allele out of the total population of 
cells exposed to the transducing phage. 
3.3.3 Introduction of recA::miniTnlO mutations into the chromosome of PA147-2. 
The two independently mutated plasmids designated pPRAMI and pPRAM4 were used to 
introduce recA: :miniTnl 0 into the chromosome ofP A147 -2. Both pPRAMl and pPRAM4 
were transferred to PA147-2 by conjugation, and the mutated recA alleles were introduced 
to the genome ofPA147-2 by homologous recombination. To allow recombination to take 
place, the transconjugants were grown without selection in LB for ten hours prior to plating 
on LB supplemented with Rf and Km. KmR colonies were either recombinants (with or 
without the plasmid), or strains that had not undergone recombination and had not lost the 
plasmid. This procedure resulted in the strains PA147-2recAl and PA147-2recA4, both of 
which exhibit a loss of resistance to UV irradiation and MMS exposure. Recombination 
(rather than plasmid retention) was indicated by the loss of the vector marker (TcR) and was 
subsequently confirmed by Southern analysis (Figure 3.2), indicating the successful 
construction ofrecA mutants ofPA147-2. The two mutated cosmids pPRAMl and 
pPRAM4 were confirmed as having different insertion points by subc10ning and DNA 
sequencing of the subc10nes pPRAM1.1 and pPRAM4.1 using a primer designed to anneal 
to the IS10 ofthe miniTnlO element (appendix 3). These data are shown diagrammatically 
in Figure 3.3. 
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Figure 3.2. Southern hybridi sation demonstTating introduction of recA / and rcc;14 into the genome of 
PAI47-2 . In all panels: lane 1, lambda JlilldlII standard; lane 2, PAI47-2recA/ ; lane 3, PAI47-2recA4; lane 
4 , PA 147-2. Cienomie DNA was digested with EcoRI ancl/lillclIll. A. Agarose gel showing separation of 
genomic D:\A. B. Ilybriclisation with 6kb E('() RI /J1illuIII rccA probe. The 1:ICt that the probe hybridi ses with 
larger fragments in PA147-2recA / and PAI47-2recA4 than PA147-2 indicates incorporation of the DNA with 
mutations. C. H ybridisation with Knl gene probe from miniTn/O shows the pn;sence orthe transposon. D. 
The restriction fragment s that hybridise with the rnA probe. Because of the flilldIlI site in miniTn/O, the 
fragments hybridis ing in the rccA mutant lanes arc lIilldlIl fra gments of different sizes. The grey boxes in D. 
indicate miniTn/ () D\';\ , the bold hori zonta l arrow indicates the pos ition and orientation of rccA, and the bold 
hori7onta I lines represent recA sequenccs. 
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Figure 3.3. Diagrammatic representation ofrecA ofPA147-2. Indicates the approximate position of the 
miniTnlO insertions in P A14 7 -2recA 1 and P A14 7 -2recA 4. The bold horizontal lines represent regions 
sequenced from the ends of the transposons. * indicates the start codon position, and ~ indicates the 
termination codon position. 
3.3.4 Stability of cosmids in PA147-2 and PA147-2recA::miniTnlO mutants. 
Since the original goal was the creation of a system in which cosmids could be used to 
complement antifungal mutants in trans, the stability of a cosmid in PA147-2 and the recA 
mutant deri vati ves P A 147 -2recA 1 and P A 147 -2recA 4 was examined. The cosmid 
pPS2l22 is a pLAFR3-based cosmid thought to contain at least one gene of importance in 
antifungal activity and has been shown to restore antifungal activity to P. aureofaciens 
PAl38, a Tn5 mutant ofPA147-2, by allele exchange (See chapter 5). However, attempts 
at complementation in trans revealed that pPS2l22 was unstable in PAl38 if selection for 
the cosmid was not maintained. Cosmid pPS2l22 was introduced to PA147-2, PA147-
2recAl, and PA147-2recA4 by conjugation, and maintenance ofpPS2l22 was tested by 
growing transconjugants in lOmL LB cultures without selection for the cosmid. Samples 
of the culture were taken periodically, serially diluted, and plated on LB agar supplemented 
with Rf, and LB agar plus Rf and Tc. Total colony forming unit counts on Rf selection 
reflect the total number of culturable cells, whereas only those maintaining the cosmid 
could grow in the presence ofTc. The results indicate that pPS2l22 was considerably more 
stable in PA147-2recAl than in the wildtype (Figure 3.4), whereas there was little 
difference in stability between PA147-2recA4 and PA147-2 (data not shown). 
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Figure 3.4. Stability of cosmid pPS2122 in PA147-2, and PA147-2recAI, The proportion of cells with the 
cosmid was determined by dividing the tetracycline (Tc) resistant cfu,mL~l by the total Cfu.mL~l at each given 
time point. Tc resistance is conferred by the cosmid, and hence Tc sensitive colonies arise from cells that 
have lost the cosmid. Data presented are the average of three independent experiments and are shown with 
the standard error. 
The observation that the stability of a pLAFR3 based cosmid is increased in P A14 7 -2recAl 
but not in PA147-2recA4 is an interesting finding given that very few studies on recA have 
reported similar effects on plasmid stability. An analysis ofthe archaeI recA analog, radA, 
indicates that radA is involved in the maintenance or replication of some halobacterial 
plasmids in Haloferax volcanii (Woods & Dyall-Smith, 1997), while a recent report 
suggests that plasmid stability can be reduced in recA mutants of E. coli (Debbia, 1992). 
These studies demonstrate reduced maintenance of p1asmids in recAlradA mutants. In 
contrast, the cosmid pPS2122 shows increased stability in PA147-2recAl, but not in 
PA147-2recA4. The transposon insertion points in these mutants have been mapped to near 
the middle ofrecA (PA147-2recAl) and toward the 3' end (PA147-2recA4) (Figure 3.3). 
These data suggest that RecA is involved in the instability ofpPS2122 in PA147-2, and that 
the insertion in P A14 7 -2recAl reduces this instability effect. It is possible that the domain 
ofRecA responsible for the plasmid instability is located nearer to the N-terminus of the 
protein than the insertion in PA147-2recA4, and thus it is still expressed in the recA4 
mutant. In PA147-2recAl, the insertion point is near the middle of the gene, which appears 
to be sufficient to abolish the instability phenotype associated with pPS2122 in PA147-2. 
In this case it is tempting to suggest that the role ofRecA in plasmid instability is 
genetically separable from its role in DNA repair since both recA strains show increased 
sensitivity to DNA-damaging agents, but only one has a change in plasmid stability. 
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Regardless of the mechanistic basis for the altered cosmid stability in the recAl 
background, the observation of increased stability justified the approach taken and the 
further work required to create recA strains of Tn5 mutants. 
3.3.5 Using pPRAMl to introduce the recA::miniTnlO allele into Tn5 mutants of 
PA147-2. 
Because of the success in generating PA147-2 recA strains, and the apparent stability of 
cosmids in the recAl background, an attempt was made to generate recA mutations in the 
antifungal-defective mutants ofPA147-2. The approach was similar to the construction of 
P A14 7 -2recAl, except that it was not possible to enrich for candidate recombinants using 
KmR since the antifungal mutants already express KmR from Tn5. Instead, after incubating 
the Tn5 mutant containing pPRAMl for ten hours without selection, bacteria were simply 
plated on LB plus Rf. Colonies were then screened for Tcs to indicate the loss of the 
plasmid, and MMSs, to indicate inheritance of the recA::TnlO allele. Despite screening 
more than 5000 candidates from multiple independent experiments for the desired 
phenotypes, no candidate recombinants could be identified for either PAl38 or PA109. 
This could be due to the inability to enrich for candidates, or recombination between the 
KmR genes of Tn5 and miniTnl 0 being favoured. Experimental evidence to explain the 
failure to create recA mutants in the Tn5 mutant strains was not sought. Rather, it seemed 
more appropriate to modify the system to create defined recA mutations. 
3.3.6 Construction of partial recA deletions in PA147-2 and its mutant derivatives. 
DNA sequencing of recA from PA147-2. 
Although inactivation ofrecA with pPRAMl in PA147-2 was successful, the success could 
not be reproduced when using the Tn5 mutants ofPA147-2. This was problematic since 
the objective was to create a recA mutation in the antifungal mutants ofPA147-2. To be 
useful, the system had to be simple, relatively rapid, and reliable. Since this was not the 
case with the use ofpPRAMl in the Tn5 mutants, an alternative was sought. The DNA 
sequence ofrecA from PA147-2 was determined as a starting point for designing a strategy 
to delete recA in P. aureofaciens. This was because knowledge of the sequence could 
reveal the precise location of useful restriction sites, which could enable the design of a 
simple method for deleting some (or all) of the gene. It was hoped that construction of a 
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deletion system would circumvent the difficulties encountered when trying to introduce the 
recAl allele into Tn5 mutants. Of particular interest was the location of the left-most 
Bam HI site (Figure 3.5) with respect to recA. 
Previous mutagenesis of pRECl and pREC6g using miniTnlO allowed the approximate 
location of recA to be determined. Using this information, a sub cloning and sequencing 
strategy was devised (Figure 3.5). The inserts within the resulting clones, pRECEB, 
pRECB, and pRECBH were sequenced using T7 and T3 primers. 
The DNA sequence of recA from PA147-2 is shown in appendix 4, along with the 
alignment with recA from P. fluorescens. The sequence revealed that recA is encoded right 
to left relative to the illustration in Figure 3.5, and that the leftmost BamHI restriction site 
shown in Figure 3.5 is within recA. BamHI cuts at position 298 in the gene. The location 
of one BamHI site within recA suggested that deletion of the approximately 2.4kb BamHI 
fragment frompREC6g would remove part of recA. Furthermore, ifthis proved to be the 
case it would be possible to introduce the deletion into the genome of PAl 47-2 and its 
mutant derivatives by allele exchange, resulting in strains unable to produce RecA 
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Figure 3.5. pREC6g showing the three miniTnlO insertions. Insertion points in pREC6Ml, pREC6M2, 
pREC6M3 are indicated by triangles. The direction and approximate location of recA is indicated by the bold 
arrow in pREC6g. Also shown are the subclones pRECEB, pRECB, and pRECBH, which were used to 
determine the sequence oftecA. Arrows above the subc10nes indicate the directions of DNA sequencing. 
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Construction of a recA deletion system. 
The plasmid pREC6g is stable in PA147-2. In order to use allele exchange for mutagenesis 
ofrecA, a poorly maintained vector is desirable. For this reason, the clone pREC6L was 
used in further recA constructions. A 2.4kb BamHI fragment was deleted from pREC6L by 
digesting the plasmid with BamHI, and then religating the digested DNA without the 
internal BamHI fragment. The removal of this BamHI fragment resulted in the creation of 
the plasmid pREC6L~B (Figure 3.6). To confirm that the deletion had rendered 
pREC6L~B unable to express RecA, DH5a(pREC6L~B) was streaked onto LB agar 
supplemented with MMS. Whilst the parental plasmid (PREC6L) conferred MMS 
resistance upon DH5a, DHa (bearing pREC6L~B was unable to grow in the presence of 
MMS (data not shown). Based upon these results, it was reasonable to conclude that part 
of the recA gene had been deleted, and this deletion was sufficient to abolish RecA-
dependent functions. 
Using pREC6L~B to create recA strains. 
pREC6LLill was introduced into PA147-2 by conjugation, using E. coli S 17-1 as the donor 
strain. Transconjugants were pooled and allowed to grow without selection for ten hours, 
after which the culture was ten-fold serially diluted and plated onto LB containing Rf. 
Individual colonies that arose were tested for Tcs (to demonstrate the loss ofthe plasmid) 
and MMSs to show mutagenesis of recA by allele exchange. Greater than 90% of colonies 
tested had lost the plasmid, but despite several attempts, no MMSs strains were recovered 
by this technique. 
The lack of success using pREC6LLill to generate a deletion mutation ofrecA in PA147-2 
could be due to two possibilities. Firstly, deleting the BamHI fragment may be insufficient 
to generate MMSs strains ofPA147-2. This seemed unlikely given the MMSs phenotype 
ofDH5a bearing pREC6LLill. The second possibility is that the rate of recombination was 
not sufficiently high to allow the recovery of the desired strains by screening a small 
minority of the population (e.g. 1000 colonies from a culture containing lx109 cfu.mL-1). 
To examine the latter suggestion, a BamHI fragment of DNA encoding GmR was cloned 
into the BamHI site ofpREC6L~B, resulting in the plasmid pREC6LLillg (Figure 3.6). 
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It was thought that by introducing a selectable marker it might be possible to emich the 
population to be tested by selecting those that still possess GmR, as was the case when 
using pPRAMI to create P Al4 7 -2recAl. Only those strains that had either retained the 
plasmid or were recombinants would be GmR, thus eliminating those that had simply lost 
the plasmid. pREC6LLlBg was transferred to P A14 7 -2 by conjugation, and transconjugants 
were selected on the basis of GmR. Transconjugants were pooled and grown in ten mL LB 
without selection. Ten-fold serially diluted cultures were plated on LB supplemented with 
Rfand Gm, and single colonies were used to test for MMSs and loss of the plasmid (Tcs). 
In contrast to the results with pREC6LLill, using pREC6LLillg resulted in approximately 
25% MMSs strains. These data suggest that the loss ofthe plasmid is a frequent event, and 
that enrichment is necessary for easy recovery of recombinants. Without the enrichment 
step, most colonies that grow probably represent bacteria that have lost the plasmid before 
recombination took place, but by enriching with a marker these strains are eliminated from 
consideration. The utility ofthe technique was then demonstrated by using it to create recA 
deletions in the Tn5 mutants PAI09, PAl38, and PAH26. The use ofpREC6LLillg for 
creation of recA strains was successful, and relatively straight forward, and thus should be 
applicable to future studies. 
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Figure 3.6. Diagrammatic representation of the clones pREC6L, pREC6LLlB, and pREC6LLlBg. The 
approximate location of recA is shown by the bold horizontal line. The reduced length of the bold line 
indicates that the start of recA has been deleted in the LlB clones. 
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Confirmation of allele exchange by Southern hybridisatioll. 
Southern hybridisation was used to confirm that the Gmi{ MMSs colonies were indeed due 
to allele exchange between the wildtype recA gene and the Gm R deletion construct. Total 
DNA of wild type PA147-2 and the putative recA mutants (Gm'\ MMSs) ofPA147-2, 
PAI09, PA138 and PAH26 (designated PAI47-2rec~, PAI09rec~, PAI38rec~, and 
PAH26rec~ respectively) was digested with EcoRI and HindIII, and separated by 
electrophoresis. Following transfer to Hybond N+ nylon membrane, the DNA was probed 
with the 6kb EcoRIIHindJII fragment from pREC6g. The predicted result was that in 
PA 147-2 (recA+) a 6kb fragment would hybridise with the probe while in the recA mutants 
a newly introduced EcoRI site within the GmR gene would result in an approximately 5kb 
fragment of DNA hybridising with the probe. In addition, there would be no hybridisation 
to a 6kb fragment in the mutants, which would be sufficient to demonstrate replacement of 
the 6kb region with that containing Gm R. The result of the Southern hybridisation is shown 
in Figure 3.7 . All four putative recA mutants show the hybridisation pattern that was 
anticipated for recA mutants created using pREC6L~Bg, thus confirming that they are 
genuine recombinants. 
A B 
Figure 3.7. Southern hyhridisation showing introduction of REC6~Bg into P. (/ureo/£Iciens strains. In hoth 
panels. Lane I.lamhda Hindllf standard: Jane 2, PAI47-2; lane 3, PA147-2re('~Bg: lane 4. PAI()9n'c~Bg: 
lane 5. PAI38rec~Bg: lane 6. ]>/\H26re(.'~Bg; lane 7. pREC6L; lane 8, pREC6L~Bg. All digests apart from 
the standard were EcoRII Hindll!. A. Separation or digested DN/\ by agarose gel electrophoresis. B. Southern 
hyhridisation lIsing the 6kh recA . region from pREC6g as a prohe. Ilybridisation with a 6k.h fragment in 
lanes 2 and 7 shows the presence of the wildtype 6kh recA region, whereas hyhridisation with a 5k.h fragment 
indicates the presence of REC6~Bg in the red deletion strains. Arrows indicate the position or hybridised 
IJNA. 
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In summary, the results presented in this chapter demonstrate that the recA gene ofPAl47-
2 is important in the instability of pLAFR3-based plasmids, and that mutating recA 
increases the stability of a pLAFR3-based cosmid. A system for the relatively easy 
construction of partial recA deletions has been developed, and this system has been used to 
create recA- derivatives of the antifungal minus strains PAl09, PA138, and P AH26. In 
addition to its use in the present study, this system will be of value for the genetic analysis 
ofPAl47-2 in future studies. 
Chapter 4 
Characterisation of antifungal mutants 
4.1 Introduction. 
During a previous study (Carruthers, 1994) a collection of P. aureofaciens isolates 
defective in their ability to inhibit fungal growth was created by screening a pool of random 
TnS-generated mutants. Characterisation of some ofthese mutants is discussed in detail in 
chapter 1. Briefly, Carruthers showed that two auxotrophs, P AF30 and P AF35, require 
either all three aromatic amino acids or arginine and uracil respectively to grow. DNA 
sequence indicated that they have insertions in aroB (PAF30) and carA (PAF35). Analysis 
of the mutant PAI09 showed that the insertion was in a 16kb EeoR! region, and saturation 
mutagenesis of this region led to the suggestion that it encoded a number of genes involved 
in production ofan antifungal compound(s). Preliminary sequence data indicated that the 
insertion in PAl 09 interrupted a putative two-component regulatory gene. Finally, the 
importance ofthis genetic region for biocontrol was shown in glasshouse trials by 
comparing the ability of the wildtype and the mutant PAl 09 to suppress Phytophthora rot 
of asparagus (Carruthers et aI., 1995). 
Despite the work outlined above, only a fraction of possible infonnation had been gained 
from the collection of mutants. Three objectives were defined to significantly improve the 
understanding of fungal inhibition by P A 147 -2, and would focus future research efforts on 
PAI47-2. These objectives and their rationale are outlined below. 
4.1.1 Objective 1 - Crossfeeding studies. 
WHAT IS CROSSFEEDINO? 
The ability of mutants to complement each other by "crossfeeding" has the potential to 
demonstrate that different mutants are defective for separate steps in the same biosynthetic 
pathway. A well-known example of this is the demonstration that pigment production by 
various pigment mutants of S. mareescens can be restored when combinations of mutants 
are cultured in close proximity to each other. Production of diffusible biosynthetic 
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intermediates by one mutant compensates for a second mutant's inability to produce the 
intermediate, thus alleviating the "block" in the biosynthetic pathway (Morrison, 1966). A 
similar phenomenon occurs when antibiotic-deficient mutants of Erwinia herbicola Eh1087 
are cultured together on plates. Each mutant alone is incapable of inhibiting the growth of 
a bacterial lawn. However, when mutants are mixed and plated onto a bacterial lawn, 
certain combinations inhibit the growth ofthe lawn. As with the S. marcescens example, 
this is thought to be due to the production of diffusible biosynthetic intermediates by E. 
herbicola (S. Giddens, Pers. Comm.). 
An observation that some antifungal mutants ofPA147-2 could cross-feed would provide 
insight into the biosynthesis of the antifungal compound and allow the mutants to be 
separated into classes based upon crossfeeding results. Conversely, ifthe mutants were 
unable to cross-feed, the results could suggest that these mutants have Tn5 insertions in 
genes making up more than the biosynthetic pathway, and that the interrupted genes have 
functions other than modification of precursor compounds. It is important to note that no 
definitive conclusion can be reached based entirely on negative cross-feeding results since 
it is also possible that biosynthetic intermediates are not diffusible. However, the 
possibility that valuable insights could be gained made cross-feeding experiments a logical 
undertaking. 
4.1.2 Objective 2 Genomic distribution of antifungal genes. 
While crossfeeding experiments were intended to give some indirect biochemical 
infonnation regarding the relationship between the antifungal mutants, they would provide 
no physical infonnation regarding the organisation ofthe genes required for antifungal 
activity. Therefore, the second objective ofthe preliminary analysis was to establish the 
physical relationship among the genes that are required for antifungal activity. Since 
macro-restriction enzyme profiling techniques have previously been shown to be useful in 
genome analysis and comparison in Pseudomonas spp. (Rainey & Bailey, 1996; Smith et 
aL, 1995), field inversion gel electrophoresis (FIGE) and Southern hybridisation were 
chosen to separate and analyse large restriction fragments from PA147-2 and its mutant 
derivatives. 
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The genomic distribution of genes required for the production of antifungal metabolites by 
PA147-2 was of interest for two reasons. Firstly, from a practical point of view, the 
organisation ofthe genes would, to some extent, dictate the way in which the molecular 
basis for antifungal activity was studied. If the genes were found in close proximity to each 
other it could be feasible to study them together as an "antifungal cluster". However, a 
wide distribution would necessitate an approach in which the genes were examined 
separately. The second reason for examining the distribution of genes is more fundamental, 
and related to the origin of the antifungal phenotype. Widely distributed genes would lead 
to the suggestion that the phenotype is not encoded by genes on a horizontally mobile 
element (such as a plasmid or pathogenicity island), but rather the phenotype is a 
consequence of secondary metabolism. 
4.1.3 Objective 3 - DNA sequencing of transposon insertion points. 
A logical objective was to sequence the DNA flanking the transposon insertion points in 
the mutants, and subject the resulting DNA sequences to similarity searches using BLAST 
(Altschul et aI., 1990; Altschul et aI., 1997). Given the vast number of DNA sequences 
found in the public databases (e.g. Genbank, EMBL), it was possible that putative 
homologues could be found, and predictions of functional roles in antifungal activity could 
then be made and tested. It is important to note that while the identification of sequences 
that were unmatched with any in the databases would be interesting, such a result would not 
provide any new information regarding antifungal activity. 
4.2 Results. 
4.2.1 Cross feeding. 
Although PA147-2 consistently inhibited the growth of the fungal colony, no mutant or 
combination of mutants showed antifungal activity. Thus, the mutants in the collection 
either do not represent a series of disruptions to a single pathway, or the production of 
antifungal metabolites by P A147 -2 is not characterised by the synthesis of diffusible 
intermediate compounds. 
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4.2.2 Genomic distribution of "antifungal genes". 
To examine the distribution of genes involved in antifungal activity, field inversion gel 
electrophoresis (FlGE) was used to separate restriction fragments produced by SpeI 
digestion ofPA 147-2 and the Tn5-generated mutants. DNA was subsequently immobilised 
on a nylon membrane for Southern hybridisation with a Tn5-specific probe. In this way it 
was possible to examine the distribution ofTn5 within the antifungal mutants, and thus 
infer the distribution of genes important in antifungal activity. The FlOE gel and 
subsequent Southern hybridisation are shown in Figure 4.1. DNA from the wildtype 
PA147-2 d,id not hybridise with the probe, veri tying the specificity of the probe for 1n5. A 
single restriction fragment hybridised with the probe in each lane containing DNA from 
antifungal mutants, contirming that each mutant phenotype was the result of a single 
insertion. The hybridisation pattern shows that the Tn5 insertions are not found within a 
single region of the genome, but are spread widely. 
a b 
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387- 387- • 339.5- 339.5-
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Figure 4.1. Genomic di stribution of antifungal genes. a. HGE ofSpel digested PA147-2 and the Tn5-
generated mutants. h. Southern hybridisation of ON A fragments separated by FIGE ,md probed with a'l"n5-
specilic probe. Lanes for panels a. and b. Std= 8iorad pulsed-tield standard lambda coneaLemer. 1= PAL 2= 
PAl38. 3= PAA3. 4= PAlO!}. 5= PAH26. 6= PAE21. 7=]>All1. 8= PAF30. <)= ]>AF35. 10= PAII7. 
II=PA147-2. AliI'. (/ureojuciens isolates are digested with ,)pel. 
4.2.3 DNA sequencing. 
DNA sequencing was carried out as outlined in chapter 2, using the clones described in 
section 2.7 and a primer that anneals to rS50 ofTn5 (appendix 3). The results are 
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summarised in Table 4.1 and discussed below with respect to antifungal activity. 
Sequences are shown in appendix 4. 
Table 4.1. Results of database searches for sequences similar to those derived from the antifungal mutants. 
Mutant 
PAl 
PAI09 
Programa 
Blastn 
Blastx 
Blastn 
Blastx 
Similarity?b 
Nothing significant 
Nothing significantC 
Nothing significant 
sensor/response regulator hybrid 
(P. aeruginosa) 
Score Accession 
number 
N/A N/A 
N/A N/A 
N/A N/A 
le-168 AAG05000.1 
P A13 8 Blastn Nothing significant NI A NI A 
Blastx GstR (Bradyrhizobiumjaponicum) 2e-44 AAC17939 
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------_. 
PA168 Blastn Nothing significant N/A N/A 
PAA3 
PAH26 
Blastx 
Blastn 
Blastx 
Blastn 
Nothing sigilificant 
Nothing significant 
Nothing significant 
pstA (P. putida) 
N/A 
N/A 
N/A 
N/A 
N/A 
N/A 
le-138 AB017356 
Blastx PstA (P.aeruginosa) ge-27 AAG08752 
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------_. 
PAE21 Blastn Nothing significant N/A N/A 
Blastx Gene for galactosyl transferase 
(P. aeruginosa) ge-18 AAF23992 
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------. 
P All 7 Blastn Nothing significant NI A NI A 
Blastx 
PAI75 Blastn 
Blastx 
PAI95 Blastn 
Blastx 
Nothing significant 
3' end of gene for alginate lyase 
(Halomonas marina) 
Nothing significant 
Nothing significant 
Putative multi drug efflux pump 
protein RagC (B. japonicum) 
N/A 
N/A 
N/A 
N/A 
AB0l8795.1 
N/A 
N/A 
T31341 
Notes. a. www.ncbi.nlm.nih.govlblast.bSimilar sequences at nucleotide and predicted translation product 
levels. Significance was arbitrarily cut-off at E-scores ofless than e- IO • C The predicted translation product 
from a 470bp sequence starting 49bp away from the insertion point is similar to a predicted protein from P. 
ae/'uginosa (AE004589) 
4.3 Discussion. 
4.3.1 Crossfeeding. 
The results of the crossfeeding experiments show that no members of the existing 
collection of antifungal mutants have the ability to crossfeed. This suggests that either the 
mutations are not affecting a single biosynthetic pathway, or that none of the mutants 
produce diffusible pathway intermediates that can restore activity to another mutant. 
4.3.2 FIGE. 
The Tn5 insertions that result in an antifungal-deficient phenotype in PA147-2 appear to be 
widely spread throughout the genome, as shown by the hybridisation of the Tn5 probe to 
seven different sized fragments, ranging from approximately 50 to 400kb, from the ten 
mutants tested. This suggests that at least some of the genes for antifungal activity are not 
clustered, which is consistent with the theory that antifungal activity by PA147-2 is an 
examp Ie of secondary metabolism. The minimum size of the DNA region that could 
contain all the genes identified is approximately 560kb, indicating that at least some of the 
genes for antifungal activity are not found on a horizontally mobile element. This 
assessment of distance is likely to be an underestimate, since it assumes that the insertions 
on 380kb and 220kb regions are at one end ofthe fragments, that these fragments:flank all 
of the other SpeI fragments that have insertions, and that fragments with insertions are not 
separated by any without insertions. Thus, the total of 560kb is the sum of the sizes of all 
fragments that have insertions, apart from the 380 and 220kb fragments. 
The Southern blot data obtained from the FIGE-separated SpeI fragments shows that the 
three mutants PAl 09, P AlII, and PAl all have insertions in an approximately 180kb SpeI 
fragment. A previous study (Carruthers et aI., 1994) had shown that these three mutants all 
have insertions within 3kb of each other in the same l6kb EcoRI region. SpeI cuts rarely in 
the PA147-2 genome, and digestion of the l6kb EcoRI region showed that it did not cut 
between the Tn5 insertions in PA109, PAl, and PAll!. Thus, the three mutants were 
expected to have insertions on the same SpeI fragment, allowing them to serve as internal 
quality controls for this experiment. 
The Tn5 insertions in the auxotrophic mutants P AF30 and P AF3 5 both appear to be on a 
SpeI fragment of approximately 140kb in size. It is therefore possible that the two genes 
interrupted in these mutants are located within 140kb of each other (although the possibility 
of similarly sized fragments co-migrating has not been ruled out). This proximity is 
probably not suggestive of an antifungal biosynthetic cluster because the genome sequence 
of P. aeruginosa shows these genes are within 300kb in P. aeruginosa.. In a previous 
study, preliminary DNA sequence data was obtained from the region flanking the insertions 
in these mutants (Carruthers, 1994). The sequences predict that the gene aroB (encoding 3-
dehydroquinate synthase) is interrupted in P AF30, and P AF35 has an insertion in carA, 
which codes for the small subunit of carbamoylphosphate synthetase. These enzymes are 
required for aromatic amino acid biosynthesis and pyrimidine and arginine biosynthesis 
respectively, which is consistent with the auxotrophic requirements ofthe mutants. 
4.3.3 DNA sequencing. 
REGULATORY GENES. 
The mutants P Al 09 and P A13 8 both appear to have Tn5 insertions in genes that encode 
global regulators. 
In the case ofPA109, the mutation is in a gene that encodes a two-component regulator, in 
agreement with previous findings (Carruthers, 1994). Two-component regulators are 
widespread in microbes, controlling systems such as extracellular proteolytic activity of 
Staphylococcus aureus (Fournier & Hooper, 2000), capsule production by Streptococcus 
pneumoniae (Levin & Wessels, 1998), and secondary metabolite production by P. 
fluorescens (Corbell & Loper, 1995). Given the involvement of two-component regulators 
in numerous cellular processes, and particularly in expression of virulence factors and 
secondary metabolites, it is not surprising to find that such a system plays a role in 
expression of antifungal metabolites in P. aureofaciens PA147-2. 
The Tn5 insertion in P A138 occurs in a sequence whose predicted translation product has 
similarity to LysR-type transcriptional regulators. Like the two-component system, 
members of the LysR family have been shown to be involved in the regulation of a variety 
of processes. Examples include regulation of p-Iactamase in P. aeruginosa (Lodge et aI., 
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1993) and Streptomyces cacaoi (Magdalena et aI., 1997), catabolism of phenolic 
compounds by Agrobacterium tumefaciens (parke, 1996), and regulation of the production 
of the antifungal compound pyoluteorin by P.jluorescens (Nowak-Thompson et aI., 1999). 
The P. aureofaciens mutant PAI09 was of interest because the results of Carruthers (1994) 
indicated that the two-component regulator gene disrupted in PAl 09 was located within an 
antifungal gene cluster. P A13 8 was chosen for further study because at the time the initial 
sequence was obtained, there were no reports of LysR-type transcriptional regulators 
involved in antifungal activity. The mutants PAI09 and P Al38 are the subject of chapter 
5. 
MUTANTPAI. 
The Tn5 insertion point in PAl was previously shown to map 2.lkb away from the 
insertion in PA109 (Carruthers 1994; Carruthers et aI., 1994). However, no DNA sequence 
covering the insertion point was obtained in those studies, so the question of whether or not 
PAl had an insertion in the same gene as P Al 09 remained unanswered. The DNA 
sequence data generated in the present study suggests that P Al has an insertion 43bp 
downstream of the putative initiation codon of the two-component regulator that is 
disrupted in PA109, and is 49bp downstream of an ORF ofunlmown function. The 
position of the insertion derived from the sequence data indicates it is most likely that the 
Tn5 has interrupted the two-component regulator gene, thus preventing expression of the 
gene product. The lack of sequence similarity shown in Table 4.1 can be explained by the 
fact that the DNA sequence from clone pCM1 reads toward the start of the two-component 
gene, and finishes upstream of the gene. 
P AH26 has a TnS insertion in a sequence that is predicted to encode the gene pstA, based 
upon similarity to pstA from P. aeruginosa and P. putida. In other bacterial species, PstA 
forms part of the membrane-spanning portion of the phosphate specific transport complex, 
which is an ABC transporter required for high affinity uptake of inorganic phosphate 
during phosphate limitation (Cox et aI., 1988). Thus, PstA is important during phosphate 
starvation. In addition to its role in phosphate transport, an intact Pst complex is required 
for the repression of the phosphate (Pho) regulon, which is expressed during phosphate 
limitation (Wanner, 1996). Null mutations to pstA would be predicted to result in an 
inability to rapidly uptake inorganic phosphate under phosphate starvation conditions, and 
constitutive derepression ofthe Pho regulon. The fact that a pstA mutation renders P. 
aureofaciens PA147-2 antifungal minus leads to the following hypotheses: 1. phosphate 
uptake is required for antifungal activity; 2. expression of the Pho regulon represses 
antifungal activity; 3. Pst has roles in PA147-2 antifungal expression in addition to those 
characterised in other organisms. These hypotheses are tested in relation to the mutant 
P AH26 in chapter 6. 
PAI95. 
The predicted translation product from the DNA sequence derived from the Tn5 insertion 
point in P AI95 shows a high degree of similarity to Rage from Bradyrhizobium japon/cum 
(Krummenacher & Narberhaus, 2000); and to a number of efflux systems and drug 
transport proteins. Thus, P AI95 is predicted to have a mutation in a cytoplasmic membrane 
protein that functions as a pump from the cytoplasm to the periplasm. With respect to 
antifungal activity, there are two obvious roles that such a pump could potentially play. 
Firstly, a pump might be required for the transport of one or more antifungal metabolites 
from the cytoplasm to the extracellular environment. Proteins with similar sequences have 
been implicated in the efflux of toluene (Ramos et al., 1998), and resistance to a number of 
dyes, detergents and antibiotics by pumping them out of the cell (Ma et al., 1993). A 
second possible role is environmental sensing. It is conceivable that a pump could allow P. 
aureofaciens PA147-2 to sense the presence of a fungal competitor, perhaps by the uptake 
of a particular molecule from its environment. Such a sensing system would allow P A14 7-
2 to specifically respond to the presence of a fungus, rather than synthesising antifungal 
compounds constitutively. 
Although there is no evidence for either of the above suggestions, some indirect evidence 
indicates that the second possibility is less likely. IfPA147-2 uses a membrane channel to 
detect and respond to fungi, then it is likely that antifungal compounds would not be 
constitutively expressed. However, it has been possible to prepare a crude extract of 
antifungal compounds from a culture of P A14 7 -2 that has not been exposed to fungi. This 
indicates that fungi are not required to induce synthesis of antifungal metabolites, although 
it does not rule out fungi inducing an increase in compound synthesis from a "nonnal" 
basal level. However, if this was the case, PAI95 would be predicted to produce some 
antifungal compounds at the basal rate, but this has not been observed. Additionally, an 
inducer need not be fungal the possibility exists that something in the culture media used 
can induce synthesis. Indeed, glucose concentration has been shown to influence 
production of antifungal compounds by P.fluorescens HV37a (James & Gutterson, 1986) 
and carbon sources affect pyrrolnitrin and pyoluterin production in P. fluorescens (Duffy & 
Defago, 1999). Godfrey (1997) reported that glucose concentration did not influence 
antifungal activity by PAI47-2, and no effect of carbon source has been observed 
throughout the course ofthe present study. However, it is important to note that 
optimisation of synthesis conditions was not an objective of this work, so no explicit 
examination of media conditions has been made. 
The possibility that the mutated gene in P AI9 5 encodes a transmembrane pump is 
intriguing, and requires further study. TnphoA mutagenesis would be a straightforward 
method to examine the membrane topology of the protein, and cell lysis experiments might 
reveal whether antifungal compounds are being synthesised, but not exported. 
PAE21. 
Based on similarity searches, the Tn5 insertion in P AE21 appears to interrupt a sequence 
whose predicted translation product is similar to a galactosyl transferase enzyme from P. 
aeruginosa serotype 06 (Belanger et a1., 1999) and Vibrio cholerae 0139 (Comstock et al., 
1996). Specifically, the translation product is similar to WbpU, which is an a-D-glycosyl 
transferase in P. aeruginosa (06 serotype). Belanger et al (1999) suggest that WbpU is 
similar in function to RfbF from Klebsiella pneumoniae, which is an initiating galactosyl 
transferase. It is thought that mutations in wbpUwould result in loss ofB-band 0 antigen 
biosynthesis. If this were the case in P AE21, it would be possible to detect the absence of 
the B-band by comparing LPS ofPAE21 with PA147-2 using a tricine-SDS-P AGE system 
(Lesse et a1., 1990). 
Exactly how loss ofB-band 0 antigen synthesis affects antifungal activity is unknown. 
The 0 antigen is a significant component ofthe outer membrane, and has been implicated 
as a virulence factor, enabling pathogens to evade the immune system (Jacques, 1996; 
Schnaitman & I(1ena, 1993). In addition, 0 antigen is thought to have some role in cell-cell 
interactions between pathogens and hosts, and may be involved with the secretion of 
extracellular compounds (Wandersman & Letoffe, 1993). In terms of antifungal activity, it 
seems unlikely that an 0 antigen is important for protection of the antagonistic bacterium, 
since the expression of antifungal factors effectively minimises any close physical 
interaction between bacteria and fungus. It seems more likely that alterations to the cell 
surface interfere with secretion ofthe antifungal compound(s) produced by PA147-2, 
leading to the observed antifungal-deficient phenotype ofP AE21. 
PAA3, PAI17, PA168, ANDPAI75. 
The DNA sequences that flank the transposon insertion points in P AA3, PAIl7, and PA168 
have no significant similarity to any sequences deposited in public databases, at both DNA 
and predicted translation product level. For these mutants, DNA sequencing has failed to 
provide any clues about the possible functions of mutated genes, and does not lead to any 
speculation about why these mutants are unable to inhibit fungal growth. The sequence 
from PAI75 showed short stretches of similarity to two regions from the 3' end of a gene 
for alginate lyase in Ha[omonas marina. However, the fact that there was no similarity at 
the predicted translation product level suggested that the sequences do not encode similar 
proteins. Examination of the similar sequences shows that one region from the PAI75 
sequence is similar to two stretches of DNA from the alginate lyase gene, and these two 
sequences are adjacent to each other, in opposite directions. It is thus possible that the 
mRNA from them can fonn a stem and loop structure, and they may be a termination 
sequence (Figure 4.2). 
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a .. 
PAI75: 391 tgatcntteeeaegctccgegtgggaatgeegeeecggaegeteegegttecatgee 447 
11111 111111111111111111111111 1111 1111111111111 1111111 
H.mar: 1441 tgategtteeeaegeteegegtgggaatgeageeegggaegeteegegteeeatgee 1497 (Plus) 
PAI75: 392 gatentteeeaegeteegegtgggaatgee 421 
1111 1I111111111 1111111111111 
H.mar: 1552 gategtteeeaegetetgcgtgggaatgee 1523 (minus) 
b. 
H.mar: (1441) tgatcgttcceacgctccgcgtgggaatgc 
1111111111111111 11111111111 
H.mar: (1552) etageaagggtgcgagagcacccttacgg 
loop of 
unmatched 
nucleotides 
99 
Figure 4.2 Comparison of sequence fromPAI75 with sequence from an alginate lyase gene. a. Alignment of 
the sequence from P AI7 5 with two short sequences from the alginate lyase gene from Halomonas marina 
(H.mar). "Plus" indicates the plus strand, while "minus" indicates the sequence shown is the minus (opposite) 
strand. h. Putative stem and loop structure formed by the alginate lyase sequences. The minus strand 
sequence was converted to a plus strand for this arrangement. 
4.3.4 What does all of this mean? 
The DNA sequences and predicted translation products lend themselves to speculation 
regarding possible roles in fungal inhibition. Since this chapter does not test the functions 
of the mutated genes, there is no way to know whether the database matches accurately 
predict the functional nature of these genes. However, regardless of whether the sequences 
described here actually carry out their predicted functions, one thing is clear - none of the 
identified sequences show similarity to the biosynthetic genes for common antifungal 
metabolites such as phenazines, pyrrolnitrin, pyoluteorin, and 2,4-diacetylphloroglucinol. 
It seems unlikely that the sequences uncovered in this study are ofbiosynthetic genes; 
rather, these sequences probably participate primarily in normal cellular activities, and have 
been recruited into the secondary metabolism over evolutionary time. The fact the mutants 
do not cross-feed, and that the mutations are spread throughout the genome supports this 
suggestion because biosynthetic genes for antifungal compounds identified to date tend to 
be clustered (Bangera & Thomashow, 1999; Hammer et aI., 1997; Mavrodi et aI., 1998; 
Nowak-Thompson et aI., 1999) 
The failure to isolate obvious biosynthetic genes could indicate that the original mutant 
screen did not cover the whole genome. Alternatively, PA147-2 may not synthesise 
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antibiotics using gene products that resemble those already known. The isolation of global 
regulatory mutants deficient for antifungal compound synthesis suggests that there are 
target genes that encode antibiotic synthesis proteins. The failure to find these could also 
be explained by a masking effect, where mutants for a single antibiotic are not found due to 
production of a second compound. Global regulators that prevent synthesis of all 
compounds would thus be much easier to find, as appears to be the case for P Al4 7 -2. 
Knowledge of the inhibitory compounds produced by PA147-2 would potentially facilitate 
the development of a system to screen mutants for the loss of individual compound 
synthesis. 
Given the results outlined above, it was decided that the most logical way to examine the 
molecular basis for fungal inhibition was to investigate mutants individually. Both of the 
regulatory mutants (PAl 09 and P A 138) were chosen for further study because they might 
reveal details on the regulatory hierarchy controlling the antifungal phenotype. In addition, 
it might be possible to develop methods to identify their targets, which could lead to the 
identification of the biosynthetic genes. These mutants are discussed in more detail in 
chapter 5. The pstA mutant (P AH26) was also selected for further analysis because of the 
interesting link between "normal" metabolism (phosphate assimilation) and what is 
presumably an example of secondary metabolism. P AH26 is examined further in chapter 6. 
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Chapter 5 
Global regulators involved in fungal inhibition 
5.1 Introduction. 
Fluorescent pseudomonads that are of interest in biocontrol produce a range of secondary 
metabolites that inhibit fungal growth in vitro and correlate with disease suppression in situ 
(for example, Keel et aI., 1990; Thomashow & Weller, 1988). Well-characterised strains P. 
fluorescens CHAO and Pf-5 both produce HCN (Kraus & Loper, 1992; Voisard et aI., 
1989), 2,4-diacetylphloroglucinol (PhI) (Maurhofer et al. 1992; Nowak-Thompson et aI., 
1994) and pyoluteorin (Howell & Stipanovic, 1980; Maurhofer et aI., 1992), and 
pyrrolnitrin (Howell & Stipanovic, 1979). Several levels of regulation are important for the 
control of antibiotic production by these and other fluorescent pseudomonads, and 
individual metabolites are often controlled in part by positive feedback loops (Haas et aI., 
2000). In addition, the observation of mutants with pleiotrophic defects in antibiotic 
synthesis revealed that there are global regulators that operate at a level above specific 
metabolite control, to coordinate the expression of antifungal metabolites. 
One global regulatory system is known as the "two-component signal transduction" system, 
which typically consists of a sensor (histidine protein kinase) and a response regulator 
(Parkinson & Kofoid, 1992; Stock et aI., 1990). For example, the product of gacA is a 
response regulator member of a two-component system that was found to control the 
synthesis of multiple compounds in P.fluorescens CHAO (Laville et aI., 1992), and was 
subsequently shown to be important for survival of CHAO in soil (Natsch et aI., 1994). The 
sensor kinase partner of GacA, ApdA (now known as GacS), was independently 
demonstrated to be essential for antibiotic production by P. fluorescens Pf-5 (Corbell & 
Loper,1995). Production of HCN, pyrrolnitrin, and chitinase by P.fluorescens BL915 is 
also dependent on the two-component system GacA/S (Gaffney et aI., 1994). Furthermore, 
the stationary phase sigma factor encoded by rpoS is required by Pf-5 for pyrrolnitrin 
production, while pyoluteorin and Phi are over-expressed by rpoS mutants ofPf-5 
(Samiguet et aI., 1995). 
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5.1.1 Two-component signal transduction. 
Two-component signal transduction systems are involved in many processes that utilise an 
environmental signal, such as virulence/pathogenesis (Hrabak & Willis, 1992; Huang et aI., 
1993; Lucas et aI., 2000; Rahme et aI., 1995), antibiotic synthesis (Chancey et aI., 1999; 
Corbell & Loper, 1995; Gaffneyet aI., 1994; Laville et aI., 1992), response to phosphate 
limitation (Wanner, 1996), chemotaxis (Hess et aI., 1988a; Hess et aI., 1988b), 
osmoregulation (Forst et aI., 1989; Igo et aI., 1989), and degradation of aromatic 
hydrocarbons (Coschigano & Young, 1997; Labbe et aI., 1997; Velasco et aI., 1998). Two-
component regulators operate by sensing an environmental cue via a sensor kinase (SK), 
and subsequently activating gene expression via a response regulator (RR). This system 
employs auto-phosphorylation of the SK, and subsequent transfer of the phosphate to the 
RR, upon sensing the appropriate signal. Signal transduction is achieved by the utilisation 
of specialised modules within the two-component proteins. Sensors generally have a 
specific input domain which receives the signal, and the transmitter module then passes the 
signal ("transduces") to the receiver module ofthe RR via phosphorylation, thus activating 
the RR. The output domain ofthe RR is then responsible for activating target genes. 
Although the transmitter and receiver modules are conserved, the input and output domains 
are umelated, allowing specific signals to be acted upon with minimal cross talk between 
systems (Parkinson & Kofoid, 1992). Auto-phosphorylation of the SK occurs when the SK 
uses ATP to phosphorylate a highly conserved histidine residue. When a signal is received, 
this phosphate is transferred to an aspartic acid side chain in the receiver module ofthe RR 
(Stock et aI., 1990). 
5.1.2 LysR-type transcriptional regulators. 
LysR-type transcriptional regulators (LTTRs) are perhaps the most common regulatory 
systems in prokaryotes (Schell, 1993). LTTRs possess some or all of the following 
characteristics: 
1. High degree of similarity at the N-terminus, particularly in a helix-turn-helix domain. 
2. Responsive to specific co-inducer molecules. 
3. Bind regulated targets with similar structural features at similar positions. 
4. Divergently transcribed from a promoter close to that of a regulated target. 
5. Show some degree of autoregulation. 
L TTRs are often found linked to a target gene, in a divergent arrangement, but are also 
known to regulate unlinked regulons (Schell, 1993). In keeping with the Ubiquity of 
L TTRs in prokaryotic regulation, they regulate a diverse range of cellular activities. 
Examples include virulence factors (Clough et aI., 1997; Harris et aI., 1998), exotoxin 
production (Hamood et aI., 1996), aromatic hydrocarbon catabolism (Laurie & Lloyd-
Jones, 1999; Parke, 1996), and antibiotic resistance (Lodge et aI., 1993; Magdalena et aI., 
1997). Despite the. large range of targets, the reported involvement of L TTRs in synthesis 
of antifungal compounds is limited to a single example, in which the pyoluteorin regulator 
(PltR) specifically regulates pyoluteorin production in P. jluorescens Pf-5 (Nowak-
Thompson et aI., 1999). 
In his 1993 review, Schell describes a model for LTTR-mediated gene regulation (Schell, 
1993). This model is briefly described here. Most LTTRs, acting as dimers or tetramers, 
bind a ~15bp partially dyadic sequence, featuring the T-Nll-A motif, within the promoter 
of the target gene. This "recognition site"is generally found near position -65, and 
because of the divergent promoter arrangement, this site can overlap the LTTR's own 
promoter. Thus, when regulating the downstream gene, binding can result in the negative 
autoregulation that characterises some LTTRs. Nucleotides of the dyad are thought to 
provide for specificity of recognition for binding. In addition to the recognition site, there 
is an "activation site" downstream (near the -35 sequence), with which LTTRs interact. 
Interaction with the activation site often requires a co-inducer molecule, and is necessary 
for transcriptional activation of the target gene. It seems that a co-inducer may alter the 
LTTR-DNA complex, possibly by inducing DNA bending that would lead to transcription 
initiation by increasing RNA polymerase affinity. A large number of different co-inducers 
have been identified, and these are thought to be specific for each regulator. Examples 
include diaminopimelate, a precursor in lysine biosynthesis, acting as co-inducer for LysR, 
a regulator in lysine biosynthesis, and cyanate is thought to be the co-inducer for CynR, 
which is involved in cyanate detoxification. These and other examples are summarised by 
Schell (1993). One thing that seems evident among known co-inducers is that they tend to 
be compounds related to the function ofthe regulator, such as biosynthetic intermediates. 
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5.1.3 Regulation of antifungal compound synthesis. 
The well-characterised antifungal metabolites are regulated on more than one level. They 
are generally subject to global regulation, in which multiple traits are simultaneously 
coordinated and controlled, and each appears to be the target of specific regulation. 
Multilevel regulatory systems presumably allow fine control over phenotypes regulated in 
this way. Because ofthe relevance to the work presented in this chapter, details on global 
regulation of antifungal compound synthesis are provided below. A review of metabolite-
specific regulation is given in chapter 1 ofthis volume. 
GLOBAL REGULATION. 
In addition to the specific regulation of the production of particular antifungal compounds, 
the synthesis of antifungal metabolites is also controlled collectively by global regulators 
(Corbell & Loper, 1995; Gaffneyet aI., 1994; Laville et aI., 1992). The two-component 
regulators are a prominent example of global regulators, and gacAIS in particular has been 
heavily implicated in the regulation of antibiotic production. 
gacA/S. 
The two components of the gacAIS system were initially identified separately. A mutation 
in the gacA gene (global regulator of gntibiotic and fyanide) was found to be the cause of 
pleiotrophic defects in secondary metabolite production by P. fluorescens CHAO (Laville et 
aI., 1992), while gacS (initially called lemA, for lesion manifestation), was found to be 
required for formation of disease lesions on bean plants by P. syringae (Hrabak & Willis, 
1992). lemA was subsequently found to be important for secondary metabolite production 
by P. fluorescens (where it was called apdA, for gntibiotic Qroguction) (Corbell & 
Loper, 1995), and was fmally renamedgacS (Kitten et aI., 1998). The demonstration that 
mutations in gacA and gacS have pleiotrophic effects provided clear evidence that these 
two genes were involved in global regulation (Corbell & Loper, 1995; Laville et aI., 1992). 
As previously mentioned, the mechanism by which the response regulator (RR) acts is 
thought to be determined by its output domain (Parkinson & Kofoid, 1992). Evidence 
suggests that the RR GacA is a transcriptional activator, at least in the case ofphenazine 
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production, in which GacA regulates PhzI production (Chancey et aI., 1999). However, in 
the case ofHCN synthesis GacA appears to influence metabolite production via a post-
transcriptional mechanism, as demonstrated by the fact that gacA mutations had minimal 
impact on expression of a hcnA: :lacZ transcriptional fusion, but profoundly reduced 
expression of a translational hcnA::lacZ fusion (Blumer et aI., 1999). This observation was 
also extended to include expression of AprA, a GacA-regulated metalloprotease. Small 
changes in the ribosome binding site (RBS) of the GacA-regulated genes in CHAO were 
sufficient to repress GacA control. It is interesting to note that the same sequences that 
were responsive to GacA post-transcriptional regulation were also susceptible to repression 
by the repressor of secondary metabolism, RsmA. Since RsmA is a global negative 
regulator, Blumer et al (1999) suggest a model in which GacA increases expression of 
another regulatory molecule, which can relieve RsmA repression. Of further interest was 
that the expression of hcnA from P. aeruginosa, which usually is controlled by a system 
similar to PhzRfI (which is in tum regulated by GacA), was poorly expressed in CHAO, 
indicating that GacA mediates control of similar systems in a variety of ways. 
Regulation of PCA expression in P. aureofaciens 30-84 is controlled by GacA/S in two 
ways. Firstly, there is direct transcriptional activation of phzI (Chancey et aI., 1999). 
However, since addition of N-acyl-homoserine lactones did not restore PCA production in 
30-84 gacA mutants, an additional mechanism for GacA-mediated control must exist 
(Chancey et aI., 1999), and it has been speculated that a post-transcriptional control similar 
to that described above might be involved (Haas et aI., 2000). 
GacA is also important in the regulation of PhI production. In a gacA mutant of P. 
jluorescens CHAO, expression of a phi: :lacZ fusion was reduced considerably, and the 
fusion was only minimally responsive to PhI induction (Schnider-Keel et aI., 2000). Thus it 
appears that GacA operates at a level above PhIF, since disruption of gacA effectively 
removes the PhlF-dependent subtleties from the system. 
The systems outlined above, and in chapter 1, provide a detailed and complex picture of 
regulation with respect to secondary metabolite production. There is a clear rationale for 
the further investigation of antifungal compound regulation, particularly in strains such as 
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P. aureofaciens PA147-2 that do not appear to make the same range of compounds as the 
better characterised biocontrol pseudomonads. The sequence data presented in chapter 4 
suggested that mutations in two types of regulator lead to abolition of fungal inhibition by 
PA147-2. It was of interest to examine these mutants in more detail for three reasons. 
Firstly, the examination of regulatory mutants will add to the growing picture of global 
regulation of secondary metabolism. Secondly, by investigation of regulatory mutants it 
might be possible to identify some of the regulated targets, thus revealing additional genes 
for fungal inhibition. This second reason was particularly compelling given that analysis of 
Tn5 mutants had failed to reveal the nature of the antifungal compounds produced by 
PA147-2. Finally, only one LTTR has been implicated in biocontrol thus far, and it has a 
very specific function in pyoluteorin synthesis. Investigation of the putative L TTR 
identified here might provide the first example of a LTTR involved in global regulation of 
fungal inhibition. 
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5.2 Analysis of a putative LysR-type transcriptional regulator. 
5.2.1 Complementation of the mutation in PA13S. 
Three cosmids spanning the insertion point in PAl38 were introduced into PAl38 by 
conjugation, and the transconjugants were assessed for their ability to inhibit fungal growth. 
None of the three cosmids was able to restore antifungal activity to PAl38, and the same 
result was observed when a recA derivative ofPAl38 was used. These results suggested 
that either PAl38 had an additional, unknown mutation that contributed to the loss of 
fungal inhibition, or inserts contained in the cosmids were not complementary to the Tn5-
disrupted region. To test the latter suggestion, the cosmids were digested with a variety of 
restriction enzymes, and analysed by Southern hybridisation. Each cosmid had a sequence 
that hybridised with the insert DNA from the clone pCMl38, confinning that the cosmids 
were genuinely derived from the correct genomic region. To further examine the problem, 
one cosmid (pPS2122) was used in an.allele-exchange experiment, to replace the Tn5-
mutated region in PAl38. PAl38(pPS2l22) was grown without selection for 24 hours, and 
diluted to obtain single colonies upon plating. The colonies were tested for Tcs (indicates 
loss of cosmid vector) and Kms (indicating loss of Tn5). Two putative recombinants were 
isolated and tested for antifungal activity. Results from the bioassay confinned restoration 
of fungal inhibition, and the allele-exchange was confinned by Southern hybridisation 
(Figure 5.1). Therefore, the mutation in PAl38 was unable to be complemented in trans, 
but could be complemented by allele-exchange. This result raised the possibility that the 
mutated gene was dominant over the wildtype, since the presence of the wildtype in trans 
did not restore antifungal activity. This suggestion is examined below. 
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Figure 5.1. Southern analysis of allele-exchange between pPS2122 and the PA I 38 genome. Lambda DNA 
digested with HilldlO (lane I) is shown as a moleculm weight standard. DNA from PA147-2 (lane 2) , PADS 
(lane 3) and two recombinants (lanes 4 and 5) was digested with EcoRl and probed with the cloned region 
from pe M 138. peM I 38E (lane 6) was included as a control. T he Southern was probecl with the 4kb Sail 
fragment eloned in pCM 138 . Hybridisation of the probe with a fragment of 5.5kb in the recombinants shows 
a wildtype region of DNA has replaced the mutated region (11.5kb). 
5.2.2 Plasmid constructs. 
All plasmids constructed in the study of PA 138 are detailed in chapter 2, section 2.7.3. 
Plasmids created in the study of PAI09 are described in section 2.7.4 of chapter 2. 
5.2.3 Is the defective gene of PA13S dominant over the wildtype? 
To test the hypothesis of recessive dominance, the clone pCMsub was introduced into 
PA147-2 by conjugation. The clone pCMsub is a subclonc from pCM138E containingfinR 
interrupted by Tn5, as it is in PA138. PA147-2(pCMsub) was assessed for its ability to 
inhibit fungal growth relative to PA147-2 harbouring the vector pME6000. The result, 
shown in Figure 5.2, demonstrates that when the mutated allele is present in trans, PA147-2 
is reduced for it ability to inhibit fungal grmvth. This observation is consistent with the 
hypothesis that the mutated gene is dominant over the wildtype. 
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Figure 5.2. Inhibition of P. megasperma var. sojae by PA147-2 and derivatives. Four colonies (A-D) of 
PA147-2 containing pCMsub were compared with the wildtype PAI47-2. The strains containing pCMsub 
have a reduced ability to inhibit the ftmgal growth, as determined by the gap between the bacterial streaks and 
the ftmgus. 
5.2.4 Does PA138 have a mutation in a putative LysR-type transcriptional regulator 
gene? 
In chapter 4, the DNA sequence flanking the Tn5 insertion in PA138 was described. 
BLAST analysis suggested similarity to LysR-type transcriptional regulators (LTTRs), at 
the predicted translation product level. As discussed above, L TTRs are involved in 
regulating a number of different systems in prokaryotes, and several have been well-
characterised. Further characterisation of the mutated gene in PA 138 was essential in order 
to provide convincing evidence of a role for the gene in antifungal activity. 
DNA SEQUENCING. 
Further DNA sequencing was undertaken to complete the sequence of the ORF mutated in 
PA 138, in order to improve the search for putative homologues. To obtain the desired 
DNA sequence, pCM138E was sequenced on both strands in its entirety. The complete 
sequence of the ORF that is interrupted in PA 138 showed similarity to L TTRs, and was 
designatedfinR (fungal inhibition regulator). The predicted translation product offinR has 
greater than 30% identity with other L TTRs, which is sufficient similarity to indicate the 
presence of a L TTR (Schell, 1993). Figure 5.1 shows the predicted translation product of 
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jinR aligned with a predicted LTTR from P. aeruginosa. The DNA sequence ofjinR is 
shown in appendix 4, along with a list of similar sequences and their accession numbers. 
FinR : 1 MDKLLALKMFVQTVDSKGFSSAARQLGLATSSVTRMIDGLEAELGAVLLNRSTRQVT 57 
+D L ALK+F + GF++AARQ+ L+ ++V++ + LEA L L+NR+TR ++ 
Match: 1 MNYPVDHLTALKVFRAVAANGGFAAAARQMNLSPAAVSKNVAELEAHLKVRLINRTTRSMS 61 
FinR : 58 LSDAGSAYYLKAREILSAMADADASVTDRGDAPTGQLRISVPVAFGRRLISPHIGAFLQRY 118 
L++AG Y + IL + ADA++T P+G LR+S P+ ++P I AFLQRY 
Match: 62 LTEAGEVYRQRLERILDDLEAADAALTSMQQGPSGLLRVSAPLTLALTCLTPAIPAFLQRY 122 
FinR : 119 PDLELDMTLSDDIVDLLGERIDLSIRLGTAATMDGVVSRAIGTFRRKVVASPEYLDVRGFP 179 
P+L L++ L D DL+ E IDL++R G+V+R + + A+P YL G P 
Match: 123 PELRLELLLQDGRQDLIAEGIDLALRGSDRVADSGLVARPLLVLEHVLCAAPAYLSQHGQP 183 
FinR : 180 KQPTDLLQHDCMRFSYGPQQQVWTFQEDSGEVRVSVDGRFKSNNAEVLREVALAGGGVALL 240 
+P L +H+C+RFS WTF++D + V + GR++ +++ +R+ LAG G++L+ 
Match: 184 LRPEALREHECIRFSLSGHADRWTFRKDRECIAVPIAGRYRVSSSLAVRDALLAGFGLSLI 244 
FinR : 241 PDWLVSEDIESGRLTSLFESFVVNPNSASSAISALYLPNYRGSRSSRRVNAFIEFLSELL* 301 
P V ++ GRL L + + +AI A+ Y + + + F++FL+E + 
Match: 245 PRLYVQAELAEGRLVELLADW----KADETAIHAV----YPSRQLAGKTRVFLDFLTETMA 297 
Figure 5.3. Alignment ofFinR with an LTTR fromP. aeruginosa. The P. aeruginosa sequence is labelled 
"match", and the accession number is AAG05935.1. Overall, there is 34% identity, and 57% similarity 
between the translated products. Identical residues are shown between the two sequences, and similar 
residues are indicated by +. Predicted HTH motifs are shown in bold type, dashes are indicative of gaps, and 
*=the predicted termination codon of FinR. 
5.2.5 Is finR expressed under antifungal bioassay conditions? 
Having identified an ORF with potential importance in antifungal activity, it was of interest 
to determine whether the ORF was expressed under conditions relevant to fungal inhibition. 
Two approaches were taken to address this question. 
EXPRESSION OF A FINR: :LACZ FUSION. 
AjinR::lacZ fusion on the plasmid pFRTF833 was introduced into PA147-2 by 
conjugation. The transconjugant was streaked onto a buffered PDA plate in the presence of 
Rhizoctonia solani, and incubated at 22°C until inhibition zones could be seen. Bacterial 
cells were recovered from the plate, and ~-galactosidase activity was determined as a 
measure ofjinR expression. ThejinR::lacZ fusion produced 3392.1 Miller units, compared 
to approximately 1000 units from the vector control, showing that FinR is expressed under 
bioassay conditions. 
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RT-PCR TO MEASURE FlNR EXPRESSION . 
As additional Sllpp0l1 to the IneZ fusion studies, the expression offinR was examined by 
reverse transcription PCR (RT-PCR). PA147-2 was recovered from a bioassay plate which 
showed clear zones of inhibition, and RNA was prepared . RT -PCR using the 
aforcmentioned RNA as a template confirmed thatjinR is transcribed under bioassay 
conditions (Figure 5.4) . 
Figure 5.4. RT-PCR to examinejinR expression under bioassay conditions. RNA was prepared from a 
colony show'ing strong fungal inhibition, and used in the RT-PCR . Lane 1 shows a lambda HindI![ standard. 
Lane 2 is the <lmplificdjil/R, and lane 3 shows the RT-PCR carried out after heat inac tivation orthe reverse 
transcriptasc. Primers used were fincxFwd and fine xRcv (appendix 3). 
5.2.6 Deletion ofjinR. 
Bccausc the Tn5 insertion in PAl3S was near the 3' end offinR, it was dcsirable to 
construct a definedjinR null mutant. For simplicity of interpretation a deletion OfjlllR was 
sought (see section 2.7.3). Construction oftheJinR deletion was accomplished by allele 
exchange between pDELKL and th e PA147-2 genome. Recombination was confirmed by 
cloning the K.Jni{ region from the recombinant (PAI47-2jinR.0.) and determining the DNA 
seq uence ncar the ends of the cloned region (data not shown). Bioassay ofPA147-2fiIlR.6. 
indicated that deletion of.finR resulted in the loss of an tifungal activity, supporting the 
relevance offinR in this study (see Figure 5.11). 
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5.2.7 Computer analysis. 
LTTRs have a characteristic helix-tum-helix (HTH) motif at their N-tenninus (Schell, 
1993). Using the program BLOCKS (http://motif.genome.ad.jp), the predicted translation 
product derived from the DNA sequence of jinR was analysed for known protein motifs. 
This search identified a sequence at the N-terminus ofFinR that strongly resembles a LysR-
type HTH motif. Analysis using the program Pfam suggested thatjinR is a member of the 
HTH LysR family of regulators, and together with the sequence similarities and the HTH 
data, supports the suggestion that P A 138 has an insertion in a L TTR. Thus, predictions 
were made based upon the knowledge of other LTTRs, and tests of these predictions were 
used to further analyse the insertion in P A 138. 
5.2.8 Predictions of the LTTR hypothesis. 
Several predictions can be made based upon the hypothesis thatjinR is a LTTR. These are 
listed here, and details oftheir rationale and testing are provided below. 
A divergently transcribed open reading frame (ORF) will be present downstream ofjinR. 
A T -N 11-A motif with interrupted dyad symmetry will exist between the coding sequences 
ofjinR and the divergent ORF. 
The downstream ORF will be regulated by FinR. 
The downstream ORF will be involved in antifungal activity. 
Is TIIERE A DIVERGENT ORF? 
A common feature ofLTTRs is the presence of an adjacent ORF expressed from a 
divergent promoter (Schell, 1993). Thus, it was reasonable to examine the DNA region 
immediately upstream ofjinR for the presence of an ORF. This would also reveal the 
sequence of the promoter region of jinR, providing further information that could contribute 
to its classification as a LTTR (see below). The DNA sequence upstream ofjinR was 
subsequently obtained. Computer analysis suggested that there was an ORF of 942bp, and 
BLAST queries of public databases revealed that the predicted translation product had 
similarity to a family of reductase enzymes. The DNA sequence of this ORF (designated 
jinA) is shown with that ofjinR in appendix 4, and the arrangement of the genes is 
illustrated in Figure 5.5. 
--=25 
.Figure 5.5. Diagrammatic representation of the organisation ofjinR andjinA. The open reading frames are 
divergent, and separated by an 182 bp intergenic spacer region. 
Is TIlERE A T -N 11-A MOTIF BETWEEN FINR AND FINA? 
The inter genic region between a LTTR and its target gene should have the promoters for 
both genes, characterised by the presence of -10 and -35 consensus sequences (Schell, 
1993). In addition, LTTRs recognise a sequence ofT-Nn-A, with interrupted dyad 
symmetry, often with symmetrical guanines that are important for binding via HTH motifs 
(Jordan & Pabo, 1988). Examination of the DNA sequence betweenfinR andfinA reveals 
the presence of a putative LTTR recognition site (Figure 5.6). 
S'-TGCGCATTGCGCA-3' 
3'-ACGCGTAACGCGT-S' 
Figure 5.6. PutativejinR recognition sequence (T-Nn-A motif) found betweenjinR andjinA. Dyad 
symmetry is underlined. Note the presence of symmetrical guanines. 
Is FINA REGULA TED BY FINR? 
The arrangement of ORFs at the locus mutated in PA138 is consistent with a LTTR model 
in which FinR would regulate expression offinA. To test the hypothesis thatfinA is 
controlled by FinR, a number offinA::lacZ fusions were constructed, and p-galactosidase 
expression was used as a marker for FinA. 
Expression of FinA from pFATF833. 
The plasmid pFATF833 has afinA::lacZ fusion, and includes both the intergenic region 
betweenfinR andfinA, and the first 45bp offinR upstream offinA. The rest ofthefinR 
gene was replaced by an omega cassette, which provides transcriptional and translational 
stop signals. Although the precise location of the finA promoter was not known, it was 
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expected that any FinA expression would be a result of activity of the jinA promoter, since 
the omega cassette should prevent expression from other promoters on the plasmid. To 
investigate the possible influence ofjinR onjinA, pFATF833 was introduced into PA147-2 
(jinR+) and P Al3 8(jinR138) and ~-galactosidase assays were carried out for both strains 
after growth in buffered potato dextrose broth (PDB) at 25°C. The medium and incubation 
temperature were chosen because of the relevance to the synthesis of antifungal compounds 
by P A14 7 -2. Preliminary investigations into the antifungal compound have revealed that 
PA147-2 produces inhibitory compounds in buffered PDB culture grown at 25°C. 
Overnight growth (18 hours) resulted in very similar ~-galactosidase levels from the two 
strains (Figure 5.7), suggesting that FinR had little influence onjinA. 
5000 
Cl) 
~ .. ~4500 
.... = ~ == 4000 
t ~ ~-
-; :-= 3500 o/l~ 
en.. 3 000 +-----'---'--~=c.L _ ___.___ 
PA147-2 PA138 
Strain 
Figure 5.7. p-galactosidase expression from P A14 7 -2(PF ATF833) and P A 13 8(pF ATF83 3) grown overnight 
in buffered PDB. Data shown are the averages from three separate experiments. Standard errors are shown 
Possible reasons for the lack of difference between FinA expression by PA147-2 and 
P A13 8 include the fact that the assays were carried out in broth culture, whereas fungal 
inhibition assays are conducted on agar plates, and the possibility that the presence of the 
fungus stimulates antifungal activity. To examine the effects of solid versus liquid growth, 
and the effect of time on gene expression, two further experiments were carried out. 
Firstly, PA147-2(pFATF833) and PAl38(pFATF833) were inoculated onto buffered PDA 
plates, with and without fungi present. When the inhibition zones produced by PA147-2 
were clearly visible, bacteria were removed from the plates, and ~-galactosidase assays 
were performed. These results (Figure 5.8) supported the initial findings from broth culture 
that FinR appeared to have little effect onjinA::lacZ expressed from pFATF833, and also 
suggested that the presence of the fungus has no role in the induction ofFinA expression. 
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An alternative approach would be to examine induction of lacZ using a protein gel stained 
for ~-galactosidase. Although the data show that FinA expression is slightly higher in the 
presence of fungus, the difference is not great. 
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Figure 5.8. ~-ga1actosidase expression fromPA147-2(pFATF833) and PA138(pFATF833) from antifungal 
bioassays. The strains were grown on buffered PDA in the presence or absence of G. graminis var. tritid. 
These data are the result of a single experiment. 
Secondly, a time course experiment was conducted in buffered PDB. Duplicate cultures of 
PAI47-2(pFATF833) and PA138(pFATF833) were grown for 400 hours, and~­
galactosidase activity was measured periodically. These data (Figure 5.9) demonstrate that 
FinA expression is not greatly different between the two strains over the initial 150 hours, 
although the strains do differ after this time point, with FinA expression from P A138 
increasing approximately two-fold. The difference is unlikely to be important in antifungal 
activity since the inhibition assays are generally complete before 150 hours of incubation. 
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Figure 5.9. Time course experiment measuring p-ga1actosidase fromPA147-2(pFATF833) and 
PA138(pFATF833). Data shown are from two independent cultures. Standard errors are shown. 
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It appears from the data above that FinA may not be regulated by FinR, at least under the 
conditions tested. However, a report on the ilv YC operon of E. coli suggested that the 
characteristic organisation of the divergent promoters in LTTR systems has evolutionary 
significance, and is important for regulation of the gene adjacent to the regulator gene 
(Rhee et aI., 1999). Since the construct pFATF833 has only 45bp ofjinR present, the 
expression ofFinA from the plasmid might not reflect what actually occurs whenjinA is 
encoded divergent from jinR and jinR138. To test the possibility that the jinR or jinR138 
influence onjinA was dependent upon the proximity ofthejinR alleles, pFATF1000 and 
pFATF2000 were constructed (see section2.7.3, pp 52-53). Both of these new constructs 
had ajinA::lacZfusion, but differed in the region upstream ofjinA. pFATF1000 had a 
wildtype jinR gene in an identical arrangement to that found in PA147-2, while 
pFATF2000 had thejinR138 allele in place ofjinR. Expression ofFinA from these 
plasmids would address the significance of the genetic arrangement ofLTTR loci, and 
extend the examination of the possible effect ofjinR138 onjinA. 
FinA expression from pFATFI000 and pFATF2000. 
pFATF1000 and pFATF2000 were constructed to test the hypothesis that the influence of 
FinR on FinA was at least partly due to the genetic arrangement ofjinR andjinA. The two 
plasmids were separately introduced to PA147-2 by conjugation, and ~-galactosidase levels 
were measured after overnight growth in buffered PDB. Contrary to the findings with 
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pF ATF833, in which the presence of finR138 in trans had no significant impact on FinA 
expression, there was a considerable difference in FinA expression between pF ATF1 000 
and pF ATF2000 (Figure 5.10). It is likely that this difference can be attributed to the fact 
that pF ATF1 000 has the wildtype finR allele present, while pFATF2000 has the finR138 
allele. 
8000 
6000 
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2000 
pFA1FIOOO pFA1F2000 pHRP309Cm 
Plasmid 
Figure 5.10. ~-galactosidase expression from P A14 7 -2 containing either pF ATFIOOO (finR+), pF ATF2000 
(finK), or pHRP309Cm (vector control). ~-galactosidase levels are indicative of the level ofFinA expression 
from each plasmid. These data are the average of four independent experiments for pF ATFl 000 and 
pFATF2000, and three experiments for pHRP309Cm. Standard errors are shown. 
With an intactfinR gene in cis, ~-galactosidase expression is approximately 7000 Miller 
units, compared to 2000 units when the finR13 8 allele is present, and 4000 units from 
pFATF833, in which neitherfinR allele is present in cis. Table 5.2 shows the levels of~­
galactosidase expression when the background level from the plasmid vector is removed. 
Further support for the cis requirement of finR comes from finA expression experiments in 
whichfinR was present in trans on a plasmid (pFin3M). These experiments demonstrate 
that addition of finR in trans does not increase ~-galactosidase levels from pF ATF1 000 or 
pFATF2000 (Table 5.2). 
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Table 5.2. Expression of IJ-galactosidase fromfinA: :lacZ fusions. 
Plasmid finR allele FinA expressiona Relative expression 
(cis and trans) levelb 
pFATF833 None 3735.1 3.2x 
pFATFI000 finR (cis) 6166.8 5.3x 
pFATF2000 finR138 (cis) 1167.0 Ix 
pFATFI000 and finR (cis) 6935.6 5.9x 
pFin3M finR (trans) 
pF ATF2000 and finR138 (cis) 905.3 .78x 
pFin3M finR (trans) 
a. Expression ofFinA is expressed in Miller units of IJ-galactosidase expressed from the relevant fusion 
construct. These data have had the background level oflJ-galactosidase expression (from the vector) 
subtracted. 
b'Relative to expression from pF A TF2000, which is arbitrarily assigned Ix. 
Is FINA INVOLVED IN ANTIFUNGAL ACTIVITY? 
The final prediction of the LTTR hypothesis was that the adjacent ORF (/inA) would be 
involved in antifungal activity. This was based upon the putative identification offinR as a 
LTTR, which suggested it would regulate an adjacent ORF. Since thefinR mutation 
rendered PAl3S antifungal deficient and the likely function offinR was as a regulator of 
the adjacent gene, it was reasoned that the adjacent gene was probably involved in fungal 
inhibition. 
To investigate the possibility that finA is involved in fungal inhibition, a finA mutant was 
constructed. The mutation was made by introducing a GmR gene into the finA coding 
sequence of the clone pRED2L. Specifically, the GmR gene interruptsfinA at base 606, 
thus creating the finA606 allele. The resulting clone, called pRED2Lgm, was introduced 
intoP A 14 7 -2 by conjugation, and finA was replaced by finA606 via allele-exchange. An in 
vitro bioassay revealed that the resulting P A 147 -2finA606 strain was reduced in its ability 
to inhibit fungal growth (Figure 5.11). Thus, it appears that finA is necessary for complete 
inhibition of fungal growth, but is not in itself sufficient for antifungal activity. The 
sequence analysis ofFinA is not revealing in terms of possible roles for FinA in antifungal 
activity, since no similar proteins are known to contribute to in vitro antibiosis. The best 
studied member of the broad flavoprotein reductase family is old yellow enzyme (OYE) 
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found in several yeast species. However, the physiological role of OYE is unclear (Kohli 
& Massey, 1998). Similar proteins are known to be capable of catalysing the denitration of 
nitrate esters (Blehert et aI., 1997; French et aI., 1996) and the reduction of a, p-unsaturated 
aldehydes and ketones (Kohli & Massey, 1998). Some of these flavoprotein reductases 
have roles in degrading xenobiotic compounds such as TNT and nitroglycerine (Blehert et 
aI., 1999; French et aI., 1998). 
Figure 5.11. Bioassay results ofjinA- andjinR-defective isolates. Samples: wildtype PA 147-2 (A), PA147-
2jinA606 (8), PA147-2finRI1 (C), and PAl38 (0), assayed against R. solani. While PA147-2 inhibits the 
fungal growth, both PA 138 and PA147-~finR!1 are unable to inhibit the fungus, and become overgrown by it. 
PA147-2jinA606 has reduced inhibitory activity. The fungus can grow to the colony edge, but cannot grow 
over the colony. 
5.3 Analysis of a putative two-component global regulator. 
5.3.1 Complementation of the mutation in PA109. 
In a previous study, the mutation in PA 1 09 was complemented by allele-exchange, as a 
high rate of homologous recombination hampered trans complementation experiments 
(Carruthers et aI., 1994). In chapter 3 of the present study, the construction of recA strains 
ofPA147-2 and its mutant derivatives was described. Since the failure of trans 
complementation was believed to be due to recombination, it was decided to attempt 
complementation in PA 1 09recAgm. The Tn5 insertion in PA 1 09 lies in a 16kb EcoRl 
fragment. The plasmid pAF16M is a clone of that 16kb EcoRl region, and the plasmids 
pAF2M, pAF6M, pAF7M, pAF8M, and pAF9M are all subclones ofpAF16M (Figure 
5.12b). These plasm ids were all transferred to PAI09recAgm by conjugation, and the 
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resulting transconjugants were assessed for their ability to inhibit the in vitro growth of G. 
graminis var. tritid. The results are shown in Figure 5.12. It appears from these results 
that the gene interrupted in PAl 09 is encoded by pAF8M, and that the gene spans the 
BamHI site. This is based upon the observation that neither pAF2M nor pAF6M could 
complement the mutation, indicating neither clone contained the complete gene that was 
disrupted in PA109. However, pAF8M, which covers both pAF2M and pAF6M was able 
to complement the mutation in PAl 09, allowing the conclusion that both pAF2M and 
pAF6M encoded part but not all of the gene of interest. It is also noteworthy that 
complementation by pAF8M appears to result in a larger zone of inhibition than that 
produced by PA147-2, suggesting the possibility that multiple copies of the regulator gene 
can up-regulate expression of antifungal compounds. 
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Figure 5.12. Complementation of the mutation in PAI09. A. Diagrammatic representation ofa 16kb EcoRI 
region from PAI47-2, that is interrupted by Tn5 in PAI09. The transposoll is indicated by a triangle . B. 
Illustration of the various subclones of the 16kb region that were used in complementation. Their abil ity to 
complement the mutation in PA109 is indicated. C. Bioassays ofPAI09 complementation experiments. 
PA 147-2 and PA 109 were used as controls. Plasmid names on the figure represent the plasmid in a PA I 09 
background . The fungus used was G. graminis var. tritici. 
5.3.2 DNA sequence of the mutated gene in PAI09. 
The DNA sequence presented in chapter 4 indicated that PAl09 had a Tn5 insertion in a 
gene probably encoding a two-component regulator. There are a number of different 
classes of two-component regulators, so in order to verify the identification and aid in 
classification, the putative two-component regulator gene interrupted in PAl09 was 
sequenced. Using the complementation data it was determined that the gene of interest was 
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encoded by pAF8M, and that part of the gene was found within pAF2M. This was in 
agreement with the location ofthe Tn5 insertion previously determined (Carruthers et aI., 
1994). To obtain the DNA sequence, the cloned regions in pAF2M and pAF8M were 
cloned in pBLUESCRIPT KS-, and DNA sequence was determined. The complete DNA 
sequence of the probable two-component regulator gene (designatedfin1) is shown in 
appendix 4. The highest scoring sequence in a Blastx search is shown aligned with FinT in 
Figure 5.13. 
FinT : 1 
Match: 1 
FinT : 181 
Match: 61 
FinT : 361 
Match: 121 
FinT : 538 
Match: 181 
FinT : 712 
Match: 241 
FinT : 889 
Match: 301 
MTFRRRWDINTRTQLITLGPALLLTLLLISFFTFVRIQDLRQELDHTGQFIANQLAPATE 180 
M+ R WDI TR I+LGPALLLTLLL ++FT+ R+QDLRQEL HTGQ IA+QLAPA E 
MSQRHGWDIRTRMLAISLGPALLLTLLLTAYFTYSRLQDLRQELTHTGQLIADQLAPAAE 60 
YGVISGNNDVLESLLRATLATPHVRSWRFRTCCRKYPGVCRATVGEARSLAVGESLPGAD 360 
YGVI+GN VL+ LL+ATL TPHVR R G ++ A + 
YGVIAGNTPVLQKLLQATLDTPHVRFIEVRDRNDNILVYVEQLSGALQNAAPIDIFHSTI 120 
SLQHIQLGNDFFQDSTAEPKAPRA-DYLGRVIVGMSNDAFSQRQQEILFKAGlLALSPCC 537 
Q I L +D D +E DYLGRV+VGMSNDAFSQRQQEIL KA +LA 
QRQRIALASDPLLDGASEGDGQSGEDYLGRVVVGMSNDAFSQRQQEILLKAALLAAFALI 180 
LPSAGPAPGAS-LSQPISAMGNAVKAIQQGDYQTPLPIVDDSELGT-CRHINNLADALTR 711 
L A LS PIS MG AV+A~Q GDY+T LPI+DD E+G RHINNLA L R 
LTFLVARRLAQRLSAPISTMGQAVEAIQSGDYKTSLPILDDGEIGDLARHINNLASGLDR 240 
888 
300 
TEYAALASEVHRTPAEGDQRHPRLLAHRAGPLELEHIPFDLVELIGSCAQAFQHAAQQRG 1068 
EY ALA+E + G LELE IPF+L+EL+ A FQH+AQQRG 
AEYTALATESTEHLLKVINDILDFSRIERGALELECIPFNLLELVQGSALVFQHSAQQRG 360 
FinT : 1069 LALEVPIPQGLGSLQVQGDPTR 
LALE+ I GL +++V GDPTR 
1248 
Match: 361 LALELQIQAGLENIEVCGDPTR ~~~~~~ 420 
FinT : 1249 
Match: 421 
Asp-l 3 
FinT : 1429 
Match: 481 
GHGSVFTLE I PLAI YQQSLPVLAPNTEGNGR - AGEGRNVLLVE ~ NPVNRTVVEACLRSLG 1605 
G GS FTLEIPL +QQS P G+ G+ +LLVE D NPVN+TV+EA LRSLG 
GSGSTFTLEIPLP-FQQS-PAHRQQAAGDAAPVAAGQEILLVE D NPVNQTVIEAMLRSLG 538 
Asp-57 
FinT : 1606 
Match: 539 
FEVSIATDGAEAIRSAESLIFTAILM ~ CRLPGIDGYEATRQIRQLPGCAELPIIA--SRP 1779 
+ V++ DG +A+RSAE + AILM D CRLP +DGY ATR+IR +PIIA + 
YRVTLVADGIQAVRSAERQRYDAILM D CRLPVLDGYSATRElRAQENGRRVPIIALTANA 598 
FinT : 1780 
Match: 599 
LY,~09 MLAGRSGSLPGSWNERLPA K PFKRTDLQQILQRWVQ*1884 
+ R L N+ L A K PFKR +LQ+ILQRW+ 
LQGDRENCLQAGMNDYL-A K PFKRAELQRILQRWI 632 
1428 
480 
:Figure 5.13. Alignment ofFinT with a probable two-component regulator fiomP. aeruginosa. These 
sequences are 54% identical, and 63% similar. The accession number for the P. aeruginosa protein is 
AAG05000.1. The sequence shown starts at the predicted initiation codon, and finishes at the predicted stop 
codon (*). Conserved features of two-component regulators are shown in boxes, labelled in the alignment. 
The Asp-l3, Asp-57, and Lys-109 positions are those suggested by Carruthers (1994). The H, N, Gl, F, and 
G2 boxes were found manually, and are based upon consensus sequences described by Parkinson and Kofoid 
(1992). 
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The results of database searches using the Blastx program support the suggestion thatjinT 
encodes a global regulator protein, and indicate that this protein is probably of the 
sensor/response regulator hybrid type. The possibility that the H, N, Gl, F, and G2 
sequences (features of the transmitter portion of the sensor proteins), and the conserved 
Asp-13, Asp-57, and Lys-l09 of response regulators are found on the same protein lends 
additional support to the hybrid organisation. Block H contains the histidine residue that is 
autophosphorylated, and serves to transmit the phosphorylation signal to Asp-57 in the 
cognate response regulator (parkinson & Kofoid, 1992). 
5.3.3 Maxicell protein analysis. 
In the previous study (Carruthers, 1994), it was suggested that the two-component regulator 
regulates a number of genes found in close physical proximity to it. Specifically, it was 
thought that these genes were located within the same 16kb EcoRI fragment that encodes 
jinT. One approach to address this hypothesis was the expression of proteins using E. coli 
maxicells. coli CSR603 is highly sensitive to UV irradiation due to recAl, uvrA6, and 
phr-l mutations (Sancar et aI., 1979). Thus, UV exposure leads to chromosome 
degradation. Proteins expressed from medium copy number plasmids can be studied by 
transforming CSR603 with the plasmid DNA, then subjecting the transformed strain to UV 
irradiation. While chromosome degradation will be considerable, it is likely that at least 
some plasmid molecules will survive because of their copy number and relatively small 
size (compared to the E. coli chromosome). Once the chromosome is destroyed, 
radioactively labelled amino acids can be added to the culture, and these will be 
incorporated into proteins synthesised de novo. Since there is little or no chromosomal 
DNA, most proteins will be synthesised from plasmid-based genes. SDS-PAGE followed 
by autoradiography allows plasmid-encoded proteins to be visualised with minimal 
contamination by proteins encoded on the chromosome. 
E. coli CSR603 was transformed with the plasmids pWTI09, pFCI09, pBR322, and 
pACYC184, and the proteins encoded by these plasmids were examined. pWTI09 is a 
pACYC184-based clone of the wildtype 16kb EcoRI region (Figure 5.12a), and pFCI09 is 
a clone of the 16kb: :Tn5 in pBR322. Thus, ifjinT is important for the expression of 
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proteins encoded by the 16kb region, there should be a clear difference between the protein 
profiles ofpWTl09 and pFC109, and the faet the clones were constructed using different 
vectors would be insufficient to explain these differences. From the results (Figure 5.14) it 
is clear that there is no significant difference in proteins expressed by the two plasmids. 
There are at least two possible explanations for the l11axicell results. The first possibility is 
that FinT does not positively regulate expression of genes encoded within the 16kb region 
under investigation. The second scenario is thatjinT cannot be expressed in E. coli, or is 
not expressed in sufficient quantity, so even if thcre were genes under FinT control, they 
would not be expressed due to a lack of FinT protein. The second suggestion is supported 
by examination of the maxicell protein gel and autoradiograph . Based upon DNA sequence 
ana1lysis, FinT is predicted to be 68.7kDa, but there is no highly expressed protein of this 
size evident on the autoradiograph, suggesting FinT is not well expressed in E. coli. These 
two possible explanations are not mutually exclusive, but can both be tested. 
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Figure 5.14. Expression of proteins encoded by clones of the 1 6kbjillT region using E. coli ma xicelb. A. 
12% SDS-PAGE gel stained with eoomass ic blue. B. Autoradiograph of the gel shown in A . In botb panels, 
all lanes show expression of proteins from plasmid-encoded genes. The plasmids were , lanel, pACYCIS4 ; 
!Jne 2, pWTl09; lane 3, pFCI09; lane 4 , pFe l; lane 5, pBR322. No diffe rences can be observed between 
proteins from the wildtype 16kb (pWTI09), or the two clones bearing 1'n5 insertions in the 16kb region 
(pFe: 1 09 and pFC I) , indicating that no FinT regulated genes were expressed in this experiment. The arrow 
inLlicatc$ the Cm" protein li'OIn pi\.CYCIS4. Note that it is absent in lane 2, due to the fact that the 16kb 
region is cloned into the HeuRl sitc, which is in the em" gene. Sizes in kDa are shown between the pane.ls. 
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5.3.4 Saturation mutagenesis. 
Saturation mutagenesis was used to further investigate the possibility that there are 
antifungal genes clustered in the 16kb EcoRI region. The mutagenesis approach was 
chosen to complement the maxicell analysis, which showed no evidence ofFinT-regulated 
gene expression. While not testing the regulation of genes by FinT, the use of mutagenesis 
would directly test the theory that antifungal genes are found in the 16kb region by creating 
a range of mutants. 
The clone pAF9 was subjected to insertional mutagenesis using miniTnlOkm (Kleckner et 
aI., 1991). Seven mutated plasmids were recovered and their insertion point mapped 
(Figure 5.15a). Each mutant was separately introduced into P A147 -2 by conjugation. The 
transconjugants were h'Town in the absence of selection to encourage recombination 
between the particular plasmid and genome. Recombinant strains were enriched by 
selecting KmR colonies, and selected by screening for Tcs colonies. Recombinants were 
generated with each of the seven mutated pAF9 plasmids, and recombination of five of 
these was confirmed by Southern analysis (Figure 5.15b). The recombinant strains were 
designated P A14 7 -9 oX, where X represents the particular transposon insertion point (as 
shown in Figure 5.15a). In vitro bioassays were used to assess the impact ofthe various 
insertions on antifungal activity. These assays showed that all recombinants were still able 
to inhibit the growth of Gaeumannomyces graminis var. tritici, indicating that the insertions 
had not interrupted sequences important for antifungal activity. 
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Figure 5.15. Mutagenesis ofpAF9and introduction of mutations into the PA147·2 chromosome. a. 
Diagrammatic representation of the miniTnlO insertions in pAF9. Transposons are represented as triangles. 
b. Southern analysis of five recombinant strains. Each has a miniTnlO in the 9kb BamHVEcoRI region 
cloned in pAF9. Lane 1 is a lambda HindIII standard. Lane 2 is a PA147-2 control. Lanes 3-7 are 
recombinants PA147-9.6, PA147-9.68, PA147-9.45, PA147-9.38, and PA147-9.66 respectively. All genomic 
DNA was digested with BamHI and EcoRI. Lane 8 shows BamHVEcoRI digested pAF9. The membrane was 
probed with the 9kb region from pAF9. Hybridisation to two bands in the recombinant lanes is expected 
because the miniTnlO has two BamHI sites, thus splitting the 9kb into two pieces. The absence of the 9kb in 
the recombinants is strong evidence for successful allele exchange mutagenesis. 
5.4 Protein profiles of P A138 and P Al09. 
The possibility that P AI38 and PAl 09 have mutations in global regulator genes suggested 
that it might be possible to observe the regulatory effects of the mutations by SDS-PAGE. 
After 24 hours of growth in media that supports antifungal compound synthesis, total 
soluble protein from PAI47-2, PA138, and PAI09 was examined using SDS-PAGE, and 
proteins synthesised de novo at the end of 24 hours were examined by labelling with 35S_ 
labelled methionine and cysteine, SDS-PAGE, and autoradiography. Total protein profiles 
(Figure 5.I6a) revealed that there was at least one protein present in PA147-2 that was 
absent in both mutants. Examination of the autoradiograph (Figure 5.I6b) indicates that in 
addition to the difference noted on coomassie-stained SDS-PAGE gels, there were at least 
two more proteins present in P AI4 7 -2 and absent in both mutants. Furthermore, it is 
interesting to note that it seems the mutants make some proteins that PA147-2 does not 
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make. This is interesting because it adds weight to the suggestion thatflnR andfinT 
encode regulators, and also because it suggests that FinR and FinT may have common 
regu latory targets. 
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Figure 5.16. Comparison or proteins expressed by P!d47-2 and mutants PAI09, PA138, and PAH26. A. 
Coomnssie blue stained SDS-PAGE ortotal protein from PA147-2, PAI09, ancl PA138. The arrows show the 
protein missing in PAl 09 and P A 138. This protein was su~iected to N-terrninal sequencing. B. 
Autoradiograph of the gel shown in B. Proteins were labelled with .15S-cysteine and methionine lor one hour 
alkr 24 hours growth. Arrows labdkd "a" indicate places where proteins are missing in J> A I 09 and PA 138. 
AO'o\\'s labelled "b" indicate proteins eXllressed by PA I 09 and PA 138 thnt are not seen in P A 147-2 extracts. 
In hoth panels. lane 1, P;\ I 09; lane 2. P A 147-2; lane 3, PA 138; lane 4, PA 147-2; lane 5, PA1126. 
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In an effort to identify one of the regulatory targets, N-tenninal sequence was obtained for 
the protein whose differential expression was easily observed in coomassie blue stained 
SDS-PAGE gels (arrowed in Figure 5.l6a). Eight residues from the N-tenninus were 
obtained, and the ScanProsite tool on the ExPASy www server 
(http://expasy.proteome.org.auitools/scnpsit2.html) was used to search the Swissprot 
database for similar proteins. No matches were found for the sequence (Figure 5.17), 
suggesting that one target for FinR and FinT regulation encodes a previously 
uncharacterised protein. 
[Ser/Ala] - Val Leu Thr- Xxx - Thr- [Leu/GIn] - Lys 
Figure 5.17. Deduced N-terminal amino acid sequence of the protein indicated in Figure 5.16a. Xxx 
indicates an undefined residue, and residues in square brackets indicate ambiguity. 
5.5 Discussion. 
The results presented in this chapter represent the preliminary characterisation of two 
putative global regulators of antifungal activity in P. aureofaciens PA147-2. Although 
global regulation of secondary metabolism has been extensively studied in fluorescent 
pseudomonads, the emerging complexity of regulatory circuits in other situations indicates 
that the picture is far from complete (Schell, 2000). Thus, the studies presented here add to 
the growing picture of secondary metabolite regulation. 
5.5.1 Analysis of a two-component regulator. 
The DNA sequence of a putative two-component regulator gene (designated finT) was 
completed to examine the possibility that it was a homologue of gacA or gacS, which 
encode a wen characterised two-component system in pathogenic and biocontrol 
pseudomonads (Kitten et aI., 1998; Laville et aI., 1992; Rahme et aI., 1995). The results of 
database searching using the Blastx algorithm show that FinT has some similarity to GacS 
(accession number AAG13658.1). The proteins are, 27% identical, but FinT also has 27% 
identity with RtpA from P. tolaasii (accession number BAA34 717.1). Furthennore, FinT 
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appears to be more similar to two-component sensor/regulator hybrids, suggesting that it is 
not a homologue of either GacA or GacS. The predicted protein sequence of FinT contains 
sequences that are consistent with features of both sensors and response regulators, which 
adds additional support to the classification ofFinT as a hybrid sensor/regulator. 
Expression ofjinTin ajinT isolate ofPA147-2 (shown in Figure 5.12) suggests that 
multiple copies ofjinT can lead to increased antifungal activity. This indicates that 
regulation by FinT might be dose dependent. IfPA147-2 were to be developed further as a 
biocontrol strain, it would be useful to examine the possibility of enhancing the strain by 
integrating one or more additional copies of jinT into the genome, with a view to over-
expressing antifungal metabolites. 
FINT DOES NOT ACT LOCALLY. 
In a previous study it was suggested that FinT regulated genes are found in close proximity 
to thejinT gene (Carruthers, 1994). This suggestion was based upon mutagenesis of a 16kb 
EeoR! fragment from PAI47-2, which contained the sequence forjinT. In this thesis, two 
approaches were taken to further examine FinT gene regulation. Saturation mutagenesis of 
a 9kb region adj acent to jinT was carried out to identify genes important in antifungal 
activity, and maxicell protein studies were performed to compare proteins expressed from 
clones of the 16kb EeoR! region containing either wildtype or mutatedjinT. Mutagenesis 
failed to identify sequences that were important for fungal inhibition, while the maxi cell 
protein experiments did not indicate any major differences between proteins expressed in 
the presence of wild type and mutatedjinT. Taken together, these results indicate that, 
contrary to the earlier study, FinT probably does not regulate genes found in close 
proximity to the jinT coding sequence. The apparent discrepancy between the mutagenesis 
results reported here, and those reported previously (Carruthers, 1994) could possibly be 
explained by an independent loss of antifungal activity during the allele-exchanges carried 
out by Carruthers. In chapter 8 of this volume, experiments indicate that while in culture 
PA147-2 can lose the capacity to inhibit fungal growth. It is therefore possible that the 
mutants examined by Carruthers (1994) were not generated by allele-exchange as 
supposed, but were the result of concomitant, spontaneous loss of antifungal activity. 
Given that five of seven insertions within the 16kb region that were introduced to the 
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PA147-2 genome were reported to be antifungal-deficient, it seems improbable that each 
was the result of spontaneous mutation, but this explanation cannot be ruled out. An 
additional approach to address the question would be to re-examine the mutations created 
by Carruthers (1994). No Southern hybridisation data is presented in that study to support 
the introduction of the miniTnlO insertions into the genome by allele-exchange. Thus, the 
possibility exists that the putative recombinants were the result of illegitimate 
recombination, which would generate the KmR Tcs phenotype, but not the introduction of 
the miniTnlO into the desired chromosomal location. Such events have been observed to 
hamper allele-exchange in PA147-2 throughout the course of the present study (data not 
shown). 
The results from the maxi cell protein analysis support a conclusion that FinT does not 
regulate the expression of any genes within the 16kb region. However, the possibility that 
the PA147-2 genes could not be properly expressed in coli was not excluded. IfjinT 
could not be efficiently expressed due to poor promoter recognition or different codon 
preferences in E. coli, it would be difficult to observe gene regulation by FinT. The 
observed result from the maxicell experiment is consistent with the conclusion that FinT 
does not regulate a proximal gene, but is also consistent with the alternative suggestion that 
jinT is not properly expressed in E. coli. Although there are no data regarding expression 
of jin Tin E. coli, some preliminary data suggest that jinR and jinA are not well expressed in 
E. coli (data not shown), supporting the possibility that jinT is poorly expressed in coli. 
A useful approach to the question ofFinT expression in E. coli would be to use western 
blot analysis to compare FinT expression by E. coli bearingjinr plasm ids and PA147-2. 
This would simultaneously address whether FinT can be made in E. coli, and how much is 
expressed relative to expression in PA147-2. However, even if FinT does mediate 
expression of genes in the 9kb region, downstream ofjinT, it seems unlikely that these 
genes would be involved in antifungal activity but have simply escaped the mutagenesis. 
To examine the problem further, it might be possible to generate maxicells using the 
previously constructed recA strain ofPA109, bearing either a clone of the mutated or 
wildtype 16kb EcoRI region disrupted in PA109. If FinT has an influence on the 
expression of genes in the 16kb region, this should be readily observable by comparison of 
the proteins expressed by P A1 09 maxicells harbouring the mutated and wildtype 16kb 
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region. This is because P A1 09 has a mutation in jinT, so expression of any FinT -dependent 
genes on the plasmid would result from the presence of jinT in the wildtype clone, and 
would not be seen from the mutated clone. In addition, deletion of some or all ofthe 9kb 
region from the chromosome ofPA147-2 would provide a definitive exposition ofthe 
involvement of the region in antifungal activity. 
5.5.2 Analysis of a LysR-type transcriptional regulator. 
DNA sequence analysis supports the identification of jinR as a L TTR in a number of ways. 
The overall similarity between FinR and a number of other LTTRs is greater than 30%. In 
addition, the prediction of a LysR-type HTH motif in the N-terminus, the discovery of a T-
NII-A sequence with dyad symmetry in the intergenic region betweenjinR andjinA, and 
the regulation of a divergent gene all point toward a LTTR system. Experimental evidence 
to verify FinR as a LTTR would be the next logical step, and analysis of the DNA-binding 
properties of FinR in the intergenic region would be the most useful start point. 
FINR138 IS DOMINANT WHEN PRESENT IN TRANS. 
When the jinR138 allele was present in PA147-2 on a plasmid, a reduction in antifungal 
activity was observed. This result suggests that jinR138 is dominant over the wildtype 
allele, when over-expressed. Such an observation is consistent with current knowledge on 
LTTRs, which indicate that the functional form ofLTTRs are homodimers or 
homotetramers (Schell, 1993). IfFinR functions as a dimer or tetramer, the presence of 
multiple copies of jinR138 would likely lead to dimers or tetramers containing both 
functional and non-functional subunits, resulting in reduced or abolished functionality. The 
fact that antifungal activity was not completely abolished in these experiments suggests that 
either multimers containing both wildtype and mutant forms of the protein are somewhat 
active, or a subset ofmultimers are composed solely of wild type protein. This basic 
experiment cannot distinguish between these explanations. 
FINR AFFECTS FINA WHEN PRESENT IN CIS. 
Investigations into the possible regulation ofjinA by FinR revealed that FinR had minimal 
impact on FinA expression whenjinR was in trans, relative to the effect ofjinR138 in 
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trans. However, when expression from ajinA::lacZ fusion was measured from constructs 
with eitherjinR orjinR138 present in cis, it became clear that the presence ofjinR has a 
significant regulatory effect on expression of FinA, and that replacingjinR withjinR138 in 
PA138 probably results in dramatically reduced FinA expression. 
The observation thatjinR was required in cis to affectjinA is intriguing. The divergent 
arrangement of regulator and target genes is a common feature ofLTTR systems (Schell, 
1993), and a cis requirement might be the result of co-evolution of the system. In 
experiments on the ilvYC operon of E. coli, it was found that the genes are transcriptionally 
coupled (Rhee et aI., 1999). Specifically, activity ofthe ilvC promoter was shown to be 
influenced by the transcriptional activity ofthe regulator ilvY. This was suggested to result 
from increased local supercoiling of DNA as a result of ilv Y transcription, which increased 
activation of the superhelix-sensitive ilvC promoter (Rhee et aI., 1999). The observation of 
transcriptional coupling provides supporting evidence for the suggestion that expression of 
the regulated gene is in part dependent upon the presence and location of the regulator 
gene, in addition to the DNA binding activity of the regulator protein. The ability of 
LTTRs to regulate expression of unlinked genes (Schell, 1993) could be a relatively new 
function ofLTTRs (in evolutionary terms), not dependent upon genetic linkage. In other 
words, it is tempting to speculate that although LTTRs may have co-evolved with a linked 
target gene, it is possible some were recruited as regulators of unlinked genes at a later 
stage, with no requirement for linkage. 
WHAT IS THE ROLE OF FINR IN FUNGAL INHIBITION? 
It seems clear from the experiments described that jinR is required for in vitro inhibition of 
fungal growth. A deletion ofjinR lacks the antifungal phenotype, as does the Tn5 mutant 
PA138. Investigation ofFinA regulation revealed that whenjinR is present in cis, there is 
greater than five-fold increase in FinA compared to the situation with the jinR138 allele 
present. However, whenjinR is absent (deleted), FinA appears to be expressed at 
intermediate levels. Furthermore, an insertion injinA did not abolish fungal inhibition, but 
reduced it. These data show that jinA is required for full antifungal activity, but is not 
responsible for complete antifungal activity. Also, although the expression studies were 
plasmid based, the constructs mimic the genomic arrangement such that it might be 
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expected that somefinA expression would occur in PAI47-2finRil, leading to the 
conclusion that while finA plays some role in antifungal activity, low levels are insufficient 
to cause observable fungal inhibition. Therefore, besides its role in the regulation offinA, 
FinR most probably regulates additional, as yet uncharacterised, antifungal genes as 
discussed below. 
WHAT IS THE ROLE OF FINA IN FUNGAL INHIBITION? 
In addition to identifyingfinR as a probable LTTR of antifungal activity, study ofPA138 
and the finR locus identified a putative flavoprotein reductase gene (jinA) that has a role in 
fungal inhibition. While there is considerable data in the literature regarding the substrates 
of such enzymes, and the reactions they catalyse, there is no evidence that any flavoprotein 
reductase enzymes have previously been implicated in antifungal compound synthesis. 
Thus, the demonstration of a role for FinA in fungal inhibition is a novel finding. 
However, although FinA has been shown to be important, no role for FinA can currently be 
assigned, due to the fact that the structure of the compound or compounds produced by 
PA147-2 has remained elusive. If a structure could be solved, it would then be possible to 
construct a testable pathway for the synthesis of the compounds, and a role for FinA might 
then be forthcoming. This has not yet been possible, due to the difficulty involved in 
preparing large, pure samples of inhibitory compound, and the apparent instability of 
antifungal extracts from PA147-2 (Godfrey, 1997). The synthesis ofpolyketide antibiotics 
(e.g. pyoluteorin, 2,4-diacetylphloroglucinol) requires a ketoreductase, either as a domain 
of a polyketide synthase or as a separate protein that forms part of a enzyme complex 
(Bender et aI., 1999). One speculative suggestion is that FinA is in some way involved in 
synthesis of a polyketide, but since FinA has no resemblance to any known ketoreductase 
this seems unlikely. 
5.5.3 FinT and FinR regulate common proteins. 
As an approach to confirming that FinT and FinR encode global regulators, protein profiles 
ofPA147-2, PA109, and PA138 were compared after growth in conditions that support 
antifungal compound production. In addition to examining total protein, de novo protein 
synthesis was examined by labelling proteins with 35S-methionine and 35S-cysteine for one 
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hour prior to SDS-PAGE and autoradiography. Examination of both the total protein and 
the de novo synthesised protein suggests that there are differences between PA147-2 and 
the mutants, and that some of these differences are common to both mutants. These results 
may represent an under-estimation of the differences between PA147-2 and the regulatory 
mutants because of the low resolution of the lD analysis, and the fact that membrane-
bound and secreted proteins would have escaped detection in these experiments. The 
differences in protein profiles supports the suggestion that both jinR and jinT encode global 
regulator genes, but does not reveal whether the regulation occurs at the level of 
transcription or translation. Two further approaches to the question of global regulation 
would be revealing in this regard. Firstly, it would be useful to build upon the one-
dimensional SDS-PAGE study, and carry out two-dimensional PAGE. The use of 2-D 
PAGE would greatly increase the ability to detect differences in protein profiles between 
PA147-2 and the regulatory mutants, as its resolution is far superior to l-D SDS-PAGE. A 
second and complementary approach would be RNA subtractive hybridisation, which 
would provide· a means by which the degree of transcriptional regulation can be assessed, 
relative to that occurring at the post-transcriptional level. There is sufficient reason to 
consider both options for the future study ofPA147-2. Using DNA and protein 
sequencing, differentially regulated genes can be identified. Construction of knockout 
mutants would then allow the role of these genes in fungal inhibition to be assessed. The 
probability of success is high, given that 1-D SDS-P AGE has already allowed differential 
gene expression to be visualised. The comparison of differentially regulated genes revealed 
by subtractive hybridisation with those found by protein profiles might allow the level of 
regulation of particular genes to be assessed. This could be very informative given the 
recent suggestion of a post-transcriptional mechanism for GacA (Blumer et aI., 1999) in 
addition to its role as a transcriptional regulator (Chancey et aI., 1999). 
The observation that FinR and FinT are required for the expression of common proteins 
indicates a relationship between FinR and FinT. While the nature ofthe relationship 
remains unknown, preliminary data (not shown) on expression ofjinT::lacZ andjinR::lacZ 
fusions in PA147-2, PAl09, and PA138 indicate that expression ofjinTis independent of 
jinR, and vice versa. While these data need to be confirmed, they point to a model in which 
FinR and FinT interact, perhaps in a synergistic fashion, to control the expression of a 
Chapter 5 Global regulators involved in fungal inhibition 135 
number of genes. The growing picture of regulatory cascades indicates that phenotypes 
such as virulence and antifungal activity are characterised by a number of interacting 
regulators, which provide fine control over the various individual traits that contribute to 
the overall phenotype (Blumer & Haas, 2000b; Haas et aI., 2000; Schell, 2000). 
The experiments outlined in this chapter have shown that FinR has a role in the regulation 
ofjinA, a gene that is required for full expression of antifungal activity. In addition, 1D 
SDS-PAGE analysis ofthe mutants PA138 and PA109 provided evidence that a number of 
proteins are regulated by FinR and FinT. The identification of one target protein was 
attempted by N-terminal sequencing, but database searches failed to find any matching 
sequences. Despite the inability to identify the protein based upon its sequence, elucidation 
ofthe N-terminal sequences ofthe proteins with altered expression in the regulatory 
mutants may provide an avenue for further investigation. By designing degenerate primers 
based on the N-terminal sequence and.carrying out peR amplification with the degenerate 
primer and a universal primer, it may be possible to clone some or the entire gene encoding 
that protein. In combination with 2D protein electrophoresis, such an approach might 
facilitate the discovery of genes regulated by FinR andlor FinT. Establishing a role for that 
gene in fungal inhibition could then be accomplished by a site-directed mutagenesis 
approach and once the gene had been isolated, more quantitative techniques could be used 
to formally demonstrate regulation by FinR, FinT, or both proteins. Another useful 
approach would be to generate mono-specific polyclonal antibodies for each protein that is 
shown to be differentially expressed between the mutants and wildtype. Such antibodies 
could be used in westerns to show whether expression of the protein in question is 
abolished, reduced, or has migrated at a different rate due to altered post-translational 
modification in the mutants. Further studies using westerns could assess the effect of 
altered nutrient levels on protein expression in the wildtype, which would be interesting 
given the importance of minerals and carbon source in the expression of a number of 
lmown antifungal metabolites (Duffy & Defago, 1999; James & Gutterson, 1986; Slininger 
& Jackson, 1992). 
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Chapter 6 
Involvenlent of the pbosphate specific transport system in 
antifungal activity 
6.1. Introduction. 
6.1.1 The phosphate specific transport system. 
The phosphate specific transport (Pst) system mediates high affinity uptake of inorganic 
phosphate under phosphate limiting conditions (Wanner, 1996). The genes encoding the 
Pst system are arranged in an operon, and in most cases are organised as shown in Figure 
6.1. 
Figure 6.1. Organisation of the genes encoding the Pst system. The black arrow indicates the start of 
transcription. 
Phosphate transport. 
The Pst system is a transport complex belonging to the ABC transporter superfamily, and 
as such has a number of conserved features (Higgins, 1992). PstA and PstC are membrane 
spanning proteins, which associate to form a channel for Pi transport. PstB is an ATPase 
(Chan & Torriani, 1996) which forms a dimer that interacts with PstA and PstC on the 
cytoplasmic side of the inner membrane. PstB is thought to hydrolyse ATP providing the 
energy for Pi uptake, and PstS is located in the periplasm where it functions as a Pi binding 
protein, directing Pi to the transport complex. The Pi uptake system is illustrated in Figure 
6.2. PhoU is not required for Pi uptake, but is essential for the regulatory functions in 
which the Pst complex is involved (Steed & Wanner, 1993). E. coli is known to have a 
number of other phosphate uptake systems, including a low affinity Pi transport (Pit) 
system, and transporters for organophosphates (Argast et aI., 1978; Rao & Torriani, 1990; 
Wanner, 1996), and it is likely that P. aeruginosa also has a phosphate uptake system in 
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addition to Pst (Nikata et aI., 1996). However, the Pst system is the main mechanism for 
scavenging inorganic phosphate under Pi limiting conditions in E. coli and P. aeruginosa. 
® ® ================~®:!i' ========Outer membrane 
Periplasm 
ATP 
Cytoplasm 
Figure 6.2. Diagram illustrating the current model for Pi uptake by the Pst complex. PhoU has no discernible 
role in Pi uptake,but is part of the Pst complex, having a regulatory role (see text for details). 
Expression ofthe Pst operon is controlled largely by extracellular Pi concentration. The Pst 
complex is part of a regulatory network called the Pho regulon. In response to low 
extracellular Pi, expression of the genes in the Pho regulon is induced. There are at least 38 
genes in the Pho regulon, including the pst genes, and for the most part these encode 
products involved with Pi transport and metabolism (Rao & Torriani, 1990; Wanner, 1995). 
Activation of the genes in the Pho regulon is controlled by PhoB, the response regulator of 
the two-component pair PhoRlPhoB. Phosphorylation ofPhoB by the sensor kinase PhoR 
allows PhoB to activate transcription of Pho regulon genes by binding to a consensus Pho 
box within the promoters of target genes (Wanner, 1995; Wanner, 1996), 
Control of the Pho regulon. 
In addition to its role in high affinity Pi uptake, a membrane integrated Pst system also 
plays a pivotal role in the repression of the Pho regulon in high Pi environments. Evidence 
for this function comes from studies showing that certain mutations in pst genes result in 
loss of Pi uptalce and derepression of the Pho regulon (Cox et aI., 1989; Steed & Wanner, 
1993). Loss ofPhoU had no discernible impact on Pi uptake, but resulted in derepression 
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of the Pho regulon (Steed & Wanner, 1993). Additional evidence supports a role for Pst in 
both Pi uptake and Pho regulon repression, and also indicates that these two functions can 
be independent. Site directed mutagenesis was used to create mutations in pstA and pstC 
that abolished high affinity Pi uptake, but had no impact on Pho regulon expression (Cox et 
aI., 1988; Cox et aI., 1989). These mutations altered the membrane spanning proteins PstA 
and PstC, maldng them incapable of Pi transport. Presumably the overall structure of the 
complex remained unchanged, a feature which may be responsible for the continued ability 
to repress the Pho regulon. 
Exactly how the Pst system and PhoU repress the Pho regulon is not well understood. The 
current model suggests that the sensor ldnase PhoR is closely associated with the Pst 
complex, and this association is mediated via PhoU (Figure 6.3). Under high Pi conditions, 
a so-called "repression complex" forms in which occupation of Pi binding sites in the Pst 
complex (and possibly PhoR) lead to a change in PhoR conformation, inhibiting its ability 
to transfer phosphate to PhoB. Since PhoB is not phosphorylated under these conditions, 
the Pho regulon is repressed. The low Pi found in phosphate limiting environments results 
in low occupation of Pi binding sites, releasing PhoR from the "repression complex". In 
this situation, PhoR phosphorylates PhoB, thus derepressing the Pho regulon (Wanner, 
1995). 
The Pst system is expressed as part of the Pho regulon in response to Pi limitation, so PhoB 
activation mediated by PhoR release from the "repression complex" leads to higher levels 
of pst operon expression, and thus more Pi uptake. Although the Pst system and PhoU are 
essential for Pho regulon repression, they are only synthesised at a high level once 
repression has been removed. Seemingly a basal level of Pst system activity is sufficient to 
repress the Pho regulon under high Pi conditions. 
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Figure 6.3. Model for the involvement of the Pst system and PhoU in repression of the Pho regulon (adapted 
from Wanner, 1996) .. High Pi (left) results in formation of a repression complex, and PhoB cannot be 
phosphorylated. Low Pi (right) releases PhoR from the repression complex, causing PhoB phosphorylation, 
and thus transcription ofPho regulon genes. PhoRR= PhoR repression due to high extracellular (and 
periplasrnic) Pi. PhoRA= PhoR is activated in response to low Pi. The exact nature of the repression complex 
is unclear. 
Pst systems in other organisms. 
The paradigm outlined above summarises findings regarding the Pst system in E. coli. To 
what degree are Pst systems conserved among diverse prokaryotes? Pst systems have been 
identified in a number of species including Salmonella enterica (Typhimurium) (Jiang et 
a1., 1995), Bacillus subtilis (Takemaru et al., 1996), P. aeruginosa (Nikata et al., 1996), P. 
putida (Wu et al., 1999), Caulobacter crescentus (Gonin et a1., 2000), and 
Streptococcus pneumoniae (Novak et a1., 1999). With a few exceptions, initial studies 
seem to suggest that the organisation of the Pst genes, and the functions of the Pst system in 
these organisms are highly conserved. 
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6.1.2 Involvement of the Pst system with complex traits. 
In addition to defects in Pi transport and Pho regulon control, a number of complex traits 
appear to require an intact Pst system. These traits would not intuitively be linked with the 
Pst system, and their dependence upon Pst indicates a role for the Pst system as an 
environmental sensor allowing diverse traits to be switched on or off depending on the 
extracellular Pi concentration. Although the Pst system directly senses periplasmic Pi 
levels, this can be taken as an indirect system to sense extracellular Pi, since Pi freely enters 
the periplasm from the extracellular milieu (Rao & Torriani, 1990). Three examples are 
outlined here. 
PATHOGENICITY OF AN E. COLI THAT CAUSES SEPTICEMIA IN PIGS. 
E. coli strain 5131 is serum-resistant and causes septicemia in infected pigs. A mutant 
screen was conducted with the aim of isolating strains with reduced pathogenicity. One 
such mutant was found to have a transposon insertion in the gene pstS, and was shown to 
be avirulent in chickens and pigs, and serum sensitive (Daigle et aI., 1995). Expression of 
the Pho regulon by the wildtype appeared to have no effect on serum resistance, and the 
authors suggest that the avirulent phenotype is not related to Pho regulon expression. 
Rather, they propose that virulence is modulated directly by Pst via an unlmown 
mechanism, or indirectly by Pst-mediated regulation of a gene or genes not linked to the 
PhD regulon. 
!Nv ASION GENE EXPRESSION IN SALMONELLA ENTERICA TYPHIMURIUM. 
A screen for S. enterica serovar Typhimurium mutants that were reduced in their ability to 
express hilA and invasion genes identified pstS as being important for hilA expression 
(Lucas et aI., 2000). HilA activates invasion gene expression, and a transposon insertion in 
pstS reduced hilA expression 2-3 fold. Construction of a pstS-phoB double mutant (cannot 
express the Pho regulon) suppressed the effect of the pstS insertion on hilA expression, 
indicating that the reduced hilA expression in the pstS mutant was due to an increase in Pho 
regulon activity. These authors suggest that using the Pho regulon to regulate invasion 
allows S. enterica to sense its location. They speculate that the site for invasion (lumen) is 
high in Pi, allowing expression of the invasion genes, while other environments (such as 
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the interior of a macrophage) are low in Pi, leading to repression of invasion genes, and 
expression of other genes required for survival (Lucas et al., 2000). 
STALK ELONGATION IN CAULOBACTER CRESCENTUS. 
Caulobacter crescentus produces morphologically distinct progeny as a result of 
asymmetric cell division. One cell (the swarmer) has a polar flagellum, while the other has 
a polar stalk. Environmental phosphate has a dramatic effect on stalk length low Pi 
concentrations lead to elongation of the stalk by as much as 30 times, and it is thought that 
this allows C. crescentus to uptake Pi more efficiently. To determine the underlying 
mechanism, mutants were generated that produced elongated stalks irrespective of Pi 
concentration. A number of mutants were found to have insertions in the pst genes, and to 
examine the possibility that constitutive Pho regulon expression caused the stalk 
elongation, PhoB mutants were made. The results indicate that PhoB is required for stalk 
length, and this requirement is likely to involve PhoB-mediated expression of the Pho 
regulon (Gonin et al., 2000). 
6.1.3 Phosphate and antibiotic expression. 
The production of a number of antibiotics has been shown to be inhibited by high 
phosphate concentrations. These include candicidin and tetracycline production by 
Streptomyces spp., and vancomycin fermentations (Martin & Demain, 1980). Of particular 
relevance to biocontrol is the observation that phosphate can inhibit phenazine production 
by some (but not all) phenazine producing bacteria (Turner & Messenger, 1986), and that 
synthesis of 2,4-diacetylphloroglucinol and pyoluteorin by P. fluorescens CHAO is reduced 
when phosphate concentrations are high (Duffy & Defago, 1999). 
6.1.4 Objectives of this stndy. 
The antifungal mutant PAH26 was described in chapter 4. DNA sequence analysis 
indicated that this mutant had an insertion in a homologue of pstA. mterestingly, in an 
independent study, a pstC mutant (P AB 1 08) was isolated on the basis of a biofilm-
defective phenotype (Monds, 2000). The main objective of the work presented was to 
examine the impact of a pstA mutation on antifungal activity, with a view to development 
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of a testable model. To accomplish this, it was necessary to undertake preliminary studies 
on Pho regulon control and Pi uptake by P. aureofaciens. The objective ofthe Pi uptake 
and Pho regulon studies was to develop an understanding of the impact of pst mutations on 
P. aureofaciens, which would then allow the design of experiments to examine the 
antifungal nature ofthe pstA mutant. 
In this chapter the investigation into Pho regulon control and Pi uptake by PA147-2 and 
pstA and pstC mutants is presented. These data is used to design experiments to assess the 
cause of the antifungal defective phenotype. Speculative models regarding the role of Pst 
in antifungal activity are outlined, along with possible experimental approaches to test 
them. Finally, the novel aspects of Pi uptake and Pho regulon control by PA147-2 are 
discussed. Because the theme ofthis thesis is biocontrol, limited consideration is given to 
the biofilm-defective phenotypes. A manuscript detailing the biofilm results and aspects 
from this study has been submitted to Molecular Microbiology for pUblication. 
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6.2 Results. 
6.2.1 PAH26 and PAB108 are antifungal- and biofilm-defective. 
The DNA sequences derived from the mutants PAH26 (chapter 4) and PABI08 (Monds, 
2000) indicated that both isolates have insertions in genes whose predicted translation 
products have a high degree of similarity to PstA and PstC (respectively) from P. putida 
and P. aeruginosa. Since the genetic basis of the Pst system is well conserved, it was 
predicted that the transposon insertions in PAH26 and PAB 108 would not only interfere 
with expression of pstA and pstC respectively, but they would have polar effects on the 
expression of the downstream genes of the pst operon. Thus, it was reasoned, the insertions 
could lead to similar phenotypic effects. For this reason PAH26 was tested for its biofilm 
formation, and PAB 1 08 was tested for the ability to inhibit in vitro growth of G. graminis 
var. tritici. Consistent with predictions, PAH26 did not form biofilms on abiotic surfaces, 
and P AB 108 was unabJe to inhibit fungal growth (Figure 6.4). 
a. 
PABI08 
b. 
Figure 6.4. Phenotypic properties of PA 147-2 and derivatives. a. Antifungal phenotype of PA 147-2, 
PABI08, and PAH26 on tris-buffered PDA. A clearing zone between bacteria and fungus (Gaeumannomyces 
graminis) indicates inhibition of fungal growth. Both pst mutants are defective for fungal inhibition. b. 
Biofilm phenotypes ofPAI47-2, PABI08, and PAH26. Biotilm formation is visualised by staining with 
crystal violet. Biofilm formation is indicated by a ring of stained bacteria. Both pst mutants are defective for 
biofilm formation. 
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Further DNA sequencing was undertaken to confinn that the PA147-2 pstA was found in a 
similar arrangement to that inP. putida. DNA sequence was obtained from the ends of the 
clones pCMH26E and pCMH26. The sequences indicated that upstream of pstA were 
sequences with similarity to pstC and pstS (Figure 6.5). While not providing conclusive 
evidence that the pst genes ofPA147-2 are organised identically to other organisms, these 
sequencing results indicated that at least three genes are in the anticipated configuration. 
PA81 08 PAH26 
a. 
b. .. ... I I pCMH26E 
EcoRI EcoRI 
..... ~ 
I pCMH26 
Sail Sail 
Figure 6.5. Cloning the Tn5 insertion point from P AH26. a. Arrangement of pst genes in E. coli (Rao & 
Torriani, 1990) and P. putida (Genbank accession number ABO 17356), with transposon insertion points in 
P AB 108 and P AH26 indicated. b. Clones pCMH26E and pCMH26, aligned with the pst genes in a. Regions 
of DNA sequence data derived from these clones are indicated by the broken arrows. 
6.2.2 The physiological effects of pst mutations in P. aureofaciens. 
Based upon the published analyses of pst mutants of E. coli and P. aeruginosa (Nikata et 
a1., 1996; Steed & Wanner, 1993), PAH26 and PAB108 were predicted to have two 
physiological traits related to involvement in high-affinity Pi assimilation and Pho regulon 
contro1. Firstly, pst mutants have severe defects in high-affinity Pi uptake under Pi 
starvation conditions, and secondly, pst mutants show constitutive derepression ofthe Pho 
regulon. These phenotypes were examined in P AH26 and P AB 1 08 in order to gain an 
understanding of the basic consequences of pst mutations in P. aureofaciens, so that 
predictions could be made as to why insertions inpst genes render PA147-2 antifungal 
defective. In experiments that use media with defined Pi concentrations, the stated 
inorganic concentration represents that Pi which was added. The presence of 
contaminating Pi from other sources was not ruled out, but was deemed to be of low 
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importance because phenotypic traits were always examined to determine whether a 
medium was limiting or sufficient for Pi. 
P AH26 AND P AB 1 08 HAVE DEFECTS IN PRO REGULON CONTROL. 
A membrane integrated Pst system is required to repress expression of the Pho regulon 
under Pi sufficient conditions. Thus, it was predicted that both P AH26 and P AB 1 08 would 
show constitutive Pho regulon expression, since PstA and PstC are both required for a 
functional Pst complex. The gene for alkaline phosphatase (APase) is a member of the Pho 
regulon in E. coli, and is often used as an indicator ofPho regulon activity (Wanner & 
Wilmes-Riesenberg, 1992) because its expression is relatively easy to assay. The effect of 
the pstA and pstC mutations on Pho regulon control was initially examined in a qualitative 
manner, by streaking PA147-2 and the pst mutants onto KlOP agar plates (see appendix 1). 
K2HP04 was added to give final calculated phosphate concentrations of 0.1, 1, and 25mM, 
and the plates were supplemented with BCIP. lOOP plates were used because it is known 
that 10% King's B (KlO) with the standard Pi concentration supported both antifungal 
activity and biofilm formation. In the presence ofO.lmM Pi, PA147-2 and the mutants 
were all blue, indicating APase (and Pho regulon) expression. When lmM Pi was used, the 
mutant colonies were still blue, but the wildtype was not. On 25mM Pi plates, all strains 
showed negligible APase activity. The lack of APase expression by the pst mutants when 
grown on 25mM Pi was unexpected since studies of other organisms report that the Pho 
regulon in pst mutants is constitutively derepressed. 
Quantitative assays for Pho regulon (APase) activity were carried out as described in 
chapter 2. The compound p-nitrophenol phosphate (pNPP) is cleaved by APase releasing a 
yellow compound (p-nitrophenol). Spectrophotometric measurement ofthe change in 
absorbance at OD410 over time allows the quantitative determination of APase activity for 
strains grown in the presence of different Pi concentrations. PA147-2, PAH26, and 
P AB 1 08 were grown for 16 hours in Kl OP supplemented with K2HP04 to give final Pi 
concentrations of 0.1, 0.5, 5, 10 and 25mM. Consistent with predictions, APase activity 
was comparably high for all strains when grown in Pi-limiting conditions (O.lmM Pi). 
When the Pi concentration was 0.5mM, P AH26 and P AB 1 08 still showed high APase 
activity, while PA147-2 showed very low APase activity, indicating repression of the Pho 
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regulon. However, as Pi concentration was increased to 5, 10, and 25mM, both of the pst 
mutants demonstrated progressive reductions in APase activity. Although both pst mutants 
have defects in Pho regulon control, they both show some ability to repress the Pho regulon 
if extracellular Pi concentrations are high enough. Further to this, it is interesting to note 
that the pstC mutation appears to have a more adverse affect on Pho regulon control than 
the pstA mutation (Figure 6.6). 
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Figure 6.6. APase activity ofPA147-2, PAH26, and PAB108 after 16 hours growth in Pi limiting, and excess 
conditions (K10P made with the stated Pi concentrations). 
Alkaline phosphatase control experiments with P. aeruginosa. 
Since the APase experiments with P. aureofaciens yielded some surprising results, control 
experiments were performed using P. aeruginosa PA01 (wildtype) and NT1 (pstCAB-phoU 
deletion) (Nikata et aI., 1996). APase assays were carried out on both strains following 16 
hours of growth in K10P-0.1, K10P-1, and K10P-25 media. As expected, PA01 showed 
APase expression after growth in O.lmM Pi, but negligible APase after growth in 1 and 
25mM Pi. Also consistent with expectations, NT1 had a high level of APase after growth 
in 0.1 and 1mM, indicating loss ofPho regulon control. Intriguingly, after growth in 
25mM Pi, the APase level was reduced (Figure 6.7). This is discussed further in section 
6.3.2. 
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Figure 6.7. APase assays for P. aeruginosa PA01 and NT1 grown in the presence of O.1mM, 1mM, and 
25mM inorganic phosphate. APase is derepnissed in P AO 1 grown in O.1mM Pi, but repressed at the higher Pi 
concentration. Data were averaged from three replicates, and are shown with standard errors. 
PI UPTAKE IS DEFECTIVE BUT NOT ABOLISHED. 
Since a major function of the Pst system is high affinity uptake of Pi under Pi-limiting 
conditions, it is reasonable to expect that mutations in pst genes would result in abolition of 
high-affinity Pi uptake. Indeed, this has been the subject of extensive study in E. coli and 
P. aeruginosa, and pst mutants of both species are incapable of high affinity Pi uptake (Cox 
et aI., 1988; Cox et a1., 1989; Nikata et a1., 1996; Rao & Torriani, 1990). Similar results 
were predicted for P AH26 and P AB 1 08 since the mutations in these strains are thought to 
lie inpstA andpstC, the genes encoding the transmembrane proteins of the Pst system. To 
test Pi transport in P AH26 and P AB 1 08, Pi uptake studies using [32p ]K2HP04 were carried 
out for strains grown in Pi-limiting and excess conditions. Two strains of P. aeruginosa, 
PAOI and NTI were included as controls. 
Pi uptake under Pi excess conditions. 
To determine the level of Pi uptake that is considered to be independent of the Pst system, 
initial measurements were made in Pi-excess conditions, in which PA147-2 should not be 
using high affinity transport. PA147-2, PAH26, and PABI08 were grown for 5 hours in 
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KlOP-O.1. Following this, Pi uptake was measured at 30 second intervals for a three 
minute period. While K10P-0.1 is Pi limiting after 16 hours growth (Figure 6.6), APase 
assays showed that after only five hours, K10P-0.1 is still Pi-sufficient. This was 
demonstrated by the fact that PA147-2 had low APase activity under these conditions, 
relative to PAH26 andPAB10S (Figure 6.S). 
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Figure 6.8. APase assays for PA147-2, PAH26, andPAB108 grown for five hours in KlOP-O.1. The low 
APase activity ofPA147-2 indicates Pho regulon repression, suggesting that Pi was not limiting in these 
cultures. Data are the average from three replicates. Standard errors are shown. 
PA147-2 showed negligible Pi uptake under the Pi sufficient conditions, but contrary to 
expectations, PAH26 and PAB10S were able to assimilate a considerable amount of Pi, 
relative to the wildtype. Furthermore, P AB10S could uptake more Pi than P AH26 (Figure 
6.9). 
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Figure 6.9. Pi uptake by P. aureofaciens strains grown for five hours in KIOP-O.1. Although these are Pi 
sufficient conditions, P AB 108 and P AH26 show considerable Pi uptake, compared to the very low Pi uptake 
by PA147-2. These data were averaged from three independent experiments, and standard errors are shown. 
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Pi uptake in Pi-limiting media. 
Because of disruptions to the Pst complex, pst mutants are expected to have serious defects 
in their ability to assimilate Pi when grown under Pi limiting conditions. To test this 
assumption, Pi uptak:e by P AH26 and P AB 1 08 was measured after growth for 20 hours in 
the Pi limiting medium To.o5 (see appendix 1). P. aeruginosa PAOI and NTI were included 
as controls. This was important given the unexpected results for Pi uptake in Pi sufficient 
conditions. 
When grown in To.os medium, PAH26 and PAB108 exhibited an approximately 50% 
reduction in total Pi uptake relative to PA147-2 (Figure 6.1 0). This was in stark contrast to 
P. aeruginosa NTl, which assimilated a negligible amount of Pi compared to PAOI and all 
three P. aureofaciens strains. P AB 1 08 was able to assimilate approximately the same 
amount of Pi as it could in Pi--excess conditions, while P AH26 assimilated slightly more 
than under Pi-excess conditions. However, both mutants internalised less Pi than PAI47-2, 
despite .the observation that all three strains were expressing approximately equal levels of 
APase (indicating equivalent Pho regulon activity) Figure 6.1 Ob). While this reduced Pi 
uptake ability is in agreement with the predicted affect of pstA and pstC mutations, it is 
clear that both strains were still capable of significant high-affinity Pi uptake (Figure 
6.lOa). The fact that the To.os was limiting for Pi was confirmed by carrying out APase 
assays. PA147-2 andPAOI both showed expression of APase, indicating de-repression of 
the Pho regulon in response to Pi starvation (Figure 6.1 Ob). 
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Figure 6.10. Pi uptake and alkaline phosphatase activity after growth in Pi limiting media. a. Pi uptake by P. 
aureofaciens and P. aeruginosa strains grown for 20 hours in To.os medium. Only NT1 is completely 
defective for Pi uptake. b. APase assays carried out after 20 hours growth in To.os. 
Pi-uptake after growth in excess Pi (5 and 25mM). 
P AH26 and P AB 1 08 demonstrated some ability to repress the Pho regulon when grown in 
excess Pi conditions (5 and 25mM). It was of interest to examine the effects of Pi excess 
on high-affinity Pi uptake - would this mirror the APase observations? PA147-2 and the 
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two pst mutants were grown for five hours in K10P-5 and K10P-25, after which Pi uptake 
assays were carried out. These results (Figure 6.11) demonstrate that as Pi increases in the 
growth medium, the ability of P AH26 and P AB 1 08 to rapidly assimilate Pi is diminished. 
The implications ofthe observation are discussed in section 6.3.3. 
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Figure 6.11. Cumulative Pi uptake by P A14 7 -2, P AH26, and P AB 1 08. P. aureofaciens strains were grown 
in Pi limiting and excess conditions, and the amount of Pi assimilated in three minutes was measured. Pi 
uptake ability is reduced for all strains with increasing Pi in the growth media. 
6.2.3 How does a pstA mutation affect antifungal activity? 
The experiments outlined above were undertaken to establish an understanding of how pst 
mutations affect the physiology of P. aureofaciens. Having established that P AH26 differs 
from PA147-2 in both Pho regulon control and Pi uptake, in a Pi-dependent fashion, the 
task was to ask whether these results had any significance to antifungal activity. 
Experiments were conducted to examine the following three possible explanations for the 
defect in fungal inhibition shown by P AH26. 
1. The defect in high-affinity Pi assimilation might result in a loss of antifungal activity as 
a consequence of Pi starvation, and the induction of phosphate starvation induced (psi) 
genes. 
2. Antifungal activity is subject to negative regulation by PhoB, or a member of the Pho 
regulon. Thus, the apparent loss ofPho regulon control in P AH26 would be the reason 
P AH26 is antifungal minus. 
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3. The Pst system might be required for the control of antifungal activity in low Pi 
conditions, via a mechanism not linked to PhoBlPhoR-mediated control of the Pho 
regulon. Thus, P AH26 is antifungal-defective because of the loss of the Pst complex, 
and not the high expression ofPho regulon genes in P AH26. 
Is PI STARVATION RESPONSIBLE FOR THE ANTIFUNGAL MINUS PHENOTYPE OF P AH26? 
Investigation of the high-affinity uptake of Pi by P AH26 revealed a defect in Pi 
assimilation under low Pi conditions. However, P AH26 was also shown to be capable of 
assimilating more Pi than the wildtype when the extracellular Pi concentration was 
sufficient. To test the role of Pi starvation, P AH26 was tested for antifungal activity on a 
minimal medium containing O.SmM Pi. APase assays had previously shown that PA147-2 
did not express the Pho regulon under such conditions, indicating they were Pi-excessive. 
Thus, it was predicted that if Pi starvation was responsible, the provision ofO.SmM Pi 
would overcome the starvation and restore antifungal activity. The result is shown in 
Figure 6.12. It is clear that P AH26 is still incapable of inhibiting fungal growth under these 
conditions. 
Is PHO REGULON EXPRESSION RESPONSIBLE FOR THE ANTIFUNGAL MINUS PHENOTYPE OF 
PAH26? 
Results from the investigation ofbiofilm formation by pst mutants indicate that expression 
of the Pho regulon negatively regulates biofilm formation (R. D. Monds, M. W. Silby, and 
H. K. Mahanty, manuscript submitted). To examine this possibility with respect to fungal 
inhibition, antifungal assays were carried out on minimal media supplemented with O.OS, S, 
and 2SmM Pi. It was predicted that if the Pho regulon had a negative effect on fungal 
inhibition, PA147-2 would be rendered antifungal minus on the O.OSmM Pi plate, while 
P AH26 would be restored in its ability to inhibit fungal growth when supplied with S or 
2SmM Pi. These predictions were made on the basis that O.OSmM Pi would derepress the 
Pho regulon in PA147-2, while S or 2SmM Pi might sufficiently reduce Pho regulon 
expression by P AH26, as shown previously. As can be seen from the result in Figure 6.12, 
P AH26 was capable of inhibiting G. graminis var. tritici when provided with 2SmM Pi. 
However, PA147-2 was still capable of fungal inhibition under Pi-limiting conditions, 
although it appears slightly reduced in this capacity. 
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Figure 6.12. Fungal inhibition assays with in the presence of varied Pi concentrations. Bioassays were 
carried out against G. gruminis var. tritici, on minimal bioassay mediwn with 0.05 , 0.5, 5, and 25mM added 
Pi. PA 147-2 is capable offungal inhibition under all conditions, although the zone of inhibition in the 
presence of 0.05mM Pi appears to be smaller than that produced under Pi excess conditions. PAH26 is 
restored in its ability to inhibit fungal growth in the presence of25mM Pi. 
6.2.4 Can PA13S and PAI09 be restored for antifungal activity by higb Pi? 
The experiment outlined above indicated that PAH26 could inhibit fungal growth on media 
containing high Pi concentrations, but the significance of this was not cJear. The possibility 
existed that restoration of antifungal activity was common among the mutants, and not 
necessarily directly linked to the pstA mutation. To test whether this is a common trait 
amongst PA147-2 antifungal mutants, antifungal assays were carried out with PA138(finK) 
and PAl 09(finT) under low Pi and high Pi conditions. These experiments show that 
PA 138 is defective for fungal inhibition under all conditions tested. However, PAI09 
showed signs of inhibition at 5mM Pi, and strongly inhibited G. graminis var. tritiei in the 
presence of 25mM Pi (Figure 6.13). Therefore, restoration of antifungal activity in the 
presence of excess Pi is not unique to PAH26, but is also not a general feature of antifungal 
mutants ofPA147-2. 
Chapter 6 The phosphate specific transport system and antifungal activity 154 
25mM 5mM O.5mM O.05mM 
Figure 6.13. Fungal inhibition by P. aureo(aciens PA I 47-2, PAI09 and PA138 in the presence of varied Pi 
concentrations. The bioassays were carried out against G. graminis var. trWei on minimal bioassay media 
supplemented with 0.05, 0.5 , 5, and 25mM Pi. PAI38 is unable to inhibit growth of the fungus. PA147-2 is 
capable of fungal inhibition under all conditions tested. PA I 09 is restored for fungal inhibition in the 
presence of25mM Pi, and shows limited inhibition in the presence of 5mM Pi. 
6.2.5 Soluble protein profile of PAH26. 
The Pst system is involved in the regulation of the Pho regulon, and the Pho regulon is 
differentially expressed in PAH26 relative to PA 147-2. Thus, the possibility existed that 
the antifungal defect in PAH26 was the result of negative regulation of antifungal genes by 
a member of the Pho regulon, or an intact Pst system was required for expression of the 
antifungal genes. If the pstA mutation was directly or indirectly preventing the expression 
of a number of antifungal genes, the protein profile of PAH26 might resemble that of the 
regulatory mutants PA138 and PA109 (chapter 5). To examine this possibility, PAH26 was 
grown in buffered PDB for two days, and a sample was removed each day and incubated 
with Promix for one hour to allow incorporation of labelled methionine and cysteine into de 
novo expressed proteins. Total soluble protein was then separated by SDS-PAGE, and the 
profile was compared to that ofPA147-2, PA138, and PA109. The protein pattern from 
PAH26 was indistinguishable from PA147-2, rather than showing differences such as those 
in the profiles ofPA138 and PA109 (Figure 5.16). Autoradiography of the de novo 
expressed proteins confirmed the observations of total soluble protein. Thus it appears that 
the defect in P AH26 does not impact upon gene expression in the same way as the 
regulatory mutations. 
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6.3 Discussion. 
In this chapter, the initial characterisation of phosphate-specific transport (pst) mutants of 
P. aureofaciens PA147-2 is reported. Two aspects of the results presented are novel; 
phosphate specific transport has not previously been associated with either fungal inhibition 
or biofilm formation, and pst mutants of P. aureofaciens have different characteristics 
compared to pst mutants of E. coli and P. aeruginosa. 
6.3.1 The Pst system is involved in antifnngal activity and biofilm formation. 
Mutations in pstC and pstA have been shown to abolish fungal inhibition and biofilm 
formation by PA147 -2. Given the role of the Pst system in other organisms, three possible 
explanations for the observations were forthcoming. Firstly, loss of the ability to inhibit 
fungi and form biofilms could result from a generalised reduction in intracellular phosphate 
concentration (i.e. phosphate starvation), given that both PstA and PstC are part ofthe 
membrane-spanning channel for high-affinity Pi uptake. A second possibility was that 
biofilm formation and antifungal activity could be repressed by the Pho regulon, which is 
expressed under both Pi limiting and sufficient conditions by pst mutants. Finally, Pst 
could regulate the antifungal and biofilm phenotypes by mechanisms unrelated to Pi uptake 
or metabolism. 
PHOSPHATE ST ARV A TION? 
In P. aeruginosa, null mutations in the pst operon result in an inability to rapidly uptake Pi 
under phosphate limiting conditions (Nikata et aI., 1996). However, the results presented 
here demonstrate that both P AH26 and P AB 1 08 are still capable of assimilating Pi, and are 
thus unlikely to be experiencing abnormally low intracellular Pi concentrations. To 
separate Pi starvation from Pho regulon activity, an alternative phosphate source was 
sought. In E. coli, the organophosphates glycerol-3-phosphate (G3P) and glucose-6-
phosphate (G6P) are imported by specific mechanisms unrelated to Pst (Argast et aI., 1978; 
Winkler, 1966), and G3P does not repress the Pho regulon (Brzoska et aI., 1994). Based 
upon these observations in E. coli, it was reasoned that if Pi starvation is responsible for the 
loss of fungal inhibition, providing G3P or G6P should restore activity. However, ifPho 
regulon activity is the cause of the antifungal defect, the organophosphates should have no 
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effect since they do not repress the Pho regulon. Unfortunately, this experiment failed to 
make the distinction between phosphate starvation and Pho regulon activity because 
preliminary APase assays revealed that the organophosphates could repress Pho regulon 
expression in P. aureofaciens (not shown). To test the possible role of Pi starvation, fungal 
inhibition assays were carried out using a medium containing 0.5mM Pi. APase assays on 
P A14 7 -2 showed these conditions to have excess Pi, so the fact that antifungal activity is 
not restored in P AH26 under these conditions supports the conclusion that Pi starvation 
cannot adequately explain the antifungal phenotype of P AH26. The low APase expression 
by PA147-2 indicates that PA147-2 is not starved for Pi under such conditions, so P. 
aureofaciens strains should have sufficient access to Pi, independent of the high affmity 
uptake shown by P AH26. 
The fact that P AH26 and P AB 1 08 stilI display considerable Pho regulon activity when 
grown in Pi sufficient conditions allows the question of Pho regulon control to be 
considered independently of Pi starvation. Antifungal activity by P AH26 can be restored in 
the presence of 5mM Pi or higher. This observation correlates with the reduction in Pho 
regulon activity at high Pi concentrations. However, P A14 7 -2 is still capable of inhibiting 
fungal growth when assayed on media containing only O.1mM Pi, a concentration at which 
the Pho regulon is expressed by P A14 7 -2. Thus, although there is a correlation between the 
restoration of antifungal activity and reduction in Pho regulon expression in P AH26, it is 
unlikely that Pho regulon-mediated repression of antifungal activity provides a suitable 
explanation for the antifungal defect ofPAH26, since PA147-2 would be expected to be 
antifungal defective when expressing the Pho regulon. This is in contrast to the production 
ofa biofilm, in that PA147-2 is unable to fonn biofilms under Pi-limiting conditions 
(Monds 2000). Furthennore, mutants with insertions in ph oR are unable to express the Pho 
regulon, and these mutants are able to fonn strong biofilms in Pi-limiting conditions (R. D. 
Monds, M. W. Silby, and H. K. Mahanty, manuscript submitted). Hence, it seems that the 
Pho regulon negatively regulates biofilm fonnation, but probably not fungal inhibition. 
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PST-MEDIATED CONTROL OF FUNGAL INHIBITION. 
The final possible explanation for the antifungal defective phenotype of P AH26 is that the 
Pst system is involved in fungal inhibition in a way umelated to phosphate assimilation and 
metabolism. The defect can be overcome by high Pi, but the apparent correlation between 
reduced Pho regulon activity and restored fungal inhibition under these conditions may be 
merely coincidental- Pi could act to suppress the defect in some other, unknown way. A 
similar observation has been made in Streptococcus pneumoniae (Novak et aI., 1999). 
Although a pstB mutant demonstrated inhibition of autolysis when challenged with 
penicillin (i.e. increased tolerance), Pi concentration had no effect on the penicillin 
tolerance of the wildtype. This indicates that PstB might be involved in a Pi-independent 
signalling pathway. 
The observation that Pho regulon expression does not prevent antifungal activity by 
PA147-2, but that high Pi can restore antifungal activity in P AH26 separates regulation by 
the Pho regulon from the puzzle. The question that remains is how does the pstA mutation 
ofP AH26 render the strain defective for fungal inhibition? Two speculative models are 
presented below. Both are consistent with current knowledge, and have explanatory power. 
Furthermore, both models are testable, allowing future investigators to examine the 
situation more closely. 
Model one - alternative regulatory pathways. 
A possible explanation for the observations regarding P AH26 is that there are two 
regulatory pathways that PA147-2 uses to synthesise the antifungal metabolite. Pathway 
one is dependent upon the Pst system, in a manner independent ofPho regulon expression. 
This model must include the requirement that the Pst-dependent system is independent of 
the Pho regulon because of the fact that P A14 7 -2 can inhibit fungal growth while 
expressing the Pho regulon. In this model, increasing Pi would lead to repression ofthe 
Pho regulon, and therefore a reduction in the synthesis ofthe Pst complex, and therefore 
reduced Pst-dependent expression of the antifungal metabolite. The second regulatory 
pathway in this model would operate under excess Pi conditions, and may be under 
negative regulation by a member ofthe Pho regulon. By controlling the second pathway 
with the Pho regulon, a smooth transition between the two pathways could be assured -as 
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Pst levels decrease and pathway one (Pst dependent) ceases activity, pathway two would be 
released from the negative regulatory constraints of the Pho regulon, to take over from the 
first pathway. 
The most obvious experimental test for this model is a mutant hunt. If the proposal is 
correct, it should be possible to isolate mutants with opposite traits to P AH26. These new 
mutants would demonstrate antifungal activity under low Pi conditions, but would be 
antifungal defective under excess Pi conditions. It is possible that some such mutants 
would have defects in the second regulatory pathway, such that when the Pst-dependent 
system discontinues its activities, there is no second pathway to replace it. The mutant hunt 
could be complemented by RNA subtractive hybridisation, to examine genes that are 
expressed at different Pi concentrations, and 2-D protein electrophoresis, which would 
allow differences to be detected at the level of translation. While neither of the latter two 
approaches would provide phenotypic.information, they could be readily applied to the 
analysis of mutant P AH26 and any new mutants obtained in the testing ofthis model, 
aiding in the identification of regulator genes and their targets. 
Clearly, the experimental approach outlined above is heavily dependent upon the successful 
isolation of mutants. If none were recovered, it would be difficult to draw solid 
conclusions. However, assuming a large number of candidates were screened, the failure to 
obtain mutants would reduce the likelihood of the model being correct, and alternatives 
would be sought. 
Different antibiotics are made in different environments. 
In order to account for the observations regarding P AH26, the second model is similar to 
the first in that it has two components, one of which is Pst-dependent but independent of 
the Pho regulon, and the second is important in excess Pi conditions. In this second model 
it is proposed that PA147-2 produces at least two antifungal compounds, and that their 
production is dependent upon Pi concentration. Under low Pi, one compound is produced 
in a Pst-dependent fashion, and the second is repressed, possibly by the Pho regulon. In Pi-
excess conditions, the Pst-dependent antifungal metabolite is not produced due to very low 
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levels of the Pst complex, but the second compound is produced, possibly as a result of 
being removed from the regulatory repression of the Pho regulon. 
This model could be tested in a similar manner to the fIrst model, by conducting a hunt for 
mutants able to inhibit fungal growth on Pi-limiting media, but not on Pi-excess media, and 
vice versa. Such a mutant search would be likely to identify regulator genes (as for model 
one), but could also reveal genes specifIc for the synthesis of antifungal compounds. While 
biosynthetic genes have not been found to date, a mutant search under specifIc conditions 
might be fruitful since the knockout of a single metabolite could be observed. This is in 
contrast to searching for mutants that are defective under all conditions, which may have 
mutations in a gene required for the expression of a number of antifungal compounds. A 
complementary strategy to test this model would be to examine the chemical nature of 
inhibitory compounds produced under low and high Pi conditions. If crude extracts 
showed different properties this approach would lend support to the notion of different 
compounds. PurifIcation of the inhibitory compounds would allow a defInitive assessment 
of whether Pi concentration leads to the synthesis of different compounds, although such 
analyses have proven diffIcult due to instability of antifungal extracts (Godfrey, 1997). 
The possibility that Pi concentration leads to the differential regulation of antibiotic 
expression is supported by the observation that production of PhI and pyoluteorin by P. 
fluorescens CHAO is reduced in the presence of high Pi (Duffy & Defago, 1999). 
Furthermore, Duffy and Defago (1999) show that PhI production by a range of other P. 
fluorescens biocontrol strains is reduced by high Pi. Similar observations have been made 
regarding the production of antibiotics by Streptomyces griseus and S. aureofaciens in 
fermentation. Addition of greater than 10mM inorganic phosphate can repress antibiotic 
production (Martin & Demain, 1980). Since the mechanism for the repression by Pi is 
unknown, these observations could support both models outlined above. P A14 7 -2 might 
make an antibiotic whose synthesis is repressed by high Pi, but also be capable of 
producing a second compound in the high Pi environment. Alternatively, Pi dependent 
repression could act on a regulator of antibiotic synthesis, preventing its expression in high 
Pi environments (see discussion below on the role ofFinT). PA147-2 could circumvent 
this by use of an alternative regulator at high Pi concentrations. 
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Does the Pho regulon repress a Pi sufficient antifungal system? 
Both of the models outlined above require that when Pi is limiting, there is repression of an 
antifungal system that is expressed under Pi-excess conditions, and it is suggested that a 
member of the Pho regulon could be involved in this repression. A simple test of this Pho 
regulon dependent repression would be to create null mutations in either phoR or phoB in 
P AH26. Since PhoB/R is the two-component regulator system that controls expression of 
the Pho regulon, the resulting mutants would be unable to express the Pho regulon. The 
prediction is that by abolishing Pho regulon expression, any antifungal systems normally 
repressed by the Pho regulon would be expressed, and P AH26 would be restored to full 
antifungal activity irrespective of Pi concentration. 
A role for finT in Pi dependent fungal inhibition? 
The observation that PAl 09 could inhibit fungal growth on high Pi media suggests that one 
ofthe two models above may approach the true situation. It is possible that FinT is 
required for fungal inhibition at low Pi, as part ofthe Pst-dependent system, while at high 
Pi concentrations the requirement for FinT is reduced because of the activity of a Pst-
independent, high Pi system. The investigation into soluble protein profiles ofPAl09 and 
P A138 suggested some common regulatory targets (chapter 5). These experiments were 
conducted under low-Pi conditions, so it would be interesting to examine the profile of 
PAI09 after growth in high Pi. It is also interesting to note that in the protein profile 
experiments, P AH26 did not show the absence of proteins that were missing in PAl 09. It 
is tempting to speculate that FinT regulates a number of genes for antifungal activity under 
low Pi, while the Pst complex has very specific effects on just one or a few genes/proteins. 
A COMMON SWITCH FOR BIOFlLM FORMATION AND FUNGAL INIllBITION? 
It is intriguing that both fungal inhibition and biofilm formation are dependent upon an 
intact Pst system. Although the experiments outlined here and elsewhere. {Monds 2000; R. 
D. Monds, M. W. Silby, and H. K. Mahanty, manuscript submitted) indicate that the Pst 
mutations affect biofilm formation and fungal inhibition differently, it is very interesting to 
find that there is a commonality between these phenotypes. This represents an exciting and 
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novel link between a developmental process and secondary metabolism. The possibility 
that the Pst system represents a "switch" involved with the control of both phenotypes 
could be of evolutionary significance. It is likely that antifungal activity and biofilm 
formation evolved separately, but the fact that they would often function in the same 
environment (rhizosphere/rhizoplane) could have led to the common use of a single switch 
(Pst). It is possible that PAl47-2 uses the Pst system as an environmental sensor, allowing 
finely co-ordinated control over root colonisation by biofilm formation and expression of 
antifungal genes. Phosphate is an extremely important compound in biological systems - it 
is required for synthesis of membrane lipids, complex carbohydrates, nucleic acids, and 
also has a pivotal role in energy metabolism. The linking ofbiofilm formation and 
antifungal activity to a system that responds to phosphate limitation may indicate the 
relative importance controlling these phenotypes has for bacterial survival. 
The speculations outlined above assume that the Pst defect in P AH26 results in repression 
of antifungal genes. Although some genes could be expressed differently in P AH26, those 
that are altered in the regulatory mutants PAl38 and PAl09 appear to be unaffected in 
P AH26. Therefore, any impact on antifungal genes is either subtle, or affects genes other 
than those regulated by finR andfinT. Such regulatory effects could be more easily 
visualised using 2-D separation of proteins, which provides far greater resolution than the 
l-D system employed here. 
6.3.2 Pho regulon control by P. aureofaciells PA147-2. 
In addition to the discovery that the Pst system is important for antifungal activity and 
biofilm formation, novel observations were made with respect to fundamental aspects of 
Pho regulon control and Pi assimilation by P. aureofaciens PAl47-2. In contrast to reports 
on E. coli and P. aeruginosa, although defective in their ability to repress the Pho regulon, 
neither pst mutant exhibited constitutive Pho regulon expression. As Pi concentration was 
increased in the culture media, APase levels were reduced. It is important to note that even 
with 25mM Pi, the APase levels from P AH26 and P AB 1 08 cultures were not as low as 
from cultures ofPA147-2. Further to this, the mutation inpstC appears to have a more 
profound effect than the pstA mutation, since P AB 1 08 consistently expressed the Pho 
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regulon at a higher level than P AH26. Two possible explanations for these observations 
are presented below. 
Remaining Pst components mediate partial Pho regulon repression in PABIOg and 
PAH26. 
Experiments with E. coli and P. aeruginosa show that, under some circumstances, 
components of the Pst system can compensate for the loss of other components. In E. coli, 
introduction of a nonsense codon near the start of pstA only resulted in a 10% derepression 
of the Pho regulon. This result was interpreted as showing that PstC could substitute for 
PstA in the formation of a partially functional repression complex (Cox et aI., 1988). In P. 
aeruginosa, the loss of either PstA or PstC has no effect on repression of the Pho regulon, 
but the loss of both PstA and PstC completely abolishes repression (Nikata et aI., 1996). 
These observations in other organisms point to the possibility that the components of the 
Pst system whose expression has not been disrupted by the transposon insertions in 
P AB 108 and PAH26 are capable of mediating some degree of Pho regulon repression at 
high Pi concentrations, without the requirement for a completely intact Pst system. 
However, the types of mutants characterised in the studies of Cox et al (1988) and Nikata et 
al (1996) are fundamentally different to the Tn5 mutants ofPA147-2 in that they used 
substitutions and short deletions to inactivate protein products of the genes in question 
without causing polar effects. 
It is likely that transposon insertions in pstC and pstA would have polar effects on the 
expression of downstream genes, suggesting that P AB 1 08 still encodes a functional PstS, 
while P AH26 can express PstS and PstC. Neither strain should be able to express PstB or 
PhoU. Therefore, the repression of the Pho regulon by P AB 108 would be solely due to 
PstS, while Pho regulon repression by P AH26 could be attributed to PstS and Pstc. This is 
unprecedented, and it is generally accepted that a membrane integrated Pst complex 
(including PhoU) is absolutely required for proper interaction with PhoR and formation of 
the repression complex (Wanner, 1995). Although preliminary sequence data indicates that 
the pstSCA genes ofPA147-2 are present in the same order as in other organisms, no 
information is available regarding whether these genes are expressed as an operon in 
PA147-2. Thus, although unlikely, the possibility that downstream components ofthe Pst 
Chapter 6 The phosphate specific transport svstem and antifUngal activity 163 
system are being expressed in P AB 1 08 and P AH26 cannot be ruled out. If the transposon 
insertions in P AB 1 08 and P AH26 only affect pstC and pstA respectively, partially 
functional repression complexes could be assembled in which PstA substitutes for PstC, 
and vice versa. In this scenario, the difference in Pho regulon repression between P AB 1 08 
and P AH26 could be explained by the different abilities of Pst A and PstC to functionally 
substitute for one another. To examine this model it will be necessary to establish whether 
the pst genes are expressed as an operon in PA147-2, and use a technique such as RT-PCR 
to examine which genes are still expressed in P AB 1 08 and P AH26. 
A second system can control the Pho regulon. 
The general mode ofPho regulon activation/repression by the Pst system is characterised 
by an "all or nothing" appearance - in response to a set threshold of external Pi, the Pho 
regulon is either switched on or off (Wanner, 1996). In contrast, the pst mutants described 
here exhibit a slow decrease inPho regulon activity concomitant with increasing Pi. This 
suggests the possibility that some other mechanism in addition to Pst exists that can control 
the Pho regulon, but its effects are only observable in pst defective mutants. It is tempting 
to speculate that such a system is operating, but without considering some role for PstC, a 
second system lacks full explanatory power. This is because ofthe difference between 
P AB 1 08 and P AH26, which appears to have greater control of the Pho regulon. If a second 
system is operating, there must still be a role for PstC, since expression ofPstC is the only 
known difference between the two pst mutants. Control ofthe Pho regulon by systems 
other than the Pst complex is not unheard of. In a study of Bacillus subtilis, the Pst system 
was shown to be responsible for high affinity Pi uptake, and part ofthe Pho regulon, but did 
not appear to have a role in control of the Pho regulon (Qi et aI., 1997). However, the 
nature of the Pho regulon control system was not described in that study. 
A number of experiments need to be conducted to determine whether there is reason to 
implicate a second regulatory system. Of paramount importance is the examination of 
whether the disrupted Pst systems of P AH26 and P AB 1 08 are sufficient to account for 
observations, which would allow a distinction between the propositions above. Firstly, a 
deletion of the entire pst operon in PA147-2 would be useful. Ifthis strain showed a Pho 
regulon repression phenotype similar to that ofP AB108, then it would be suggestive ofthe 
Chapter 6 The phosphate specific transport system and antifungal activity 164 
involvement of another system. However, if the pst deletion strain was constitutive for Pho 
regulon expression, this would be an indication that PstS (in P AB I 08 and P AH26) and 
PstC (in P AH26) were sufficient to explain the observations. Furthermore, the phenotype 
of the pst deletion strain could be made to mimic P AB 1 08 or P AH26 by simply expressing 
(in trans) PstS, or PstS and PstC respectively, and the relative contribution of pstS and pstC 
could be tested by expressing both separately and examining the impact on Pho regulon 
expressIOn. 
Pho regulon control in P. aeruginosa. 
Although partial repression of the Pho regulon has not previously been reported in studies 
of pst mutations in E. coli or P. aeruginosa, the review of published data from a study of P. 
aeruginosa hints at such a phenomenon. In their study of pst genes in P. aeruginosa, 
Nikata et al (1996) constructed a pst deletion that removed pstCAB and phoU. This strain 
(NT1) may be analogous to PAB108 in that, of the pst genes, it can only express pstS. The 
miniTn5 insertion in P AB 1 08 is predicted to abolish expression of all pst genes except pstS. 
NT1 was reported to be constitutive for Pho regulon expression, but examination of the 
published data suggests that there is a 38% decrease in APase expression by NT1 after 
growth in 5mM Pi, relative to that after growth in a medium with no added Pi. This is in 
agreement with the findings of the present study, in which control experiments with PA01 
and NT1 showed that the APase expression by NT1 was reduced by greater than 50% when 
grown in 25mM Pi, relative to APase expression in 1InNI Pi. Thus, either PstS can mediate 
some degree of repression in P. aeruginosa, or there is a second system that can partially 
repress the Pho regulon of P. aeruginosa in response to increasing Pi. Like the situation 
with PA147-2, a mutant that lacks pstS as well as the rest of the pst genes (and phoU) 
would be required to discern between the possibilities. In contrast, a transposon insertion 
in pstC in E. coli led to constitutive expression of the Pho regulon in Pi concentrations up 
to 10mM (Daigle et aI., 1995). It is thus possible to speculate that P. aureofaciens and P. 
aeruginosa have Pho regulon control mechanisms distinct from those of E. coli. 
6.3.3 High affinity phosphate uptake by P. aureofaciens PA147-2. 
Since P AH26 and P AB 1 08 have transposon insertions in pstA and pstC respectively, it was 
predicted that both mutants would be defective for high affinity uptake of inorganic 
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phosphate. Comparisons of Pi uptake by mutants and the wildtype grown under Pi limiting 
and sufficient conditions were carried out, and revealed somewhat surprising results. 
Pi assimilation under phosphate sufficient and limiting conditions. 
As predicted, PA147-2 was unable to take up significant amounts of Pi when grown under 
Pi sufficient conditions. This is probably due to repression of the Pho regulon, and 
therefore very low expression of the Pst system. However, contrary to expectations, both 
P AB 108 and P AH26 showed significant uptake of Pi, with P AB 1 08 importing almost twice 
the amount ofP AH26. The pst mutants should be able to uptake an equal amount or less 
than the wildtype, since the wildtype would have at least some (although not many) 
functional Pi transporters, whereas the mutants should have none. However surprising this 
result was, it did not indicate whether P AH26 and P AB 1 08 had any defect in Pi transport 
relative to the maximum uptake by PA147-2 when grown under Pi limited conditions. 
When assayed in Pi limiting conditions, P A14 7 -2 imported the most Pi of any strain tested. 
P AB 1 08 was able to import the same amount as it could when grown in Pi sufficient 
conditions, but this was less than 50% of that imported by PA147-2. PAH26 could uptake 
only 30% as much as PA147-2. These data indicate that when the wildtype and mutants are 
in a similar physiological condition with respect to Pho regulon activity, the mutants show 
defective high affinity Pi assimilation. However, this defect is not as severe as that shown 
by the control strain P. aeruginosa NT 1. NT 1 imported negligible Pi - the amount was 
comparable to that imported by P A14 7 -2 under Pi sufficient conditions. Thus it appears 
that while P AH26 and P AB 1 08 have defects in high affinity Pi uptake, the defect is quite 
dissimilar to that of other Pst systems - they are still capable of some degree of high 
affinity Pi uptake. Generally, when the Pho regulon is repressed, Pi uptake can be assumed 
to be the result of a basal level of Pst systems, along with low affinity uptake systems such 
as Pit in E. coli (Wanner, 1996). However, since both mutants uptake considerably more 
than a Pho regulon repressed wildtype, it seems unlikely that the presence of a constitutive 
low affinity system is able to explain the observations. 
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Correlation of Pi uptake capacity with Pho regulon activity. 
The mutations in P AH26 and P AB 1 08 result in different abilities to repress the Pho 
regulon. Interestingly, Pi uptake after five hours growth in KIOP-O.l (Pi sufficient) showed 
that P AB 1 08 had a greater capacity for Pi uptake than P AH26, and this difference 
correlated with the different Pho regulon activity of the two mutant strains. This led to the 
proposal that the difference in Pi uptake is not due to different functionality of the Pi 
assimilation systems of the mutants, but that the Pi uptake system in both mutants is under 
Pho regulon control. This would explain the observation that P AB 1 08 assimilated more Pi 
in KIOP-O.l (Figure 6.11), but when Pho regu10n levels were more similar (To.o5 
experiments, Figure 6. lOb ), P AH26 and P AB108 assimilated similar amounts of Pi (Figure 
6.11). Given that P AH26 and P AB 1 08 showed a lowering of Pho regulon activity as Pi 
concentration was increased, if the Pi uptake system in these mutants was Pho regulon 
controlled it was predicted that Pi uptake would be reduced in high Pi growth conditions. 
The experiments on Pi uptake in KIOP-5 and KIOP-25 are in agreement with this 
prediction. They show that the more Pi in the growth medium, the lower the uptake 
capacity, and this correlates with Pho regulon activity results. Furthermore, the difference 
in reduction in Pi uptake between the mutants correlates with the different Pho regulon 
activities of the two strains. P AB 1 08 is less able to repress Pho regulon activity, and 
correspondingly shows a lesser reduction in Pi uptake. This correlation between Pho 
regulon activity and Pi uptake provides persuasive support for the proposition that the 
mechanism responsible for Pi uptake in P AH26 and P AB 1 08 is expressed as part of the Pho 
regulon in response to extracellular Pi. 
6.3.4 Explaining inorganic phosphate uptake by P. aureofaciens. 
The ability of the Pst system to import Pi is not necessarily linked to its ability to repress 
the Pho regulon, since the loss of one function does not always result in the loss of the other 
(Cox et aI., 1988; Nikata et aI., 1996). Thus, the mechanism by which the pst mutations 
affect Pi uptake does not have to be the same as the mechanism for loss ofPho regulon 
control. However, the nature of the mutations in P AH26 and P AB 1 08 probably prevents 
the production of much of the Pst complex, suggesting that in this case the most 
parsimonious explanation for defective Pi uptake is similar to that for loss ofPho regulon 
control - the inability to form a fully functional Pst complex. Although this explanation is 
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useful to describe the defects seen in Pi limiting conditions, the effects seen at higher Pi 
concentrations require further examination. As has been done above for Pho regulon 
control, two alternative models are outlined below which could explain the observations 
regarding Pi uptake by P. aureofadens. 
A second Pho regulon controlled Pi uptake system. 
The possibility that PA147-2 possesses a second Pi uptake system, in addition to Pst, 
cannot be excluded. To be consistent with observations, this second system must be under 
Pho regulon control. The phenotypes ofPAH26 and PAB108 with respect to Pi uptake 
could be explained by inactivation of Pst by the transposon insertions, and the presence of 
the second system. Under high Pi, both mutants express the Pho regulon, and thus the 
second system imports Pi. The level of import is correlated with the Pho regulon activity, 
since expression (and therefore capacity) of the second uptake system would reduce with 
reduction ofPho regulon expression. The observation that PA147-2 takes up considerably 
more Pi than the mutants under Pi limiting conditions could be explained by cooperative 
assimilation by the two systems. The nature of any such second system is highly 
speculative. If it were the result of duplication of pst genes, the defects in Pho regulon 
control observed in both mutants could only be explained if the duplicated system had 
diverged, and lost its regulatory function. The possibility of a second Pi uptake system has 
some support in the literature. Rhizobium tropid has two Pi uptake systems that resemble 
ABC transporters, which are subject to induction by growth in Pi limited environments and 
have different affinities for Pi (Botero et aI., 2000). Studies of Mycobacterium tuberculosis 
indicate the presence of multiple copies of pstS, pstA, and pstC, although only a single pstB 
has been found thus far. It is suggested that there may be several related, functional 
phosphate permeases (Lefevre et aI., 1997). In E. coli, Pi can be imported by the 
constitutively expressed low affinity Pit system (Wanner, 1996), and the presence of a 
second system in P. aeruginosa PA01 is indicated by the biphasic Pi assimilation kinetics 
(Nikata et aI., 1996). Any second system in PA147-2 is clearly different from those that are 
well characterised (E. coli and P. aeruginosa). Published data (and data presented here) 
show that the P. aeruginosa strain NT1 cannot take up an appreciable amount of Pi under 
limiting conditions (compared to P AB 1 08 and P AH26). Furthermore, the Pit system in E. 
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coli is constitutive, which would be inconsistent with the data presented here that suggests 
Pho regulon control of Pi assimilation by Pst and the putative second system. 
Partial function of Pst transporters. 
An alternative to the above model is one in which the remaining components of the Pst 
system can form a partially and equivalently functional transporter. Based upon the operon 
arrangement known in other organisms, it is likely that of the pst genes, P AB 108 can only 
express PstS, while P AH26 can express PstS and PstC. The condition that the transport of 
Pi is correlated with Pho regulon activity can be satisfied by this model because the pst 
genes are known to be part of the Pho regulon. However, it seems highly unlikely that PstS 
alone, or in conjunction with PstC, could form any kind of functional transport system. 
Even ifPA147-2 can express each pst gene separately, and the insertions inpstC andpstA 
only affect those genes, the likelihood of forming a functional Pi transporter is low. 
Although there is a high degree of similarity between PstC and PstA, and they are both 
transmembrane components of the Pst system, investigations in E. coli and P. aeruginosa 
show that they are both required for Pi uptake (Cox et aI., 1988; Cox et aI., 1989; Nikata et 
a1.,1996). 
The second model outlined above seems less likely than the first to explain the 
observations. These models can be distinguished by the construction of mutants with the 
pst operon completely deleted. If this abolished all high affinity Pi uptake, the existence of 
a second, Pst-independent system would be effectively ruled out. The role for PstS and 
PstC could then be confirmed by expressing them separately and together in the pst deletion 
background, and monitoring the effect on Pi uptake. One problem with this approach is 
that if the second system was dependent upon some Pst components, its ability to import Pi 
would be eliminated by the pst deletion strain, leading to the erroneous conclusion that 
there is no second uptake system. Conversely, if there was only a minimal impact of Pi 
uptake, this would lend support to the existence of a second functional system. 
Clearly, deciphering the mechanisms ofPho regulon control and Pi uptake in PA147-2 will 
be interesting and challenging. The fact that the Pst system seems linked to fungal 
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inhibition and biofilm fonnation are novel findings, and add to the range of complex traits 
whose expression appears to involve sensing inorganic phosphate concentration (Daigle et 
aI., 1995; Gonin et aI., 2000; Lucas et aI., 2000). Uncovering the mechanism by which Pst 
influences antifungal compound production would be a great step forward in the 
understanding of fungal inhibition by P A14 7 -2. A number of experiments outlined herein 
would be of value in the further study of this question, and the models developed provide 
useful start points. 
7.1 Introduction. 
Chapter 7 
Field trial 
Biological control agents are becoming increasingly popular as alternatives to chemical 
pesticides. Extensive laboratory studies, glasshouse trials, and limited field trials are 
essential before large-scale commercial development can be considered. One of the most 
important questions that can be addressed with field studies is, does in vitro antibiosis 
correlate with in situ disease suppression? Doubts surrounding this issue include the 
possibility that antibiotics are unstable in soil (reviewed in Gottlieb, 1976), whether 
antibiotics are produced in sufficient quantities to be effective in situ (Williams & Vickers, 
1986), and whether the introduced organism can establish and survive long enough to be 
effective. Successful glasshouse and field studies indirectly answer these questions, and are 
reviewed in chapter one. An additional problem relates to the soil type. P. jluorescens 
CHAO was shown to be effective in the suppression of black rot of tobacco grown in soil 
containing vermiculitic clay minerals, but it was ineffective in soils with illitic clay 
minerals (Stutz et aI., 1989). A study by Thomashow et al (1990) is a good example of a 
more direct approach to the question of in situ antibiotic synthesis and relevance. Studies 
on P. jluorescens 2-79 and P. aureofaciens 30-84 demonstrated that both strains produce 
phenazine-l-carboxylic acid (PCA) in the rhizosphere of wheat, under both growth 
chamber and field conditions. Furthermore, PCA production in a growth chamber 
correlated with suppression oftake-all of wheat (Thomashow et aI., 1990). Further 
examples are examined in chapter one, and although encouraging, it must be noted that 
investigations using one biocontrol organism are not directly applicable to another because 
of the numerous potential differences between the organisms involved. 
In a previous study under glasshouse conditions (Carruthers et aI., 1995), some of the issues 
regarding in situ biocontrol efficacy were examined. However, the environmentally 
controlled conditions of a glasshouse are quite different from the variable conditions that 
can be encountered in an asparagus field. Therefore it was decided that a small-scale field 
trial would be of value in further establishing the potential of P A14 7 -2 as a biocontrol 
agent. Since P A14 7 -2 shows strong in vitro inhibition of p, megasperma var. sojae, and 
the previous glasshouse trials had used Phytophthora rot of asparagus as a model disease 
system, it was logical to examine the efficacy ofPA147-2 in the same system under field 
conditions. 
In this chapter, the results of a field trial in which P A 147 -2 was assessed for its ability to 
suppress Phytophthora rot of asparagus are presented. Since the previous glasshouse trial 
ofPA147-2 (Carruthers et aI., 1995) has been described in chapter 1, only a brief mention 
will be given to it in the introduction to this chapter, The results of this trial have been 
published (Godfrey et al., 2000, see appendix 5), and the published work fonns the basis of 
the results shown here. 
7.1.1 Cultivation of asparagus. 
Asparagus (Asparagus ofJicinalis) is a'perennial plant with an average harvest life in New 
Zealand of 12 years (Robb, 1984). There are three main ways to establish asparagus. The 
traditional method is to transplant 10 month - 1 year old crowns from a nursery block to a 
field for production. Crowns are dug from the nursery during donnancy (winter), and 
either held in storage or transplanted immediately. A second method is direct seeding, and 
the third method involves raising seedlings for 10-12 weeks in a glasshouse and 
transplanting to fields during spring. For the first 2-3 years of its production life, asparagus 
is not harvested. During this time, the fern-like foliage is allowed to grow over the summer, 
throughout which photosynthesis leads to the production of carbohydrates that are stored in 
buds and storage roots attached to the crown. Fern is removed before winter, and the plant 
survives the winter and begins growth in spring by utilising the stored carbohydrates. 
Asparagus spears are harvested by cutting the stems while the buds at the tip of the stem are 
still tightly compressed, usually before the stems are 25cm tall. 
Crop yields tend to be determined by the amount of fern foliage produced in the first three 
years before harvesting (p. Falloon, Pers. Comm). Thus, the health ofthe young plants is 
of paramount importance. Factors that influence the crop yields include rainfall, 
temperature, wind, weed competition, pests and disease. A number of diseases affect 
asparagus in New Zealand, including viral diseases (e.g. asparagus virus II), and soil-borne 
fungal pathogens such as Fusarium rot and Phytophthora rot. Phytophthora megasperma 
var. sojae is a particular problem because disease resistant cultivars have not been 
forthcoming (P. Falloon, Pers. Comm.). 
7.1.2 Phytophthora rot of asparagus 
Phytophthora rot is associated with heavy rainfall (Falloon et aI., 1986) and temperatures 
around 15°C (Falloon, 1991). In addition, young asparagus plants appear to be more 
susceptible than older, mature plants (Falloon, 1991). Thus, Phytophthora rot can be a 
problem with long lasting consequences, given the importance of vigour in young 
asparagus ferns. Phytophthora rot can lead to significantly reduced plant emergence 
(Fa1loon et aI., 1991), and it has been suggested that two consecutive years of disease could 
result in a permanent decrease in productivity of the affected plants (Falloon et aI., 1986). 
Dispersal of Phytophthora is dependent upon water, which explains the increased severity 
of outbreaks in wet conditions. Phytophthora zoospores move passively in water currents, 
but are also motile and tactic toward growing root tips and wounds (reviewed in Carlile, 
1983). Presumably the taxis is toward exudates from growing or wounded roots. Within 
30-60 minutes of zoospore entrapment, cysts germinate and form germ tubes that penetrate 
asparagus tissue. The subsequent development of active mycelia results in the rotting of 
feeder roots, storage roots, crowns, spears and fern stalks. This process leads to the 
observable symptoms described below. 
SYMPTOMS. 
The most revealing symptoms of disease occur below the ground, on the roots. While 
healthy roots are firm, opaque, white, and have numerous feeder roots, Phytophthora rot 
infection results in pulpous, cream-coloured storage roots that appear partially transparent 
and water-soa1ced (Carruthers et a1., 1995) (Figure 7.1). As the disease progresses, feeder 
roots become water soaked and after several weeks of infection are often completely 
absent. 
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Figure 7.1. Asparagus crowns with and without Phylophlhora rot. a. Healthy asparagus crown. b. Diseased 
asparagus crown showing the water-soaked appearance of the roots typically associated with Phytophthora 
rot . 
Above the ground, symptoms begin with wilting of fern fronds, foliage browning, and 
eventual death (Figure 7.2). Although the disease requires water to begin, it may be during 
water stress that the symptoms become visible above the ground. This is due to the damage 
to the roots, which leaves the plant unable to meet the water demands of the foliage (P. 
Falioon, Pers. Corum.). 
Figure 7.2. Asparagus ferns with and without symptoms of Phylophthora rot. a. Healthy asparagus fern. b. 
Asparagus fern showing symptoms of Phytophthora rot. Note the reduced overall vigour, and the browning 
of the extremities. 
In New Zealand, Phytophthora rot is widely controlled by using formulations that contain 
metalaxyl (P. Falloon, Pers. Comm.), which acts by inhibition of fungal RNA synthesis 
(Davidse, 1984). Use of metalaxyl is recommended during transplantation of crowns, at 
which time crowns should be dipped. In addition, metalaxyl can be applied to a field of 
established asparagus 10-14 days before harvest. Metalaxyl is more effective as flooding 
decreases (Falloon et aI., 1991), indicating that in extremely wet seasons, metalaxyl may 
not be completely effective against Phytophthora rot. Thus, the problem of Phytophthora 
rot has not been completely solved by the use of metalaxyl, and altematives such as 
biocontrol are worthy of investigation. 
In a glasshouse study, Carruthers et al (1995) examined the significance of antibiotic 
production by PA147~2 for the control of Phytophthora rot. Using PA147-2 and an 
antibiotic defective mutant, Carruthers demonstrated that disease suppression was 
correlated with the ability to produce antifungal compounds. Treatment with PA147-2 
reduced disease from 97% (control) to 72%, while treatment with the antifungal mutant 
P AI09 had no impact on disease occurrence. While a number of plants treated with 
PA147-2 still showed disease, the severity was reduced. 
The observation that PA147-2 reduced disease severity on asparagus was important given 
that it is plant vigour in the first few years of life that determine long term productivity. 
The ability to reduce disease severity would be valuable to growers, especially organic 
growers who do not use chemical treatments. To further examine the potential ofPAI47-2, 
the field trial objectives below were proposed. 
7.1.3 Field trial objectives. 
1. The primary objective of the field trial was to examine the performance ofPA147-2 in 
the suppression of disease under field conditions. Because the antifungal mutants are 
considered to be genetically modified organisms, it was not possible to include one in 
the trial as a control. Therefore, this objective was not intended to explicitly examine 
the role of antibiosis in disease suppression. Instead, it was decided to assess the 
performance ofPA147-2 relative to Ridomil® 250EC, a metalaxyl-based fungicide. 
2. In addition to disease suppression, the survival ofPA147-2 in the field was of interest. 
Thus, the second objective was to monitor the population ofPA147-2 in the soil and 
rhizosphere. 
7.2 Experimental design. 
7.2.1 The field trial. 
The trial was carried out over six months (September 1996 - March 1997) in an isolated 
area of Eyre shallow fine sandy loam soil inoculated with P. megasperma var. sojae using 
22-month-old asparagus crowns (cultivar Ue157 Fl hybrid) previously grown in 
Templeton silt loam soil. Planting of treated crowns was performed using a randomised 
complete block design (Steel & Torrie, 1976). Each plot consisted of20 crowns planted 
300 mm apart within a single row at a depth of 80 mm. Each treatment was replicated 4 
times. Dams (200 mm high) were erected at the end of each plot to prevent leaching and 
cross-contamination of treatments. Guard rows were planted on the sides ofthe trial. 
Randomly selected crowns in the guard rows were inoculated with PA147-2 for use in the 
popUlation study experiment. General maintenance of plants consisted of25 mm of 
irrigation every 14 days applied over a 3-h period. Because saturated or near saturated soil 
conditions are essential for Phytophthora zoospore production and dispersal (Falloon & 
Tate, 1986), flooding ofthe plot was achieved by irrigating for extended time periods 
(Table 7.1). Fertiliser, insecticides, and herbicides were applied as indicated in Table 7.2. 
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Table 7.1. Watering schedule applied to asparagus (Asparagus officinalis) field trial plot. 
Date (1996) Irrigation (mm) Time Period (h) 
26 Sep 100 8 
27 Sep 200 16 
17 Oct 200 16 
18 Oct 200 16 
24 Oct 100 8 
25 Oct 200 16 
Table 7.2. Chemicals applied to asparagus (Asparagus officinalis) field trial plot 
Date Chemical applied Description Amount applied 
(kg ha-1) 
Karmex Herbicide 2 
2 Oct 1996 
11 Dec 1996 Malathion Insecticide 2 
13 Dec 1996 Linuron Herbicide 1 
14 Dec 1996 Crop Master 13 Fertiliser 350 
18 Jan 1997 Malathion Insecticide 2 
2 Feb 1997 Malathion Insecticide 2 
16 Feb 1997 Malathion Insecticide 2 
Harvest was carried out 160 days after planting. The fern from each plot was cut at soil 
level, washed with tap water to remove soil particles and placed into paper bags. Following 
oven drying at 75°C for 72 h, dry weights of the fern were determined. 
7.2.2 Experimental treatments. 
Four experimental treatments were used. Treatment 1 was the application of a 
commercially available fungicide, Ridomil® 250EC, which is applied for the control of 
Phytophthora rot of asparagus throughout New Zealand. In Treatment 2, asparagus crowns 
Chapter 7 Field trial 177 
were left untreated. Treatment 3 was the inoculation of asparagus crowns with PA147-2. 
The fourth treatment was the application of LB medium to crowns. The four treatments 
allowed the comparison ofPA147-2 treatment to a current chemical control, and to 
asparagus that has no "added protection". In addition, any unexpected effect of the 
bacterial growth medium could be assessed. 
7.3 Materials and Methods. 
Materials and methods other than the design of the experiment are described in chapter 2. 
7.4 Results. 
7.4.1 Disease severity. 
Phytophthora megasperma var. sojae disease symptoms were observed on asparagus plants 
at harvest (Figure 7.3), indicating that Phytophthora was well established in the plot. 
Symptoms ranged from reduced fern vigour with slight browning of fern tips, to stunted 
growth and wilting with browning over most ofthe plant. 
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Figure 7.3. Disease severity visually observed from plants growing in diseased plot. Individual asparagus 
plants were visually graded on overall plant condition on a scale of 1-5 to indicate percentage of foliage 
affected by disease (1 = 0%, 2 = 1-20 %, 3 = 21-40%,4 = 41-80%,5 = 81-100%). 
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When visual disease severity data were analysed using an ordinal logistic model it was 
found that there was no significant heterogeneity, so treatment effects were tested against 
theoretical multinomial values. Fitted model coefficients for Ridomil® 250EC, P A14 7 -2, 
and LB were -1.1, -0.9, and -0.2 respectively. The standard error of these coefficients was 
0.30. Fern dry weights are shown in Table 7.3. Visual observation of the trial plants 
indicated that treatment of asparagus crowns with Ridomil® 250EC provided a high degree 
of protection against Phytophthora rot. In contrast, the untreated and LB treated controls 
were severely affected by Phytophthora rot, with all plants showing some degree of 
disease. The plants treated with P A14 7 -2 showed signs of disease, although the symptoms 
were significantly less severe than those displayed by the untreated plants. 
Table 7.3. Summary of asparagus (Asparagus officinalis) fern dry weights used in statistical analysis. 
Treatment Weight (g) 
Untreated 160 
Ridomil® 250EC 437 
PA147-2 252 
LB 186 
LSD (5%), 7 d.f. * 109 
* degrees of freedom 
7.4.2 Effect ofPA147-2 on disease severity. 
PA147-2 improved dry weights of fern by almost 60% (significant at 5% level using a one-
sided test), but Ridomil® 250EC improved dry weights by much more, averaging 173% 
more than untreated plants. 
7.4.3 Bacterial population study. 
UNTREATED CROWNS. 
Comparison ofRfZ isolates from untreated crowns revealed four morphologically dissimilar 
colony groups which API 20 NE strip analysis revealed to be three P. fluorescens biotypes 
(0147475,0147755, and 0147775) and one P. aureofaciens strain (0147577). Bioassay 
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revealed one of the three P. fluorescens biotypes (0147755) to have antifungal activity 
toward P. megasperma var. sojae. 
PA147-2 TREATED CROWNS. 
Culturable R:f bacteria (CFU g-l of soil) isolated from PA147-2 inoculated crowns are 
presented as a logarithmic linear graph with comparison to R:f CFU g-l of soil isolated 
from control crowns (Figure 7.4) 
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Figure 7.4. Rifampicin-resistant bacteria isolated during the field trial. (RHIZ = bacteria isolated from the 
rhizosphere of inoculated plants; NON = bacteria isolated from soil surrounding the roots of inoculated 
plants; Natural line shows the rifampicin resistant bacteria isolated from control plants that were not 
inoculated with PAI47-2). Data presented are the mean ii-om four samples (a = LSD (5 %) for comparing 
Rhiz with Non-rhiz positions at any of weeks 1-11 (d.f. =18); b = LSD (5 %) for comparing Rhiz mean with 
zero, for weeks 13-21 (d.f. = 15». 
Comparison of all R:f bacterial isolates from P A 147 -2 inoculated crowns indicated six 
morphologically distinguishable colony types. A single representative of each was purified 
onto PMM and labelled as PA147-2 crown isolate (PAC I) A-F. When PACI isolates A-F 
were bioassayed against P. megasperma var. sojae, all demonstrated antifungal activity 
comparable to PA147-2 after seven days. PACI isolates A-F exhibited siderophore 
production on PMM agar after five days with equal fluorescence intensities to PAI47-2. LB 
agar supplemented with the respective antibiotic revealed that all PACI isolates A-F had 
resistance to Rfand Ap but were sensitive to Km, Gm, Nal, Strep, and Tc, like PAI47-2. 
Gram stain preparation of PAC I isolates revealed Gram-negative rods, identical in size and 
cellular morphology to PAI47-2. Biotypes obtained using API 20 NE were identical for 
PACI isolates and PA147-2 (0147577). 0147577 is 83% confirmation of a "very good 
identification to the genus P. aureofaciens" (1996 API Software Database). Southern 
hybridisation analysis showed that a 16kb EeoRI fragment of DNA derived from PA147-2 
which is involved in antifungal activity (chapter 5) hybridised with an identically-sized 
EeoRI DNA fragment in PACI isolates, supporting the identification of the P ACI isolates 
as PA147-2 (data not shown). 
7.5 Discussion. 
The field trial presented in this chapter was carried out to see whether inhibition of 
Phytophthora rot of asparagus by PA147-2 observed in glasshouse trials (Carruthers et aI., 
1995) could also be demonstrated under field conditions. These are preliminary findings of 
the field application ofPA147-2 as a biocontrol agent against P. megasperma var. sojae. 
7.5.1 PA147-2 compared to RidomU® 250EC. 
Fern dry weight was used as a measure of plant vigour because fern vigour of asparagus 
plants in the first three years of planting is proportional to the yield of spears obtainable 
over future (Scheer & Ellison, 1960). The percentage increase in total fern dry weight 
obtained from plants treated with Ridomil® 250EC and PA147-2 was calculated in 
comparison to the fern dry weight obtained from untreated plants. Dry weight increases 
relative to the untreated control were considered to result from disease suppression 
provided by the respective treatment. Treatment with Ridomil® 250EC and PA147-2 
resulted in dry weight increases of 173 and 55.8% respectively. Although Ridomil® 250EC 
shows considerably greater protection than PAI47-2, the bacterial treatment is still 
significantly better than the untreated control (5% LSD). It is interesting to note that 
treatment with LB resulted in a slightly greater fern weight than the untreated plants. One 
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can speculate that the LB may have stimulated growth of indigenous bacteria on the 
crowns, resulting in either greater competitive exclusion of the pathogen, or production of 
antifungal metabolites by the resident microbes. This effect would be short lived because 
the LB concentration would be reduced quickly after planting and watering. 
One of the Ridomil® 250EC treated plots only provided 21 % of its expected dry weight of 
fern, after adjusting for systematic local variation (which comprised block effects and a 
30% reduction of fern dry weight in plots along one edge of the trial near some shelter 
trees), so data from this plot were excluded from statistical analysis of fern dry weights. 
7.5.2 Survival of PA147-2 in the field 
During the field trial, monitoring of P A14 7 -2 survival was achieved by periodic re-
isolation. Based on differences in colony morphology, initial doubt was raised as to 
whether all RtR bacteria isolated from PA147-2 inoculated crowns were the same P. 
aureofaciens PA147-2 strain used for inoculation. Subsequent phenotypic analysis 
indicated that those RtR isolates chosen for analysis were indistinguishable from PA147-2 
and Southern hybridisation indicated genetic similarity to a 16kb genomic region from 
PA147-2 previously shown to be involved in antifungal activity (Carruthers et aI., 1994). 
The result of the Southern hybridisation supports the identification of the PACI isolates as 
PA147-2, although 16s rDNA sequencing and macro-restriction enzyme profiling using 
FIGE would provide a more definitive identification. The variation in morphology might 
not be too surprising given that when populations of P. fluorescens have evolved to occupy 
different niches, this has been concomitant with changes in morphological characteristics 
(Rainey & Travisano, 1998). Although not all RtR bacteria isolated from PA147-2 
inoculated crowns were analysed by Southern hybridisation, the number ofRtR bacteria 
isolated from PA147-2 inoculated crowns far exceeded natural background levels ofRtR 
bacteria therefore suggesting RtR bacteria isolated were an accurate estimation ofPA147-2 
survival (Figure 7.4). 
The observation that the PA147-2 population declined over time indicates that PA147-2 
might be unable to establish and maintain high populations when inoculated into new field 
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environments. When sampling was stopped, PA147-2 was present at approximately 100 
cfulg of soil in the rhizosphere, and was undetectable in bulk soil. Whether the rhizosphere 
population was stable is unclear. The low population density could reflect a lack of 
competitive fitness, which is a potential problem for a biocontrol agent. One possible cause 
of a lack of fitness is the metabolic load of producing antifungal compounds. This is 
addressed in a preliminary, in vitro study in chapter 8. 
Results of this field study have indicated that the direct inoculation of asparagus crowns 
with PA147-2 before planting resulted in a 55.8% increase in fern yield compared to the 
untreated control. Disease control is essential during wet field conditions (achieved here by 
flooding, see Table 7.1), whenPhytophthora zoospore production and dispersal is maximal 
(Fa1loon et aI., 1985). These conditions are encountered early in the growing season, and in 
this study the extensive watering period correlates with the period in which PA147-2 
numbers were highest (the first 2 months). The results ofthe bacterial population study 
suggest that P A 14 7 -2 survival was sufficient during the trial to enable fungal inhibition by 
either: 1) the production of a sufficient quantity of antifungal compounds resulting in 
inhibition of P. megasperma var. sojae establishment; or 2) the inhibition of the pathogen 
by the introduction of microbial competition due to the establishment ofPA147-2 in the 
rhizosphere. Specific experiments could be designed to examine which ofthe above 
mechanisms is responsible for disease suppression, or whether suppression results from the 
combined action of antibiotic production and microbial competition. The previous 
glasshouse trial (Carruthers et aI., 1995) provides strong support for the suggestion that 
disease suppression is linked to suppression ofthe pathogen by synthesis of antifungal 
compounds. 
7.5.3 Prospects for using biocontrol. 
The observation that PA147-2 inoculated asparagus plants showed a 55.8% increase in fern 
dry weight compared to untreated plants indicated the potential ofPA147-2 as a biocontrol 
agent. However the fungicide Ridomil® 250EC, provided a 173% increase and therefore re-
emphasises that biological control of Phytophthora rot of asparagus with P. aureofaciens 
still needs extensive investigation before becoming a viable option that provides 
comparable protection to that given presently by chemical pesticides. As a result ofthe 
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increasing demand being generated in the area of organic farming (Figiel, 1994), PA147-2 
application may provide an alternative non-chemical option resulting in an increase in crop 
yields. Application ofPA147-2 at the time of planting will provide protection to the plants 
as they become established, but the bacterial population study suggests that the bacterial 
numbers will be very low by the time of harvest which is important when considering the 
issue of human consumption. In addition, the use of an integrated strategy of pest 
management in which PA147-2 is used in combination with a chemical fungicide may 
allow a reduction in the amount of chemicals applied to crops. Although such an approach 
would not eliminate the use of chemicals, the reduced need for them could have both 
economic and environmental benefits. Future trials would be useful for three reasons. 
First, further investigations involving larger trials with more sophisticated bacterial 
application techniques will enable a more extensive analysis of the ability ofPA147-2 to 
inhibit Phytophthora rot of asparagus. Such a study would naturally build upon this initial, 
small-scale work, and using modem approaches to soil inoculation (e.g. pellet 
formulations) would improve upon the rather crude approach used in this study. Second, it 
would be useful to isolate the biocontrol agent from experimental plants (rather than guard 
row plants as in this study), in order to assess the effects of any interactiol1B between the 
bacterium and the pathogen. Finally, long-term studies would allow an assessment of 
whether biological control of disease in the early life of asparagus leads to an increased 
crop yield when the plants begin to produce harvestable spears. 
The potential ofPA147-2 to control Phytophthora rot is clear, and it would be interesting to 
extend the investigation into protection of other crops. The conditions under which 
Phytophthora disease develops are rather harsh, and the relative success ofPA147-2 under 
these conditions is encouraging. In crops where disease develops more readily it is possible 
that PA147-2 would be even more effective since the bacteria might not have to endure 
such stressful conditions. Also, the extension ofthe analysis into crops that are sown 
commercially from seed would allow the efficacy of application by seed coating to be 
examined. 
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Chapter 8 
In vitro competition between PA147-2 and antifungal mutants 
8.1 Introduction. 
Many fluorescent Pseudomonas spp. that inhabit soil are capable of producing antifungal 
metabolites. As discussed (chapter 1), the possibility that these organisms might be 
exploited as biological alternatives to chemical control of agricultural diseases has led to 
intense investigation of regulation and synthesis of compounds that inhibit fungal growth. 
Such investigations have yielded mutants that no longer produce antifungal compounds, 
and these mutants have been used to demonstrate the importance of antifungal metabolites 
forbiocontrol of fungal diseases of crop plants (Carruthers et aI., 1995; Howie & Suslow, 
1991; Keel et aI., 1990; Thomashow & Weller, 1988). The successful use of bacteria in 
biological control is dependentupon an evolutionary adaptation that presumably allows the 
bacterium to compete with fungi in their shared niche. However, biocontrol involves the 
application of these bacteria to new environments, a situation in which bacterial fitness is of 
critical importance. The introduced organism must be sufficiently fit to compete with the 
indigenous microbes and establish a population. A number of studies have demonstrated 
the effects of genetic modification of bacteria with respect to fitness in laboratory and soil 
microcosm systems. Generally these experiments have examined the impact of genetic 
markers, and have found both positive (Blot et aI., 1994) and negative effects (Brockman et 
aI., 1991; De Leij et aI., 1998; Orvos et aI., 1990) associated with modification. Such 
investigations aid in the choice of marker systems for monitoring organisms introduced into 
soil environments. Though these studies clearly demonstrate the impact on fitness of 
several marker systems relative to wildtype strains, they do not provide insight into the 
absolute fitness of unmarked strains. 
Pseudomonas aureofaciens PA147-2 inhibits the in vitro growth of a number of 
phytopathogenic fungi (Carruthers et aI., 1994), and can suppress Phytophthora rot of 
asparagus in glasshouse and field trials (Chapter 7; Carruthers et aI., 1995; Godfrey et aI., 
2000). In chapter 7, it was shown that while PA147-2 could suppress Phytophthora rot in 
the field, this protection was only a ~60% increase in asparagus fern weight as compared to 
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a 173% increase provided by a chemical fungicide relative to untreated controls (see 
chapter 7). Furthennore, the population ofPA147-2 decreased considerably over the 
course of the trial indicating that despite the high initial inoculation density, PA147-2 was 
displaced by indigenous microbial populations. This was of interest because laboratory 
studies have indicated that PA147-2 can efficiently colonise sterile plant roots (R. D. 
Monds and H. K. Mahanty, unpublished data). Two questions arising from the field study 
were (i). Could the lower level of disease control be related to the declining population of 
PA147-2; and (ii) could the apparent inability ofPA147-2 to establish a high population be 
due to a lack of competitive fitness? A question that can be derived from these is whether 
producing antifungal metabolites is associated with a fitness cost. It is intuitively obvious 
that there would be a metabolic cost to producing antifungal compounds because the 
process would require energy. However, does the metabolic load translate to reduced 
fitness, and does any such fitness cost have the potential to result in the failure ofPA147-2 
as a biocontrol agent? As a preliminary means to examine these questions, in vitro 
competition experiments between PAl47-2 and five Tn5-generated antifungal-deficient 
mutants have been carried out. It was reasoned that if there was a fitness cost involved in 
producing antifungal compounds, one or more mutant should display increased fitness and 
thus outcompete the wildtype under these selectively neutral conditions. However, if the 
inhibition of fungal growth does not represent a significant metabolic investment by 
PA147-2, mutants and wildtype should be similarly fit under the conditions employed. 
8.1.1 Objectives. 
The work presented in this chapter began with a single objective, which was to determine 
whether P A14 7 -2 was less fit than the antifungal mutant derivatives. Such a result would 
indicate that there is a fitness cost to production of antifungal metabolites by PA147-2. 
After the initial experiments were completed, further objectives were defined. 
1. What effect, if any, does aging PA147-2 for ten to 20 days in culture have on its ability 
to compete? 
2. Do antifungal mutants arise spontaneously during starvation? 
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8.2 Results. 
8.2.1 Construction and tests of fitness of PA147-21acZY. 
Before any competition assays were possible, it was necessary to introduce a selectable 
marker into P A14 7 -2, so that it could be distinguished from the KmR Tn5 mutants. The 
introduction ofTn7-/ac7117 (lacZY) into PA147-2 resulted in the creation ofPA147-lacZY, 
which allows selection based upon the ability to utilise lactose and differentiation from lac· 
strains when plated on media containing Xg. To ensure that the incorporation ofTn7 and 
the expression of /acZY had no uncontrolled effects, the newly created P A14 7 -2lacZY was 
tested for fungal inhibition, growth rate, and competition against wildtype PA147-2 (Figure 
8.1). P A147 -2lacZY was able to inhibit the in vitro growth of R. solani and G. graminis 
var. tritid as strongly as the wildtype (Figure 8.1 a). 
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Figure 8.1. Experiments to examine the impact ofTn7::1acZY insertion on important phenotypes of P. 
aureofaciens PA147-2. a. In vitro inhibition of the plant pathogenic fungus G. gram in is var. tritici by PA147-
2 (Wt) and PA147-21acZY (lacZY). b. Competition between PA147-2 (II) and PA147-21acZY (0) 
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The growth rate ofPA147-2lacZYwas indistinguishable from that ofPA147-2, and the 
competition experiment showed that PA147-2 and PA147-2lacZYappear to be equally fit 
under starvation conditions, with neither strain dominating the culture (Figure 8.1 b). These 
results suggest that there was no fitness cost to expression of lacZY under conditions 
relevant to this study. 
8.2.2 Competition between PA147-21acZYand Tn5 mutants (1 :1 ratio). 
Five Tn5 generated antifungal mutants were used in initial competition experiments with 
PA147-2IacZY. The results for 1: 1 competitions are summarized in Figure 8.2. These data 
show that the mutants can be divided into two categories based upon their competitive 
ability relative to PA147-2IacZY. One group (comprising PAI95, PAH26, and PAE21), 
appear to be of equivalent fitness compared to PA147-2IacZY, while members ofthe 
second group (PAl09 and PAl38) both showed an ability to outcompete PA147-21acZY 
under these conditions. 
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Figure 8.2. In vitro competition between PA147-2 and antifungal-defective mutants in Pseudomonas 
minimal medium. For competition experiments between PA147-2lacZY (0) and Tn5-generated antifungal 
minus mutants (e), approximately equal numbers of group 1 mutants (a) or group 2 mutants (b) were mixed 
with P A147-2 in PMM and grown for eight to ten days. Strains were enumerated daily. Data shown 
represent the averages from three independent experiments. Standard errors are shown, but error bars are 
sometimes hidden by the data point. 
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However, it is worth noting that in competition with PA 138 and PA 109, PA 14 7-21acZY 
was always detectable -- the wildtype continued to persist as a minority population for as 
long as the experiments continued. Analysis of growth rate showed that all five mutants 
were comparable to PA 147 -2IacZY, suggesting that the initial exponential growth rate 
could not account for the differences observed. 
8.2.3 Does the Tn5 transpose in starved cuJtures'? 
One possible explanation for the observation that PA 138 and PA 109 have higher fitness 
than PA 14 7-21acZY is that the Tn5 element is unstable, and transposes randomly. Such 
transposition might yield fitter mutants, and the fitness of these mutants would cause them 
to be emiched in the population. To examine this possibility, Southern analysis was used. 
Two monocultures ofPA138 and PAI09 were grown for ten days, after which total DNA 
was prepared and probed with a Tn5 specific probe. If the transposon had transposed on a 
number of occasions, hybridisation would be seen with more than one EcoRI fragment, 
whereas if the transposon were stable, hybridisation would occur as it does in the original 
strains . The results (Figure 8.3) show that the DNA isolated from starvation cultures had 
Tn5 in EcoRl fragments of the same size as the un starved mutants. 
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Figure 8.3. Southern analysis ofTn5 stability in competition cultures. Total bacterial DNA was digested 
with FcoRI, and probed with a Tn5 probe. Lanes arc: L. Lambda I-findlll standard; 2, 1'AI47-2; 3, PAl38; 4, 
PAI09; 5 and 6, Starved PAl3S; 7 and 8, Starved PAI09; 9, pCM138E control; 10, pFCI09 control; II, 
pSLlP2021 digested with HilldIII (source oUhe probe) . The probe has hybridised with an I L5kb fragment in 
starved and non-starved PAl38, and in the pCM138E control. The probe has hybridised with an 
approximately 21kb fragment in starved and nOD-starved PAI09, and in the prC109 control. 
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8.2.4 P A138 as a minority inoculum. 
To further examine the competitive nature of the group 2 mutants relative to PA147-
21acZY, competition experiments were conducted in which the ratio ofPA138 to wildtype 
inoculum was 1 :250. In these experiments, PAl38 was able to establish and eventually 
dominate the cultures (Figure 8.4a). This is in contrast to control experiments in which 
PA147-21acZY was inoculated as an average 1: 125 minority population in competition with 
PA147-2. In this control, the minority wildtype was unable to establish a high population, 
and the ratio of strains remained comparable over the ten days (Figure 8.4b). 
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Figure 8.4. Competition experiments involving strains inoculated as minority populations. a. Competition 
between PA138 (fD) and PA147-21acZY (0). PA138 was inoculated as a 1 :200 minority population relative to 
PA147-2IacZY. Despite the low initial inoculum, PA138 was able to outcompete PA147-2IacZY. b. Control 
experiment. PA147-2IacZY(0) was inoculated as a 1:125 minority relative to PA147-2 (II1II). PA147-21acZY 
was not able to increase its relative representation in the population. 
8.2.5 Determination of DNA sequence flanking Tn5 insertions. 
DNA sequences flanking the transposon insertion points are described in chapter 4. Of 
particular interest is the finding that the transposon in PAl38 had interrupted a sequence 
whose predicted translation product resembles members of the LysR family of 
transcriptional regulators, and the insertion in PAl 09 interrupted a putative two-component 
regulator gene. The group two mutants appear to have mutations in global regulator genes, 
which are likely to lead to altered expression oflarge numbers of genes (see chapter 5). 
This is in contrast to the group 1 mutants P AH26 and P AI95 whose mutations would be 
expected to have more specific effects, since they do not appear to disrupt genes encoding 
regulatory proteins. Since the other group 1 mutant (P AA3) has an insertion in an 
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apparently novel sequence it is not possible to predict the global impact of the mutation, 
beyond the fact it does not lead to increased fitness. 
8.2.6 Do antifungal mutants arise in PA147-2 monoculture? 
The ability ofPAl38 and PA109 to outcompete PA147-2 bears a striking resemblance to 
the so-called GASP phenomenon, which is well studied in E. coli (Kolter et aI., 1993; 
Zambrano & Kolter, 1996). During prolonged starvation, the GASP (growth advantage in 
stationary phase) mutants proliferate and take over cultures, displacing the less fit parental 
strain. Such take-overs occur more quickly than population shifts in continually growing 
cultures, reflecting the versatility of the bacterial response to starvation (Huisman et aI., 
1996; Zambrano & Kolter, 1996). This phenomenon has been associated with a number of 
different mutations, notably in rpoS (Zambrano et aI., 1993) and lrp (Zinser & Kolter, 
2000). RpoS is a sigma factor involved in the regulation of a cascade of genes in response 
to the transition to stationary phase growth (Lange & Hengge-Aronis, 1991), and Lrp (the 
leucine-responsive regulatory protein) is a transcriptional regulator of an extensive regulon 
comprised of between 35 and 75 genes in E. coli (Newman et aI., 1996). Our group 2 
mutants show similar abilities to rapidly outcompete their parental strain, and both appear 
to have insertions in genes that encode global regulators. The similarity between group 2 
mutants and the GASP phenotype led to the speculation that the group 2 mutants were 
analogous to GASP mutants. It was predicted that mutants of higher fitness than the 
wildtype would arise during prolonged starvation ofPA147-2, and that these mutants 
would dominate the culture. Since PA109 and PAl38 are also antifungal minus, it was of 
interest to address the possibility that some of the fit mutants would also be antifungal 
mutants. This is of particular interest from a biocontrol perspective. To address the 
possibility that antifungal mutants arise in PA147-2 mono culture, two independent cultures 
ofPA147-2 were grown in PMM for 20 days. Individual colonies from both cultures were 
, tested for their ability to inhibit fungal growth. The results (Table 8.1) show that antifungal 
minus and reduced mutants arise in PA147-2 monocultures, but there is extreme variation 
between replicates. Previous long term starvation experiments have also shown 
considerable variation between initially identical lines (Finkel & Kolter, 1999). 
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Table 8.1. Fungal inhibition by colonies arising in starvation monoculture" 
Replicate Antifungal 
plus 
Number one 80/157 
Number two 72/95 
Antifungal 
reduced 
4/157 
20/95 
Antifungal 
minus 
73/157 
3195 
192 
II Two cultures of P A 147 -2 were grown for 20 days in Pseudomonas minimal medium. Upon plating, 
colonies from both cultures were assessed for ability to inhibit fungal growth. Data are expressed as number 
of colonies with a particular phenotype over total colonies tested. 
8.2.7 PA138 and PAI09 vs aged PA147-21acZY. 
If the observations outlined above are a consequence of GASP evolution it follows that 
aged cultures ofPA147-2 (and PAl 47-2IacZY) will have accumulated mutants of greater 
fitness in vitro than the original ancestral strain. A prediction of this hypothesis is that 
PAI09 and PAl38 would be less able to displace populations derived from aged cultures 
than 'young' PA147-2 cultures in competition experiments. To test the hypothesis, 
competition experiments were inoculated with 'young' PA109 (or PAl38) and either ten or 
20 day old PAI47-2IacZY. Consistent with predictions, neither PAl38 nor PAI09 were as 
competitive against the 'aged' PAl 47-21acZY (Figure 8.5). In competition against 'young' 
PAl 47-2IacZY, PAI09 and PAl38 eventually establish a population up to four orders of 
magnitude higher than that of PAl 47-2IacZY. However, in these competitions against 'old' 
PAI47-2IacZY, the difference was never more than one order of magnitude. 
10 a. 10 b. 
..Ja E 8 
-:l 
'136 6 
0 
Ci 
,34 4 
2 ----: .. I 2 
0 1 2 3 4 5 6 7 8 9 10 0 2 3 4 5 6 7 a 9 10 
Days Days 
C .. d. 
10 1 10 .. 
..J 8 a E 
-:l 
-(J 6 6 
0 
..... 
C) 
04 1 4 
..J 
2 T' 1· , 2 
0 2 3 4 5 6 7 8 9 10 0 1 2 3 4 5 6 7 8 9 10 
Days Days 
Figure 8.5. Competition between group 2 mutants and aged PA147-21acZY. Competition between PA138 (a, 
b;8) or PAI09 (c,d; e) and either 10 day old (a, c) or 20 day old (b,d) PA147-21acZY(O). The aged PA147-
21acZY is fitter than the parental P A14 7 -21acZY, as evidenced by the increase in its competitive fitness 
relative to PA138 and PA109. 
8.3 Discussion. 
In this chapter experiments demonstrating that a subset of P. aureofaciens P A14 7-2 
antifungal defective mutants has an in vitro competitive advantage over the wildtype are 
presented. The two members of this group appear to have mutations in genes that encode 
global regulators of antifungal activity, whereas the mutations in the non-competitive class 
are likely to have more specific effects. Why do PA138 and PA109 appear to have 
increased fitness relative to the parental strain? Previous research has demonstrated that the 
bleomycin resistance gene ofTn5 can confer a growth advantage on E. coli (Blot et aI., 
1994). However, this is an unlikely explanation for the results presented here because only 
two of the five Tn5-containing strains sho'Yed increased fitness. Ifthe mere presence of 
Tn5 was sufficient to confer a growth advantage, all five Tn5-generated mutants would be 
expected to outcompete PA147-21acZYwith equal success. Since this was not observed it 
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is reasonable to conclude that the competitive phenotypes are a consequence of the specific 
mutations in PAl 09 and PAl38. Transposition of Tn5 to produce fitter mutants is also 
unlikely, based upon Southern analysis of strains from starved cultures. Based upon two 
observations it appears that it is also unlikely that incorporation of the lacZYon Tn7 was 
responsible for the reduced fitness of the wildtype seen in competition with group 2 
mutants. Firstly, if introduction of Tn71acZY resulted in a wildtype of inherently lower 
fitness one would expect the group 1 mutants to be as competitive as the group 2 mutants. 
Secondly, the competition and bioassay experiments did not reveal any differences between 
P A14 7 -2 and P A147 -21acZY under relevant conditions, supporting the neutrality of the 
introduced marker. This is in agreement with experiments on P. fluorescens SBW25 
suggesting that, under some conditions, the addition of lacZY genes had no effect on the 
fitness of this strain which had been previously modified by the incorporation of aph-l 
(KmR) and xylE (catechoI2,3-dioxygenase) (De Leij et aI., 1998). Finally, the analysis of 
growth rates indicates that PAl38 and,PAl09 have a similar exponential growth rate to 
PA147-2IacZY. Thus, the group 2 mutants do not have an obvious advantage in the first 
hours of the competition experiments. Further to this, the fact that PAl 47-21acZY does not 
start to "lose" the competition until between the second and third days rules out differences 
in generation time as a possible explanation. 
8.3.1 PA109 and PAl38 behave like GASP mutants. 
The competitive phenotype displayed by PAl 09 and PAl38 strongly resembles the GASP 
phenotype of E. coli. Both mutants show increased fitness relative to the wildtype, and 
even when inoculated as a minority population, P A13 8 was sufficiently fit to take over the 
culture. Thus, it appears that the fitness increase of P Al3 8 and PAl 09 might not be due to 
being defective for antifungal activity per se, but rather the pleiotrophic effects of the 
global regulatory mutations confers a GASP-like phenotype. The correlation of global 
regulation with increased fitness strengthens the relevance of this work to GASP studies, 
since mutations in the global regulator genes rpoS and lrp have both been implicated in the 
GASP phenotype in E. coli (Zambrano et aI., 1993; Zinser & Kolter, 2000). However, to 
unequivocally ascribe the GASP-like effect to the Tn5 mutations in PAl09 and PAl38, 
complementation experiments need to be carried out. It is possible that PAl38 and PAl09 
have coincidentally both acquired a secondary mutation that confers increased fitness. 
Chapter 8 Competition between PA147-2 and antifUngal mutants 195 
PAI09 and PAl38 that have both been restored for fungal inhibition by allele exchange 
(Carruthers et aI., 1994; chapter 5), and use ofthese strains in competition would reveal 
whether the Tn5 insertion is the genuine origin of the competitive phenotype. Our 
observation that aged cultures ofPA147-21acZY are more competitive with PAl38 and 
P Al 09 than the parental (not starved) strain suggest that, as is the case in E. coli, fitter 
(GASP) strains arise in aged cultures of P. aureofaciens. The increased fitness is also 
accompanied by loss or reduction of antifungal activity by a large number of strains 
isolated after 20 days of starvation. This observation provides indirect support for the 
notion that the group 2 antifungal mutants might be akin to GASP strains. In addition, 
these results suggest that under stressful conditions (e.g. starvation), reducing or 
eliminating antifungal activity can result in enhanced survival of P. aureofaciens, possibly 
by reducing the metabolic burden of synthesizing an antifungal metabolite. The fact that 
the replicates of starvation cultures ofPA147-2 have variation between them supports the 
suggestion that the.loss or reduction of antifungal activity results from mutations arising in 
culture, and the difference between them could be explained by beneficial mutations which 
arise early or late in the experiment. Zinser and Kolter (2000) proposed that mutations in 
regulator genes are highly beneficial because they result in the simultaneous alteration of 
multiple cellular activities. P Al 09 and P A13 8 are regulatory mutants and appear to support 
their proposal. The addition of mutations in two-component and lysR-type regulators to the 
spectrum of potential GASP alleles strengthens the hypothesis that fitter strains can emerge 
as a result of the coordinated repression of a large number of genes (Zinser & Kolter, 
2000), and the observation of a GASP-like phenotype in a non E. coli system increases the 
relevance of GASP research to the study of microbial evolution. Future analysis aimed at 
determining whether the antifungal mutants that arose in 20-day cultures have mutations in 
genes for global regulation of fungal inhibition, and whether they show increased fitness in 
competition with P Al 09 and P Al3 8 would be of great interest. Such observations would 
support the suggestion that some regulatory mutations are favoured by selection because of 
the benefits to fitness of reducing expression of an entire regulon (Zinser & Kolter, 2000). 
8.3.2 Culture takeover by PAI09 and PA138 is not complete. 
PAl38 and PAI09 do not drive PA147-21acZYto extinction. Superficially, this 
observation is in contrast to many GASP experiments in which the less fit strain becomes 
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undetectable by the end of the experiment (Finkel & Kolter, 1999; Zinser & Kolter, 1999). 
However, over longer term experiments the "rise and fall" of different strains can be 
observed as conditions change (Finkel & Kolter, 1999). Even those strains that fell below 
the threshold of detection could revive. It is thus possible that if conditions were to change, 
PA138 and PAI09 may lose their competitive advantage, allowing PA147-21acZYto 
recover. However, given that antifungal defective mutants arise in monoculture, we 
speculate that even if P Al4 7 -2lacZY recovered as conditions changed, it is possible that at 
least some of those "wildtype" strains that recover will have acquired mutations that render 
them defective for fungal inhibition. 
8.3.3 Implications for biocontrol? 
Although these experiments were entirely in vitro, it is worth considering the potential 
importance ofthe observations in the application ofbiocontrol agents in the field, given 
that stresses such as starvation are likely to be commonplace in the soil environment. In 
this regard, our results would suggest that PA147-2 might not be an ideal biocontrol agent. 
However, detailed inspection of the mode of application (e.g. seed coating, pellet 
formulations) ofbiocontrol bacteria, and the affinity ofPA147-2 for plant root attachment 
(R.D. Monds and H.K. Mahanty, unpublished data) indicate that PA147-2 and similar 
bacteria can still be useful in combating fungal disease in plants. The methods of 
application aid in targeting the bacteria to the root, where the environment encountered is 
considerably different to the more stressful conditions found in soil. From the work 
presented it is clear that under starvation conditions, antifungal minus and reduced mutants 
can arise and persist and two antifungal mutants (P A109 and PA138) have the ability to 
outcompete P A147-2IacZY. The competitive advantage of some antifungal mutants 
suggests that if this kind of mutant should arise in the soil, it could be accompanied by a 
concomitant loss ofbiocontrol efficacy as the mutant population increases at the expense of 
the wildtype. However, a recent study by Mirleau et al. (2000) has shown that a mutant of 
P. fluorescens C7R12 that is defective in pyoverdine synthesis (designated PL 1) and is less 
fit than the parental strain in competition experiments under gnotobiotic conditions, shows 
similar competitive fitness to the wildtype in non-gnotobiotic soil experiments. Since 
pyoverdine has been implicated in biocontrol this study provides some insight into the 
contribution ofbiocontrol factors on competitive fitness. Pyoverdine is a siderophore, 
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which are compounds involved in iron scavenging (Neilands, 1981), and thus thought to 
contribute to biocontrol efficacy by reducing iron availability for the fungal pathogen rather 
than antibiosis per se (Leong, 1986). Mirleau et al (Mirleau et aI., 2000) suggest that the 
ability to compete well in non-gnotobiotic conditions could be a consequence of the ability 
of P. fluorescens C7R12 and PLI to uptake siderophores produced by other organisms. 
This would result in PLI being able to scavenge enough iron as long as other siderophore 
producing organisms were present. 
Studies on phenazine production indicate that producing the antibiotic is a factor in the 
ecological success of P. fluorescens 2-79 and P. aureofaciens 30-84 (Mazzola et aI., 1992). 
This was thought to be because the ability to kill competitors provides a competitive 
advantage when nutrients are limited. Phenazines would be very effective compounds in 
that regard, given that they have antibacterial properties in addition to their antifungal 
activity. This is in contrast to PAI47-2, which has never been observed to inhibit the 
growth of bacteria in vitro. Thus, production of antibiotics by PA147-2 would have limited 
success in excluding all competitors, since bacteria would most likely be unaffected. Since 
our mutants P Al 09 and P A138 are deficient in production of an exclusively antifungal 
metabolite, and the experimental system lacks other competing species, it is unclear 
whether the complex environment of soil would lead to observations similar to those of 
Mazzola et al (1992) or Mirleau et al (2000), or whether our starvation experiments 
accurately simulate events that could take place in soil. Furthermore, although starvation 
conditions may be encountered in the soil, the environment on and adjacent to plant roots 
(the rhizosphere) may be supplied with nutrients (sugars and amino acids) from root 
exudates (Jaeger et aI., 1999). Thus, it is possible that starvation may be a rare or sporadic 
occurrence in the rhizosphere, which is also the site of action for biocontrol agents used in 
the suppression of root diseases. Therefore, an important distinction may exist between 
P A14 7 -2 that is active in biocontrol and has colonized the rhizosphere, and those cells that 
are left to persist in the soil once crops have been removed. If this is the case, cells 
remaining between crop plantings could be the most likely to endure starvation and 
accumulate GASP mutations, making their long-term reliability questionable. 
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As discussed in chapter 7, during the field trial PA147-2 in bulk soil reduced to 
undetectable levels, whereas in the rhizosphere PA147-2 persisted for the duration of the 
study, albeit at low levels. The observed difference may support the suggestion (above) 
that it is the cells in bulk soil that may be the least likely to survive. Whether the lack of 
survival in soil indicates that PA147-2 will not persist by acquiring GASP mutations is 
uncertain as the conditions used to induce Phytophthora rot are reasonably harsh, involving 
flooding followed by water stress. A trial that requires less severe treatments and provides 
a better chance for rhizosphere colonisation would provide better data in this regard. An 
example would be the control of take-all of wheat. In this system, bacterial seed coating 
could be used, which is likely to be better than dipping roots in a bacterial suspension, with 
regard to colonisation efficacy. These intriguing and testable questions could be addressed 
by comparisons between soil microcosm and rhizosphere experiments under controlled 
conditions, followed by further fieldwork. Such work would go a long way to addressing 
the question of whether soil bacteria accumulate GASP mutations as a survival strategy, 
and whether such processes have implications for the selection ofbiocontrol bacteria. 
In summary, I have demonstrated that global regulatory mutations can improve the 
competitive fitness of P. aureofaciens P A14 7 -2 in a manner similar to the GASP phenotype 
in E. coli. These observations are of interest for the study of both microbial evolution and 
biological control. Future experiments will focus on the questions arising from our in vitro 
starvation experiments from which spontaneous antifungal mutants were recovered. I am 
interested in examining the fitness of individual clones from the starved populations, and 
testing the hypothesis that they have mutations in global regulators of antifungal activity. 
These experiments could then be extended into systems that model field conditions. 
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Chapter 9 
Summary of results, comments, and future directions 
The work presented in this thesis was undertaken with a view to furthering the 
understanding of how P. aureofaciens PA147-2 inhibits fungal growth, and increasing the 
lmowledge of the usefulness ofPA147-2 as a biocontrol agent. Research results are 
presented in six chapters (Chapters 3-8), and although at first glance these appear to be 
unrelated, this is not so when the whole body of work is considered in detail. Below I 
assess the relative success of the work presented in these chapters, show how the chapters 
are related, and summarise the novel findings of the research. 
An analysis of the recA gene in PA147-2 was undertaken to develop a tool for use in the 
study ofPAI47-2.Construction of a simple system for the introduction of recA mutations 
would be of great value in the study ofPA147-2 mutants. In Chapter 3, the successful 
development of a recA deletion system was described, and this system was employed in the 
complementation of the mutation in PAl 09 (Chapter 5). In addition, a seemingly novel 
function ofrecA was uncovered in this study. In PAI47-2, it appears that recA is involved 
in the observed instability ofthe pLAFR3 cosmid vector, and cosmids constructed using 
pLAFR3. The introduction of the recA I mutation increased stability of a cosmid, while the 
recA4 mutation had no significant effect on cosmid stability. Both mutations rendered 
PA147-2 sensitive to UV and MMS induced DNA damage. Thus, the investigation ofrecA 
was successful, and relates to other aspects of this thesis in that it led to the creation of a 
tool that was subsequently used in this study ofPAI47-2. Furthermore, the study of recA 
resulted in a publication in the Canadian Journal of Microbiology (Silby & Mahanty, 2000) 
(appendix 5). 
Three chapters present results pertaining to the study of antifungal mutants in PAI47-2. In 
Chapter 4, a range of mutants were subjected to a preliminary analysis, which identified a 
number of potentially important genes for antifungal activity. Apart from the identification 
of two putative global regulators, the genes found were not similar to those normally 
associated with antifungal activity. Potential roles for these genes were discussed. The 
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results presented in Chapter 4 were important for the rest ofthis thesis in that these results 
provided the initial information required for the studies detailed in Chapters 5 and 6. The 
genes identified were also important in discussion and interpretation of the results of the 
competition experiments described in Chapter 8. The major limitation of the work outlined 
in chapter 4 was the failure to identify a gene or gene cluster required for the biosynthesis 
of antifungal metabolites~ as found in other Pseudomonas spp. biocontrol strains. Since 
characterisation by chemical means has been unsuccessful (Godfrey, 1997)~ it was hoped 
that a molecular approach would be useful in the identification of the compound(s) 
responsible for fungal inhibition. One possible remedy for this situation is the creation of 
further mutants. The original antifungal mutants were created using a wildtype Tn5, but the 
isolation of large numbers of mutants was relatively difficult (F. Carruthers~ Pers. Comm.). 
Recently, miniTn5 derivatives (De Lorenzo et aI., 1990) have been successfully used in 
PA147-2 for the isolation ofbiofiIm-defective mutants (Monds, 2000). Thus, the use of 
miniTn5 elements may facilitate the isolation of additional antifungal mutants, and DNA 
sequencing of insertion points might permit the identification ofbiosynthetic genes. 
Chapter 5 describes experiments that were used to study two putative regulators of 
antifungal activity. One of these, designated FinR, had similarity to LysR-type 
transcriptional regulators, while the other (FinT) was similar to hybrid two-component 
sensor/regulators. When present in cis, FinR was shown to affect expression of an adjacent 
gene (jinA), which was also involved in antifungal activity. In addition, the results 
suggested that FinR had other regulatory targets that were important for antifungal activity. 
This is a novel finding, given that most global regulators of antifungal activity appear to be 
of the two-component type. FinT appears to be a two-component regulator of antifungal 
activity, but does not seem to be a homologue ofthe GacAiGacS two-component regulator 
often described in biocontrol pseudomonads. It seems that FinT and FinR share regulatory 
targets, as revealed by examination of their protein profiles relative to the wildtype. 
Common proteins are missing in the finR and finT mutants. Interestingly, the influence of 
FinT appears to be dependent upon extracellular inorganic phosphate concentration. 
Experiments in Chapter 6 show that the finT mutant can be antifungal positive in the 
presence of high Pi, lending support to a model for phosphate-regulated fungal inhibition in 
PA147-2. It would be interesting to examine the protein profile ofPA109 grown in the 
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presence of 25mM Pi. Given the antifungal phenotype under Pi excess, the protein profile 
would be predicted to resemble PA147-2, rather than PAl38 or PA109 grown in limited Pi 
conditions. FinR appears to be unaffected by Pi, an observation that provides support to the 
suggestion that FinR operates near the top of the antifungal regulatory hierarchy. 
Additional experiments presented in Chapter 6 suggested that the phosphate specific 
transport (Pst) system has an influence on the expression of antifungal activity in low 
phosphate conditions. Thus it appears that there may be an important link between the 
regulator FinT, and the Pst system with respect to inhibition of fungi in low phosphate 
environments. Further experiments to examine FinT -regulated genes under low and high 
phosphate conditions would be revealing. Such studies, using 2-D protein separations, or 
even DNA arrays could allow the isolation ofbiosynthetic genes controlled by FinT, or 
provide information regarding the possible link between FinT and the Pst system. 
Additionally, if FinR was included, a picture of regulatory hierarchy could emerge. 
Finally, studies ofjinT fused to report~r genes would be of interest because the expression 
ofFinT could be monitored in different mutant backgrounds (e.g.jinR,pstA), and with 
different phosphate concentrations in the growth media. This type of experiment would 
indicate whether Pst affects jinT or vice versa, whether jinT is controlled in some way by 
FinR, and whether phosphate influences expression of FinT. 
The remaining experimental chapters are important in the assessment of the applicability of 
PA147-2 as a biocontrol agent. In Chapter 7 the results of a field trial are presented. This 
was a preliminary trial, and therefore was limited in its size and scope. Despite this, it 
showed that PA147-2 provided significant protection from Phytophthora rot to asparagus 
plants. While this protection was relatively limited compared to chemical controls, the fact 
that it was significant relative to untreated controls suggests PA147-2 is a strain worthy of 
further study. It is possible that the results would be considerably better if the trial design 
was improved. For example, the method of applying the bacterial treatment was crude, and 
could have easily contributed to the declining population ofPA147-2 that was evident in 
the trial. More sophisticated application techniques might give the bacteria a better chance 
at survival. 
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The observation that the PA147-2 population did not establish at a stable levelled to the 
experiments shown in Chapter 8. Previous studies on the biocontrol strains P. jluorescens 
2-79 and p, aureofaciens 30-84 had implicated phenazine antibiotic production as an 
important factor in the competitive fitness ofthe organism in soil (Mazzola et aI., 1992). 
The fact that PA147-2 was unable to establish a population in the field raised the question 
of whether antibiotic production was a burden for this strain. This was addressed in vitro in 
Chapter 8. The hypothesis was that if producing antifungal compounds was a burden, 
mutants that do not produce those compounds would outcompete the wildtype. The results 
indicated that global regulatory mutants have increased relative fitness, and this trait 
resembled the GASP phenomenon known in E. coli. This study provided evidence that 
PA147-2 could mutate to an antifungal-deficient fonn, and that these mutants could survive 
and proliferate in long tenn cultures. These experiments provide a strong rationale for 
further examination of P A147 -2 fitness, under more complex conditions such as in soil 
microcosms. They also lead to a cautipnary note on the use ofPA147-2 in that perhaps this 
strain will not establish high populations because of relatively low fitness, or alternatively, 
in the absence of fungal pathogens PA147-2 will mutate to a fitter, antifungal-defective 
variant, resulting in reduced biocontrol efficacy. It would be intriguing to examine the 
fitness ofPA147-2 relative to the seemingly fitter mutants PA109 and PAl38 under more 
natural conditions, and competition experiments against other soil pseudomonads would 
provide valuable data on the relative fitness against the type of organism PA147-2 would 
encounter in a biocontrol situation. 
As has been outlined, the several lines of research presented in this thesis are intimately 
linked. The early chapters (3 and 4) provided invaluable tools and resources for the 
molecular studies (Chapters 5 and 6). The analysis ofPA109 and PAl38 as regulatory 
mutants (Chapter 5) led to the tests ofFinR and FinT as candidates for a hypothetical low-
phosphate regulator in Chapter 6. Putative identification of the genes interrupted by 
transposons, described in Chapters 4, 5 and 6, allowed suggestions to be made in Chapter 8 
regarding competitive fitness, and the possibility that regulatory mutants were fitter than 
non-regulatory mutants and the wildtype. The experiments carried out in Chapter 8 were 
initiated as a result ofthe field trial (Chapter 7), and the observed population decline of 
PA147-2 which suggested low competitive fitness. 
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Future directious. 
The work described has opened a number of avenues for future research, all of which 
would add greatly to the growing understanding ofPA147-2 as a biocontrol strain. The 
studies on global regulation have shown that there are a number of differences that PAl38 
and PAI09 share compared to PAI47-2. An intensive study on the proteins that PA138 
and PAI09 cannot synthesis would reveal at least some of their regulatory targets, which 
could be involved in antifungal activity. Having identified the proteins, it would be 
possible to identify and mutate the gene, allowing its role in fungal inhibition to be tested. 
As a complement to that study, it would be interesting to revisit the chemical nature ofthe 
antifungal compound(s). Although it has proven difficult to study, the identification of the 
compound(s) is perhaps the single most pressing need for the future study ofPAI47-2. 
Identification of the compound(s) will allow hypotheses to be made and tested regarding 
the biosynthetic pathway(s). Furthermore, simple purification procedures might open 
possibilities to study production in situ, and to address questions regarding its stability in 
soil. All of this is important for the application of PAl 47-2 as a biocontrol agent. As 
mentioned above, soil microcosm studies will more accurately assess the fitness of P A 147-
2 compared to a range of bacteria. Another important question to arise from this study is 
the nature of the link between antifungal compound production, phosphate concentration, 
and biofilm formation. Clearly there is a complex regulatory system involved, possibly 
using the Pst system as an environmental sensor. Further elucidation of the role of 
phosphate in controlling both fungal inhibition and biofilm formation will be of value from 
fundamental and applied points of view. 
Although there are many directions that have been opened by this work, it seems that the 
future research must also involve the generation of new mutants. The present collection is 
small, and does not seem to give clues regarding the biosynthetic genes. Thus, a new 
mutant hunt would be a useful undertaking, particularly ifthe chemical characterisation of 
the antifungal compound is also undertalcen. Together these approaches might finally 
reveal the nature of the compound produced by P Al4 7 -2. 
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Summary statement. 
At the start of this chapter the broad goals of "furthering the understanding of how P. 
aureofaciens PA147-2 inhibits fungal growth, and increasing the knowledge of the 
usefulness ofPA147-2 as a biocontrol agent" were mentioned. This work has shown that 
two global regulators are involved in antifungal activity, one of which appears to be 
required only under low phosphate conditions. The phosphate specific transport system has 
been implicated in low-phosphate fungal inhibition, probably via a mechanism unrelated to 
its role in phosphate assimilation and metabolism. A tantalising link between antifungal 
activity and biofilm formation also emerged from this study. A number of mutants were 
subj ected to preliminary characterisation, and these results suggest a range of physically 
unlinked genes are required for fungal inhibition. A field trial demonstrated that PA147-2 
can suppress Phytophthora rot of asparagus, and that PA147-2 could not establish a stable 
population. In vitro experiments provided some evidence that antibiotic production by 
PA147-2 is metabolically costly, and that fitter mutants can arise during starvation culture. 
Thus, while there is clearly a considerable amount of work to be done on PA147-2, the 
investigations presented in this thesis have successfully increased the understanding of the 
molecular mechanisms that contribute to fungal inhibition by PA147-2, and demonstrated 
the potential ofPA147-2 as a biocontrol candidate. 
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Appendix 1 
Media, Buffers, Solutions 
Media 
H-TopAgar 
1 % Bactotryptone 
0,8% NaCl 
0.8% Agar 
In dH20; Autoclave 
King's medium B (King et aI., 1954) 
2% w/v bactotryptone 
65mM K2HP04 anhydrous 
60rnM MgS04.7H20 
1.5% w/v Glycerol 
In dH20; Autoclaved 
KI0 medium 
AI: 10 dilution of King's B 
KI0P medium 
10% strength King's B prepared without the K2HP04 
A number after K1 OP- signifies the amount of added inorganic phosphate 
M9 minimal medium (Sambrook et aI., 1989) 
47.7M Na2HP04.7H20 
22mM KH2P04 
8.5mM NaC] 
18.7 NH4Cl 
In dH20; Autoclave, then add desired carbon source at appropriate concentration 
Minimal 'A' medium (Miller, 1972) 
60mM K2HP04 
33mM KH2P04 
7.6mM (NH4)2S04 
1.7mM Sodium citrate.2H20 
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In dH20; Autoclave, then add desired carbon source at appropriate concentration 
Luria Bertaui Medium (LB) 
1 % w/v Bactotryptone 
0.5% w/v Yeast extract 
0.5% w/v NaCI 
In dH20; Autoclaved 
Solidify by adding 1.5% agar prior to autoclaving. 
LBMM (for miuiTnlO mutagenesis) 
LB broth supplemented with 0.2% maltose and lOmM MgS04 (after autoclaving). 
PGTIPS medium 
25mM KCI 
8mM (NH4)2S04 
1.2mM MgS04 
20rnM Tris-Hel (PH7) 
0.2% w/v Glycerol 
In dH20, Autoc1aved. 
Pseudomonas minimal medium (Kirner et a!., 1996) 
35mM K2HP04.3H20 
22mM KH2P04 
8mM (NH4)2S04 
25mM Sodium succinate 
In dH20; Autoclaved 
1.2mM MgS04 (added after autoclaving) 
Solidify by adding 1.5% w/v agar prior to autoclaving 
SOC medium (for electroporation) (Sambrook et aI., 1989) 
2% w/v bactotryptone 
0.5% w/v Yeast extract 
10mM NaCI 
2.5mM KCI 
10mM MgCh 
10mM MgS04 
0.36% w/v Glucose 
In dH20; Autoclaved 
T medium (Nikata et aI., 1996) 
80mM TrisHCI pH7.6 
85mM NaCI 
20mM KCI 
20mM N"f4CI 
2.5mM Na2S04 
ImM MgCh 
3MM FeCh 
0.2% w/v Glucose 
In dH20; Autoclaved 
Inorganic phosphate is added to this medium in defined quantities. A subscript number 
indicates the addition of that concentration of inorganic phosphate (in mM). 
Minimal bioassay medium 
T medium supplemented with the desired inorganic phosphate concentration and 2% 
glucose (w/v). 
Tris Buffered Potato dextrose agar (TPDA) 
PDA is made up as described by the manufacturer (Oxoid), except TrisHCI (pH7.6) is 
included at a final concentration of 80mM. 
Buffers and solutions 
All buffers and solutions were made using dH20. 
Common buffers and solutions 
TIOEI (TE) 
10mM 
ImM 
50xTAE 
Tris-HCI pH8.0 
EDTApH8.0 
242g Tris 
100mL 0.5M EDTA (pH8.0) 
57.lmL Glacial acetic acid 
dH20 to I litre; pH adjusted to 8.0; Dilute to Ix for use. 
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lOxTBE 
121g Tris 
51.35g Boric acid 
3.72g EDTA Na22H20 
dH20 to one litre; pH adjusted to 8.0; Dilute to 0.5x for use 
20x SSC 
175.3g NaCI 
8S.2g Na3Citrate 
dH20 to llitre; pH7 (adjust with HCI), 
Loading buffer for agarose gel electrophoresis 
30% Glycerol 
0.25% Bromophenol blue 
0.25% Xylene cyanol 
RN aseA to final concentration of lOl-lg/mL 
GES lysis solution for genomic DNA preparation 
5M Guanidium thiocyanate 
100mM EDTA 
0.5% Sarkosyl 
Dissolve 60g guanidium thiocyanate in 20mL O.SM EDTA and 20mL dH20 with heating (6S°C). 
Add SmL 10% sarkosyl, make volume to 100mL (dH20), filter through O.4Sj.tm filter 
Solutions for alkaline lysis plasmid DNA preparations (small and large scale) 
Solution 1 
1% 
25mM 
10mM 
Solution 2 
0.2M 
1% 
Solution 3 
Glucose 
Tris-HCI pHS.O 
EDTA 
NaOH 
SDS 
3M Sodium acetate pH4.S 
5MLiCI 
21.2g LiCI 
dH20 to 100mL 
~-galactosidase assay solutions 
ZBuffer 
60mM Na2HP04.7H20 
40mM NaH2P04.H20 
10mM KCI 
1mM MgS04.7H20 
SOmM ~-mercaptoethanol 
pH7; Do not autoclave 
1M Na2C03 
10.6g Na2C03 
dH20 to 100mL; do not autoclave 
SDS-PAGE solutions and gel recipes 
Resolving gel buffer 
l.SM Tris-HCI pH8.8 (adjusted with HCI) 
Stacking gel buffer 
O.SM 
Tank buffer 
2SmM 
192mM 
0.1% 
Tris-HCI pH6.8 (adjusted with HCI) 
Tris 
Glycine 
SDS 
2x Sample treatment buffer 
2.SmL O.SM Tris-HCI 
4.0mL 10% SDS 
2.0mL Glycerol 
1.0mL 2-mercaptoethanol 
0.2mL 0.1 % w/v bromophenol blue 
dH20 to 10mL; pH6.8 
Coomassie stain stock 
1 % Coomassie brilliant blue R-2S0 
Stir to dissolve; Filter through Whatman number 3. 
Coomassie brilliant blue R-2S0 stain solution for protein gels 
62.SmL Coomassie stain stock 
2S0mL Methanol 
SOmL Acetic acid 
dH20 to SOOmL. 
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Destain solution 1 
500mL Methanol 
100mL Acetic acid 
dH20 to 1 litre, 
Destain solution 2 
50mL Methanol 
70mL Acetic acid 
dH20 to 1 litre. 
SDS-PAGE protein gel recipes 
230 
8% 
Separating gela ~ Stacking gel 
12% .................. ···r-
1
-
6
-%- ··---···l····4~~··············· ................. -
Acrylamide/Bisb 26.67mL 40mL j53.3mL 1.3mL 
Separating gel buffer 25rnL i25mL I 25ml 
Stacking gel buffer ' - 1- 2.5mL 
\0% SDS lmL IlmL 11rnL IOOftL 
dHzO i 46.78mL I 33.5mL ! 20.12mL 6.1mL 
-~-~---------------------------------------------t-----------------------------r------------------------------1-----------------------~----------------------~~-· 
10% APSe I 500jlL ! 500jlL i 500jlL 1 50jlL 
TEMED' 150ftL 1 50ftL i 50ftL 110ftL 
Total volumed IIoomL ilOOmL ! lOOmL 110mL 
"Any combination can be used to pour gradient gels. 630% stock. "Add after 10 minutes degassing, and 
immediately prior to pouring the gel. bean be scaled up or down to get desired volmnes 
Buffers and solutions for transfer of proteins to PVDF membrane 
Transfer buffer 
25mM 
192mM 
20% v/v 
Tris 
Glycine 
methanol 
Coomassie brilliant blue G-250 stain stock 
1 % Coomassie brilliant blue G-250 in dHzO 
Stir and filter 
PVDF membrane staining solution 
ImL Coomassie G-250 stock 
4mL Methanol 
100jlL Acetic acid 
Make up to lOmL with dHzO. Prepare fresh each time. 
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PVDF destain solution 
SO% Methanol in dH20 
Solutions and media for maxicell experiments 
Kmedium 
M9 medium with: 
1% 
O.IJ.!g/mL 
Casamino acids 
Thiamine 
Hershey salts (without sulphate) per litre 
S.4g NaCI 
3g KCI 
1.1g ~CI 
ISmg CaCh.2H20 
200mg MgCh.6H20 
0.2mg FeCh.6H20 
87mg KH2P04 
12.1g Tris 
In dH20. Adjust pH to 7.4 with HCI. Autoclave. 
Sulphate free HerShey medium (add per lOOmL Hershey salts) 
2mL Glucose 
O.SmL Threonine 
ImL 
ImL 
ImL 
O.lmL 
Solutions for FIGE 
Leucine 
Proline 
Arginine 
Thiamine 
O.5x TBE (as recommended by Biorad) 
4SmM Tris 
4SmM Borate 
1.0mM EDTA 
In dH20; pH8.3 
SE buffer 
20mM 
SOmM 
Lysis buffer 
O.SM 
O.Smg/mL 
1% 
NaCI 
EDTA 
EDTA 
Pronase E 
N -lauryl sarcosine 
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Me buffer for PI transduction 
lOOmM MgS04 
5mM CaCb 
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Appendix 2 
DNA sequencing, and peR parameters 
LI-COR sequencing 
Cycle in PCR machine 
1. 95 2min 
2.9530 sec 
3. 50 for 15 sec 
4.70 for 15 sec 
5. go to 2 29 times 
Scanner control parameters 
Data collection configuration file 
Quick SequencIR configuration file 
Voltage 
Curtent 
Power 
Temperature 
Scan speed 
Prerun time 
Frames to collect 
FIGE parameters 
Voltage Forward 180V 
Reverse 180V 
Run time 10 hours 
Switch time Initial fWd 1.2 seconds 
Final fwd 9 seconds 
Initial rev 0.4 seconds 
Final rev 3 seconds 
Ramp Linear 
RT-PCR cycle (finR expressi01l analysis) 
(Primers fmexfWd and finexrev) 
42°C 30 minutes (RT step) 
95°C 5 minutes ( one cycle) 
66-cm-STD .col 
Quik66cm.col 
2000 Volts 
25.0mA 
45.0 Watts 
45.0°C 
2 1.2 frameslhour) 
1 hour 
32 
94°C 30 seconds, 4rC 30 seconds, 72°C 90 seconds (35 cycles) 
94°C 30 seconds, 47°C 30 seconds, 72°C 3 minutes (1 cycle) 
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peR cycles 
Amplification ofpDELl insert 
(PrimersfinRdfwd1 andfinRdrev1a) 
95°C 5 minutes (one cycle) 
94°C 30 seconds, 47°C 30 seconds, noc 90 seconds (30 cycles) 
94°C 30 seconds, 47°C 30 seconds, 72°C 3 minutes (1 cycle) 
Amplification of pDEL2 insert 
(Primers finRdfwd2 and finRdrev2) 
95°C 5 minutes (one cycle) 
94°C 30 seconds, 43°C 30 seconds, 72°C 90 seconds (30 cycles) 
94°C 30 seconds, 43°C 30 seconds, 72°C 3 minutes (1 cycle) 
Amplification ofpDEL3 insert 
(Primers finRdfwd 1 and finRdrev2) 
94°C 1 minutes (one cycle) 
94°C 30 seconds, 55°C 30 seconds, 72°C 2 minutes (30 cycles) 
94°C 30 seconds, 55°C 30 seconds, 72°C 3 minutes (1 cycle) 
234 
Appendix 3 Primers tor sequencing and peR 235 
Appendix 3 
Primers for Sequencing and peR 
Standard primers 
ISlO 5' GGGATCATATGACAAGATGT 3' 
IS50 5' GCACGATGAAGAGCAGAAG 3' 
T7 promoter 5' GTAATACGACTCACTATAGGGC 3' 
T3 promoter 5' AATTAACCCTCACTAAAGGG 3' 
Custom primers 
Primers for RT-PCR 
finexFwd 5' AAGGAGTCATATGGACAAGC 3 ' 
finexRev 5' CCACGGGATCCGATCAAAGC 3 ' 
Primers for construction of finR deletion 
JznRdfwdl 5' CTGATCGCGAATAACCGATC 3 ' 
JznRdfwd2 5' TCCATAAGGATCCTTAAACG 3 ' 
JznRdrevla 5' TGGCACTGGATCCTGACTGG 3 ' 
JznRdrev2 5' AGGCACACCGCTGTAACTTC 3 ' 
Primers for sequencing 
PR138a 5' CACTCAGAATTTCCCGAGCC 3 ' 
REDSEQ 5' ATCATCACAGAGGCTTCTCA 3 ' 
JznTfwdl 5' ACTGGCTGGATGTGCTCGAC 3 ' 
JznTfwd2 5' ACGACATCCTCGACTTCTCG 3 ' 
Jzn Trev1 5' AACGGAATGTGCTCAAGCTC 3 ' 
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DNA sequences 
A4.1 Complete open reading frames 
recA 
a) Open reading frame 
1 ATGGACGACA ACAAGAAGAA AGCCTTGGCT GCGGCCATGG GACAGATCGA 
51 ACGTCAATTC GGCAAGGGTG CCGTAATGCG TATGGGCGAT CACGACCGTC 
101 AGGCGATCCC GGCTATCTCC ACTGGCTCTC TGGGTCTGGA CATCGCGCTC 
151 GGCATTGGCG GCCTGCCAAA AGGCCGTATC GTTGAGATCT ACGGTCCTGA 
201 ATCTTCCGGT AAAACCACCC TGACCCTGTC GGTGATTGCC CAGGCACAAA 
251 AAATGGGCGC CACCTGTGCG TTCGTCGATG CCGAGCACGC CCTGGATCCT 
301 AAATACACCG GCACGCTGGG CGTCAACGCT GACGACCTGC TGGTTTCGCA 
351 ACCGGACACC GGTGAGCAAG CGCTGGAAAT CACCGACATG CTGGTGCGCT 
401 CCAACGCCAT CGACGTGATC GTGGTCGACT CCGTGGCAGC CCTGGTACCC 
451 AAGGCTGAAA TCGAAGGCGA AATGGGCGAC ATGCACGTGG GCCTTCAAGC 
501 CCGCTTGATG TCCCAGGCCC TGCGTAAAAT CACCGGTAAC ATCAAGAACG 
551 CCAACTGCCT GGTGATCTTC ATCAACCAGA TCCGGATGAA GATCGGCGTG 
601 ATGTTCGGCA GCCCGGAAAC CACCACCGGT GGTAACGCGC TGAAGTTCTA 
651 CGCTTCGGTC CGTCTGGACA TCCGTCGTAC TGGCGCGGTG AAGGAAGGTG 
701 ACGAGGTTGT CGGTAGCGAA ACCCGCGTTA AAGTCGTGAA GAACAAGGTG 
751 GCCCCGCCGT TCCGTCAGGC CGAGTTCCAG ATTCTCTACG GCAAGGGTAT 
801 CTACCTGAAC GGCGAGATGA TCGACCTGGG CGTGCTGCAC GGTTTCGTCG 
851 AGAAATCCGG TGCCTGGTAT GCCTACAACG GCAGCAAGAT CGGCCAGGGC 
901 AAGGCCAACT CGGACAAGTT CCTTGCGGAT AACCCGGATG TTGCCGCTAC 
951 GCTCGAGAAG CAGATTCGCG ACAAGTTGCT GACCCCGGCA CCTGACGTCA 
1001 ACGCTGCCGC CAACCGCGAG CCGGTTGAAG AAGTAGAAGA AGTCGACACT 
1051 GACATCTGA 
b) Highest Blast hits 
Score E 
Sequences producing significant alignments: (bits) Value 
gi 1515291gb M96558.1IpSERECAOE Pseudomonas fluorescens (cl .. . 1608 0.0 
gi 66890641 IAJ249265.11PTo249265 Pseudomonas tolaasii re .. . 1600 0.0 
gi 29437419b1L12684.11pSERECAO Pseudomonas putida recA prot .. . 894 0.0 
gi 16175911gblu70864.11pPU70864 Pseudomonas putida RecA and .. . 886 0.0 
gi 453831emb1X52261.11PAP7RECA Pseudomonas aeruginosa PAM 7 .. . 866 0.0 
gi 15595198IrefINC_002516.11 Pseudomonas aeruginosa, comple .. . 850 0.0 
gi 9949772 gb1AE004782.11AE004782 Pseudomonas aeruginosa PA .. . 850 0.0 
gi 454131 X05691.1IPARECA Pseudomonas aeruginosa recA gene 850 0.0 
gi 2861851 ID13090.1IpSERESA2 Pseudomonas aeruginosa gene ... 850 0.0 
gi 2487041gb S96898.11s96898 recA [Azotobacter vinelandii, 690 0.0 
c) Alignment with P. fluorescens recA 
Identities 997/1059 (94%) 
PA147: 1 atggacgacaacaagaagaaagccttggctgcggccatgggacagatcgaacgtcaattc 60 
111111111111111111111111111111111111 1111 1I1111111111111111 
p.Flu: 156 atggacgacaacaagaagaaagccttggctgcggccctgggtcagatcgaacgtcaattc 215 
PA147: 61 ggcaagggtgccgtaatgcgtatgggcgatcacgaccgtcaggcgatcccggctatctcc 120 
11111111111111111111111111111111111111111 11111111111111 III 
P.flu: 216 ggcaagggtgccgtaatgcgtatgggcgatcacgaccgtcaagcgatcccggctatttcc 275 
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PA147: 121 actggctctctgggtctggacatcgcgctcggcattggcggcctgccaaaaggccgtatc 180 
11111111111111111111111111 111111111111111111111111111111111 
P.flu: 276 actggctctctgggtctggacatcgcactcggcattggcggcctgccaaaaggccgtatc 335 
PA147: 181 gttgagatctacggtcctgaatcttccggtaaaaccaccctgaccctgtcggtgattgcc 240 
11111 111111111111111111111111111111111111111111111111111111 
P.flu: 336 gttgaaatctacggtcctgaatcttccggtaaaaccaccctgaccctgtcggtgattgcc 395 
PA147: 241 caggcacaaaaaatgggcgccacctgtgcgttcgtcgatgccgagcacgccctggatcct 300 
II II 11111111111111111111111111111111 11111111111111 II II 
P.flu: 396 caagcgcaaaaaatgggcgccacctgtgcgttcgtcgacgccgagcacgcccttgacccg 455 
PA147: 301 aaatacaccggcacgctgggcgtcaacgctgacgacctgctggtttcgcaaccggacacc 360 
11111 1111 I 11111111111111 111111111111111111 II 111111111 
P.flu: 456 gaatacgccggtaagctgggcgtcaacgttgacgacctgctggtttcccagccggacacc 515 
PA147: 361 ggtgagcaagcgctggaaatcaccgacatgctggtgcgctccaacgccatcgacgtgatc 420 
11111111111 111111111111111111111111111111111111111111111111 
P.flu: 516 ggtgagcaagccctggaaatcaccgacatgctggtgcgctccaacgccatcgacgtgatc 575 
PA147: 421 gtggtcgactccgtggcagccctggtacccaaggctgaaatcgaaggcgaaatgggcgac 480 
11111111111111111 11111111111 II 111111111111111111111111111 
P.flu: 576 gtggtcgactccgtggctgccctggtaccgaaagctgaaatcgaaggcgaaatgggcgac 635 
PA147: 481 atgcacgtgggccttcaagcccgcttgatgtcccaggccctgcgtaaaatcaccggtaac 540 
11111111111111 111111111 1111111111111 11111111111 111111111 
P.flu: 636 atgcacgtgggcctgcaagcccgcctgatgtcccaggcgctgcgtaaaattaccggtaac 695 
PA147: 541 atcaagaacgccaactgcctggtgatcttcatcaaccagatccggatgaagatcggcgtg 600 
11111111111111111111111111111111111111111111 11111111111111 
P.flu: 696 atcaagaacgccaactgcctggtgatcttcatcaaccagatccgtatgaagatcggcgta 755 
PA147: 601 atgttcggcagcccggaaaccaccaccggtggtaacgcgctgaagttctacgcttcggtc 660 
11111111111111111111111 111111111111111111111111111111111111 
P.flu: 756 atgttcggcagcccggaaaccactaccggtggtaacgcgctgaagttctacgcttcggtc 815 
PA147: 661 cgtctggacatccgtcgtactggcgcggtgaaggaaggtgacgaggttgtcggtagcgaa 720 
11111111111111 11111 11111111111111111111111 11111 111111111 
P.flu: 816 cgtctggacatccgccgtaccggcgcggtgaaggaaggtgacgaagttgttggtagcgaa 875 
PA147: 721 acccgcgttaaagtcgtgaagaacaaggtggccccgccgttccgtcaggccgagttccag 780 
II 11111111111111111111111111 II 11111 11111111111 111111111 
P.flu: 876 actcgcgttaaagtcgtgaagaacaaggtcgctccgcctttccgtcaggcagagttccag 935 
PA147: 781 attctctacggcaagggtatctacctgaacggcgagatgatcgacctgggcgtgctgcac 840 
1111111 I 111111111111111111111111111111111 11111111111 111111 
P.flu: 936 attctctacggcaagggtatctacctgaacggcgagatgattgacctgggcgtactgcac 995 
PA147: 841 ggtttcgtcgagaaatccggtgcctggtatgcctacaacggcagcaagatcggccagggc 900 
11111111111111 11111111111111111111111111111111111111 111111 
P.flu: 996 ggtttcgtcgagaagtccggtgcctggtatgcctacaacggcagcaagatcggtcagggc 1055 
PA147: 901 aaggccaactcggacaagttccttgcggataacccggatgttgccgctacgctcgagaag 960 
1111111111111 111111111 II II 111111111 I I III 11111 111111 
P.flu: 1056 aaggccaactcggccaagttcctggcagacaacccggatatcgtcgccacgcttgagaag 1115 
PA147: 961 cagattcgcgacaagttgctgaccccggcacctgacgtcaacgctgccgccaaccgcgag 1020 
111111111111111 1111111111 II II 11111 II 111111111111111111 
P.flu: 1116 cagattcgcgacaagctgctgaccccagcgccagacgtgaaagctgccgccaaccgcgag 1175 
PA147: 1021 ccggttgaagaagtagaagaagtcgacactgacatctga 1059 
11111111111111 1111111 11111111 111111 
P.flu: 1176 ccggttgaagaagtggaagaagctgacactgatatctga 1214 
Figure A4.1. a) Open reading frame of P. aureofaciens recA. Predicted start and stop codons are shown in 
bold. b) Best matches using Blastn. c) Alignment of P. aureofaciens recA (PA147) with P. jluorescens recA 
(P . flu), accession number M96558.1. 
jinT 
1 ATGACATTTC GTCGCCGTTG GGACATCAAC ACCCGGACCC AGCTCATTAC 
51 CCTGGGCCCG GCACTCCTGC TGACGCTGCT GTTGATCAGC TTCTTCACCT 
101 TCGTGCGGAT CCAGGACCTG CGCCAGGAAC TGGACCACAC CGGCCAGTTC 
151 ATCGCCAACC AACTGGCGCC GGCCACCGAA TACGGGGTGA TTTCCGGCAA 
201 CAACGACGTG CTTGAAAGCC TGTTGCGGGC CACCCTCGCC ACGCCGCACG 
251 TGCGCTCCTG GAGATTCAGG ACATGCTGCA GAAAATATCC TGGTGTATGT 
301 CGAGCAACCG TCGGAGAAGC ACGATCGCTC GCTGTCGGTG AAAGTCTTCC 
351 AGGCGCCGAT TCGCTGCAAC ATATCCAGCT GGGCAATGAC TTCTTCCAGG 
401 ACAGTACTGC CGAGCCCAAG GCCCCGCGCG CGGACTACCT GGGGCGAGTG 
451 ATTGTCGGCA TGTCCAACGA TGCGTTCAGC CAGCGCCAGC AGGAAATCCT 
501 GTTCAAGGCC GGGATTCTCG CGCTGTCGCC CTGCTGTTTA CCTTCTGCTG 
551 GCCCGGCGCC TGGCGCCAGC CTGTCGCAAC CGATCAGCGC CATGGGCAAT 
601 GCGGTCAAGG CGATCCAGCA GGGCGATTAC CAGACGCCGC TGCCCATCGT 
651 GGATGACTCG GAGCTGGGCA CCTGTCGCCA CATCAATAAC CTCGCCGATG 
701 CTTTAACCAG GCCAGTCGTG AACAGCACCA GGCCATGGCC AGGTTTATCC 
751 AGACCCGCGA AGAAGCCGAG CGGCAACAAT GCCAAGTCGG ACTTCCTGGC 
801 AATGATGAGC CATGAATTGC GCACGCCGAT GAACGGGGTG CTGGGCATGC 
851 TGCAACTGCT GGAAACCACC GACATGACCG AGGAACAGAC CGAATACGCG 
901 GCGCTGGCCT CGGAAGTCCA CCGAACACCT GCTGAAGGTG ATCAACGACA 
951 TCCTCGACTT CTCGCGCATC GAGCAGGACC CCTGGAGCTT GAGCACATTC 
lOOl CGTTCGACCT GGTGGAGCTG ATCGGCAGTT GCGCCCAGGC CTTCCAGCAC 
1051 GCCGCCCAAC AACGCGGGCT GGCGCTCGAA GTGCCGATCC CCCAGGGCCT 
1101 GGGCTCGCTG CAGGTACAGG GCGACCCGAC CCGCATCCGG CAGATTTTGG 
1151 TGAACCTGAT CGGCAATGCC CTGAAGTTCA CCGAGCAGGG CACCGTCACC 
1201 GTCGAACCCC ACTGGCAGAC CCTGGACCAT GAATTGCTGT GGTTCACCTG 
1251 CACCGTACGC GATAGCGGGA TTGGCATTTC CGCCGAGCGC CTGGAACTGA 
1301 TGTTCGATGC GTTCCAGCAA GCCGACAGTT CCATTTCAAG ACGTTACGGC 
1351 GGCACCGGAC TGGGACTGCC TATCGCACGC ACCCTGGCCG AACGCATGGG 
1401 CGGCACCCTG CGCGCCCAGA GCGAAGAAGG CCACGGCTCG GTGTTCACCC 
1451 TGGAAATCCC GCTGGCGATC TACCAGCAGA GCTTGCCGGT GCTCGCGCCG 
1501 AATACCGAAG GCAATGGCCG TGCGGGTGAA GGGCGCAACG TGTTGCTGGT 
1551 GGAAGACAAC CCGGTCAATC GCACGGTGGT CGAAGCATGC TTGCGCAGCC 
1601 TGGGGTTCGA GGTGAGCATC GCCACCGACG GCGCCGAAGC GATTCGCAGC 
1651 GCCGAGAGCC TGATTTTTAC CGCAATCCTG ATGGACTGCC GACTGCCGGG 
1701 CATCGATGGC TACGAGGCTA CCCGGCAGAT TCGCCAGTTG CCCGGTTGCG 
1751 CCGAGCTGCC AATCATTGCC TCACGGCCAA TGCTTGCAGG GCGATCGGGA 
1801 AGCCTGCCTG GCAGCTGGAA TGAACGATTA CCTGCAAAGC CGTTCAAACG 
1851 CACGGATTTG CAGCAAATCC TGCAGAGATG GGTGCAGTAA 
Figure A4.2. Open reading frame ofJinT. Predicted start and stop codons are shown in bold. 
finR and finA 
3' TCCGTAGGGCTCACCTTACCGCGCGAAACGGTGCAGTAGACTAGTTTCGTTAAG 
CGAATCTTTAAGCTACTTGCGTAACTGAGAAGATCTCGAAGATCTCGGAGCTATTAACCC 
GTCTATTTCGCGACTCTACCGGCTCGAGCGCGATAACCCCAACTGGTGTTTTCTAAGTTT 
GTTCCTGCAGTCGGAAGGCGAAAGCTATAGAAGCGACTGCTCGGTCAGTCCGTTGTCACG 
GTGCGGTGGCGGACGGTCACGCTGAAGCGCGTTCTGAAGCCGTAACAATGAAAACTTGGC 
CGGTAGTTGGCTATGCGCCTGGAGGGGTGACAGAAGGACTTTCCAGGTCTGGACGACGAC 
TCCCGGTATCGACTTCGCGTATGTCAGTACAACGTTGTCCAGCCAACCGACGAAACCTTT 
CGGCGCATGCAGGTCCATAAGCCCCGACCGCTGATGAAAAGCCGCTTTGCATGGATACCG 
CGCCGACTGGTGAGGCAGGTACCAACGACGACAAGGGTCAGACTATCTTTCTAGCTATGC 
GAGTGGCTCGTTTAGCTGCTACAGTAGGCTGTTCCAGTATAGATTAAGTTCCAGACCTAT 
CGCGACATCTTTACGTGGCTATACTCCCGACTAGTTAGCAGCAGGTTTGCGCTGTCCGTG 
ACTTTATGCATTAACGGGCCATCCACGTAGTGGGGCTAGGCACTGGCTGCGTAGTCGCAG 
TCGGTACCGTGAGTCTTAAAGGGCTCGGAAGTTTATTATACGCCTCGGGCGCAGTCTGTT 
CCACTGAACTGCCCAACTCGCTAACTCGTTATGTCGCGGATCAAGCCGAAGGTCGGGTAG 
CTAGTAAGCGCAATGGCTTCTCCAACGGTCCGGGTTAACAGACCGGCGTCTACTTTTCGG 
AACACTCCT 
GAACCTCAGCTGCCAGACGTGCTTGTAGAAGTCCCGGTCGTCGAACAGGTATTGTGAGGA 
tinR 5' 
TAAACGGTATCAGCGCGTCTGTTGGTGCAGTTGATAGCGATCAGAGATTCTTCTCTGACC 
ATTTGCCATAGTCGCGCAGACAACCACGTCAACTATCGCTAGTCTCTAAGAAGAGACTGG 
GCGCATGTCGAGATCCGCAGGGTGCTTTGCGCATTGCGCAAGATTGTGTTGCAGATCGCA 
CGCGTACAGCTCTAGGCGTCCCACGAAACGCGTAACGCGTTCTAACACAACGTCTAGCGT 
CCGATTCTCCTGTTGAGACAGCGCCGCTACCTTGCACGCCTGAAACCTATTCATGCGCGG 
GGCTAAGAGGACAACTCTGTCGCGGCGATGGAACGTGCGGACTTTGGATAAGTACGCGCC 
5'----, tinA 
CGTAGCCCGCTTATCTACAGGAAAGCC~TGAAACTTTTCGACCCCATTACAATTGGCAC 
GCATCGGGCGAATAGATGTCCTTTCGGA 
TCACACTCTCAAGCATCGTATCGCGATGGCTCCCCTGACGCGCTCGCGTGCCGGTCAACC 
AGGTAACGTGCCGACGCAGTTGAATGTCGAGTATTACCGTCAACGTGCAAGCGCCGCGCT 
AATCATCACAGAGGCTTCTCAAATTTCACAGCAGGGTCAAGGTTACGCCTGGACTCCAGG 
TATCTACACGCCCGAGCAAGTTGCTGGATGGAAGGCCGTCAGCGATGCCGTTCATGCCGA 
AGGCGGTACGATATTCTTGCAGCTTTGGCACGTGGGTCGTATCTCCCATCCCAGTTTTCA 
ACCCAACGGTGGATTGCCGGTCGGGCCGAGTGCTTTGAGTGTAGAGGGCGGCAAGACATT 
CATTATTGATGAAGAAGGCAATGGCGTCTGGGGTGACGTTCCAGTACCACAGGCCCTGAC 
AATCGAGGGTATCCAGTCAATTATTCAGGACTACCGTGTTGCCGCGCGTAATGCTGTACT 
GGCGGGTATGGATGGCGTAGAAATCCATTCTGGCAATGGGTATCTGCTAGACCAGTTCAT 
CGATTCCAACAGCAATAAGCGTGATGATATTTACGGAGGGAGTATTGAGAATCGTGCTCG 
ATTTTTGCTCGAAGTCACTCAGGCAGTGATTGAGGAAGTGGGGGCTCACCGTGTCGCGGT 
ACGCCTGACGCCCATGGGGCGTTTCATGGGCATGGGAGATGCGACACCAGAAGCGACATT 
CGGTTATGTGGTGACGCAGCTCAACACGATGAATCTGGCCTATCTGCACCTGGTCGAACC 
GGTCATTGTGGGCATCGAGCGAGATGAAAACTTCGATCCGCGCTGGGACACGATCATCAA 
GCAGCTTCGTGAGAAGTTACAGCGGTGTGCCTGA 3' 
Figure A4.3. DNA sequences ofjinR (903bases) andjinA (906 bases) shown as arranged in PA147-2. Bold 
type indicates putative start and stop codons. Both strands ofthe intergenic region (italics) are shown. Only 
the coding strands ofjinR andjinA sequences are shown, and these are indicated with 5' and 3' annotation, 
and arrows to show coding direction. 
A4.2 Sequences flanking transposon insertion points 
pCMl 
GCTGGGTCCGGGTGTTGATGTCCCAACGGCGACGAAATGTCATGGGCGTTTTTCTCCTTCGGCCAGGCGGGCG 
GCGACGTTGGTTTCGTCCACCTGTTCGATCCCCAGTGAGCGCGCAACCTGCGGGTTGCCTACGACTTTGAAAC 
GTTCCGGGTACAGCGAGCGCGGCCAACTGGCCGGCGCATGATCCAGCAGGCGGTCGAGCACATCCAGCCAGTC 
GGTCTGATCGCTGTAGGTGCTGGCCAGGCTGCCGGCCTTGACGAACCCGGCGTTGGGCCCGACCAGTGGCAAT 
TGCCTGGCGTAGCTGCTGAGCAGCAGGTTTTTCGCGGTTTTCGGGTTGTACAGCTGGGGATCATCCAGCCCCA 
GCAAGACGTCGCTGTTCTTGAACAGGCTTTGCAGCGGGCGACTGTCATTAATGTTTTCCCAAAGCTGGGGCAC 
GATCTCCAAGCCCATGGGCGCGGCGTACTGGCGCAGATCGCGCAGNANGAACTCGCTGTCGATGCCATAAANC 
ACGCCGATTNCGCCCGGGCCTTGAGGCNNGAATGCCCGGTNAATCAAGGCNCANTTTGTTCGGTTCCCANNCN 
GNTTGGGGTTCCNTCCCACAANNCAAGNGCTTGGATTCTTTCCGGCAANGGCAAA 
pCMH26 
AGCCAGCGCTTTTCAGGCGCTCGNGGGGCACTTCTTCTTTCTGCACCACTTCGCCGACGACGATGTGATTTTC 
CTGGCCCGGCACGTTGTAGTTGGCCTGGATCAGGTCGGCCGGCCAGAAGTGGCCCAGGCCACGCACGGCAATC 
ACGGCAAGCAAACCAATGGTCATGATGACCGCGATGGACACCGCGCCACCGCTGATCCAGACGCCCGGGGCGC 
CGCTCTTGAACCATCCATTCAGGGAGTTCTGTTTCACAGACTTCTACCTTTCTTAAAGCGACGAGTATTTCTT 
GCGCAGACGCTGACGAATCAGCTCGGCGAGGGTGTTCATGATGAAGGTGAACAGCAGCAGCACCAGCGCCGAG 
AGGAACAGCACGCGGTAGTGGCTGCCGCCGACTTCCGATTCGGGCATTTCCACCGCGACGTTGGCTGCCAGGG 
TGCGCAGGCCTTCAAACAGGTTCATCTCCATCACCGGCGTGTTGCCGGTGGCCATCAGCACGATCATGGTTTA 
CCGACCGNCGGCCCATGCCCGATCATCAGCGCCGAGAAGATGCCTGGGCTTGGNCGGGTCAAGGATCACCGAC 
GCNGGGTTCAATGGTCTGCCCATTGGGCGTGGGCGCCCCAANGGGGCCANGGGGAGCCCCCAAGGGGTCAAGG 
GCCCGCGCCGGGCACCGCNTTNAACACCGGGNGGTNTTTTCGGGGNGAATGGGGAGTAAGAATNGTTTCNGGG 
GAATCAACCCGNGGNAAAACCCATTGGGNCCAAGGGCCCGACNTTANCCAA 
pCMI17 
GGATCAGATTGATGTAGGAGCGAGNNNGTGTGGGAGCGGGCTTGCTCGCGAAAAACGTCAACGATAACGCGGG 
CAGTCTGGTTCCCCGCGTTGTCTGGACGTTCTTCGCGAGCAAGCTCCNTCCCACAGGGTTCAGAGTTGGTAGC 
TGAAACTCAGGGTATACCCGTGGCCGCCGATTGAAGCTGTCCAGGGCGATATCCGACATTGGCTTGGCGCTTC 
CAGCGCGATGTTGTACGTACTTGTTATCCCCGAAGCGCAGCCCACCGCTGCCGATGACATGTTGTTGCCCTTG 
NCCGGCAGTTCGTTGAACCAGGTCTTGGCCTTGTCGAGCACCACGTACGGCTGCAGGATTTTTACCCACTCGC 
CACTGCGGTTGAAGCTGTAGTTGACCTCATACGCCACGCCCAGCCCTTGTCGCCCGAGCCCTGGTCATCCGGG 
TAGCACGCCCGAAATTCTGCCCGCCGAACGTCGCGCCGTTCGCTGTCGGGCAAGGGCGTCGTTGCTCCAGTAG 
AAGGCACCCGATGCCACGCCTTGCCAGTTGTCGAAGAACTTGTCGCTCTGTACGCCCCGAGACGCGCAGCGGA 
AAGAAGTCGATGTCCGGGTTTTATACCCTCGAAGTCACTCCGGGTGCTTGGCGCCCAGCCGTCGATCCCTGGT 
ACAGGCCGCGCTGAGAATCGCAGTTNCCGGTGTCGGATTTGCNCATCACCTTNGAANCGCCANGGCNCGCAGG 
TTGGTTTTCAAGNCGAAACGTTGCGGGAAAACCCACCAAGTGGATAACGGG 
pCMI75 
GGCATGTGGTTGGTCTTGAAATAAATCCCGACCATCGCCCCCAGTTCCAGGTANATGAACAGCAGCAAGATGT 
CATCGATCTTGATGTGCCCCGTCTCCAGCATCCCCAGAAATTCCATCACCGCGGCATAGGCGGTCACCGCACC 
AATGGCGAACAGGGCCAGGTAGTGGAAGGTCTCGACGAACAGATTTCCCAAGGACTCGGCCAGTTGGTGCACG 
GTCTTGCGCANGTTTTCAGCCCAGTTGATTTTCACNATGATGCTTCCTTAGGTCGGCTCGACCGGATAATGCG 
GGTTGGACGTGACGGTTTCTCTGCATGCAGAAAAAAGGCCAGGGAACAGGAAGTGAGATGGTGGCGGGGTGAT 
ATGAGGCACTTATCTTGCTGCTTGATGATCNTTCCCACGCTCCGCGTGGGAATGCCGCCCCGGACGCTCCGCG 
TTCCATGCCCCATGGTTTCNGGTAGAAGTGACCGCNGAGCGTCACGGTATGCATTNCCACCGCAGAGCGTGGG 
GAACGATCCATCTATGTGACCCGGGTGATTTCAAGTTCAAGGTCNGGGGNCGACTTTGATTCCACCNCTTTGG 
ATTCCGACCCAATTAAACCCACNTCATTTTTCAACCNANTTTGGATGGGATCCGC 
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pCMI95 
CTCCTTCAGTCATCAACTTCCTGTCTGGATCACATCTATGCTCAACCTCGTGCGCATCGCATTGCGGCGCCCC 
TATACCTTCCTGGTATTGGCTATTTTCATTCTGATTGTGGGCCCGCTCGCGGCCTGGCGTACCCCGACCGACA 
TCTTCCCCGAAATTCGCATCCCCGTGATTGCCGTGATCTGGCAGTACACCGGCTTGCCGCCCGACCAGATGGC 
CGGCCGCATCACCTCGCCGTTCGAGCGGGTGCTGACCACCACGGTCAACGACATCCGCCATATCGAGGCGCAA 
TCGCTGAACGGCTACGGCATCGTCAAGGTGTTCTTCCAGCCGGGAGTCAACATCAGTACGGCCAACGCGCAGA 
TGACTTCGGTGTCCCAGGCCATCCTGCGTNAACTGCCGCCGGGCACCACGCCGNCGNTGATCCTCAACTACAG 
CGCCTCGACAGTGCCGATCGTGCAGTTGGCGTTGTCCGGCAAAGGCCTNANCGAACAGAAACTCGGTGACCTG 
GGNCTNAACACCGTGCGCCTGATGTTGACCACCGTGCCCNGNGGCCGCACTGGCATACCCGTTCGGNGGGAAG 
ACCCGCANGTGCAGATCGANCTNGACTTCCGCACGCATGCAGGGCCCGTGGTNTTTTNNGNGCAAGAACGTGG 
GGCACTTGNCCTTGGGCACCCCANAAAACCTTGGATTCACCCCCCGGNGGGGG 
pCME21 
CATCAGTCCCAGTTCGGCCAAGGGGTTACGGCCGCTACGTGAAAGCGGCAACGGGTGAAACTCGAAACCTTCA 
GCGGCAATAGCCGCAACAGCCGGACCAGGCATGCACGCCACATGAACCCTATAGCCCTCTGCCTGCGCGCCCT 
TGGCAACTGCCAGCCGGTGCGAAAGAAAAAAACCCGGGTCGTTGACGATAAACAAAAGTACTTTACTCATGCC 
TGCTCTTCCAACCATGCCTGGAACATGAGGATGGTCCACAAGTGAGGCTGCCAGTTTCCCCGGCCCTCAAGAT 
GTTCCTGCCACATGTGCCTGATGCGTTCAGGGTGGAAGTATCCCTCCTGGNGCAAGCGCGCTTNATNCAACAA 
AGACTCTGCCACTCCCGTAAAGGACCCGCGTAGCCACGCCCCAAGCGGGATACCAAAACCTTGCTTGGGCCTT 
TCGATCAACTCCTTGGGAACATGACGATAAAGCACTTNTNGCAACAGCCATTTGCCCTGGCCGGTACGAATNT 
TNAGGTCAGAGGNATGCGCCAGCCAGTTCGACAATNCTGTGGTCAAACATANGGACCCGACCCTNAATGCTTG 
CGGNCATNGCAGCGCGATCCAATTTCACCATGATGTCATNCTGACATATAGGTCTGGGGNGTCCATTGNCATN 
ATTNCANTGGTCGGAAACTTTTTTGGTNTTNGGGGNCAACCCCGAAANGGGTCAATTGAAAAAAAGGGNTTCG 
GGGTTTNCTTTGGCCACCCCGATTNACCAANAACTTGGGNANGGGGNGGAAGTNCCNAATGGACTTGTTTGAA 
ACNTGCCAAGGNTAANAAANNTTTATTTGNCCCCNTC 
pCMA3B 
GGTCACGACAGAGGAGGAGCGGGCGTTCCTGGAGGACGGTGGCTTTTCGGGCTAGGCCTCGGGTTCAGCCACT 
AAGTCTCTGACGCCCGCCTGGCGAAAACGCCGCACACCTTTGAGATCAATCGCCCAGCGCAACGCTTCAGTCG 
CCGACGGACGTTCGCCTTGGGTAATCGCCGCGTCATCGGTGGTCAGTTTATTCAGGTAGCCCTTGGCGCCGCC 
GCGTTCGCTCCAGTAATGGGTGTGGCTGAGCCAGGACCTGGCGAGCCAGCCTTTCCATTTGCCCACGCTGACC 
GGCAGGTCCAGTACGCCGGGGCCCATCACCGGGCTGACCGGGCCGCCGACGATGTCGCCAAACAGGCCCAGGG 
GCGCGGGGAAGTAGAGGTTGGTCCAACGGGTCACGGCGAAGGCCGCGGCATGGTGCAAATACAGGGGTGAAAA 
TGGGCGACCGCCCACGGTGACGGGCAAGCCGGCCGCTGTAGCCCGTAGCCCTTATCGTCGAGCGTCGGCGGGC 
ANGCGGGGGGCTTCGCGGCGTTTCGATGCGGCGCTGGAAGTCGCTCACGCTTGCGGCCCAACAACANGCTGGC 
GTGGGCCATCNGGGCTTCCCGAGGGTGACCAGGTCCGTGATGCGCCACNGGTTTGCCGANGNTGCGTTGTTCG 
ATAAANGCTTCGGCTTGCTGNTCNCGGAACCTTGANGANGNTTTGCAAGGCGGCCGTCGANGGCGTTTNCANG 
CCTTTGGCAGCGTGTCCTGGACCACCGGTTGCAGTCGCTCGTGGTTGGCGTAACNGGCGGCGAGTTCCNGGCC 
GCCGGGCTNACTATCGTGATGTTCTGCCCAAGTAGCCNACNATTCTAGCNATACCTGCCNAATTGGGCCACAC 
CATATCGAA 
pCM168 
CATCAAGCCGGCCTGCAATGTCGNGNTATCACTCTGCAAGGCGGCCACTCTGGCCTGCCTTGCCTGCGGGGTC 
TTTGAGGCGTCGGACATGGCAGCTGAGAGCTGAGCCATCTTCTCGGCGAGCTGTTTTCTCATCTCGCGAATCA 
TTTTCAACAGCTGCTTGATGTTGTCTTTCAGGTTGCTGTCGTCAATGTCCTTGTTGGAGTTGGTGCTGGCCTT 
GGAGGCTTTCAGCCCCGCCCCCGAGATATCCACCACCAGTCCTTGGGGCTTGGTGTCAGTGGCCCGATCGGTC 
GAAGACGCTTGGTCTTTATCGTCTGCAGCGGGGTCTTTTTTCGCATCAGGCACGGTTAGCGAAGAAACAATGG 
CANGGTTGGTTGCGCCAATGGAAAGCATGATCTGAGCCTNCAGCTCTAGGAGTGACAATCTTGTATCGACCTC 
NATACAAAATTCTTTATACCGCTGCTGCTTTTTTGTACACGCTGGCCTGATCGTCCCCCANTGCGGNACCCTT 
ACGTCTTATGTGTGTTTTCCCACAAGGATTTNAAAAATGTNCNANCCAATTNAACTGGCGCTCATAGCAGCTN 
ATTGCAAGGATTGCANCCTGGCCCCTTGCCTGCNCTTTCNTGATCTGAANAATGGAACCTGACANACGTAACC 
GTGCCCTGAAAAGGATTCTNTTCCANGCACAATTTACTCGTATCANACTNTGNCCTTAACTTACCTACATGGG 
GAAAANAAAACGNTCNCTGCACACTGTCGNTGTGGATGCCTNAATACCCGTNGCCAGCCCTGNACN 
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A4.3 Blastx results for searches withfinR andfinT (highest 15 matches) 
filtR 
Sequences producing significant alignments: 
113522051pirllB83328 probable transcriptional regulator 
113522431pirllB83256 probable transcriptional regulator 
31697211gb1AAC17939.11 (AF007569) GstR [Bradyrhizobium j .. . 
13473471IrefINP_I05038.11 transcriptional regulator [Mes .. . 
74487751pirlls77111 transcription regulator slr1871 - Sy .. . 
4014731splp308641YAFC_ECOLI HYPOTHETICAL TRANSCRIPTIONAL .. . 
13473045IrefINP_I04612.11 transcriptional regulator, Gst .. . 
12512936IgbIAAG54504.1IAE005196_2 (AE005196) putative tr .. . 
74487741pirl S74869 transcription regulator slr1245 Sy .. . 
113520561pir IF83412 probable regulator PA .. . 
11279620lpir IA82391 transcription regulator LysR family .. . 
134724751ref NP_I04042.11 transcriptional regulator [Mes .. . 
134718291ref NP_I03396.11 probable transcriptional regul .. . 
134764591ref NP_I08029.11 transcriptional regulator [Mes .. . 
113519441pir IF83638 probable transcription regulator PA .. . 
filtT 
Sequences producing alignments: 
gi 113518251pirl IE83443 probable sensor/response regulator 
134211161gb AAK22014.11 (AE005677) sensory box histidine .. . 
134247581gb AAK25064.11 (AE005973) sensor histidine kina .. . 
7444070lpir IS75136 sensory transduction histidine kinas .. . 
134242531gb AAK24637.11 (AE005934) sensory box histidine .. . 
gi 134240561gb AAK24472.11 (AE005918) sensory box histidine .. . 
gi 113561371pirl IC82151 sensor histidine kinase VC1831 [imp .. . 
gi 134246221gb1AAK24950.11 (AE005962) sensor histidine kina .. . 
gi 113523791pirl ID83149 probable two-component sensor PA397 .. . 
gi 134246011 gb I AAK24933 .11 (AE005960) sensory box histidine .. . 
113561431pirllE82198 sensor histidine kinase/response re .. . 
134247251gb1AAK25037.11 (AE005970) sensor histidine kina .. . 
113525581pirllE83529 sensor/response regulator hybrid PA .. . 
11351830lpirllH83132 probable sensor/response regulator .. . 
gi 134249011gb1AAK25181.11 (AE005986) sensor histidine kina .. . 
(bits) Value 
185 8e-46 
182 7e-45 
181 2e-44 
181 2e-44 
179 6e-44 
176 3e-43 
174 le-42 
174 le-42 
171 le-41 
170 3e-41 
169 6e-41 
168 8e-41 
167 2e-40 
166 3e-40 
166 5e-40 
(bits) Value 
593 e-168 
221 2e-56 
214 4e-54 
212 Ie-53 
209 ge-53 
208 2e-52 
206 8e-52 
204 2e-51 
200 4e-50 
200 6e-50 
199 1e-49 
198 2e-49 
197 4e-49 
197 5e-49 
195 le-48 
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Biological control of Phytophthora megasperma var. sojae, 
causal agent of Phytophthora rot of asparagus, 
by Pseudomonasaureofaciens PA147-2: a preliminary field trial 
SCOTT A. C. GODFREyl,-
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Abstract Pseudomonas aureofadens PA147-2 
produces an antibiotic that inhibits the growth of 
Phytophlhora megasperma var. sojae, the causative 
agent of root-rot disease of asparagus (Asparagus 
officillalis). To assess the potential use ofPA147-2 
as a biocontrol organism, we report preliminary find-
ings ofa field application ofPA147-2 to asparagus 
crowns. To determine the ability ofPA147-2 to sup-
press Phytophthora rot, asparagus crowns inoculated 
with PA147-2 were planted in Eyre shallow fine 
sandy loam soil inoculated with P. megaspemw var. 
sojae. During the 6-month trials, PA147-2 was iso-
lated from inoculation points with a decreasing fie-
quency. Harvesting and analysis of asparagus plants 
revealed that inoculation of crowns with PA147-2 
resulted in a 55.8% increase of fern dry weight in 
comparison to untreated plants. Preliminary field 
trial results suggest the direct inoculation of as para-
gus crowns with PA147-2 before planting causes a 
c statistically significant increase in the yield of plant 
material in the presence of p, megasperma val'. sojae. 
H99019 
Received 6 May /999; accepled 23 March 2000 
Keywords Pseudomonas aureofaciens; 
Pl1ytophthora megasperma val'. sojae; Asparagus 
officina/is; biocontrol; bacterial survival; RidomiF'(l 
250EC 
INTRODUCTION 
Phytophthora root rot causes significant yield reduc-
tion of asparagus (Asparagus officinalis) crops 
throughout New Zealand (Falloon 1991). 
Phytophthora megasperma val'. sojae has been iso-
lated from asparagus fields throughout the main 
growing areas within New Zealand (Boesewinlde 
1974; Falloon 1982). Asparagus growers cun'ently 
depend on chemical fungicides for control of the 
disease. However, many chemical pesticides are not 
specific for a particular organism, and can therefore 
have hannful effects on beneficial micro-organisms 
in the soil (Heger et al. 1995). Research directed 
toward non-chemical altematives which continue to 
maintain high crop yi~lds is desirable (Cook et al. 
1995). 
Fluorescent pseudomonads are suitable biocontrol 
antagonists in part because of their adaptive metabo-
lism and ability to produce a wide range of second-
ary metabolites inhibitory toward plant pathogens 
(Leisinger & Margraff 1979; Thomashow & Weller 
1988). Pseudomonads are common inhabitants of the 
rhizosphere where they contribute to the control of 
many deleterious fungal pathogens (Fravel 1988; 
Lievens et al. 1989). 
In a previous study, a bacterium fi'om soil with 
in vitro antifungal activity was identified as a strain 
of Pseudomonas aureofadens and was designated 
PA147-2 (Canuthers et al. 1994). Glasshouse trials 
indicated that suppression of root rot ofA. officina/is 
seedlings caused by P. megasperma var. sojae was 
possible by PA147-2 (Canuthers et al. 1995). Here 
we describe a field trial in which the ability of 
PA147-2 to suppress P. megasperma var. sojae root 
rot of asparagus plants was assessed. TIle trial was 
designed to address whether biocontrol could pro-
vide comparable protection achieved by current 
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chemical control strategies (Baker 1987). To address 
this question, four experimental treatments were 
used to enable a direct analysis of the degree of pro-
tection P A 147 -2 provided against Phytophthora root 
rot of asparagus under field conditions. Results of 
our trial are presented in this paper. 
MATERIALS AND METHODS 
Trial design 
The trial was carried out over 6 months (September 
1996-March 1997) in an isolated area of Eyre shal-
low fine sandy loam soil inoculated with P. 
megasperma var. sojae using 22-month-old aspara-
gus crowns (cultivar 'DCI5T FI hybrid) previously 
grown 1n Templeton silt loam soiL Planting of treated 
crowns was performed using a randomised complete 
block design (Steel & Torrie 1976). Each plot con-
sisted of 20 crowns planted 300 mm apart within a 
single row at a depth of 80 mm. Each treatment was 
replicated 4 times. Dams (200 mm high) were 
erected at the end of each plot to prevent leaching 
and cross-contamination oftreatments. Guard rows 
were planted on the sides of the triaL Randomly 
selected crowns in the guard rows were inoculated 
Table 1 Watering schedule applied to asparagus 
(Asparagus ojficilJalis) field trial plot. 
Date (1 996) Irrigation (mm) Time period (h) 
26 Sep 100 8 
27 Sep 200 16 
17 Oct 200 16 
18 Oct 200 16 
24 Oct 100 8 
25 Oct 200 16 
with PA 147-2 for use in the population study experi-
ment. General maintenance of plants consisted of 
25 rum ofilTigation every 14 days applied over a 3-
h period. Because saturated or near saturated soil 
conditions are essential for Phytophthora zoospore 
production and dispersal (Falloon & Tate 1986), 
flooding of the plot was achieved by irrigating for 
extended time periods (Table 1). Fertiliser, insecti-
cides, and herbicides were applied as indicated in 
Table 2. 
Harvest was canied out 160 days after planting. 
The fern from each plot was cut at soil level, washed 
with tap water to remove soil particles and placed 
into paper bags. Following oven drying at 75°C for 
72 h, dry weights of the fern were determined. 
Experimental treatments 
Four experimental treatments were used. Treatment 
1 was the application of a commercially available 
fungicide, Ridomil(1!) 250EC, which is applied for the 
control ofPhytophthora rot of asparagus throughout 
New Zealand. In Treatment 2, asparagus crowns 
were left untreated. Treatment 3 was the inoculation 
of asparagus crowns with rifampicin resistant (RifR) 
PAI47-2. The fourth treatment was the application 
of Luria Bertani (LB) medium (Sambrook et al. 
1989) to crowns. The four treatments allowed the 
comparison of PA147-2 treatment to a current" 
chemical control, and to asparagus that has no 
"added protection"; In addition, any unexpected ef-
fect of the bacterial growth medium could be as-
sessed. 
Treatment of crowns 
RifR PA147-2 was cultured at 30°C in LB media to 
a viable count of 1 X 108 CFD ml-I (250 rpm 24 h). 
The culture was maintained on ice during transpor-
tation to the field. Asparagus crowns were inoculated 
by submergence in a suspension ofPA147-2 for 25 
Table 2 Chemicals applied to asparagus (Asparagus ojficinalis) field trial 
plot. 
Chemical Amount ap~lied 
Date applied Description (kg ha- ) 
--.~. 
2 Oct 1996 Kamlex Herbicide 2 
II Dec 1996 Malathion Insecticide 2 
13 Dec 19% Linuron Herbicide I 
14 Dec 1996 Crop Master 13 Fertiliser 350 
18 Jan 1997 Malathion Insecticide 2 
2 Feb 1997 Malathion Insecticide 2 
16 Feb 1997 Malathion Insecticide 2 
~.~~--.~.-~~-~-~- ---~--.---. 
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min with gentle agitation. Untreated controls were 
dipped in sterile distilled water (dH20), and LB treat-
ment was carried out by dipping crowns in the me-
dium. Crowns were planted within 30 min of 
treatment. 
Bacterial population study 
Aerobic, RifR bacteria were isolated at 2-week in-
tervals from the rhizosphere and soil surrounding the 
rhizosphere (non-rhizosphere) from both PA147-2 
inoculated and control crowns within guard rows. 
Random soil samples of 1 g each were collected 
from each sample area and placed in 100 ml of ster-
ile dH20 containing 10 g of sterile gravel (7 mm 
coarse chip). Following agitation (250 rpm for 20 
min), serial to-fold dilutions were spread-plated on 
LB agar supplemented with 50 Ilg ml-1 rifampicin 
(Rif) and 100 Ilg ml-I cycloheximide (Cx) arid in-
cubated (30DC for 24 h). Culturable rifampicin re-
sistant (RifR) colony fonning units per gram (cfu g-l) 
were determined for rhizosphere and non-
rhlzosphere samples and the mean deternlined for the 
four samples. 
RirR isolate analysis 
The following procedures used a -80DC stock of the 
L original PA147-2 inoculation culture as a compara-
tive control in all experiments. Colony morphology 
ofRifR isolates was compared using a stereo micro-
scope and cellular morphology was observed by 
Gram staining. Bioassays against P. megasperma 
var. sojae were carried out on phosphate buffered 
potato dextrose agar (PBPDA) as outlined by 
Carruthers et al. (1994). Fluorescent siderophore 
production was determined by incubation (30°C for 
72 h) of isolates on Pseudomonas Minimal Media 
(PMM) (Kirner et al. 1996) followed by viewing 
under UV illumination (260 nm). Antibiotic resist-
ance of isolates was detennined by replica-plating 
onto LB agar supplemented with either rifampicin 
(Rif, 50 Ilg/ml), ampicillin (Ap, 100 Ilg/ml), kan-
amycin (Km, 50 Ilg/ml), gentamicin (Gm, 15 Ilg/ml) , 
naladixic acid (Nal, 30 Ilg/ml), streptomycin (Strep, 
50 Ilg/ml), or tetracycline (Tc, 151lg/ml) and follow-
ing incubation for 24-72 hat 30DC, bacterial growth 
was assessed. Analytical Profile Index (API) 20 NE 
\ strip analysis was pelformed according to the manu-
facturer's protocol. 
Southern hybridisation 
c Southern hybridisation was performed on PA147-2 
isolated from treated crowns to indicate the previ-
ously identified antifungal region (Carruthers et al. 
99 
1994) was present, thus supporting the identification 
as PA147-2. Extraction and preliminary purification 
of plasmid DNA (pFC900B) for use as a probe was 
carried out using the alkaline lysis technique 
(Birnboim & Dolly 1979) and the GENECLEAWR) 
III kit (BIO 101, Inc.) was used according to manu-
facturer's recommendations for final purification 
before labeling. Genomic DNA from isolates, and 
PA147-2 were prepared using a method derived from 
Scott et al. (1981). Restriction endonuclease diges-
tion using EcoRI (Boehringer) of the respective 
genomic DNA was canied out according to enzyme 
manufacturer's recommendations. Separation of di-
gested fragments was performed using agarose gel 
electrophoresis (1 % agarose) and Southern transfer 
of DNA fragments to Hybond N+ membrane 
(Amersham) was carried out using the Pharmacia 
LKB VacuGene XL vacuum blotting system 
(Pharmacia). Probe labeling of pFC900B, hybridi-
sation, and signal detection of membranes was done 
using the non-radioactive enhanced chemilumines-
cence (ECUM) kit (Amersham). 
Harvest statistical analysis 
After harvest, individual plants were visually graded 
on percentage of diseased foliage using a scale of 1-
5 (1 = 0%,2 = 1-20%,3 21-40%,4 = 41-80%,5 
= 81-100%) and analysed by fitting an ordinal 10-
gistic modeL Fern dry weights for each treatment 
were analysed for significant differences using a one-
sided test. 
RESULTS 
Disease severity 
Phytophthora megasperma var. sojae disease symp-
toms were observed on asparagus plants at harvest 
(Fig. 2), indicating that Phytophthora was well es-
tablished. Symptoms ranged from reduced fern vig-
our with slight browning of fem tips, to stunted 
growth and wilting with browning over mos t of the 
plant. When visual disease severity data was ana-
lysed using an ordinal logistic model it was found 
that there was no significant heterogeneity, so treat-
ment effects were tested against theoretical multi-
nomial values. Fitted model coefficient for Ridomil® 
250EC, PAI47-2, and LB were-1.l,-0.9, and-0.2 
respectively. The standard error of these coefficients 
was 0.30. Fern dry weights are shown in Table 3. 
Visual observation of the trial plants indicated that 
treatment of asparagus croWDs with Ridomil® 250EC 
provided a high degree of protection against 
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Phytophthora rot. In contrast, the untreated and LB 
treated controls were severely affected by 
Phytophthora rot, with all plants showing some de-
gree of disease. The plants treated with PA147-2 
showed signs of disease, although the symptoms 
were significantly less severe than those displayed 
by the untreated plants. 
Effect ofPA147-2 on disease severity 
PA147-2 improved dry weights offem by almost 
60% (significant at 5% level using a one-sided test), 
but Ridomil® 250EC improved dry weights by much 
more, averaging 173% more than untreated plants. 
Bacterial population study 
Untreated crowns 
Comparison ofRifR isolates from untreated crowns 
revealed four morphologically-dissimilar colony 
groups which API 20 NE strip analysis revealed to 
be three P.jluorescens strains (0147475, 0147755, 
and 0147775) and one P. aureofaciens strain 
(0147577). Bioassay revealed one of the three P. 
jluorescens strains (API 20 NE profile 0147755) to 
have antifungal activity toward P. megasperma var. 
sojae. 
PA147-2 treated crowns 
Culturable RifR CFU g-I of bacteria isolated from 
PA147-2 inoculated crowns are presented as a loga-
rithmic linear graph with comparison to RifR CFU 
g--I isolated from control crowns (Fig. 1). 
Comparison of all RifR bacterial isolates from 
PA147-2 inoculated crowns indicated six morpho-
logically-distinguishable colony types of which a 
single representative of each was purified onto PMM 
and labelled as PA147-2 crown isolate (PACI) A~ 
F. When P ACI isolates A~F were bioassayed against 
P. megasperma val'. sojae, all demonstrated antifun-
gal activity comparable to PA147-2 after 7 days. 
Table 3 Summary of asparagus (Asparagus officillalis) 
fem dry weights used in statistical analysis. (LB = Luria 
Bertani medium; PA 147-2 Pseudomonas allreojaciells 
PAI47-2.) 
-~--------.-~----
Treatment 
Untreated 
Ridomil® 250EC 
PA147-2 
LB 
LSD (5%), 7 dJ. 
Weight (g) 
160 
437 
252 
186 
109 
'7 
bI) 
't 
1.0E+06 
1.0E+05 
LOE+04 
1.0E+03 
I.OE+02 
1.0E+01 ~ 
1.0E+00 ' 
I 
a 
:r 
b 
F-Rhl~'-J i-8-Non 
I .. NiltIlral 
1 3 5 7 9 11 13 15 17 19 21 
Weeks 
Fig. 1 Rifampicin-resistant bacteria isolated during the 
field trial. (Rhiz. = bacteria isolated from the rhizosphere 
of inoculated plants; non bacteria isolated from soil sur-
rounding the roots of inoculated plants; natural line shows 
the rifampicin-resistant bacteria isolated from control 
plants that were nnt innculated with PA 147-2.) Data pre-
sented are the mean frnm fnur samples (a = LSD (5%) fnr • 
cnmparing rhiz. with nnn-rhiz. pDsitions at any DfWeeks 
I-II (d.f. =18);b LSD (5%) fDr cDmparing rhiz. mean 
with zero, for Weeks 13~21 (d, f. = 15). 
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Condition category 
Fig. 2 Disease severity visually Dbserved from aspara- . 
gus (Asparagus officillalis) plants growing in diseased .' 
plot. Individual plants were visually graded nn Dverall 
plant cnnditiDn Dn a scale of 1~5 to. indicate percentage of 
fnliage effected by disease (I 0%,2= 1-20%,3 = 21~ 
40%, 4 = 41-80%, and 5 = 81-\ 00%). (Rid. = RidomilQ<'; , 
LB Luria Bertani medium; 147-2 "" Pseudomonas 
aureojaciens PA 147-2.) 
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PACI isolates A-F exhibited siderophore production 
on PMM agar after 5 days with equal fluorescence 
intensities to PAI47-2. LB agar supplemented with 
the respective antibiotic revealed that all P ACI iso-
lates A-F had resistance to Rif and Ap but were 
sensitive toKm, Gm, Nal, Strep, and Tc, likePAl47-
2. Gram stain preparation of PAC I isolates A-F re-
vealed Gram-negative rods, identical in size and 
cellular morphology to PA147-2. Biotypes obtained 
using API 20 NE were identical for PACI isolates 
A-F and PA147-2 (0147577). 0147577 is 83% con-
finnation ofa "very good identification to the ge-
nus P. aureofaciens" (1996 API Software Database). 
Southern hybridisation analysis using the ECLTM kit 
(Amersham) indicated hybridisation of the 16kb 
antifungal region contained in pFC900B to PACI 
isolates A-F and PA147-2 within an identically-
sized EcoRI DNA fragment, supporting the identi-
fication of the PAC I isolates as PA147-2 (data not 
shown). . 
DISCUSSION 
The field trial presented in this study was carried out 
to see whether inhibition ofPhytophthora rot of as-
. paragus by PA147-2 observed in glasshouse trials 
. (Carruthers et al. 1995) could also be demonstrated 
under field conditions, and focused on preliminary 
findings of the field application of PA147-2 as a 
biocontrol agent against P. megasperma val'. sojae. 
Fern dry weight was used as a measure of plant 
vigor because fern yigor, of asparagus plants in the 
first 3 years of planting is proportional to the yield 
of spears obtainable over future years (Scheer & 
Ellison 1960). The percentage increase in total fern 
dry weight obtained from plants treated with 
Ridomil® 250EC and PA147-2 was calculated in 
comparison to the fern dry weight obtained from 
untreated plants. Dry weight increases relative to the 
untreated control were considered to have arisen 
from disease suppression provided by the respective 
treatment. Treatment with Ridomil@ 250EC and 
PA147-2 resulted in dry weight increases of 173 and 
55.8% respectively, Although Ridomil® 250EC 
shows considerably greater protection than P A 147-
, 2, the bacterial treatment is still significantly better 
than the untreated control (5% LSD). It is interest-
ing to note that treatment with LB resulted in a 
slightly greater fern weight than the untreated plants. 
(c We speculate that the LB may have stimulated 
growth of indigenous bacteria on the crowns, result-
ing in either greater competitive exclusion of the 
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pathogen, or production of antifungal metabolites by 
the resident microbes. This effect would be short 
lived because the LB concentration would reduce 
quickly after planting and watering. 
One of the plots treated with Ridomil(H) 250EC 
only provided 21 % of its expected dry weight of fern, 
after adjusting for systematic local variation (which 
comprised block effects and a 30% reduction of fern 
dry weight in plots along one edge of the trial near 
some shelter trees), so data from this plot were ex-
cluded from statistical analysis of fern dry weights. 
During the field trial, monitoring of PA147-2 
survival was achieved by periodic re-isolation. Based 
on differences in colony morphology, initial doubt 
was raised as to whether all Rif'R bacteria isolated 
from crowns inoculated with P A 147-2 were the same 
P. aureofaciens PA147-2 strain used for inoculation. 
Subsequent phenotypic analysis indicated that those 
RifR isolates chosen for analysis were identical to 
PA147-2 and Southern hybridisation indicated ge-
netic similarity to a 16kb genomic region within 
PA147-2 believed to be responsible for antifungal 
activity (Carruthers et a1. 1994). The result of the 
Southern hybridisation supports the identification of 
the PACI isolates as PAI47-2, and that the PACI 
isolates still inhibit the in vitro growth of P. 
megasperma suggests that the bacteria were prob-
ably active in biocontrol in the rhizosphere. Al-
though not all RifR bacteria isolated from crowns 
inoculated with PA147-2 were subjected to South-
ern hybridisation, the number of RifR bacteria iso-
lated from crowns inoculated with PA147-2 far 
exceeded natural background levels of RifR bacte-
ria therefore suggesting RifR bacteria isolated were 
an accurate estimation ofPA 147-2 survival (Fig. I). 
Results of this field study have indicated that the 
direct inoculation of asparagus crowns with P A 147-
2 before planting resulted in a 55.8% increase in fem 
yield compared to the untreated control. Because 
disease control is essential during wet field condi-
tions when Phytophthora zoospore production and 
dispersal is maximal (Falloon et a1. 1985), the results 
ofthe bacterial population study suggest that P Al4 7-
2 survival was sufficient during the trial to enable 
fungal inhibition by either: (1) the production of a 
sufficient quantity of antifungal compounds result-
ing in inhibition of P. megasperma var. sojae estab-
lishment; or (2) the inhibition of the pathogen by the 
introduction of microbial competition because of the 
establishment of PA 147-2 in the rhizosphere. Spe-
cific experiments could be designed to examine 
which of the above mechanisms is responsible for 
disease suppression, or whether suppression results 
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from the combined action of antibiotic production 
and microbial competition. 
The observation that asparagus plants inoculated 
with PA147-2 showed a 55.8% increase in fern dry 
weight compared to untreated plants indicated the 
potential ofPA147-2 as a biocontrol agent. However 
the fungicide Ridomil<Rl 250EC, provided a 173% 
increase and therefore re-emphasises that biological 
control of Phytophthora rot of asparagus with P. 
aureofaciens still needs extensive investigation be-
fore becoming a viable option that provides compa-
rable protection to that given presently by chemical 
pesticides. As a result of the increasing demand 
being generated in the area of organic fanning (Figiel 
1994), PA147-2 application may provide an alter-
native non-chemical option resulting in an increase 
in crop yields. Application 9fPA147-2 at the time 
of planting will provide protection to the plants as 
they become established, but the bacterial popula-
tion study suggests that the bacterial numbers will 
be very low by the time of harvest which is impor-
tant when considering the issue of human consump-
tion. In addition, the use of an integrated strategy of 
pest management in which PA147-2 is used in com-
bination with a chemical fungicide may allow a re-
duction in the amount of chemicals applied to crops. 
Although such an approach would not eliminate the 
use of chemicals, the reduced need for them could 
have both economic and environmental benefits. 
Future trials would be useful for three reasons. First, 
further investigations involving larger trials will 
enable a more extensive analysis of the ability of 
PA147-2 to inhibit Phytophthora rot of asparagus. 
Second, it would be useful to isolate the biocontrol 
agent from experimental plants (rather than guard 
row plants as in this study), to assess the effects of 
any interactions between the bacterium and the 
pathogen. Finally, long-tenn studies would allow an 
assessment of whether biological control of disease 
in the early life of asparagus leads to an increased 
crop yield when the plants begin to produce 
harvest able spears. 
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The importance of recA mutant strains for the 
study of antifungal genes in Pseudomonas 
aureofaciens PA147 .. 2 
Mark W. Silby and H. Khris Mahanty 
Abstract: Pseudomonas aureofaciens PA147·2 shows antifungal activity toward a variety of plant pathogenic fungi. We 
have been investigating the molecular mechanisms underlying the fungal inhibition, and during these studies it was ob-
served that the use of pLAFR3-based cosmids for in trans complementation of mutants lacking antifungal activity is 
hindered by cosmid instability. It was hypothesised that the cosmid stability could be improved by inactivation of recA. 
The recA gene of PA147-2 was cloned and shown to complement recA mutants of E. coli, restoring RecA-dependent 
functions when expressed in trans. Two recA mutants of PA147-2 were constructed. Both of these mutants show sensi-
tivity to DNA damage. Cosmid pPS2122 restores antifungal activity to a mutant by allele exchange, but is unstable in 
trans. The stability of pPS2122 is shown to be improved in a recA mutant of PA147-2 with respect to the wild type. 
Key words: antifungal, complementation, recA, Pseudomonas aureofaciens PA147-2. 
Resume: Le Pseudomonas aureofaciens PA147-2 possede une activite antifongique contre une variete de champignons 
phytopathogenes. Nous nous sommes interesses aux mecanismes mo16culaires de cette inhibition fongique et avons 
constate que l'instabilite des cosmides entravait l'utilisation des cosmides bases sur pLAFR-3 pour la complementation 
in trans de mutants depourvus d' activite antifongique. Nous avons emis I'hypothese que la stabilite des cosmides pou-
vait etre augmentee par I'inactivation de recA. Le gene recA du PA147-2 a ete clone et il s'est avere capable de com-
p16menter des mutants recA d' Escherichia coli, retablissant les fonctions dependantes de RecA lorsqu' il est exprime in 
trans. Deux mutants recA du PA147-2 ont ete construits et les deux etaient sensibles 11 voir leur ADN endommage. Le 
cosmide pPS2122 a pu retablir l'activite antifongique chez un mutant par echange d'alleles mais il etait instable in 
trans. Dans un mutant recA du PA147-2, '!a stabilite du pPS2122 etait meilleure que chez Ie type sauvage. 
Mots dis : antifongique, complementation, recA, Pseudomonas aureofaciens PAI47·2. 
[Traduit par la Redaction] 
Introduction 
Pseudomonas aureofaciens PA147·2 is a soil bacterium 
that has potential as a biological control agent against fungal 
diseases in agriculture. PA147-2 inhibits growth of the 
phytopathogenic fungi Phytophthora megasperma var. sojae 
and Rhizoctonia solani in in vitro studies, and has also been 
shown to suppress Phytophthora rot of asparagus in glass-
house trials (Carruthers et al. 1995). We are investigating the 
molecular basis for the antifungal phenotype of PAI47-2; 
however in our laboratory the frequent loss of pLAFR3-
based cosmids from PA147-2 and its mutant derivatives has 
been observed, hindering the trans complementation of mu· 
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tants (Carruthers et al. 1994). Our interest in the recA sys-
tem of P. aureofaciens PA147-2 is two-fold. Firstly, since 
the loss of cosmids had often been accompanied by allele 
exchange between the cosmid and the genome, we were in· 
terested to examine any possible role of RecA in this pheno-
type. Secondly, construction of recA mutants might facilitate 
further genetic analysis of PA147-2 and its derivatives by 
stable in trans complementation experiments. 
The recombination-deficient phenotype involving recA in 
Escherichia coli was first discovered during Hfr mating ex-
periments, when it was noted that a recipient strain inherited 
nutritional markers at a lower-than-expected frequency 
(Clark and Margulies 1965). The defect was shown to be in 
homologous recombination between the incoming DNA and 
the recipient genome. RecA is now known to be a multi-
functional protein in E. coli, with well-characterised roles in 
homologous recombination (Kowalczykowski et al. 1994), 
recombinational DNA repair, and induction of the SOS 
regulon (Miller and Kokjohn 1990). In the first two of these 
processes, RecA promotes homologous pairing and strand 
exchange, while in the SOS response RecA acts as a co· 
protease in the cleavage of the LexA repressor of the SOS 
regulon. RecA also appears to function in homologous re-
combination and DNA repair in Pseudomonas fluorescens 
(De Mot et al. 1993), P. putida (Luo et al. 1993), and 
© 2000 NRC Canada 
Notes 
Table 1. Bacterial strains, plasmids, and phages used in this study. 
Bacterial strains, 
plasmids, and phages Genotype or description 
745 
Reference or source 
E. coli 
DE880 /:,,(lac-argF)U169 relA] thi-] cps-3 suIA::Mu d (lac Ap)XCam (Mu+) (Ennis et al. 1989) 
srIC300::TnlO . 
DE1491 /:"(lac-argF)U169 relAl thi-l cps-3 malF55::Tn5 sulA::Mu d (lac Ap)XCam (Ennis et al. 1989) 
(Mu+) /:"(recA-srlR)301::TnlO 
DHS<x 
MC4100 
S17·1 
W3110 
MT2 
supE44 MacU169(4iacZ/:,.M15) hsdR17 thi-l relAl recAl endA] gyrA96 
araDI39 /:"(lacIPOZYA-grgF)U169 rpsL Ihi recA56 supO 
(Hanahan 1983) 
(Gilson et al. 1987) 
(Simon et a!. 1983) 
(Kohara et al. 1987) 
(Toman et a!. 1985) 
recA294::Tn7 Ira+ (contains chromosomally integrated RP4 derivative) 
Wild-type K12 
ilv his rpsL recAl (N7N53cI+) 
RfR inhibitor of fungal growth 
recA::miniTnlO derivative of PA147-2 
recA::miniTnlO derivative of PA147-2 
(Carruthers et a!. 1994) 
This study 
This study 
P. aureofaciens 
PA147-2 
PA147-2recAl 
PA147-2recA4 
Plasmids 
pBLUESCRIPT KS-
pRECI 
pME6001 
Cosmid containing recA gene of PA147-2 
GmR cloning vector 
Stratagene 
This study 
Stephen Heeb 
This study 
This study 
This study 
This study 
Lab collection 
pREC6g 
pREC6M3 
pPRAMI 
pPRAM4 
6kb EcoRllHindIII recA+ clone in pME6001 
MiniTnlO recA- mutant of pREC6g 
MiniTnlO recA- mutant of pRECI 
MiniTnlO recA- mutant of pRECI 
pPS2122 Cosmid from PAI47-21ibrary. Complements antifungal minus mutant PA138 
by allele exchange 
Phages 
ANK1316 Lambda delivery vehicle for rniniTnlO derivative 103 (Kleckner et al. 1991) 
et al. 1984) 
P. aeruginosa (Sano and Kageyama 1987). In addition to the 
functions above, RecA has been shown to be involved in the 
secretion of an extracellular nuclease by Serratia marcescens 
(Ball et a1. 1990), and in the regulation of colicin E1 expres-
sion in E. coli (Salles et a1. 1987). Construction of recA mu-
tant strains of P. syringae (Willis et a1. 1988) and P. putida 
(Luo et a1. 1993) resulted in strains that were useful in trans 
complementation studies. 
Here we present a preliminary investigation into the recA 
homolog of PAI47-2. We show 0) recA-dependent functions 
in E. coli can be complemented by arecA + clone from 
PA147-2, (Ii) the construction of recA mutants of PA147-2, 
and (iii) the demonstration of increased cos mid stability in 
recA deficient P. aureofaciens PAI47-2. 
Bacterial strains, plasmids, and bacteriophages 
Bacterial strains, plasmids, and bacteriophages used in 
this study are listed in Table 1. All bacterial cultures were 
grown in Luria Bertani (LB) medium (Miller 1972) which 
was solidified with 1.5% bacteriological agar (Gibco BRL) 
when required. Antibiotics were included in the growth me-
dium at the following concentrations: ampicillin (Ap) 
100 Ilg/mL; kanamycin (Km) 50 j.lg/mL; rifampicin (Rf) 
50 Ilg/mL; tetracycline (Tc) 15 j.lg/mL; gentamicin (Gm) 
15 Ilg/mL. Methyl methanesulphonate (MMS) was used at 
200 Ilg/mL and mitomycin C (Sigma) was used at 
0.5 j.lg/mL. Escherichia coli strains were grown at 37·C and 
P. aureofaciens at 30·C. 
Isolation and subcloning of MMS resistance-encoding 
cosmids 
The ability to provide recA defective E. coli strains with 
resistance to the DNA-damaging agent MMS has previously 
been associated with complementation by recA+ clones 
(Better and Helinski 1983). The genomic library of PA147-2 
(stored in E. coli DH5a) was plated on LB plates supple-
mented with tetracycline and MMS, Six colonies grew after 
overnight incubation, and these were. all shown to contain 
identical cosmids (data not shown). One of the cosmids 
(pRECl) was used to transform a recA mutant of E. coli 
MC4100 to MMS resistance, thus confirming the ability to 
confer MMS resistance. A 6kb EcoRIlHindIII fragment that 
encodes MMS resistance was cloned into the vector 
pME6001, creating pREC6g(recA+). A recA mutant of 
pREC6g(recA+), called pREC6M3(recA), was created by 
insertional mutagenesis with I).1iniTnlO, as previously de-
scribed (Kleckner et a1. 1991). 
Induction of the SOS response in Escherwhia coli 
RecA plays a critical role in the SOS response in E. coli, 
acting as a catalyst in cleavage of the LexA protein and thus 
derepressing the SOS regulon. Expression of sulA is induced 
in E. coli by the SOS response, and SulA arrests cell divi-
sion through interaction with FtsZ (Bi and Lutkenhaus 
1993). We tested the ability of the PA147-2 recA to induce 
SOS induction by measuring expression of the sulA gene in 
E. coli strains DE1491(recA) and DE880(recA+). DE1491 
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Fig.!. Induction of the SOS response in E. coli DE1491(recA) 
and DE880(recA+), The p-galactosidase level from DE1491 with 
each of the plasmids shown was measured, with and without 
mitomycin C (MC) added to the cultures. The recA+ strain 
DE880 was induded as a controL Both E, coli DE1491 and 
DE880 have a sulA::lacZ fusion, so p-galactosidase levels reflect 
the level of SuIA, which is induced in the SOS response, 
lOOOO,--------------------r------~ 
DE880 DE1491 DE1491 DE1491 
(pME600l) (pREC6g) (pREC6M3) 
Strain 
and DE880 have a Mudlac insertion into sulA, creating an 
in-frame sulA::lacZ fusion. The expression of sulA can 
therefore be inferred by measuring the f)-galactosidase level 
according to the method of Miller (1972). When 
pREC6g(recA+) was present in DE1491, an increase in sulA 
expression was observed, relative to DE1491 with either 
pME6001 or pREC6M3(recA). The expression of sulA was 
further increased when the SOS response was induced by 
exposure to the DNA-damaging agent mitomycin C for 
60 min prior to the ~-galactosidase assay, In contrast to 
these observations, the presence of either pME600l or 
pREC6M3(recA) in DE1491 had no impact on su/A expres-
sion with or without addition of mitomycin C (Fig. 1). When 
E. coli DE880, an otherwise isogenic recA + strain of 
DE1491, was assayed under the above conditions, the level 
of ~-galactosidase produced after mitomycin C exposure was 
comparable to that from DE1491(pREC6g(recA+» (Fig. 1). 
Resistance to DNA damage induced by UV and MMS 
Escherichia coli strains DH5a and MC4100 are sensitive 
to exposure to UV and MMS, due to DNA damage. Resis-
tance toUV and MMS was assessed qualitatively by the 
ability of bacterial strains to survive treatment with these 
DNA damaging agents. When pREC6g(recA+) was present 
in trans, both strains showed an increased resistance to UV 
and MMS. However, this increase in resistance was not de-
tected when pREC6g(recA+) was replaced with either 
pME6001 or pREC6M3(recA), indicating a role for the 
PA147-2 recA gene in the provision of UV and MMS resis-
tance, presumably by the restoration of RecA-dependent 
DNA-damage repair systems. Pseudomonas aureofaciens 
PA147-2 recA mutants (described below) showed increased 
sensitivity to both UV and MMS, and resistance was 're-
stored by in trans complemeritation with pREC6g(recA+), 
but not with pME6000(vector) or pREC6M3(recA::Tn10) 
(data not shown). 
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Table 2. Promotion of homologous recombination. 
Strain 
MT2 (pREC6g) 
MT2 (pREC6M3) 
MT2 
Inheritance of hisa 
3.7 x 
<2,6 x 10-1 
<1.8 X 10-1 
Inheritance of ilva 
9.5 x 
<2,6 x 10-7 
<1.8 X 10-7 
Note: Homologous recombination is inferred from the frequency of 
inheritance. 
"Inheritance is expressed as the number of cells inheriting the particular 
allele out of the total population. 
Promotion of homologous recombination by 
pREC6g(recA +) 
The ability of the MMS resistance-encoding clone 
pREC6g(recA+) to promote homologous recombination was 
tested by PI transduction of functional amino acid bio-
synthetic his and ilv alleles to a his ilv E, coli mutant (E. coli 
MT2), Plvir stock was grown on E. coli W31l0, and used to 
transduce the auxotrophic E. coli strains by the method of 
Miller (1972). Inheritance of the nutritional marker was used 
to indicate recombination between the transduced DNA and 
the genome of the recipient. Strains (E. coli MT2) contain-
ing pREC6g(recA+) showed inheritance of transduced mark-
ers whereas transductants of the control strains bearing 
either pME6001 or pREC6M3(recA) were not detected (Ta-
ble 2). No spontaneous revertants of MT2 to either His+ or 
Ilv+ were detected. 
Our primary motivation for this study was to investigate 
the possibility that disruption of recA in PA147-2 might alle-
viate the problem of recombination during complementation 
experiments. Since genetic systems are not well developed 
in P. aureofaciens, we used an E. coli system to test homolo-
gous recombination frequency. Our data show that the wild-
type recA clone of PA147-2 (pREC6g(recA+» can promote 
homologous recombination in E. coli, and an insertional mu-
tant (pREC6M3(recA» was unable to promote this RecA-
dependent function. 
Introduction of recA mutations to the chromosome of 
PA147·2 
The cosmid pRECI, which carries recA+ derived from 
PA147-2, was subjected to insertional mutagenesis with 
miniTn10 (Kleckner, et al. 1991). Insertions in recA were 
identified by assaying for a loss of MMS resistance when 
the mutated cosmid was in an E. coli DH5a background. 
Two independent mutants were recovered and designated 
pPRAM1 and pPRAM4. These plasmids were transferred to 
PA147-2 by conjugation, and the mutated recA alleles were 
introduced to the genome of PA147-2 by homologous re-
combination. This resulted in the strains PA147-2recAl and 
PA147-2recA4, both of which exhibit a loss of resistance to 
UV irradiation and MMS exposure. Recombination was in-
dicated by the loss of the vector marker (Tc resistance) and 
the inheritance of MMS sensitivity and Km resistance (from 
the recA::miniTn10), and was subsequently confirmed by 
Southern analysis (data not shown). The two mutant cosmids 
pPRAM1 and pPRAM4 were confirmed as having different 
insertion points by DNA sequencing using a primer designed 
to anneal to the IS10 of the miniTnlO element (the IS10 
primer sequence is 5'-GGGATCATATGACAAGATGT-3,). In 
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Notes 
Fig. 2. Stability of cosmid pPS2122 in PA147-2, and PA147-
2recAl. The proportion with the cosmid was determined by di-
viding the tetracycline (Tc)-resistant cfu'mL-l by the total 
cfu,mL -I at each given time point. Tc resistance is conferred by 
the cosmid, and hence Tc-sensitive colonies arise from cells that 
have lost the cosmid, Data presented are the average of three In-
dependent experiments and are shown with the standard error, 
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addition to demonstrating the different mutant insertion 
points, the DNA sequence data showed greater than 90% 
similarity to recA sequences from other Pseudomonas 
spp. (data not shown). 
Stability of cosmids in PA147·2 and recA deficient 
derivatives 
Since we were interested in creating a system in which 
cosmids could be used to complement antifungal mutants in 
trans, we examined the stability of a cos mid in PA147-2 and 
the recA mutant derivatives PA147-2recA1 and PA147-
2recA4, The cos mid pPS2122 is a pLAFR3cbased cosmid 
thought to contain at least one gene of importance in anti-
fungal activity and has been shown to restore antifungal ac-
tivity to P. aureojaciens PAl38, a Tn5 mutant of PAI47-2, 
by allele exchange (SHby and Mahanty 1999a). However, at-
tempts at complementation in trans revealed that pPS2122 
was unstable in PA138 if selection for the cosmid was not 
maintained, Cosmid pPS2122 was introduced to PAI47-2, 
PAl47-2recAl, and PA147-2recA4 by conjugation, and 
maintenance of pPS2122 was tested by growing trans-
conjugants in 10 mL LB cultures without selection for the 
cosmid. Samples of the culture were taken periodically, seri-
ally diluted, and plated on LB agar supplemented with Rf 
and LB agar plus Rf and Tc. Total colony forming unit 
counts on Rf selection reflect the total number of culturable 
celIs, whereas only those maintaining the cosmid could grow 
in the presence of Tc. Our results indicate that pPS2122 was 
considerably more stable in PA147-2recAI than in the 
wildtype (Fig. 2), whereas there was little difference in sta-
bility between PA147-2recA4 and PAI47-2. 
We have shown that the stability of a pLAFR3-based 
cosmid is increased in PA147-2recAl, but is not signifi-
cantly improved in PA147-2recA4. This is an interesting 
finding given that very few studies on recA have reported 
similar effects on plasmid stability. An analysis of the 
archaeI recA analog, radA, indicates that radA is involved in 
the maintenance or replication of some halobacterial 
plasmids in Haloferax volcanii (Woods and Dyall-Smith 
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1997), while a recent report suggests that plasmid stability 
can be reduced in recA mutants of E. coli (Debbia 1992). 
These studies demonstrate reduced maintenance of plasmids 
in recAlradA mutants, In contrast, the cosmid pPS2122 
shows increased stability in PA 147-2recA 1 , but not in 
PA147-2recA4. The transposon insertion points in these mu-
tants have been mapped to near the middle of recA (PA147-
2recAl) and toward the 3' end (PA147·2recAl). These data 
suggest that RecA is involved in the instability of pPS2122 
in PA147-2, and that the insertion in PA147-2recA4 reduces 
this effect. It is possible that the domain of RecA responsi-
ble for the plasmid instability is encoded upstream of the in-
sertion in PA147-2recA4, and thus it is still expressed in the 
mutant. In this case it is tempting to suggest that the role of 
RecA in plasmid instability is genetically separable from its 
role in DNA repair since both recA strains show increased 
sensitivity to DNA-damaging agents, but only one has a 
change in plasmid stability. In PA147-2recAl, the insertion 
point is near the middle of the gene, which appears to be 
sufficient to abolish the instability phenotype associated 
with pPS2l22 in PA147-2. One possible role for RecA in 
cbs mid stability is cosmid loss during homologous recombi-
nation between the cosmid clone and the host genome. How-
ever, similar experiments using the cosmid vector pLAFR3 
with no PA147·2 genomic insert give similar results to those 
described here, making the recombination hypothesis un-
likely (SHby and Mahanty 1999b). It is possible that recom· 
bination between pLAFR3 molecules or fomlation of 
multimers could lead to the instability, but this has yet to be 
tested. Further mutagenesis may uncover the important re-
gion in RecA that leads to the observed phenotype, and a 
complete DNA sequence of recA will aid in the analysis of 
the mutants. Regardless of the molecular basis for the obser-
vation, the increased stability ofpPS2122 in PAI47-2recAl· 
strongly suggests that the creation of recA strains will be im-
portant in in trans complementation analysis of antifungal 
minus mutants of PA147-2. Further studies will test the sta-
bility of additional cosmids, and the necessity to develop a 
simple system for the creation of unmarked recA mutants in 
PA147-2 and its Tn5 mutant derivatives. 
In summary, we have shown the isolation and functional 
analysis of recA from Pseudomonas aureojaciens PA147-2, 
and the creation of recA mutants of PA147-2. The PA147-2 
recA can restore RecA·dependent phenotypes in E. coli recA 
strains, and recA mutants of PA147-2 show increased sensi-
tivity to MMS and UV compared to the wild type. With re-
gard to our original aim of improving complementation in 
PA147-2 and mutants lacking antifungal activity, we have 
shown that (I) cosmids are more stable in recA mutants of 
PA147-2 than the wildtype, and (ii) a mutant recA allele 
from PA147-2 cannot promote homologous recombination in 
E. coli. The combination of these two effects will help in the 
analysis of antifungal genes by complementation in recA-de· 
fective strains of PA147-2 and antifungal minus mutant de-
rivatives. 
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